<SEC-DOCUMENT>0000912282-15-000245.txt : 20150717
<SEC-HEADER>0000912282-15-000245.hdr.sgml : 20150717
<ACCEPTANCE-DATETIME>20150716175737
ACCESSION NUMBER:		0000912282-15-000245
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20150717
DATE AS OF CHANGE:		20150716
EFFECTIVENESS DATE:		20150717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-205708
		FILM NUMBER:		15992269

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>oncolyticss8_071515.htm
<TEXT>
<html>
<head>
    <title>oncolyticss8_071515.htm</title>
    <!--Licensed to: sand-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">
<div style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: right; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="TEXT-ALIGN: center">
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>

<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">As filed with the Securities and Exchange Commission on July 16, 2015</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Registration Statement No. 333-&#9679;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">UNITED STATES</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">SECURITIES AND EXCHANGE COMMISSION</font></font></div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; DISPLAY: inline">Washington, D.C. 20549</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="100%" style="BORDER-TOP: black 2px solid; BORDER-RIGHT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; BORDER-LEFT: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="FONT-SIZE: 12pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">FORM S-8</font> </font>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font></font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><img src="oncolytics_logo.jpg" alt=""></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">ONCOLYTICS BIOTECH INC.</font></div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center">
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>

<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(Exact name of registrant as specified in its charter)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="24%" style="BORDER-BOTTOM: black 2px solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Alberta, Canada</font></div>
</td>
<td valign="middle" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
<td valign="middle" width="24%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
<td valign="middle" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
<td valign="middle" width="24%" style="BORDER-BOTTOM: black 2px solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Not Applicable</font></div>
</td>
</tr><tr>
<td valign="top" width="24%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(State or other jurisdiction of</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">incorporation or organization)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
<td valign="top" width="24%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
<td align="left" valign="bottom" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
<td valign="top" width="24%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Suite 210, 1167 Kensington Crescent NW</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Calgary, Alberta</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Canada T2N 1X7</font></div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center">
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>

<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(Address of principal executive offices)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Amended and Restated Stock Option Plan</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">&#160;&#160;&#160;Incentive Share Award Plan</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center">
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>

<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(Full titles of plan)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Dorsey &amp; Whitney LLP</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">1400 Wewatta Street, Suite 400</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Denver, CO 80202-5549</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center">
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>

<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(Name and address of agent for service)</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">(303) 629-3450</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center">
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(Telephone number, including area code, of agent for service)</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; FONT-STYLE: italic; DISPLAY: inline">Copies to:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Kenneth G. Sam, Esq.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Jason K. Brenkert, Esq.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Dorsey &amp; Whitney LLP</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">1400 Wewatta Street, Suite 400</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Denver, CO 80202-5549</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>

<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.&#160;&#160;See definition of &#8220;Accelerated filer and large accelerated filer&#8221; in Rule 12b-2 of the Exchange Act (Check one):</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Large Accelerated Filer&#160;&#160;<font style="DISPLAY: inline" face="Wingdings">o</font><font style="FONT-SIZE: 10pt; DISPLAY: inline">&#160;&#160;&#160;&#160;&#160;</font>Accelerated Filer&#160;&#160;<font style="DISPLAY: inline" face="Wingdings">x</font><font style="FONT-SIZE: 10pt; DISPLAY: inline">&#160;</font>Non-Accelerated Filer&#160;&#160;<font style="DISPLAY: inline" face="Wingdings">o</font><font style="FONT-SIZE: 10pt; DISPLAY: inline">&#160;&#160;&#160;&#160;&#160;</font>Smaller Reporting Company&#160;&#160;<font style="DISPLAY: inline" face="Wingdings">o</font></font></div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font><br>
&#160;</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">CALCULATION OF REGISTRATION FEE</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="22%" style="BORDER-TOP: #000000 2pt solid; BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2pt solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Title of Each Class of</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Securities to be Registered</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left">&#160;</div>
</td>
<td valign="top" width="13%" style="BORDER-TOP: #000000 2pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Amount to</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">be Registered<font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; DISPLAY: inline">(1)</font></font></div>
</td>
<td valign="top" width="15%" style="BORDER-TOP: #000000 2pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Proposed Maximum<br>
Offering Price Per<br>
Share</font></div>
</td>
<td valign="top" width="16%" style="BORDER-TOP: #000000 2pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Proposed Maximum<br>
Aggregate Offering<br>
Price</font></div>
</td>
<td valign="top" width="13%" style="BORDER-TOP: #000000 2pt solid; BORDER-RIGHT: #000000 2pt solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Amount of<br>
Registration Fee</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="22%" style="BORDER-LEFT: #000000 2pt solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Common Shares reserved for issuance pursuant to the Stock Option Plan and the Incentive Share Award Plan</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td valign="middle" width="13%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">11,412,394</font></div>
</td>
<td valign="middle" width="15%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$0.70<font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; DISPLAY: inline">(2)</font></font></div>
</td>
<td valign="middle" width="16%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$7,988,675.80</font></div>
</td>
<td valign="middle" width="13%" style="BORDER-RIGHT: #000000 2pt solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$928.28</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="22%" style="BORDER-BOTTOM: #000000 2pt solid; BORDER-LEFT: #000000 2pt solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">TOTAL</font></div>
</td>
<td valign="middle" width="13%" style="BORDER-BOTTOM: #000000 2pt solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">11,412,394</font></div>
</td>
<td valign="middle" width="15%" style="BORDER-BOTTOM: #000000 2pt solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$0.70<font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; DISPLAY: inline">(2)</font></font></div>
</td>
<td valign="middle" width="16%" style="BORDER-BOTTOM: #000000 2pt solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$7,988,675.80</font></div>
</td>
<td valign="middle" width="13%" style="BORDER-RIGHT: #000000 2pt solid; BORDER-BOTTOM: #000000 2pt solid">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$928.28</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 45pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(1)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Common Shares, without par value, available for issuance by the Registrant pursuant to the Plans described herein. The Plans draw upon a common pool of Common Shares.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 45pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(2)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Calculated in accordance with Rule 457(c) and Rule 457(h)(1) under the Securities Act based on the average of the high and low prices ($0.72 and $0.67, respectively) for the Company&#8217;s Common Shares on July 15, 2015, as quoted on the NASDAQ Capital Market.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">INTRODUCTORY STATEMENT</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">This registration statement on Form S-8 by Oncolytics Biotech Inc. (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Registrant</font>&#8221;) is filed to: (i) to register additional common shares (&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Common Shares</font>&#8221;)&#160;&#160;pursuant to General Instruction E to Form S-8 which have been reserved under the Oncolytics Biotech Inc. Stock Option Plan as most recently amended pursuant to the approval of the Registrant&#8217;s shareholders on June 8, 2015 (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Stock Option Plan</font>&#8221;); and (ii) to register Common Shares reserved for issuance pursuant to the exercise of awards under the Registrant&#8217;s Incentive Share Award Plan (the &#8220;Incentive Share Award Plan&#8221; together with the Stock Option Plan are collectively referred to herein as, the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Plans</font>&#8221;). The maximum number of shares issuable under the Plans is a fixed amount of 11,412,394 Common Shares. An aggregate 6,154,997 Common Shares reserved for issuance under the Stock Option Plan were previously registered with the United States Securities and Exchange Commission (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Commission</font>&#8221;) on Form S-8 filed with the Commission on January 10, 2011 (File No. 333-171625) (&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Prior Registration Statement</font>&#8221;). With respect to the Stock Option Plan the Registrant incorporates by reference herein the contents of the Prior Registration Statement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">PART I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Item 1. &#160;Plan Information.</font>*</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Item 2. &#160;Registrant Information and Employee Plan Annual Information.</font>*</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">* This information is not required to be included in, and is not incorporated by reference in, this registration statement.</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">&#160;</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">PART II.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Item 3.&#160;&#160;Incorporation of Documents by Reference.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The following documents filed or furnished by the Registrant with the Securities and Exchange Commission (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Commission</font>&#8221;) are hereby incorporated by reference in this registration statement:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the Registrant&#8217;s Annual Report on Form 20-F for the fiscal year ended December 31, 2014 filed with the Commission on March 20, 2015;</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">all other reports of the Registrant filed pursuant to Section 13(a) or 15(d) of the United States Securities Exchange Act of 1934, as amended (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Exchange Act</font>&#8221;), since the end of the fiscal year covered by the Annual Report incorporated by reference herein pursuant to (a) above; and</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the description of the Common Shares contained in the Registrant&#8217;s registration statement on Form F-10 filed with the Commission on June 2, 2010, including any amendment or report for the purpose of updating such description.</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment that indicate that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of filing of such documents.&#160;&#160;Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.&#160;&#160;Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Item 4.&#160;&#160;Description of Securities.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Not Applicable.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Item 5.&#160;&#160;Interests of Named Experts and Counsel.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>None.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Item 6.&#160;&#160;Indemnification of Directors and Officers.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Under the <font style="FONT-STYLE: italic; DISPLAY: inline">Business Corporations Act</font> (Alberta), the Registrant may indemnify a director or officer, a former director or officer, or a person who acts or acted at the Registrant&#8217;s request as a director or officer or a body corporate of which the Registrant is or was a shareholder or creditor, and the director&#8217;s or officer&#8217;s heirs and legal representatives, against all costs, charges and expenses, including an amount paid to settle an action or satisfy a judgment, reasonably incurred by the individual in respect of any civil, criminal or administrative action or proceeding to which the individual is involved because of that association with the Registrant or other entity, and the Registrant may advance moneys to such an individual for the costs, charges and expenses of such a proceeding. The Registrant may not indemnify such an individual unless the individual acted honestly and in good faith with a view to the best interests of the Registrant, or, as the case may be, to the best interests of the other entity for which the individual acted as a director or officer or in a similar capacity at the Registrant&#8217;s request, and, in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty, the individual had reasonable grounds for believing that the individual&#8217;s conduct was lawful. In addition, the individual must repay any moneys advanced by the Registrant if the individual has not fulfilled the conditions set out in the preceding sentence. Such indemnification or advance of moneys may be made in connection with a derivative action only with court approval. Such an individual is entitled to indemnification from the Registrant as a matter of right if the individual was not judged by the court or other competent authority to have committed any fault or omitted to do anything that the individual ought to have done, and the individual fulfilled the conditions set forth above.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In accordance with and subject to the <font style="FONT-STYLE: italic; DISPLAY: inline">Business Corporations Act</font> (Alberta), the by-laws of the Registrant provide that the Registrant shall indemnify a director or officer, a former director or officer, or a person who acts or acted at the Registrant&#8217;s request as a director or officer, or a body corporate of which the Registrant is or was a shareholder or creditor, and the director&#8217;s or officer&#8217;s heirs and legal representatives, against all costs, charges and expenses, including an amount paid to settle an action or satisfy a judgment, reasonably incurred by him in respect of any civil, criminal or administrative action or proceeding to which he is made a party by reason of being or having been a director or officer of the Registrant or other entity if he acted honestly and in good faith with a view to the best interests of the Registrant or, as the case may be, to the best interests of the other entity for which he acted as a director or officer at the Registrant&#8217;s request, and, in the case of a criminal or administrative action or proceeding that is enforced by monetary penalty, he had reasonable grounds for believing that his conduct was lawful. The Registrant shall also indemnify such person in such other circumstances as the <font style="FONT-STYLE: italic; DISPLAY: inline">Business Corporations Act</font> (Alberta) permits or requires.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Registrant maintains a directors&#8217; &amp; officers&#8217; insurance policy for the benefit of the directors and officers of the Registrant and its subsidiaries against liability incurred by them in their official capacities for which they become obligated to pay to the extent permitted by applicable law.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Item 7.&#160;&#160;Exemption from Registration Claimed.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Not Applicable</font></div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Item 8.&#160;&#160;Exhibits.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="3" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; TEXT-DECORATION: underline; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"><font style="DISPLAY: inline">Exhibit No.</font></font></div>
</td>
<td align="left" valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; TEXT-DECORATION: underline; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"><font style="DISPLAY: inline">Exhibit</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Amended and Restated Stock Option Plan, dated December 1, 2010, as amended and incorporated herein by reference to the Registration Statement on Form S-8 filed with the SEC on January 10, 2011 (File No. 333-171625).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.2</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Incentive Share Award Plan</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Opinion of McCarthy T&#233;trault LLP</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">23.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Consent of Ernst &amp; Young LLP</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">23.2</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Consent of McCarthy T&#233;trault LLP (contained in its opinion filed as Exhibit 5.1)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">24.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Powers of Attorney (See page II-8 of this registration statement)</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Item 9.&#160;&#160;Undertakings.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The undersigned Registrant hereby undertakes:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(1)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">To include any prospectus required by Section 10(a)(3) of the Securities Act;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.&#160;&#160;Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represents no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(iii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 36pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-STYLE: italic; DISPLAY: inline">provided, however,</font> that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(2)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="FONT-STYLE: italic; DISPLAY: inline">bona fide </font>offering thereof.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(3)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act, (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="FONT-STYLE: italic; DISPLAY: inline">bona fide </font>offering thereof.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left">
<div style="TEXT-ALIGN: center">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(h)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.&#160;&#160;In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</font></div>
</td>
</tr></table>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">SIGNATURES</font></div>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">The Registrant</font>.&#160;&#160;Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Calgary, Province of Alberta, Canada on this 16th&#160;day of July, 2015.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>ONCOLYTICS BIOTECH INC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font><font id="TAB1" style="MARGIN-LEFT: 216pt"></font><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 216pt" align="justify"><font style="FONT-SIZE: 10pt; TEXT-DECORATION: underline; FONT-FAMILY: times new roman; DISPLAY: inline">/s/ Kirk Look&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 216pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Name: Kirk Look</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 216pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Title:&#160;&#160;&#160;Chief Financial Officer</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">POWERS OF ATTORNEY</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Each person whose signature appears below constitutes and appoints Bradley G. Thompson and Kirk Look, or either one of them, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in such person&#8217;s name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue thereof.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by or on behalf of the following persons in the capacities indicated on July 16, 2015:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; TEXT-DECORATION: underline; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"><font style="DISPLAY: inline">Signature</font></font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; TEXT-DECORATION: underline; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"><font style="DISPLAY: inline">Title</font></font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="78%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/ Bradley G. Thompson&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Bradley G. Thompson</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Executive Chairman, President, and Chief Executive Officer</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(Principal Executive Officer)</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="78%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline">/s/ Kirk Look&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Kirk Look</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;Chief Financial Officer</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(Principal Financial and Accounting Officer)</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="78%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
</tr><tr>
<td valign="middle" width="37%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/ Matt Coffey&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Matt Coffey</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="78%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/ Linda Hohol&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Linda Hohol</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="78%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/ Robert B. Schultz&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Robert B. Schultz</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="78%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/ Angela Holtham&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Angela Holtham</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="78%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/&#160;Wayne Pisano&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Wayne Pisano</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director and Chair</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="78%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/&#160;J. Mark Lievonen&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">J. Mark Lievonen</font></div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="78%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
</tr><tr>
<td valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/ James Dinning&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">James Dinning</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;&#160;<font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/&#160;William G. Rice&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">William G. Rice</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">/s/&#160;Bernd. R. Seiziner&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Bernd. R. Seizinger</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</td>
<td align="left" valign="top" width="10%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160;</font></div>
</td>
<td align="left" valign="top" width="31%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Director</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">AUTHORIZED REPRESENTATIVE</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Pursuant to the requirements of Section 6(a) of the Securities Act of 1933, the undersigned has signed this registration statement, solely in his capacity as the duly authorized representative of Oncolytics Biotech Inc. executed in Alberta, Canada, </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">on&#160;July 16&#160;, 2015.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold">Oncolytics Biotech <font style="FONT-WEIGHT: bold">(US)</font> Inc.</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="5%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></td>
<td width="45%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="TEXT-DECORATION: underline">/s/ Kirk Look<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></font></font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="5%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></td>
<td width="45%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Kirk Look</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="5%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></td>
<td width="45%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chief Financial Officer</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">EXHIBIT INDEX</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="3" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; TEXT-DECORATION: underline; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"><font style="DISPLAY: inline">Exhibit No.</font></font></div>
</td>
<td align="left" valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; TEXT-DECORATION: underline; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"><font style="DISPLAY: inline">Exhibit</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Amended and Restated Stock Option Plan, dated December 1, 2010, as amended and incorporated herein by reference to the Registration Statement on Form S-8 filed with the SEC on January 10, 2011 (File No. 333-171625).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.2</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Incentive Share Award Plan</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Opinion of McCarthy T&#233;trault LLP</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">23.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Consent of Ernst &amp; Young LLP</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">23.2</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Consent of McCarthy T&#233;trault LLP (contained in its opinion filed as Exhibit 5.1)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="14%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">24.1</font></div>
</td>
<td valign="top" width="64%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Powers of Attorney (See page II-8 of this registration statement)</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">II-9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>ex4_2.htm
<DESCRIPTION>INCENTIVE SHARE AWARD PLAN
<TEXT>
<html>
<head>
    <title>ex4_2.htm</title>
    <!--Licensed to: sand-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">EXHIBIT 4.2</font></div>

<div>&#160;</div>

<div><br>
&#160;</div>

<br>
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><a name="Schedule_C___Incentive_Share_Award_Plan"><!--EFPlaceholder--></a><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><img src="oncolyticslogo_shareaward.jpg" alt=""></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font>

<div>
<hr style="COLOR: black" align="left" noshade size="3" width="100%">
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">INCENTIVE SHARE AWARD PLAN</font></font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Board of Directors of Oncolytics Biotech Inc. (&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Oncolytics</font>&#8221;) has adopted this Incentive Share Award Plan (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Plan</font>&#8221;) governing the issuance of: (i) Performance Share Awards (as defined herein) of Oncolytics to Eligible Employees (as defined herein); and (ii) Restricted Share Awards (as defined herein) of Oncolytics to Non-Employee Directors (as defined herein).</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">1.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Purposes</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The principal purposes of the Plan are as follows:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">to retain and attract qualified directors, officers and employees for Oncolytics;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">to promote ownership of common shares of Oncolytics by such directors, officers and employees and to encourage such persons to remain in the employ or service of Oncolytics and put forth maximum efforts for the success of the affairs of Oncolytics; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">to focus management of Oncolytics on operating and financial performance and total long-term shareholder return.</font></div>

<div align="justify"><font size="2">&#160;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">2.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Definitions</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Where used herein, the following terms shall have the following meanings, respectively:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">"<font style="FONT-WEIGHT: bold; DISPLAY: inline">Adjustment Ratio</font>" means, with respect to any Share Award, the ratio used to adjust the number of Common Shares underlying such Share Award and issuable on the applicable Issue Date, subject to and in accordance with the terms of the Plan; and, in respect of each Share Award, the Adjustment Ratio shall initially be equal to one, and shall be cumulatively adjusted on a compounding basis thereafter by increasing the Adjustment Ratio on each Dividend Payment Date, effective on the day following the corresponding Dividend Record Date, by an amount, rounded to the nearest four decimal places, equal to a fraction having as its numerator the Dividend, expressed as an amount per Common Share, paid on that Dividend Payment Date, and having as its denominator the Market Price of the Common Shares on that Dividend Payment Date;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Black-Out Period</font>&#8221; means any period during which the holder of such Share Award is not permitted to trade Common Shares pursuant to the policies of Oncolytics;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Board</font>&#8221; means the board of directors of Oncolytics as constituted from time to time or, if established and duly authorized to act with respect to the Plan, any committee of the board of directors of Oncolytics;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Business Day</font>&#8221; means each day other than a Saturday, Sunday, a statutory holiday in Alberta or any day on which the principal chartered banks located in Calgary, Alberta are not open for business during normal business hours;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Cessation Date</font>&#8221; means, in respect of a Participant, the last day of active employment or service of the Participant with Oncolytics, regardless of the reason for the cessation of employment or service and regardless of whether any or any adequate or proper advance notice of termination or resignation is provided in respect of such cessation of employment or service;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Change of Control</font>&#8221; for the purposes of this Plan means:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">1</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the acceptance by the holders of Common Shares of Oncolytics, representing in the aggregate of more than 40 percent of all issued and voting Common Shares of Oncolytics, of any offer, whether by way of a takeover bid or otherwise, for all or any of the Common Shares of Oncolytics;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the acquisition, by whatever means (including, without limitation, amalgamation, arrangement, consolidation or merger), by a person (or two or more persons who in such acquisition have acted jointly or in concert or intend to exercise jointly or in concert any voting rights attaching to the Common Shares acquired), directly or indirectly, of the beneficial ownership of such number of voting Common Shares or rights to voting Common Shares of Oncolytics, which together with such person&#8217;s then owned voting Common Shares and rights to voting Common Shares, if any, represent (assuming the full exercise of such rights to voting Common Shares) more than 40 percent of the combined voting rights of Oncolytics&#8217; then outstanding voting Common Shares, together with the voting Common Shares that would be outstanding on the full exercise of the rights to voting Common Shares acquired and such person&#8217;s previously own rights to voting Common Shares;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the entering into of any agreement by Oncolytics to merge, consolidate, amalgamate, initiate an arrangement or be absorbed by or into another company;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(d)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the passing of a resolution by the Board or shareholders of Oncolytics to substantially liquidate assets or wind-up its business or significantly rearrange its affairs in one or more transactions or series of transactions or the commencement of proceedings for such a liquidation, winding-up or re-arrangement (except where such re-arrangement is part of a bona fide reorganization of Oncolytics in circumstances where the business of Oncolytics is continued and where the shareholdings remain substantially the same following the re-arrangement as existed prior to the re-arrangement); or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(e)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">individuals who were members of the Board of Oncolytics immediately prior to a meeting of the shareholders of Oncolytics involving a contest for or, an item of business relating to the election of directors shall not constitute a majority of the board of directors following such election;</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Committee</font>&#8221; has the meaning set forth in Section 3 hereof;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Common Shares</font>&#8221; means the Common Shares of Oncolytics;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Dividend</font>&#8221; means a dividend paid by Oncolytics in respect of the Common Shares, whether in cash, Common Shares or other securities or other property, expressed as an amount per Common Share;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Dividend Payment Date</font>&#8221; means any date that a Dividend is paid to Shareholders;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Dividend Record Date</font>&#8221; means the applicable record date in respect of any Dividend used to determine the Shareholders entitled to receive such Dividend;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Eligible Employee</font>&#8221; means any officer or employee of Oncolytics (including, for greater certainty, any subsidiary of Oncolytics);</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Exchange</font>&#8221; means the Toronto Stock Exchange, the Nasdaq Capital Market and such other stock exchange(s) on which the Common Shares are then listed and posted for trading from time to time;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Grant Date</font>&#8221; means the grant date for a Share Award;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Grant Value</font>&#8221; means the dollar amount of a Share Award as determined by the Board in accordance with Section 4 hereof;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Grantee</font>&#8221; means a Participant to whom a Share Award has been granted;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Insider</font>&#8221; has the meaning set forth in the applicable rules of the Exchange for this purpose;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Issue Date</font>&#8221; means the date on which Common Shares are issued to a Grantee in respect of a Share Award following completion of the applicable Vesting Period;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Market Price</font>&#8221; with respect to a Common Share, as at any date means the volume weighted average (rounded to four decimal places) of the prices at which the Common Shares traded on the Toronto Stock Exchange for the five (5) trading day period ending one Business Day prior to such date (or, if the Common Shares are not then listed and posted for trading on the Toronto Stock Exchange or are then listed and posted for trading on more than one Exchange, on such Exchange on which the Common Shares are then listed and posted for trading as may be selected for such purpose by</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div><br>
&#160;</div>

<div>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">2</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the Board acting reasonably and in good faith). In the event that the Common Shares are not listed and posted for trading on any Exchange, the Fair Market Value shall be the fair market value of the Common Shares as determined by the Board in its sole discretion, acting reasonably and in good faith. If initially determined in United States dollars, the Fair Market Value shall be converted into Canadian dollars at an exchange rate selected and calculated in the manner determined by the Board from time to time acting reasonably and in good faith;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Non-Employee Director</font>&#8221; means any director of Oncolytics (including, for greater certainty, any subsidiary of Oncolytics) who is not also an officer or employee of Oncolytics (including, for greater certainty, any subsidiary of Oncolytics);</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Participant(s)</font>&#8221; means the Eligible Employees and the Non-Employee Directors;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Performance Criteria</font>&#8221; means any performance-related measures or criteria as determined by the Board in its sole discretion at Grant Date to be taken into consideration over the Vesting Period of a Performance Share Award for purposes of determining the applicable Vesting Percentage, which measures or criteria may include, Oncolytics&#8217; performance compared to identified operational or financial targets, Oncolytics&#8217; shareholder return, and any such other performance-related measures or criteria matters as the Board may determine, in its sole discretion;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Performance Share Award</font>&#8221; means an award to Eligible Employees under the Plan pursuant to which Common Shares shall be issued on the Issue Dates, as applicable, determined in accordance with Section 7 hereof, based upon achieving the applicable Performance Criteria and subject to adjustment in accordance with the terms of the Plan;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Restricted Share Award</font>&#8221; means an award to Non-Employee Directors under the Plan pursuant to which Common Shares shall be issued on the Issue Dates, as applicable, determined in accordance with Section 7 hereof, subject to adjustment in accordance with the terms of the Plan;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Security Based Compensation Arrangement</font>&#8221; has the meaning ascribed thereto in Section 613 of the Toronto Stock Exchange Company Manual, as amended from time to time;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Share Award</font>&#8221; means a Performance Share Award or Restricted Share Award, as applicable;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Share Award Account</font> &#8220; means an account maintained by Oncolytics for each Grantee that shall be credited with such Share Awards as are granted to the Grantee and any dividend equivalent Share Awards in respect of such Share Awards;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Share Award Agreement</font>&#8221; has the meaning set forth in Section 7 hereof;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Shareholder</font>&#8221; means a holder of Common Shares;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Vested</font>&#8221; means the applicable Vesting Period having been completed and additionally in the case of Performance Share Awards, the applicable Performance Criteria in relation to a whole or percentage of the number of Common Shares covered by such Performance Share Award determined by the Board having been met, where &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Vesting</font>&#8221; (or any applicable derivative term) has a comparable meaning;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Vesting Percentage</font>&#8221; means the percentage of outstanding Performance Share Awards that will vest based upon the relative achievement of the Performance Criteria for such award during the Vesting Period, where such percentage will range from 0 percent to 100 percent reflecting the Board&#8217;s determination, in its sole discretion, of the achievement of the Performance Criteria; and</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Vesting Period</font>&#8221; means the three-year period over which Share Awards granted under the Plan shall vest in accordance with Section 7(b)(i), subject to adjustment or modification pursuant to the terms and conditions of the Plan.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">3</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">3.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Administration</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Plan shall be administered by the Board, or if delegated, by a committee of the Board that has been assigned the responsibility of determining Oncolytics&#8217; policies with respect to executive compensation. Such committee, or if no such committee has been delegated the authority to administer the Plan, then the Board is hereinafter referred to as (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Committee</font>&#8221;).</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Committee shall have the authority in its sole and absolute discretion to administer the Plan and to exercise all the powers and authorities either specifically granted to it under the Plan or necessary or advisable in the administration of the Plan subject to and not inconsistent with the express provisions of this Plan and of Section 10 hereof, including, without limitation, the authority to:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">grant Restricted Share Awards to Non-Employee Directors and Performance Share Awards to Eligible Employees;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">determine the Grant Date for Share Awards;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">determine the officers and employees who may participate in this Plan and designate any officer or employee as being an Eligible Employee under this Plan;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(d)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">determine the Participants to whom and the time or times at which Share Awards shall be granted and shall become issuable;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(e)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">determine the number of Common Shares to be covered by and the Grant Value for each Share Award (and accordingly the number of Common Shares to be covered by each Share Award) in accordance with Section 4 hereof;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(f)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">determine Performance Criteria applicable to any Performance Share Award;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(g)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">prescribe, amend and rescind rules and regulations relating to the Plan;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(h)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">interpret the Plan and the Share Award Agreements;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">approve the form and determine the terms and provisions of Share Award Agreements (which need not be identical) entered into in connection with Share Awards;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(j)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">determine whether and the extent to which adjustments shall be made pursuant to the Plan; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(k)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">make all other determinations deemed necessary or advisable for the administration of the Plan.</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Committee may delegate to one or more of its members or to one or more agents such administrative duties as it may deem advisable, and the Committee or any person to whom it has delegated duties as aforesaid may employ one or more persons to render advice with respect to any responsibility the Committee or such person may have under the Plan.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">For greater certainty and without limiting the discretion conferred on the Committee pursuant to this Section, the Committee&#8217;s decision to approve the grant of a Share Award in any period shall not require the Committee to approve the grant of a Share Award to any Participant in any other period; nor shall the Committee&#8217;s decision with respect to the size or terms and conditions of a Share Award in any period require it to approve the grant of a Share Award of the same or similar size or with the same or similar terms and conditions to any Participant in any other period. The Committee shall not be precluded from approving the grant of a Share Award to any Participant solely because such Participant may previously have been granted a Share Award under this Plan or any other similar compensation arrangement of Oncolytics. No Participant has any claim or right to be granted a Share Award.&#160;&#160;There is no obligation for uniformity of treatment of Eligible Employees, or any group of Eligible Employees.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Any interpretation, rule, regulation, determination or other act of the Committee hereunder shall be made in its sole discretion and shall be final and conclusively binding upon Oncolytics and all persons affected by the Plan. No member of the Committee shall be liable for any action or determination made in good faith pursuant to the Plan or any instrument of grant evidencing any Share Award awarded under the Plan. To the fullest extent permitted by law, Oncolytics shall indemnify and save harmless each person made, or threatened to be made, a party to any action or proceeding in respect of the Plan by reason of the fact that such person is or was a member of the Committee.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">4.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Eligibility and Share Award Determination</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Committee may grant Share Awards in such amounts and at such times as the Committee in its sole absolute discretion may determine. In determining the Participants to whom Share Awards may be granted and the Grant Value for (and accordingly the number of Common Shares to be covered by) each Share Award (subject to adjustment in accordance with the Performance Criteria in the case of Performance Share Awards), the Committee may take into account such factors as it shall determine in its sole and absolute discretion.&#160;&#160;Notwithstanding any other provision of this Plan, Performance Share Awards may only be granted to Eligible Employees and Restricted Share Awards may only be granted to Non-Employee Directors.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">4</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The number of Common Shares to be covered by each Share Award shall be determined by dividing the Grant Value for such Share Award by the Market Price of a Common Share as at the Grant Date, rounded down to the next whole number.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">5.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Reservation of Common Shares</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Unless otherwise approved by the Shareholders, the aggregate number of Common Shares that may be issuable pursuant to Share Awards granted pursuant to this Plan in combination with all other Security Based Compensation Arrangements of Oncolytics, including the Stock Option Plan, is 11,412,394 Common Shares.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The number of Common Shares issuable to Insiders at any time, under all Security Based Compensation Arrangements of Oncolytics, shall not exceed 10% of the issued and outstanding Common Shares. The number of Common Shares issued to Insiders, within any one-year period, under all Security Based Compensation Arrangements of Oncolytics, shall not exceed 10% of the issued and outstanding Common Shares.&#160;&#160;The number of Common Shares reserved for issuance under all Security Based Compensation Arrangements of Oncolytics&#160;&#160;to any one Participant shall not exceed 5% of the total number of issued and outstanding Common Shares.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Share Awards that are canceled, terminated or expire prior to the settlement of all or a portion thereof, shall result in the Common Shares that were reserved for issuance thereunder being available for a subsequent grant of Share Awards pursuant to this Plan to the extent of any Common Shares issuable thereunder that are not issued under such canceled, terminated or expired Share Award.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">6.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Participation Limits for Non-Employee Directors</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The maximum number of Common Shares that may be reserved for issuance to Non-Employee Directors pursuant to Restricted Share Awards under the Plan is 1% of the Common Shares outstanding at the time of the grant (on a non-diluted basis), less the aggregate number of Common Shares reserved for issuance to such Non-Employee Director under any other security-based-compensation arrangement, and the total annual grant of Restricted Share Awards to any one Non-Employee Director cannot exceed a grant value of $100,000 (based upon a Black-Scholes calculation or such other similar and acceptable methodology, applied consistently and appropriately as determined by the Board).</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">7.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Terms and Conditions of Share Awards</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Each Share Award granted under the Plan shall be subject to the terms and conditions of the Plan and evidenced by a written agreement between Oncolytics and the Grantee or an award letter from Oncolytics to the Grantee (a &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Share Award Agreement</font>&#8221;) which agreement shall comply with, and be subject to, the requirements of the Exchange and the following terms and conditions (and with such other terms and conditions as the Committee, in its discretion, shall establish):</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Number of Share Awards</font> - The Committee shall determine the number of Common Shares to be awarded to a Grantee pursuant to the Share Award (subject to adjustment in accordance with provisions of the Plan) in accordance with the provisions set forth in Section 4 of the Plan.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Vesting of Share Awards</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Share Awards hereunder shall vest on the third anniversary of the Grant Date of such Share Awards.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Committee shall determine the Performance Criteria for each Performance Share Award at the time of the grant of the award.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(iii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Committee shall, as soon as reasonably practicable following the completion of the Vesting Period applicable to a Performance Share Award determine, in its sole discretion, the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Vesting Percentage</font>&#8221;.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(iv)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Notwithstanding any other provision of this Plan, no term or condition of a grant of Share Awards hereunder or any Share Award Agreement may have the effect of causing any Common Shares to be issued pursuant to any Share Award under the Plan to a Grantee in satisfaction of such Grantee&#8217;s Performance Share Awards under the Plan (or any portion thereof) to occur after December 31 in the third (3<font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; DISPLAY: inline">rd</font>) calendar year following the calendar year in respect of which such Share Awards were granted.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Adjustment of Share Awards </font><font style="FONT-FAMILY: Times New Roman; DISPLAY: inline">-</font><font style="FONT-WEIGHT: bold; DISPLAY: inline">&#160;</font>Unless otherwise determined by the Committee and subject to the remaining provisions of this Section 7, following the completion of the Vesting Period for a Share Award, the number of Common Shares underlying such Share Award shall be adjusted by multiplying such number by (A) the Adjustment Ratio applicable in respect of such Share Award, and (in the case of Performance Share Awards only) (B) the Vesting Percentage, if any, applicable to such Performance Share Award.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">5</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(d)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Issuance of Common Shares </font>- Subject to Section 5, the Common Shares that are issuable to the Grantee on the Issue Date shall be issued from treasury as fully paid and non-assessable Common Shares. No fractional Common Shares will be issued and all fractional entitlements shall be rounded down to the nearest whole number.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(e)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Delivery of Common Shares </font>- The Issue Date shall occur as soon as practicable and in any event within 31 days following the completion of the Vesting Period applicable to a Share Award.&#160;&#160;Subject to the remainder of this Section 7(e), on the Issue Date, Oncolytics will issue from treasury to the Grantee that number of Common Shares to which the Grantee is entitled to receive in respect of such Share Award in accordance with this Section 7, subject to Section 9 hereof, and sent by pre-paid mail or delivered to the Grantee. Notwithstanding the foregoing, if on the Issue Date a Black-Out Period has been imposed upon a Grantee which is still in effect, then the Issue Date shall not occur until the date which is the tenth (10th) business day after the last day of the applicable Black- Out Period.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(f)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Business Combinations and Certain Adjustments</font> - Subject to Section 7(e), if, during the term of an outstanding Share Award, Oncolytics shall complete or be subject to any transaction which constitutes a Change of Control, and as a result of such transaction the holders of Common Shares receive securities of another issuer (the "<font style="FONT-WEIGHT: bold; DISPLAY: inline">Continuing Entity</font>") in full substitution or replacement for the Common Shares ("<font style="FONT-WEIGHT: bold; DISPLAY: inline">Replacement Securities</font>"), Oncolytics (including the Continuing Entity as successor thereof) will make provision such that all outstanding Share Awards shall remain outstanding and continue in effect following the effective date of such transaction, with appropriate adjustments made as required, including without limitation to (i) the number of Replacement Securities underlying the Share Awards held by each Grantee, (ii) the Dividends paid on the Common Shares (as replaced by the Replacement Securities) during the Vesting Period, and (iii) the Market Price of the Common Shares determined for the beginning of the Vesting Period, in each case to appropriately account for and provide economic equivalence based on the exchange ratio of Replacement Securities issued for Common Shares pursuant to such transaction.</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 72pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Prior to or contemporaneously with the consummation of such Change of Control transaction, Oncolytics and the Continuing Entity shall execute such instruments and do such things as are necessary to establish that upon the consummation of such transaction the Continuing Entity will have assumed all the covenants and obligations of Oncolytics under this Plan, the Share Award Agreements and the Share Awards outstanding on consummation of such transaction in a manner that substantially preserves and does not impair the rights of the Grantees thereunder in any material respect (including the right to receive Replacement Securities or other cash or property of the Continuing Entity in lieu of Common Shares upon the subsequent vesting of Share Awards).</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 72pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Subject to compliance with this Section 7(f), any such Continuing Entity shall succeed to, and be substituted for, and may exercise every right and power of Oncolytics under this Plan and such Share Award Agreements with the same effect as though the Continuing Entity had been named as Oncolytics herein and therein, and Oncolytics shall be relieved of all obligations and covenants under this Plan and such Share Award Agreements and the obligation of Oncolytics to the Grantees in respect of the Share Awards shall terminate and be at an end and the Grantees shall cease to have any further rights in respect thereof including, without limitation, any right to acquire Common Shares upon vesting of the Share Awards.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(g)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Acceleration of Payment for Certain Transactions</font> - Notwithstanding Section 7(f), in the event that:</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the Continuing Entity does not (or, upon the occurrence of the Change of Control transaction, will not) substitute or replace, or the nature of the transaction does not provide for the full substitution or replacement of, the Common Shares with Replacement Securities on the same terms as described in Section 7(f);</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the Board determines, acting reasonably, that such substitution or replacement is not practicable or impairs or does not substantially preserve the rights of the holders of Share Awards;</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="MARGIN-LEFT: 72pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 72pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">6</font></font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(iii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the Board determines, acting reasonably, that such substitution or replacement would give rise to adverse tax results to holders of Share Awards; or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(iv)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the Replacement Securities are not (or, upon the occurrence of the transaction, will not be) listed and posted for trading on a recognizable stock exchange;</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">&#160;</div>

<div style="MARGIN-LEFT: 72pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">then the Grantee shall receive a cash payment in respect of all outstanding Share Awards in respect of which payment has not yet been made (whether or not otherwise vested or payable), conditional upon the Change of Control transaction being completed, immediately prior to the effective time of the transaction.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 72pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">For the purposes of this Section 7(g), the cash amount to be paid for outstanding and unpaid (i) Share Awards shall be calculated in accordance with Section 7(c) on the basis that each uncompleted Vesting Period shall be deemed to have consisted of the time elapsed from the start of the particular Vesting Period to and including the effective date of the Change of Control transaction, notwithstanding any prior designation of that Vesting Period, and (ii) Share Awards shall be calculated based on the Market Price of the Common Shares on the effective date of the Change of Control transaction, or in each case based on such other date(s) as Oncolytics, acting reasonably, determines is practicable.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(h)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Board Discretion</font> - Notwithstanding anything else in this Plan, the Committee may, in its sole discretion, but subject to the limits described in Sections 5 and 11&#160;&#160;hereof and any other applicable requirements of the Exchange or other regulatory authority:</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">make any additional adjustments to the Vesting Percentage (in respect of any Performance Share Awards) or the number of Common Shares to be issued or delivered to a Grantee in connection with any Share Award if, in the sole discretion of the Board, such adjustments are appropriate in the circumstances having regard to the principal purposes of the Plan;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">change the Issue Date (including amending the Vesting Period related thereto) for all or any Share Awards at any time and from time to time; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(iii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">otherwise amend or modify the terms and conditions regarding any grant of Share Awards or payments in respect of any Share Awards hereunder, provided, however, that no such amendment or modification may, without the consent of the affected Grantee, impair or adversely affect a Share Award granted to the Grantee under the Plan prior to the date of such amendment or modification.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Effect of Certain Changes</font> - In the event:</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">of any change in the Common Shares through subdivision, consolidation, reclassification, recapitalization or similar transaction; or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">that any rights are granted to Shareholders to purchase Common Shares at prices substantially below fair market value, and such events do not constitute a Change of Control transaction for the purposes of Section 7(f), then, in any such case, the Board may make such adjustments to the Plan, to any Share Awards and to any Share Award Agreements outstanding under the Plan as the Board may, in its sole discretion, consider appropriate in the circumstances to prevent dilution or enlargement of the rights granted to Grantees hereunder.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(j)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Termination of Relationship as Employee</font> - Unless otherwise determined by the Committee or unless otherwise expressly set forth in a Share Award Agreement pertaining to a particular Share Award or any written employment or other agreement governing a Grantee&#8217;s role as an officer or employee, the following provisions shall apply in the event that a Grantee ceases to be an Eligible Employee or Non-Employee Director:</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-STYLE: italic; DISPLAY: inline">Termination</font> - If a Grantee (A) ceases to be an Eligible Employee for any reason other than termination without cause, death, disability or retirement of the Grantee, and regardless of the reason for the cessation of employment and regardless of whether any or any adequate or proper advance notice of termination or resignation is provided in respect of such cessation, or (B) ceases to be a director due to the decision of the Grantee to not stand for or obtain re-election to the Board, all outstanding Share Award Agreements under which Share Awards have been granted to such Grantee shall be terminated and all rights to receive Common Shares thereunder pursuant to Share Awards which have not Vested shall be forfeited by the Grantee effective on the Cessation Date. For greater certainty, no Performance Share Award shall vest during any reasonable notice period.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(ii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-STYLE: italic; DISPLAY: inline">Termination Without Cause</font> - Subject to any provisions to the contrary in the employment agreement of any particular Grantee, upon the termination without cause of such Grantee, </font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;

<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">7</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">those Common Shares awarded pursuant to any Performance Share Award to such Grantee that have not yet Vested and been issued, but would be eligible for Vesting and issuance during the notice period specified in such Grantee&#8217;s employment agreement shall vest on the Cessation Date with a deemed Vesting Percentage of 100.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(iii)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-STYLE: italic; DISPLAY: inline">Termination Upon Death or Permanent Disability or Retirement</font> - Upon the death, permanent disability or retirement of a Grantee, all outstanding Share Award Agreements under which Share Awards have been made to such Grantee prior to the Cessation Date shall be terminated and all rights to receive Common Shares thereunder pursuant to Share Awards that have not Vested shall be forfeited by the Grantee effective as of the date that is twelve (12) months from the Cessation Date.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(k)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Rights as a Shareholder</font> - Until the Common Shares underlying any Share Award have been issued in accordance with the terms of the Plan, the Grantee to whom such Share Award has been made shall not possess any incidents of ownership of such Common Shares including, for greater certainty and without limitation, the right to receive Dividends on such Common Shares and the right to exercise voting rights in respect of such Common Shares. Such Grantee shall only be considered a Shareholder in respect of such Common Shares when such issuance has been entered upon the records of the duly authorized transfer agent of Oncolytics.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">8.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Ratification and Approval by Shareholders</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Notwithstanding any other provision of this Plan:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">no Common Shares may be issued pursuant to any Share Award until the Plan has been approved by the Shareholders at a duly called meeting of the Shareholders; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">any grants of Share Awards by the Committee prior to the Plan being approved by the Shareholders must be ratified by the Shareholders at the meeting of the Shareholders at which the Shareholders approve the Plan.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">9.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Withholding Taxes</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">When a Grantee or other person becomes entitled to receive Common Shares under any Share Award, Oncolytics shall have the right to require the Grantee or such other person to remit to Oncolytics an amount sufficient to satisfy any withholding tax requirements relating thereto. Unless otherwise prohibited by the Board or by applicable law, satisfaction of the withholding tax obligation may be accomplished by any of the following methods or by a combination of such methods:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the tendering by the Grantee of cash payment to Oncolytics in an amount equal to the total withholding tax obligation;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the withholding or sale by Oncolytics from the Common Shares otherwise due to the Grantee, of such number of Common Shares having a value determined by Oncolytics in its sole discretion, acting reasonably, equal to the amount of the total withholding tax obligation (and in the case of a treasury issuance of Common Shares to settle Share Awards hereunder, such sale of Common Shares shall be automatically made on or as soon as practicable after the applicable Issue Date for the purposes of satisfying withholding tax obligations, unless otherwise agreed to by Oncolytics and the Grantee);</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">the withholding by Oncolytics from any cash payment otherwise due to the Grantee of such amount of cash as is equal to the amount of the total withholding tax obligation; or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(d)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">any other method determined by Oncolytics in its sole discretion, acting reasonably,</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">provided, however, that the sum of any cash so paid or withheld and the value of any Common Shares so withheld or sold is, sufficient, in the reasonable estimation of Oncolytics, to satisfy the total withholding tax obligation.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">10.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Non-Transferability</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The right to receive Common Shares pursuant to a Share Award granted to a Grantee may only be settled by such Grantee personally or through the Grantee&#8217;s personal representative or estate and no assignment, sale, transfer, pledge or charge of a Share Award, whether voluntary, involuntary, by operation of law or otherwise (except by will or the laws of descent and distribution), vests any interest or right in such Share Award whatsoever in any assignee or transferee and, immediately upon any assignment, sale, transfer, pledge or charge or attempt to assign, sell, transfer, pledge or charge, such Share Award shall terminate and be of no further force or effect.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">8</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">11.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Amendment and Termination of Plan</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">This Plan and any Share Awards granted pursuant to the Plan may be amended, modified or terminated by the Committee including but not limited to amending the Vesting Periods under the Plan without approval of Shareholders subject to any required approval of the Exchange.&#160;&#160;Notwithstanding the foregoing, the Plan or any Share Award may not be amended without Shareholder approval to:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">increase the number of Common Shares issuable pursuant to outstanding Share Awards at any time pursuant to Section 5 hereof;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">increase the number of Common Shares issuable to Insiders, Non-Employee Directors or any one Participant, at any time under the Incentive Share Award Plan, together with all other Security Based Compensation Arrangements of the Corporation;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">increase the number of Common Shares issued to Insiders within any one-year period, under the Incentive Share Award Plan, together with all other Security Based Compensation Arrangements of the Corporation;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(d)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">expand the categories of individuals contained in the definition of "Eligible Employee" who are eligible to participate in the Plan;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(e)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">extend the term of any Share Award beyond the term of such awards provided for under the terms and conditions of this Plan;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(f)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">permit the transfer or assignment of Share Awards, except to permit a transfer to a family member, an entity controlled by the holder of the Share Awards or a family member, a charity or for estate planning or estate settlement purposes;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(g)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">change the terms of any Share Awards held by Insiders;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(h)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">amend this Section 11 to delete any of the above.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In addition, no amendment to the Plan or Share Awards granted pursuant to the Plan may be made without the consent of the Grantee, if such amendment adversely alters or impairs the rights of any Grantee in respect of any Share Award previously granted to such Grantee under the Plan.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">12.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Miscellaneous</font></font></div>

<div align="left">&#160;</div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(a)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Effect of Headings</font> - The Section headings contained herein are for convenience only and shall not affect the construction hereof.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(b)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Compliance with Legal Requirements</font> - Oncolytics shall not be obliged to issue any Common Shares if such issuance would violate any law or regulation or any rule of any government authority or Exchange.&#160;&#160;Oncolytics, in its sole discretion, may postpone the issuance or delivery of Common Shares under any Share Award as the Committee may consider appropriate, and may require any Grantee to make such representations and furnish such information as it may consider appropriate in connection with the issuance or delivery of Common Shares in compliance with applicable laws, rules and regulations. Oncolytics shall not be required to qualify for resale pursuant to a prospectus or similar document any Common Shares awarded under the Plan, provided that, if required, Oncolytics shall notify the Exchange and any other appropriate regulatory bodies in Canada of the existence of the Plan and the granting of Share Awards hereunder in accordance with any such requirements.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(c)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">No Right to Continued Employment</font> - Nothing in the Plan or in any Share Award Agreement entered into pursuant hereto shall confer upon any Grantee the right to continue in the employ or service of Oncolytics, to be entitled to any remuneration or benefits not set forth in the Plan or a Share Award Agreement or to interfere with or limit in any way the right of Oncolytics to terminate Grantee&#8217;s employment or service arrangement with Oncolytics.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(d)</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Expenses</font> - All expenses in connection with the Plan shall be borne by Oncolytics.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(e)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Governing Language</font> -This Plan is drawn up in the English language and each notice, instrument, certificate or other communication to be given under or in connection with this Plan shall be in the English language. If this Plan or any notice, instrument, certificate or other communication is translated into any other language, the English language text shall prevail.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(f)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Unfunded and Unsecured Plan </font>- Unless otherwise determined by the Committee, the Plan shall be unfunded and Oncolytics will not secure its obligations under the Plan. To the extent any Grantee holds any rights by virtue of a grant of a Share Award under the Plan, such rights (unless otherwise determined by the Board) shall be no greater than the rights of an unsecured creditor of Oncolytics.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(g)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Market Fluctuations</font> - No amount will be paid to, or in respect of, a Grantee under the Plan to compensate for a downward fluctuation in the price of Common Shares which impacts the Share </font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">9</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Award, nor will any other form of benefit be conferred upon, or in respect of, a Grantee for such purpose. Oncolytics makes no representations or warranties to a Grantee with respect to the Plan or the Share Awards whatsoever. In seeking the benefits of participation in the Plan, a Grantee agrees to exclusively accept all risks associated with a decline in the market price of Common Shares and all other risks associated with the holding of Share Awards.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(h)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Currency</font> - Any payments and benefits under the Plan to be paid in cash shall be determined in the lawful currency of Canada and paid in the local currency of the Grantee&#8217;s country of residence using the currency exchange rate available to Oncolytics at the time of payment.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">(i)</font></div>
</td>
<td>
<div align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Participation is Voluntary; No Additional Rights</font> - Participation in the Plan shall be entirely voluntary and any decision by a Grantee not to participate shall not affect any Participant&#8217;s employment or service with Oncolytics.&#160;&#160;In such instance where a Grantee provides notice in writing to Oncolytics of his or her intent to not participate in a Share Award, such award shall be immediately terminated and the Grantee shall not be eligible to receive any form of in lieu compensation.</font></div>

<div align="justify"><font size="2">&#160;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">13.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Governing Law</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Plan shall be governed by, interpreted and construed in accordance with the laws in force in the Province of Alberta.</font></div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">14.</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-WEIGHT: bold; DISPLAY: inline">Effective Date</font></font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160;</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">This Plan shall take effect on June 8, 2015. The issuance of Common Shares under the Plan is subject to the acceptance of the Plan by the Exchange and any other relevant regulatory authorities and approval of the Shareholders.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">10</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5_1.htm
<DESCRIPTION>OPINION OF MCCARTHY T?TRAULT LLP
<TEXT>
<html>
<head>
    <title>ex5_1.htm</title>
    <!--Licensed to: sand-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">EXHIBIT 5.1</font></div>

<div>&#160;</div>

<div><br>
&#160;<br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><img src="mccarthylogo_p1.jpg" alt=""></font></td>
<td width="50%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt">

<div style="MARGIN-LEFT: 225pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"><a name="firmaddress"><!--efplaceholder--></a>McCarthy T&#233;trault <font style="FONT-SIZE: 10pt; DISPLAY: inline">LLP\</font></font></font></div>

<div style="MARGIN-LEFT: 225pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Suite 3300, 421 7th Avenue SW</font></font></div>

<div style="MARGIN-LEFT: 225pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Calgary AB&#160;&#160;T2P 4K9</font></font></div>

<div style="MARGIN-LEFT: 225pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Canada</font></font></div>

<div style="MARGIN-LEFT: 225pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Tel:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;403-260-3500</font></font></div>

<div style="MARGIN-LEFT: 225pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Fax:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;403-260-3501</font></font></div>
</td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><a name="LetterDate"><!--EFPlaceholder--></a>July 16, 2015</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Oncolytics Biotech Inc.</font></div>
</td>
<td valign="top" width="39%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="37%">
<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Suite 210, 1167 Kensington Crescent NW</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Calgary, Alberta&#160;&#160;T2N 1X7</font></div>
</td>
<td valign="top" width="39%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&#160; </font></td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Dear Sirs/Mesdames:</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline"><a name="LetterBody"><!--EFPlaceholder--></a>Re:</font></div>
</td>
<td>
<div align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">Oncolytics Biotech Inc.</font></div>
</td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">This opinion is furnished to Oncolytics&#160;&#160;Biotech Inc. (&#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Oncolytics</font>&#8221; or the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Company</font>&#8221;), a corporation incorporated under the laws of the Province of Alberta, Canada, in connection with the preparation and filing with the United States Securities and Exchange Commission (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Commission</font>&#8221;) under the United States Securities Act of 1933, as amended (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Securities Act</font>&#8221;), of the Company&#8217;s Registration Statement on Form S-8 to be filed on the date hereof (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Registration Statement</font>&#8221;) relating to 11,412,394 common shares of the Company (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Shares</font>&#8221;) issuable upon the due exercise of options granted pursuant to the amended and restated stock option plan of the Company, as amended (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Option Plan</font>&#8221;) and the vesting of restricted share awards and performance share awards (collectively, &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Share Awards</font>&#8221;) granted pursuant to the incentive share award plan of the Company (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Incentive Share Award Plan</font>&#8221; and, together with the Option Plan, the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Plans</font>&#8221;).</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">As counsel, we have made such investigations and examined the originals, or duplicate, certified, conformed, facsimiled or photostatic copies of such corporate records, agreements, documents and other instruments and have made such other investigations as we have considered necessary or relevant for the purposes of this opinion. We have also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates of public officials, certificates of officers, or other representatives of the Company, and such other documents as we have deemed necessary or appropriate as a basis for the opinion set forth herein.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed, photostatic, electronic, or facsimile copies and the authenticity of the originals of such documents. In making our examination of executed documents or documents which may be executed, we have assumed that the parties thereto, other than the Company, had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and execution and delivery by such parties, of such documents and that such documents constitute or will constitute valid and binding obligations of the parties thereto.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<img src="mccarthylogo_p2.jpg" alt=""></font></td>
<td valign="bottom" width="50%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">page 2</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In connection with our opinions expressed below, we have assumed that, at or prior to the time of the issuance of any such Shares, the authorization to issue the Shares pursuant to the Plans will not have been modified or rescinded by the Board of Directors of Oncolytics and there will not have occurred any change in law affecting the validity or enforceability of such issuance of Shares. We have also assumed that neither the issuance of the Shares, nor the compliance by Oncolytics with the terms of the Plans, will violate any applicable federal, provincial or state law or will result in a violation of any provision of any instrument or agreement then binding upon Oncolytics or any restriction imposed by any court or governmental body having jurisdiction over Oncolytics.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The opinions expressed herein are limited to the laws of the Province of Alberta and the federal laws of Canada applicable therein (the &#8220;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Applicable Law</font>&#8221;).</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Based upon and subject to the foregoing, we are of the opinion that the Shares, when issued (i) upon the exercise of options in accordance with the terms of the Option Plan and any relevant agreements thereunder and upon payment of the consideration provided therein to the Company; and (ii) upon the due vesting of the Share Awards in accordance with the terms of the Incentive Share Award Plan and any relevant agreements thereunder; will be validly issued as fully paid and non-assessable common shares of the Company.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is required under the Securities Act or the rules and regulations promulgated thereunder. This opinion is expressed as of the date hereof unless otherwise expressly stated, and we disclaim any undertaking to advise you of any subsequent changes of the facts stated or assumed herein or any subsequent changes in Applicable Law.</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Yours truly,</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">/s/ McCarthy T&#233;trault LLP</font></div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left">&#160;</div>

<div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left">&#160;</div>

<br>
<div id="PGBRK" style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex23_1.htm
<DESCRIPTION>CONSENT OF ERNST & YOUNG LLP
<TEXT>
<html>
<head>
    <title>ex23_1.htm</title>
    <!--Licensed to: sand-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">EXHIBIT 23.1</font></div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center"><img src="oncolytics_ex23.jpg" alt=""></div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>

<div id="PN" style="WIDTH: 100%; PAGE-BREAK-AFTER: always">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>oncolyticslogo_shareaward.jpg
<TEXT>
begin 644 oncolyticslogo_shareaward.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`'@"
M``,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HHHH`****`"BD=MJYKQ#]J3_`(*&?"G]D2!H_%WB2/\`MDKN
MCT:P7[5J$@]XU/R#W<J*RK5J=*//4:2\P2;T1[A17Y-_&S_@X?\`$VI7$UO\
M/?`VEZ/:\B.]UV=KJX;T/E1E47Z%FKP;5_\`@K=^TM\4+AOL'C+4(]W_`"RT
M/1(0%'L5B9OQ)->%5XHP47:%Y>B_S-O82/W=HK\&/^'A'[56C-]HF\9?$-$C
MYS<:*OECZY@Q76_#S_@NU\>/!%]''J][X9\4Q1GYX=1TM;>4C_>A*'\2#6,>
M+,+>TXR7R7^8>PD?MU17Y]_LZ?\`!P!\/_'=U;V7Q"T#4_`UY(0IOH&-_IV3
MQEBH$B#ZJP'K7W5X"^(FA?%+PS::WX<U;3]<TB^7=!>64ZS0R#V93C/J#R*]
MS"YAA\2KT9)_F9RIRCN;5%%%=A(4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!5?4]3M])L+BZNI
MHK6VM8VEFFE<)'$BC+,S'@*!R2>@J9Y!&.>YQ7Y$_P#!9S_@I3<?%/Q3J/PC
M\#ZBT?A/29?(\07ML_\`R&+E3S;*PZPQL,,!]]P1T49\[,LQIX.C[6?HEW9I
M3@Y2L;7_``43_P""WU_XANM0\'_!>^?3M)A+0WGBL#$]T1P1:`_<3_IJ1N/\
M('WCX[^QQ_P2!^)W[8$L?BCQ-<W'@SPQJ3_:'U/5(VFU+5<\EXXF.XY_YZ2D
M`]1N%?3'_!*7_@D-:^&M/TOXF?%C2DN=8N%2YT7P]=)NBTY#@I/<(>&F/54.
M0G!.6^[^DR)M%>%A<IK8^7UK,6[/:*V2\S:56,/=@OF?,/P$_P""0/P-^!%O
M;R#PE#XLU6$@MJ'B$B]=F[E8R!$G/8)7TCH'A;2_"EFMOI>FV&FVZ#"Q6MND
M*+]`H`J^!BBOIL/A:5%<M**CZ',Y-[@R[EP1D'J#WK@OBK^R_P##OXUV$EOX
MJ\#^%]>63J]WI\;2CZ28WJ?<$5WM!&:UG3C-6DD_45['YV_M0_\`!O\`>$/%
MEI<:E\*]:NO".J8+KI>HR-=Z;*?[JN<RQ?7+CVKX5\/>+_CI_P`$GOC>;5X]
M0\+WSMYDUA<$W&CZ]$#C<`#LD!Z!T(=<]CQ7[^;<BN#_`&BOV;/!_P"U+\-;
MSPKXST>'5--N03&_W;BRDQ@2PR=4D'4$?0@C(KP,;P_3E^]PC]G/RV-H5FM)
M:H\O_8$_X*->$?VZ/"#?8\:'XRTV(/JN@S2[I(AT\Z%N/-A)_B`RIX8`XS]%
MJVX5^"/[4/[,?Q$_X)6?M,:7J&EZI=QQPS&[\->(X$VI>QK]^&5>@<`[9(CP
MRMD<'C]>?^"?O[;.C_MO_`NV\0VRQV/B#3V6SU[3%;=]BN<9RO?RI!\R$]LC
MJIJ\HS6=63PN)5JL?Q\PJ4TES1V/=J***]\Q"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBC-`'RO_P5P_;%
MF_9+_9:O!I-U]G\7>,';2-'93\]L"N9KD?\`7./H>SNE?"?_``1&_84A^/?Q
M4G^)'BBR^U>%O!5RJV$,Z[H]3U/AP6S]Y800QSU=ESG!KF_^"WGQON/C3^W-
M<>&K%S<6?@>VAT6TA4Y#W<NV2;CU+/&G_;.OUH_8U_9[L_V7OV9_!_@NUC59
MM(L$-ZX`S/=R?/.Y]<R,WX`#M7R,*?\`:&9RE+^'2TMT;.B_)#3=GIT2;5[_
M`(TZBBOKM>ISA1110`4444`%!&:**`/+?VQ/V6-"_;`^!&M>#=:C6-[Q?.T^
M]V[I--NU!\J=?H3@CNI8=Z_&O]AOX\Z__P`$W_VYFL?$JR6-C%?GPYXMM"<H
M(M^T3@=_+8K(I[H6Y^:OWE==RXK\CO\`@X-_9OA\(?%WPQ\2+&W5;;Q=;/I>
MJ87AKN``QN?=X25_[8U\OQ%AG!1Q]'XX/\#>C*_N/J?K9;7*W,:R(ZR1N`RL
MIR&!Y!!J:OF?_@DC\>9OC_\`L,>$;R\F,^J>'U?0+YV.69[8A48^YB,1Y[FO
MIBOH<+65:E&K':23,91L[!12,<4;N*W$+110QVB@`HI%?/I2T`%%%%`!13=W
MTH#9':@!U%`.110`449I"V#VH`6BFA\^E*IS0`M%%%`!12;N:-XSUH`6BBB@
M`HH+8-&Z@`HHHH`**1FQZ49^6@!:*-U&Z@`HHW49S0`44`Y-&<4`%%(&W4M`
M!1110`44UFQZ4!Z`'4444`%%#'`I-W%%P%HIN[WIU`!1110`5'(^!N)VA>:D
MJOJ'_'A-_P!<V_D:F<K*X'X-_LTV9_:9_P""KNBW-\OVJ/7/'5QJ]P&Y#QPS
M2W`SZC$:CZ5^]:'Y:_"+_@D`0G_!2SP1YGWO.U(?-Z_99_UK]WATKYGA:/[F
MI/JY,Z,1\04445]0<X4444`%%%%`!1110`'I7Q__`,%P_`"^-/\`@G_X@O?+
M#3>&;^RU6)L<KB40O_XY*U?8!Z5\Z_\`!6$QK_P3K^*WF9V_V.`,''/GQ8_7
M%<>84U/#5(O^5E4_B1\K_P#!N=XVDN/"'Q0\./(=EK?66I0IGA?,C>-R!_VR
M3\A7Z95^3O\`P;EK)_PM7XHM_P`LO[)L0>.=WG2U^L5>?PW)RRZG?S_,NO\`
M&SYC_P""K'[7WBG]BW]G?3O%'A&WT>?5+S6X=.;^T86FB6-XY7)"JR_-\@YS
MZU\:?LV_\'`?BV/XJV5O\4=(\/MX1O"(;JZT>TECN=.)/$VTNWF(/XE`!QR,
MD8/N_P#P<(_\F8Z'_P!C7:_^B+BOE#]A3]@C3OV[OV"O%T6G_9]/\?>$_$DL
MNBW[\+.KVT+&TF/7RF(R"<[&.1QD'R,RQ.->9>QPT]HWMT=NGS-*:AR7D?L?
MX5\4Z=XV\-V.K:3?6NI:;J4"W-K=6T@DBN(V&5=2.H(KS+]O#XX:U^S=^R1X
MV\<>'X[";6?#MFEQ:I>QM)`6,R(=RJ03PQ[CG%?E=_P3W_X*'^*O^"='Q.O/
MAS\1K'5%\&P7K6^HZ=<(?M7AF<D;IH5_BB.=S(.&!WH23AOT7_X*6^)=,^(_
M_!,GXCZQH]Y:ZMI.I:`MW:W-M()(IX_-C975AU'&:]>CFT<5A*DX>[.*=UU3
ML9RI\LK=#RG_`()'_P#!1[Q_^V]\1O&.D^,K7PY#;Z%IT%Y;-IMJ\+EWE9&#
M;G8$8`]*^[:_)/\`X-S?^2X?$K_L!6G_`*/:OULJN'\14K8*-2J[O77YL*T5
M&=D1SSK`C,S*JJI8EC@`#J37PU^U9_P72\"?![Q'<>&_A_I-Q\2?$,4IMO.M
M9O*TU9L[=BR`,TS;N,1J03T:F?\`!>G]I'6/@Y^SGH?A70[B:QN/B!>2VE]=
M1,4D6RA0-)$".1YC.BG'\.X=Z\6_X-\?V:=!\5W?C#XDZI96]YJ>@746D:-Y
MJ!EL6,8DEE0'HY#(H;J!N`ZFN?'9C7GC%@,*^66[D];*U]/,<*:Y>>1WOA[X
M]_MZ_'>W74M#^'OA#P3IUP`T2ZI`D,FT\CY9Y3)CZH/I1KWQ8_X*!?"5?ME]
MX+\&^,+6/EH].MX9G(]ECE23\E-?HN%P:6NK^RYVUK3OZK\K$^T\D>/_`+&'
MQ8^)WQC^%:ZQ\4/`=G\/]6FDQ;V,5TTDTL8ZO)$PS`<]$9F..3BO8&.!1393
MMC)[+R:]2G%P@HMWMU9F>#_MK?\`!1#P!^P[H<!\2W$^I:_J*&33]#T_#WER
MHX\QLD+%'GC>QY/`!(Q7R5X._P""DO[5G[8TLES\'_A'HNF>'R[1Q:G?AIH^
M#@@SRO%$S#N$4X.17P1\6?'.H_M>_ML7VH:Y=2O)XP\51Z<"6/\`HMJUR((X
ME]%2/``^I[U_0AX+\':;\/O"FG:'H]G#8:3I,"6EI;0J%C@C0!54#Z"OF<'B
ML1F5:?+)PIQ=M+7?S.B<%32[GP;/>?\`!0[3(?M/V/X:ZAM&3;+]E#'VY91^
M35RMI_P6C^+7[,WC.WT'X]?"'^S3*,BYTX-:32*#R\:NSQ3`?[$@K],CTKYU
M_P""IGP(TGX[?L2^.(=0M89+[P]ILVM:7<L!YEI/`ADRK=0&4,C#N&^E=V*P
M->C3=7#UI<R5[2=T[$QDF[21Z1^SC^T_X-_:N^'D/B?P3K$.J:<[>5-&1Y=S
M92XR8IHSRCCT/!Z@D<UZ$.E?AO\`\$2_C/J7PW_;KT'2+:>1=)\<6TVFW]OG
M]W(5B::%\?WE9,`^C,.]?N0.E:Y+F3QN']K)6:T?KY$U:?(['RG_`,%9?VT?
M%O[$GP9\.Z]X/M]%N+_6-;&GS?VE`\T:Q^3))E0K+\V4')/2I/\`@DW^V9XM
M_;8^"?B#Q#XPM]&M]0TO6FT^(:;`\,;1B&-QN#,WS9<\YZ5X_P#\'$O_`";+
MX'_[&D?^DL]3?\&[W_)K?C+_`+&E_P#TF@KA^MUO[9]AS/DY;V^1?*O9<W4_
M0('-%`Z45](MC`\S_:N3XF1?"6\NOA+-H/\`PE]C^_AL]7MC+;ZB@!W0A@R^
M6YXVL<C(P<`Y'YZ_L[?\%U_&_AKXX_\`"/\`QNT/2]-T7SS8WTMGI\MK>:%.
M#C=+&SL70?Q@`,!\PSC!_51EW5\7_P#!4G_@EGI_[7.A2>+_``C':Z;\3-.A
MP"<1PZ_$HXAF/02#HDAZ?=;Y3E?&S6CBTO;X2;O'>/1_\$UIN.TC[$\/>(;/
MQ3H]KJ.GW=M?:??0K<6US;R"2*>-AE65AP01SD5Q/[3W[4'A/]DOX37OB_Q;
M?K;V-M^[M[=,-<:C.0=L$*_Q.WY`9)P`37Y-_P#!.3_@IKKG[!6OZI\/_B/9
MZU<>$+-ID_L]HB;_`,/7JY)C16(_=N_RLA.%9MXXSGF9'^+/_!:G]JMECS8Z
M3I[?*#N;3?"=B6[]/,F<#_>D8?PH.."7$D9T5&A&]66G+V?F5[&SN]CZ*_9K
M_P""I'[27[;GQVE\.^`?#/@G3-+:;SKJZN[">XAT*T)(#3RB10[X&`H`+MG`
M`!(_3NQ26'2X5N)EFG5%6658_+$C8Y8+D[<GG&3BO/?V5/V4_"?['_PGL_"?
MA&T\JWC`DO+N4`W6ISX`::9AU8XX'11@#`%>ED9%>QEN&K4J?^T3<I/?LO)&
M4VF_=/AKXY?&?]MC0_C'XFL_!?PU\':EX1M]0D31[N5HS)<6O_+-VS<J=Q'7
M*CFO)OC?^WM^VE^SAX#?Q-XT^'O@G1=#CGCMGNC`)@LDAP@(CN2>3QG'6OT]
M;I7QM_P7;_Y1]ZI_V&M._P#1M<6/P=2G1G6C6E=)O=6_(TIR3:5D?.7[/?\`
MP4U_:\_:JM]4F\`>"?`_B"+17CCO76U,*P-(&*#]Y<+DD*>F<8KT@_'O]O\`
M92%^%'@?<>%R8L9]_P#2^E8'_!N%_P`B3\6O^PEIW_HF:OTLV^]<^4X>MB<+
M"O4K2N^S7?T*J2C&322,WP6^IOX4TLZTMNNLM:1&_%OGR1<;!YFS)/R[]V/:
MN?\`VB/'UY\+/@%XT\3:<D$FH>'M#O-1MDF4M$TD4+NH8`@E<J,@$9%=I7F'
M[:/_`"9]\4O^Q4U/_P!)9*^@K-QHR:>J3_(P6Y\4?\$OO^"K?Q0_:W_:EM/!
MOBV'PK_9-SI%U>%K&Q>"99(@A7!,C#')R,5^DR]*_$'_`((0?\I`-+_[%[4/
M_08Z_;X=*\7AO$5:^#YZLKN[U9K7BHRT(KN[2R@DDD>...-2[,[;54#DDGL`
M.]?"G[4G_!=KP/\`"WQ!-X<^'.BW7Q*UY9/LPN+>0Q:;YV<;(W`9YSGC]VN#
MV8U3_P""_/[2.L?"WX#>'O!&BW$MBWCZYF749XF*N;.!4+P@CM(TB!O]E2.A
M->7_`/!O?^S9H6OQ>+?B=J5K;WFK:1>IHND>8@86`\I9)94!'#MO5=W4`,!C
M)J,9F5:IC5@,,[/=O>R\O,<::Y.>1VV@_'/]OCXZ0+J6B_#_`,'^"=.F^:--
M3@2"0J>1E)I6E_-!]*9KOQ?_`."@/PE7[7J/@CP=XPM8^633K>&=B!UPL4J2
M?DIK]%XQC-.QS77_`&7-K6M._JORL1[1=D>3?L<?%'XE?%WX31:S\3_`UGX!
MUJ=_W-A#>--(\7]^2-AF$D_P%F..N.E>KR/L'`S3L<U#?6BW]K)"^?+E4HV#
M@D$8//;KUKU(1<8*-[M=7U(EJS\]OVP?^"[%G\/O'UWX.^$OAF'QIJUI=&QD
MU.Z=_L;W&[9Y=O%'\\Y#?+G*@D$#=WK>']>_X*%?%'3EU*"S\$>#X+@!XK6]
M@MH9E'H4;S77Z-@_2O!_VD/^"1_Q9_8]^+=OX[^$JS>--)T/45U;36MXQ)J>
MENC>8JRP'_7*I_B3)8#E0:]'\"?\'#6M>#U6P^)'PKDCU*W_`'<TMA=M9,6'
M!)@N$RIZ\;^M?&QQE7VTHYE.5/LHZ+[TF;\JM[BN=7K_`(\_X*$?"<?:KKP]
MX1\96L?+)8P6LS/[;4>*3\@:]S_X)_?MA_&?]H[Q%JVF_$;X.R>";71UVRZN
MS36B2S=HDMYE+N<9)97*KQZ@5R7PT_X+V?`WQQ/##JW_``E/A.27CS+_`$[S
MH%^KPLY_2OJCX1_'OP9\>]"_M+P9XFT7Q-8KC?)872RM%GH'4?,A]F`->Q@%
M2E44L/B7)=FT_P#@D3O;5'84445[QD%,=>`.N3@T^B@#\$/@9=_\,L?\%7-+
MBOF-M!X>\>SZ;<,W&V&6>2')]MDH/TK][UX%?BE_P72^!,WPE_;/'BJSC:WT
M_P`?6<>HPS(,+'>P;8IN?[WRQ/\`\#K]3_V$_P!H^V_:I_98\'^,(Y%:^N[-
M;;4X]V6@O8?W<ZGZN"P]F4]Z^5R!^PQ%?!RW3NO1G16]Y*9Z]1117U1SA111
M0`4444`%%%%``>17QM_P71^(J>"OV"=4TSS`MQXLU2STR-<\LHD\]_PVPG/U
MK[(8X6OQ[_X+_P#[2L7C_P"/.A_#VPN!+8^`[9KK4-AROVZX4$*<==D(7Z&4
MUXV?8I4<'-]7HOF:48WF>M?\&Z'@62T^'_Q-\2LC"._U*TTV%ST;R8FD<?\`
MD9:_2NOG7_@E=\`9?V=?V(?!NDWD)M]6U:%M;U%&&&6:Y/F!3[K&8U/NM?15
M;Y/AW0P5.F][7^_4*DKS;/@[_@X2/_&&&A?]C7:_^B+BN6_X-SKGS/@I\2H<
MY\O7K=\>F;8#_P!EKZP_;G_8LTO]N?X16?A'5M:U'08++4HM3CN;.-)'+HKK
MM*OQ@AS[C`K)_8#_`."?VC_L">&?$>FZ1XBU;Q$OB2[BNY7O88X_),:%`%"#
MOGDGVKA_L^M_:JQ=O<Y;?@5SKV?*<=_P4O\`^"9&B_ML>$VUO2/LNC_$C28"
MMA?E=L>I(.1;7..J_P!U^J$]QD5^8WPM_:M\7_LO_"KXH?`'Q_8ZE#H.M:=>
M:>MA.N;CP]J!7*-&#U@D8`LHX^8.O<-^]5?-_P"W-_P3)\"_MSR6.H:M)=>'
M?$NG@1)K.G(GVB:#_GC*K#$BC.03RIZ'!(J<VR>=27UC!M*I:S[23[A3J6TE
ML?$?_!N7Q\;_`(E?]@*TS_X$/7ZV`YKY?_8(_P""7^@_L$^+_$6L:3XJUKQ#
M-XBM(K.1+V"*)(51R^1L&223W]*^GU&T5V9)A*F&PD:-56:O^9-62E*Z/D+_
M`(+)_L;ZM^UI^SG:W'ABW^W>*O!-R^I6=DOW]0A="D\"?[94*RCN4QWKXC_X
M(V_M]^'_`-D#QAXF\#^/FFT;0?$EY'*E_-&RC2KU!Y;).OWD1E"@DCY2G.`<
MC]F&7)]Z\$_:>_X)H?"+]K6]DU#Q1X:CMM?E7!UC2Y#9WK>F]E^63_@:M7-C
MLKJO$K&X1I371[/I^0XU$H\DMCVOPQXNTOQKH\.H:/J%CJNGW"AHKFSN%GAD
M![AE)!J[<7:6D#22,L<<8W,SMM51[DU^>R_\$"8/!E[)-X'^-GCSPJK-N2..
M,<?4Q/%G\16E#_P0M_X2LHOC?X[?$_Q1;]'@\_RT;_OX\@_2MXXO'6LZ&O\`
MB5O\_P`!<L>Y]V>'/%>F^+]/6\TF_L=3LV9D\^TN$GCW*<,NY21D'@CL:O2G
M"5X[^R'^PQX%_8ET34+#P1'K4<.K.LEV;[4Y;H2NN0&"'$:MSR54$\9S@5[)
M7J493<$ZJL^J3O\`B0[=#\"/^"@W[*WB3]AS]JV^N8[65=#OM6;6_#.H[28)
ME\[SA"6Z"2-OE9>N`#R#7[._L@_M?>$_VPOA)I?B+PYJ%K)>RPK_`&GIGFC[
M5IEQ@;XY$SN`#9PV,,,$5VGQ5^#_`(:^.'@VZ\.^+M$TWQ!HEYCS+2\B#KD=
M&!ZJP[,I!'8U\8>-O^"`WP_?Q&VJ>!?''CCP#<$DJEM<"Y6'V1SME`^KFOGZ
M.78G`UY5,*E.$MU>S7H^OS-I5%-)2/O,GBODW_@K=^V)X9^`?[*_BGPXVI6<
M_C'QAI\NDZ?I<<JO<*LR[))Y$!RD:(6.X]3@#->;O_P1I^(ES!]EF_:B^)+V
M)^5HAY_*^G_'S6I\*?\`@@;\*?"GB!=5\8:YXL^(5WO\QX]0N1;V\YSG]X(_
MWC_C)SWKHQ%7'UJ;ITZ7*WI=M.R]%>Y$5%.[9\B_\$+OV8-:^(G[4=I\1'L9
MH_"?@>*?_377$=W>21F-(8S_`!,JNSMCA<*#R<5^T0Z5E>#?!&D?#OPS9Z+H
M6F6.CZ3IT8AMK.SA6&&!1V55&!6K71E.6QP5#V2=WNWYA4J.;NS\]_\`@XE_
MY-F\#_\`8T#_`-)9ZD_X-X957]ESQDNY=W_"4.2,\C_1H?\`"OH[]N_]A72?
MV\?AUI/AW6->U/0(]'U(:E%/91QR,[>6\>U@XQC#YX[BOF.Q_P"#>3PSI2,M
MI\6/'5HKG+""&&,,?4A2,UYF(P>+AF?URE!25K;I="HRBZ?*S]$!(N.H_.CS
M<M_]>OSU'_!OSH8_YK)\1/\`QS_&O:OV'O\`@F#I/[$WQ"U;Q):^-O%7BR\U
M.P&GI'JD@$-LGF!V95!.6)51D]!GUKU:.(QDIJ-2CRKOS)_H0U&VC/J('--?
MFG"@C->D0?CI_P`'"'A73=!_:M\)WUG9V]M>:QX;\V^FC3:UTZ7#HC.?XF"X
M7)YP`.U?;'_!$_PKIV@_\$^?"-Y96=O;76L37ES?2HF'NY1<R(&<]20B*HST
M`JW^WG_P2PT#]O/Q]H?B#5O%FM^'KC0]/;3DCLH(I4F0R&0,=XR""2..,5[!
M^R9^S?8_LE_`;0?`.FZE>:M9Z$LH6[NE599C)*\I)"\#ER..PKYW"995IYG4
MQ+2Y&M/PZ&\JB=-1ZGI%%%%?1&`C_=KXW_X+N?\`*/O5?^PUIW_HVOLEAD5Y
M-^VC^R=I_P"VC\#KSP-JFK7VB6=U=6]W]JM$625&B?<!AN,'H:Y,?1E5PTZ<
M-VFD5"24DV?%7_!N%_R)/Q9_["6G?^BIJ_2ZOGC]@7_@GEH_[`FB>)K/1O$6
MJ^(/^$GN8+B9[Z&.+R?*1E`4(.<[CG-?0]<^3X6IA\)"C56J^8ZDKR;05YC^
MVB/^,/OBE_V*FI_^DLE>G5SOQ:^'4'Q<^%GB+PK=7$UK:^)-,N-,EFB`,D*S
M1M&67/&0&R,\<5WUHN5.45U3)6Y^,?\`P0@_Y/\`]+_[%[4/_08Z_;X=*^._
MV*O^"/'AG]BSXUP^-M-\9:_KUY;Z?/8);7=M#%%B7;N8E!DD!>![U]AH-J#/
M7O7C\/X&MA,+[*LM;M[FE::E*Z/C?_@L]^Q;K'[5_P``M/U3PK;/?>*?`MQ)
M>P62#]YJ%M(@$T2>L@VHZCN4(ZD5\:?\$8_^"@7AS]DWQ!XA\"^/II-%T/Q'
M>I=6^HS1D)IEXJB)X[@8W(K*%^8C",ISC.1^R3IN%?/_`.TW_P`$QO@_^U?J
M$NI>)/#*V.O3'+ZOI$OV.\D/_30J-LGU=6-9X[*ZKQ*QN$:4UNGLQQJ+EY)'
MN/AOQ3IWB_2(=0TF^LM4T^X4/%<VDZS0R`]PRD@U;NKV.QMVFF9(8HQN9W8*
MJCU)/2OSWB_X(%1^";V23P/\;_'GA>-FRL4<8&/J89(@?RK3@_X(6+XK9%\=
M?'3XG>*[7^.V,_EQM_W\>7^5=4<7CK6=#7_$K?Y_@3RP[_@?=GAOQ1IWC#3%
MOM)O['4[)V9%N+2X6>)F4X8!E)&000>>"*NRR^4N3T[GTKR/]D7]B/P/^Q/X
M:U#2O!*:U';:I(LUR+[4I+H2.H(#A#A$8@\E%&>,YP*]$^(O@/3_`(H>!]4\
M.ZLMP^EZS;O:7207#V\CQN,,!)&0RY'&017H4Y5'3O-6EVO^I$K7T,?P;^T)
MX#^(]U);^'_&?A;6KB&5H7BLM4@FD5U)!&U6SP16OXH^'^A>-X/+UC1=(U:-
MA@B\LH[A2/3Y@:^&O'?_``;Q?"O5KXW'ACQ3XQ\+/G*1F2*]CB_W2RJX_%S6
M5IW_``0X\;^%U:'1?VDO&]C:]!&L4Z;1Z86YQ^5>7]8QMK5:"EZ27ZHM1CW/
M3/V[_P!@']FV'X0:]X@\2Z/X?^'=U:VDLMOJ^F,MA-YH4E56%<),2V!LVDGH
M,'FOS._X)1:IXNT_]O+P"O@YKS[1=WHCU=(01'+IV#]H,XZ;`O()Z,%QSBOO
M#3/^#?\`T7Q+K$-YX]^+GCKQ>T?52%C<^PDE:5E_#%?7'[-/[&GP[_9%T22Q
M\!^'+326NE"W=ZY,U[>X_P">DS99AGG;D*.P%>=+*J^)Q4*[@J2CV>K^[0UC
M548\NYZBG3\:6BBOJSF"BBB@#YI_X*F_L<-^V%^RWJ6GZ9`LGBSPZYU;0C_%
M+*JD/;Y])4RO^]L/:OSH_P""-?[=2?LK?&JX\%>*KI[+P;XSN%AD>X)5='U%
M3L21\_=5\>6^>A"DXP:_:MXUDQN&<'(K\J_^"T?_``3+N-)U?4OC%X!TUY]/
MN\S>*=+MH]S6[][Z-1U1O^6H'0_/T+8^8SS!U:=2.8897E'==T=%&2?N2V/U
M2ADWQK_M<BI*_*__`()4?\%@K?PQIVF_#/XMZKY=A`%MM"\2W#Y6-!@+;W3?
MW1P$E/08#<?-7ZE6=Y'?6T<T,B313*'C=#N5U(R""."#ZBO8R_,*.+I>TI/U
M75&,X.+LR:B@'-%=Y(4449Q0`4$X%!.*\J_:T_;$\#_L<?#>;7_&&J+#)(I%
MAIL!#7VJ2`<1Q1]3[L<*O<BLZE2-.+G-V2Z@M79&7^W=^V-HO[%7P#U+Q5J#
MQ7&K3`VFAZ<7P^HWC*=BXZ[%^\Y[*/4C/Y'?\$WOV:-9_P""@'[:3:UXG,VJ
M:/IE]_PD?BJ]E7Y;N1I"Z0$^LL@QM'1$?VKG_BM\4_BC_P`%9/VK;.WM[-[K
M4KUS;Z/I,+$V6@V>X%G=N@`&&DE/+$`#&%6OV8_8A_8]T#]BKX%V/A'1]MW>
M%OM6K:DR[9-3NR`'D/HHP%5?X5`'7)/R-.4LWQ:J6_<T_P#R9G1)>SC9[L]>
MBA\K@!57L!T%2445]D<XFZDWU\:_\%HOVF/''[,?P2\'ZEX'U^;P[>:IXA6S
MN[B&WCFD>'R9&*A75AU`.`,G&*\]^*7[2&J?#_X<W6I:)\9/VC-2U1+<RVZS
M_#2.6`R;,J)-]E$%0GJ=_`R>:\JMFD*=25)K6*3>W57TU-%3;5S]#J`<U\Z_
M\$ROC_XR_:)_9LMM<\>:MX.U;Q#]J>-SH-PDC018&Q;E$)6.?[V57`QMX!R!
M]%#I7?0K*K!5([,SV"C-(YXKXX\#_M,>.-5_X+*>+?AG<:[))X'T_P`,)?6V
ME^1'MBG\JW;?OV[\YD?J<<U&(Q4:3A&7VG9>I48M['V112*<BEKI)"@'->!_
M\%(OVQ[C]AW]FB[\96&EQZOJUQ>1:9I\$Q*VZS2!B'E(YV*J,<`@DX&1G-<S
M\!/@O\4_C/\`"OP_XL\9_&_Q9:ZEXDTZ#4_L/AJPL;&PL5FC$BQJ7AD=RJL`
M6+<GM7'+&+VWL()N25WMHOF5RZ7/J*BO@?\`:U_:?^*7_!,?XC^";S5_&3?%
M+X=>++Q[*YM=7L;>VUC3RA0NT<T"HL@VOD;DZK@XR#7WI:S":WC8$L'4,"?0
M\U5'%1J3E3M9QW7J#BUJ29Q1NH/2O/?C5\'O$'Q0N;"31?B-XL\"I9JXECT>
M&SD6[+8P7^T0R'*X.-N!R<YKHE)I7BKDGH.ZE)Q7YV?`'Q-\7/BY_P`%!/BI
M\(;WXX>-;?0_`-H+BTNX+#31>7)8P`"0M;E,#S3]U1G`Z5]Q_!OX<:M\,_#<
MUCK/C+Q!XXN9;@S+>ZM';1S1J0`(U$$<:[1C.2"<L>:X\+C'73:BTDVNFZWZ
ME2C;<["DW4M0W3M%:R,OWE4D?4"NV3LKDDN[-&ZORP_8O_;A\<_'72?%5QXZ
M^+'Q7T^\TO53;6D7A3P5%J5N(2"?G=+.7:V<@*2#@`\YK[B_8^FO?$]A?^(&
M^('Q&\66$C&R2S\5:!%H[6\BX8R)&+:"1L@@;CE>N.<UP83,88A)P6_FOR*E
M%K<]NHHHS7H$@3BF[Z^1?^"A?[>WBOX(?&CP'\(_AQINFR^.?B&\:Q:GJBE[
M33(Y)O*5A&"/,?(=B"0`$[D@5Z!I_P"R=X^O=/\`,UCX_P#Q&GU9AEYM/LM-
ML[56_P!B#[._R^S,?K7%]<4JDJ=).3COLDG\_P!"N6RNSWP'-%<S\)O".K^!
M_!T&FZYXGU+QAJ$)8OJ=];06\TH)X!2%%3CIG&3WKIJZXNZN2%&:#TKXQ_X+
M-?M2>-_V6?AIX`U+P3KDVAW&I^)!;7S1VT<[7,"Q,YCPZMU(Z#!/3-8XK%1P
M])UI[+_,J,;NQ]G9H!KPRU_;\\'S6T;?V#\4LNH;_D0]6[_]L*\:_P""5G[7
M?C/]J'XU_'*+Q#K-[J&AZ%K$8T*SNK)+673K=Y;@"-E"APP5$!5\L".><UC_
M`&A1=2%.+NY=O+N'([-]C[8HHHKN)"BBB@`I"V*6FD9-`"[Z4'-?&/\`P2M_
M::\=?M`?%?X\:?XPUZ76K/PGXD%GI,;011BSA,MRI0;%!(Q&GWLGCK7V:G`K
MFPF)C7IJK'9W_!V')6=A:"<45\9_\%EOVC_'G[/'P]^';>`_$DGAB\\1^)!I
MMW=1VT4[>6T9QQ(I&`Q!XY.,4\5B8X>E*M+9#C&[L?98;)I<U\=_L_\`[?7B
M+X4?%J+X/_M%6]KX<\9NWEZ)XHC7RM&\6QYPK*W"Q2GC*\#.1A3@$_8#_:3\
M=_%K]M?]HGPGXHUN34M#\&ZLL.CVC01(+&,S3+M5E4$@JJ?>)Y%<T,RI2<(Z
MWDVK=4TKZKH5[-ZL^Q*"<"BFRYV<5Z)F+NP*0/DU\*?`+]KKXH?\%(OCGXXT
MOP3KT7PM^&_@69;26^@TZ&^UG5)6=U49FS'#D1,W",5!`R3G'OMA^RUXRT?6
M;&ZM?CM\2I$MY5>XM[VWTRYBND!R4P;8%<],@UY]#'*NN>C%N-[7T7ZW*E&V
MC/<**;$25YIU>@2%%%%`!4<]NL\3JRAE<;65AD,/0CTJ2BC<#\R_^"BO_!$#
M_A)+W4/&GP7M;>WNIRT]_P"%&98X9V.2SVC'Y48]XFPI/W2OW3\K?LM?\%)_
MC%_P3^UZ3PG?0W6HZ+IDGEW/A?Q"DD4E@<\B%F_>0]^,%#UQWK]W'7>N*\P_
M:+_8V^&W[56C"U\<>%-/UF:%2+>]P8;VV_W)UPX^F<>QKYK&9"_:_6,%/V<^
MJZ,Z(UM.6>J/!/@-_P`%QO@I\6K>WAU^_O\`X?ZM)@/!J\)>VW>BW$8*D>[!
M/H*^G?!_Q^\"_$&SCN-"\9>%]8AD&5:TU2";/_?+&OSS^-7_``;KVMW<S7/P
M[\?SV:,24L/$%KYZKZ#SXL-CZH37S[XH_P""$7Q^\.WK?8-+\*ZTJGB6RUE(
M2X^DJI^IK*.89M07+6H\_FO^!?\`(.6F]F?M3<^-=&LH6DFU;3(8UY+/=(JC
M\2:\K^+?_!0KX*_!:!SKWQ(\+QS(/^/:TNUOKACZ>7#N;/U`K\EH_P#@B?\`
MM(W<JQR>#]-C4_Q2>(K0J/KB0G\A7H'PU_X-[OBQK\J?\)%X@\&^%K5B-ZPO
M+?3`=\!51?\`QZAYQF4]*>&:];_Y+\Q>SAU9ZC^U'_P<(0_9;C3?A%X;F:1E
M*+KNO1[4CSQNBME.6]C(P]UKY+^"_P"S)\;O^"HWQ:FUZ:?4M6CN)`E_XIUD
MLMC9)GE(^@;`Z10C`[[>M?HU^SK_`,$*OA!\'[NWOO%']I?$35(3O']IXAL%
M(Z8MX^&_X&S#VK[-T/P_8^&=+M['3;.UT^QM$\N"WMHEBAA4=%5%`"CV`I1R
M?&8R7-F,_=_EC^I7M81^!'C?[$O[!O@O]AWP"VE^';=K[6;\*=5UNY0?:]18
M=N/N1@_=C7@=>3DGW!5VBBBOIZ-&%*"A35DNASRDV[L****T$>#_`+>W[#EG
M^W3X"T'0[SQ%?^&CH&JKJL-S:VR7#.P1D"E6(&/FSGVJ.[_9P^,M_IKVLG[0
MNJ11R(8VDMO!VG1S@$8RK\[6]#C@U[Y17++!TI3=1K5[ZM7MZ#YF>$_L5?L"
M^$?V(K'7&T&[UK6-:\42I/K&JZI.'FO'7<5^50%4`NQX!)+')/&/=ATHHK6C
M1A2BH4U9`W<1QE>.O:O"/#_[#NGZ!^W=K7QT77M0DU#6M(726TDP(+>(!(D\
MP29W$XB'&.YKWBBG4HPG9S6SNO45P'%%%%:`<?\`';X'>&/VC?ACJ7A#QAI,
M>L:%JB@2PL2K(RG*2(PY1U."&'(Q7C_PS_8Q^(7P#\+V_AWP-\;-4A\,:>/+
MT^P\0^'K;5Y+"+M$DX>)RJ]`&S@<=.*^D**YZF%ISESM:]UHQIM'R_K'_!->
MU^,?Q:T/QA\8/&VM?$R\\,/YFE:8]C!IFDVC;E8L8(LF3+*I.]SG:,Y`Q7T\
M@PHX_P#K4ZBG2P].FVX+5[^?J#DV%(XRII:*W$>#?![]AO3_`(0_MC_$#XPP
M:_J%[??$"V6VFTR2W18;$`Q$LKCYFSY0X(XR:]YHHK*C1A23C35DVW\WN-MO
M<*CGB,D3+_>!'YU)16NXCY!_9P_X)E^+?V2],UJQ\!?&S5=)L->OCJ%S#<^&
M+.[_`'I&W(+MD?*`#CKBO</A'\+?B)X-\5O=^*OBE)XSTUH&C6Q;PY::>$D)
M!$GF1?-P`1MZ'/M7IU%<E'!4J5N2ZMTN[?=>Q3DWN`Z4'FBBNLD\=_:O_8B\
M$_M?6>E-XBAU&PUKP_)Y^D:YI-Q]EU+3),ALQR<\;@K;6!&5!&#S6/HG[.WQ
MD\.6$=E;_'V\O;2%=J2ZGX0LKB]V_P"U*K(&;W*'WS7O5%<TL)3<W42LWNT[
M7];;CNSF?A/X/UKP1X46R\0>*+_QAJ7FO(^HW=I!:N0QR$"0JJ!5Z#@GU)KI
MJ**Z(JRLA`>E>"_MU_L,Z?\`MR>&_"VFZAX@U#P\OA?6%U>.2UMTF,Y"E3&0
MQXZ]17O5%95J,*L'3J:I]!IV(XD:.,#YCM&,DUX7^RA^PUI_[*?Q6^)GBJS\
M0:AK,WQ*U0:E-!<6Z1K8'S)7V*5.7YE/)QP!7O%%.5&$I1G):QV\@NPHHHK4
M04444`%-;('%.HH`\%_8W_87T_\`8^\:_$?6+'7]1UM_B-JW]J31W-ND2V)#
M2ML4J3NYE/)QT%>\KQ2T5E1HPHP]G35D5*3;NPKP;]N_]AC3_P!N7PWX5TV^
M\0ZAX=_X1?5UU:.6UMDG,Y"[=A#$8Z]17O-%%:C"K!TZBNGNB=CS_P#:(_9H
M\'?M2_#:X\*^-M%@UC2YQF-V^6XLY,8$T,G6.0>H^AR,@^6?L*_\$Y[']B+Q
MEXPUJ#QEKWBZZ\7);QR/JD2"6)82Y7<ZG,C$/@L<?='%?2=%9RP=&555G%<R
MV97,[6"D9=PI:*Z23YKU_P#X)NZ/X?\`C+J7Q`^%_BSQ'\*/$VN.7U1=*2&Z
MTS4V+%BTMI,I3)8D_*5Y)(P23746GP*^+T\T/]H?'*8V\4BNZZ?X0L;:28`@
ME2SF0`'H=H!KVRBN6.#IQ=XW7HVE]R=BN9C8L[>:=11742%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
>1110`4444`%%%%`!1110`4444`%%%%`!1110!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>mccarthylogo_p1.jpg
<TEXT>
begin 644 mccarthylogo_p1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`&X!
M+`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HHK)F\?:%;RM')K6DQR(2K*UY&"I'4$9H`UJ*S-<\:Z-X8\+
M7&N:EJVF:?HMK$9YM0N;I(;6&,<EVE8A54>I.*^:;S_@N!^R-8>*AHLG[0?P
MS^WL^P!=55X<_P#74`Q_CNQ0!]4T5D>!?B!H/Q1\*V>N^&=:TGQ%HFH)YEKJ
M&F7<=W:W"^J21DJP]P:P?C=^TC\/_P!FKPW_`&Q\0O&WA?P7IC<+<:UJ<-FL
MI]$\Q@6//1<F@#M:*^9/AC_P6<_94^,7BR/0_#WQ[^&MYJDS;(X)=62U\UN<
M*K3;%8G'`!)/&.HKZ9AF2XB62-EDC<;E93D,/4&@!U%%</\`%/\`::^&_P`#
M&5?&WQ!\#^#VD&5&N:[:Z?N'MYSKZ4`=Q17(_"[]H#P'\<+>2;P7XV\(^,(8
MP"[Z)K%OJ"H#T),+L!FNNH`**"VT9/`'4UX-\<_^"HO[.O[-.K3:?XX^-'PZ
M\/ZE;_ZZRFUJ&2ZA[8>*,LZGV(%`'O-%?-?PK_X+&_LL?&K6X=-\-_'KX9WE
M_<,(X8)M:BM'F8D*%43%-S$D`*,DD\"OI"TNXK^UCF@DCFAF4.DD;!E=3T((
MX(/K0!)117FOQV_;+^$O[,,:GXB?$KP/X+DD7>D.L:U;VD\HZ92-V#M_P$&@
M#TJBOE'P[_P7-_9#\4ZP+&S_`&@_AN;@ML_?:E]G3/3[\@5?QSBOI7P%\1O#
M_P`5/#5OK7A?7M&\2:/=#,-_I=['>6TP_P!F2-F5OP-`&S139)%AC9F9551E
MF)P`/4UDCXB>'S_S'-'_`/`V/_&@#8HIOFKY>_<NW&=V>,>M<38_M.?#;4_B
M1#X-MOB%X'N/%]T7$.AQ:[:OJ4I12S[;</YAVJ"3A>`"30!W%?@?\?/^#T'Q
M+\%_CMXS\'Q_`#0]0B\)Z]?Z,MTWBR6-KI;>XDA#E?LIVE@F2,G&:_863_@I
M3^SG#(RM\?O@HK*<$'QQI@(/_?\`K^+G]M#6;/Q%^V)\6-0T^ZMK[3[[QEK%
MQ;7-O*LL-Q$][,R.CJ2&5E((()!!!%`']F7_``2X_;3NO^"B'[!WP_\`C)>^
M'[?PM=>-8;R5]+@NS=1VGD7MQ:@"0JI;(@#?=&"V.V:]_K\OO^#=O]N?X)_"
M3_@C5\%?#OBKXQ?"SPSX@TVUU-;O3-6\66%E>6I;5KUU$D4DJNN496&0,A@>
MA%?>7PW_`&W/@O\`&3Q=;^'_``A\7?AAXJUZ\#-!INC^*;&^O)@JEF*Q12L[
M84$G`X`)H`_G0_X.V_C]X[^'/_!67^S?#OC;Q9H>GKX,TN3[)IVKW%K"KE[C
M)V1N%W'`R<9Z>E?6?_!EK\6_%7Q2\)?'D^)O%'B#Q&UG>:2(/[4U":\,`9+G
M=M,C';G`SCTKX@_X/#SG_@K]]X''@C2>!V^>YKZ^_P"#'H_\4=^T%\P_X_-'
MX[_<NJ`/WLHKP+XV?\%3_P!G']G/Q-)HOC7XU_#G0=8MW6.:QFUF*2YMV.,"
M2-"S(>0?F`X.>G->@_`;]J/X;_M1^'&U;X<^.O"GC;3X\>;+HVIQ7GD$YP)%
M1BR$X/#`&@#O**JW^M6>E,JW5W:VS2<J)953=],FFV7B"PU*;R[>^L[B3&=L
M<RLWY`T`7****`"BLJY\=Z'9W#PS:SI4,L9*NCW<:LI'4$$\59T_Q#I^K0>9
M:WUG=1@[2\4RNH/ID&@"Y7\+?[>'_)[GQ?\`^QSU?_TLEK^Z2OX6_P!O#_D]
MSXO_`/8YZO\`^EDM`'HWQ*_;P^-W[:WP&^%?[/NAIX@O_!_P_P!+BTS3/"OA
M^":X?6+@.[&YFBC!::3,FU1@A0!@`DD^,?&;]F?XD?LY7EK;_$+X?^-_`=Q?
M*6MHO$6A76EO<`=2@G1"P^E?TP?\&BO[$7A7X-_\$Y['XM'1[&3QU\3KV[>7
M5GC#7$5A#,T$5LC'E$W1.[`8W,PSG`Q];?\`!;K]EWPW^U=_P2_^,>BZ_I=G
M?W6B^&+_`%W19Y8PTFGZA:V[S0RQMU4[DVMCJK,.AH`_F&_X(_\`_!;CXE?\
M$D_'VI2:/YGBKP+K%I.EYX6O;EULS=&-O(N8\']VZR;=Q7[Z%P>=I7RGXS_%
MG]H#_@K5^T-JGB;4K+QW\5_%U](\J6.CZ;<ZD-.B)R(;>WA5_*A48`50!QSD
MY->`U_:=_P`$6/V(_"O[#7_!.SX9^']!TNSM=7UK0K36M?OE@5+G4;ZYA6:0
MRN!N;87\M<]%10,4`?QH_$KX4>*O@OXJGT+QAX:\0>$]<M<>=I^LZ?-874.0
M"-T4JJXX(/(Z$5^W'_!I%_P6!\5#XV1_LS_$#7+S6O#^O6DUSX-N;ZXWR:7<
MPH99+-68Y,4D:NRKD[73`'SX'UQ_P>(_LQ^'OB+_`,$SH/B3)I-JWBKX=Z_9
M+;ZDL(\]+2[D%O+"7QGRVD:%L$XW(.,U^!/_``1D\:S?#[_@JU^S_J4+2(__
M``F^FVI*`$E9YEA(Y/0B0Y]J`/W6_P"#G'_@O5KO["B6OP1^#NJ+I_Q*URQ6
M^UO7(2KR>'+23<(XXNH6YD`+;B,HFTCE@1^`_P"SQ^QM^T!_P4X^(>K7'@;P
MIXS^*&M1-YNJZI([3K"S$D>?=3,%#-DD!GW'D@'FNH_X+4?%&^^,/_!6#]H#
M6M0EDED7QKJ&GP[VW>7!:RFVA0>PCB0?A7]3W_!!W]EWP_\`LI_\$I/@QI>B
MV=O#=>)_#5CXJUBXC1`]Y?7]O'<2,[+]_8'6)6.?DB0=J`/Y2?C#^RM^TI_P
M2@^)&DZQXF\.^/\`X1:XTF_3-8MY)+>.=TPV(KF%BCD9!*AB>>17]/\`_P`&
M]7[>'Q>_;I_8$M?%GQJ\,76CZGI,QM++Q-<0BUA\76BKG[:(SC:5(*LZ@1N1
MN7'('V#\??V<_`O[4WPYG\(_$3PKHOC#PW<31W#V&IVRSQ"6-MR.`?NLIZ$8
M."1T)%?'/_!Q5^TR?V&/^"._CS_A$XX=%OO$$%MX-T9+-/(CL$N3Y<GEJ@`7
M;;+,%`P`=OI@@'X__P#!?3_@Y.\:?M1_$WQ!\*?@;XCNO#'PFTB9K&ZUK2YF
MAOO%;K@2-YRG*6N\$(J$&1>6)#!1^7/P+_9F^)'[57BN;2?AWX'\6^/-64>;
M/#HNF37TD0.3OD**=H//+$"LWX&?"#5OV@_C1X4\"Z"J/K/B_5K;2+/><()9
MY5C4L?[H+9)]`:_MD_X)^?L!?#[_`()P?LX:+\.?A_I5M:V]C"AU+4O)5;S7
M+K'SW-PX&6=B3@$D(N%&`!0!_&[^T-_P3<^/G[)^CMJ7Q&^$/C_PEI:D*VH7
MVCRBR4^AG4&,'V+5]2?\$3O^"[?QH_X)_?&?PYX/6ZU[XD?#/7;Z#3Y_",ID
MO9[?S'1`^G#EDF`X6)?D<X!7."/ZX/$'AW3_`!;HEUINJV-GJ6FWT;0W-K=0
MK-#<(PP5=&!5E(X((Q7QW^R5_P`$%/V=/V,OVN_%7QE\(>$T_P"$BUV7S-+L
MKM8YM/\`"A;#2&PB*_N69@<-DE%)1-JD@@'RK_P<Z_\`!93XQ?L`_#[P?X3^
M%/AW5?"[?$33S=S^.;JU!_L[D@V5NIR([L`!G,@^56&T$Y9/YTOAO\%OC-^W
M]\5[Q?#/AWQY\5O%U\YFO)K:WGU.XRQ+%YI>=@)S\SL!FO[3?VW/V)?A_P#\
M%!/V>=:^&?Q(TK^TM!UA=R2Q%4N]-G7.RYMY"#LE0G@X(.2"""0?GOX=_M(?
ML/?\$8?AE;_##3/B-\+OA_'I*K]LL(]1CN]8NY<<S7:PAYY)6Y^9U]A@```'
M\P7QP_X(K_M5?LY>!9_$WB_X&^.M.T&TC\VYO(;1;U+1.[2^0SF-1W9@`/6H
M?^"9'_!5GXI_\$N_CAIWB;P5K5]<>'6G4ZWX8GN7_LW6H>0RO'G"R`$E9`-R
MMCJ,@_U#2_\`!Q?^Q+/$T<GQ[\+NC@JRMIVH$,#U!'V>OY7O^"IS_"VX_P""
MA'Q4NO@KJ%AJ?POU#6#?:#/8P/!;".:*.62.-'565$E>1`"HP$XXQ0!_7QXI
M_:)\._M:?\$OO$GQ+\)S^=X>\:?#O4=5LFEQNC62PE)1P.C(VY&'9E(K^(VP
MG6UOH9&SMCD5CCK@'-?T^?\`!OAX^O/&G_!MAXLM+I_,_P"$=T[Q9IMOOSM6
M+R99@.2>,RMZ#V[U_+[0!^EG_!7?_@XL^)7[;=_#X#^&>O:UX#^#VAV<.GQP
M64C6E]XB:--C3W,BG>(VYVP@A0N"P+=,/_@URLKN7_@M;\)[R2*9HGCU;=,Z
M$JS'3;D_>]3_`(U]]?\`!LC_`,&_7@#XB_`+2_VA/C?X:L_%UQXEE:7PGX>U
M2$3:=!:1O@7D\+#;,\CJVU6R@0`D$M\O[J>%?A7X7\"PV\>B>&]!T>.S4)`M
MCI\5N(0%V@*$4;1MXX[<4`?PE^)/A?XF;Q%J!'AW7?\`CYD_Y<)?[Q_V:Y>>
M"2VF>.1&CDC8JRL,,I'!!'8BO[\/[%L_^?2U_P"_2_X5_#!^W.H3]MGXQ*H"
MJOC?6@`.W^GST`<%IO@#7M9LH[FST75KJWESLEALY)$?!P<$#!Y!%?HE_P`&
MM_@/7M$_X+0?#2XN]%U2TMTL]5WRSVDD:+FPF'4C%?N]_P`&S^EVMQ_P0^^!
M+R6]O(S6FJY9HP2?^)S?U]X0:9;VTF^.WAC8?Q+&`:`/Y6_^#P\_\;?OX?\`
MD2-)Z=OGN>O^?2OBG]FC_@I#\4/V0_V=OB!\._ASK4_A>'XF7-L^L:K8R-%J
M!@A25!;Q2+@QJ_FG<5^8@``@9S]K?\'A_P#RE^_A_P"1(TGIU^_<]??^F*O?
M\&E?_!.CPI^VA^V?XG\:>/-%L?$'AGX3Z?!>6VG7L0FM;K4KB1E@,D;?*ZQK
M%*^U@1N"<<4`?G#J_P"RQ\5K7X>/XZU#X<?$*/PG,V]_$%QX?O%TYV;G)N6C
M\LD]?O<U-^RM^UK\0/V+/C'I?CKX;^)=1\->(-+E6026TI6.Z0')AF3[LD;=
M"K`@@^O-?W4ZCH%CJ^AS:9=V5I=:;<0FWEM)85>"2(C:49"-I4CC!&,5_&-_
MP79_91\/_L4_\%7/B]\/O"=BFF^%]/O[;4-*M(_]7:P7EE;WGE)Z)&T[(!V"
M`<]:`/U<_P""SOB2V_X+,_\`!!WX>_M6>$(6TWQ?\-[ACK]G:RE&M(V<6]_"
M,$DJDRPS("<^6<]3BOR'_P""3G[>6M?L*_\`!0/X9_$275M0;1=/U>.TUR)K
MABLVG7!\JY!!R#B-BP]T%?M1_P`&?^BZ?^T+_P`$K?C?\-/$UNNH>'[[Q/=:
M;<6\GS(UM>Z="LBX[<ASD8Y([BOP)_;/_9CUC]C+]JOQ]\+M>25=0\$ZS<:;
MYCKM^TQ(Y\J8<#*R1E'!Q@AA0!_=/IFIV^M:;;WEI-'<6MW$LT,L;;DE1@"K
M`]P00<UYQ^VC^TUI?[&G[*/Q`^*6LF$V/@C1+C4_*E?8MS*B'RH<^LDA1`!R
M2XQ7R!_P;$_MP-^V=_P2L\)6NI7OVKQ-\+'_`.$,U,/_`*UH[:-#:2-SEMUL
MT2[S]YHWZD$GY'_X/1_VW_\`A"O@;\/_`(#:3>;+[QE='Q'KJ(Q#"RMR4MT.
M#]V2<NV"/^7<>]`'\\_Q4^)6K_&;XF^(?%VOW4E]KGB?4;C5+^X<_--/-(TC
MM^+,:_L#_P""#W_!/;3_`-B+_@F)\.O"^M:1;MXIUNW;Q)KQN8%,BWEYB3RS
MG./+B$,7_;+/4FOYI?\`@@K^PPO[?_\`P4X^'OA'4;077A71;@^(O$0:,M&U
ME:8D,3=L2R>5%SQB0GG&#_9HJA%"@8`X`]*`"OX6_P!O#_D]SXO_`/8YZO\`
M^EDM?W25_"W^WA_R>Y\7_P#L<]7_`/2R6@#^K+_@V9_Y0F_!3_KVU#_TXW5?
M27_!0<X_8-^-7++_`,4-K7*]1_H,W2OFW_@V9_Y0F_!3_KVU#_TXW5?27_!0
M<[?V#?C2=S+_`,4-K7('(_T&:@#^&.O[P?V7#G]F7X=<L?\`BF-,Y;J?]$BZ
MU_!]7]X/[+C;OV9?AT=Q;/AC3>2.3_HD5`'Q%_P=:[O^'(?Q0V[<?VCH>[/I
M_:UKT_'%?S+_`/!*S_E)C^S_`/\`90M#_P#2Z&OZ9_\`@ZWV_P##D3XG;MV?
M[2T/;@'K_:MKUQ[9Z\9QWQ7\S'_!*S_E)C^S_P#]E"T/_P!+H:`/=/\`@Y(_
M9(U;]E+_`(*V_$Z2ZLY(=%^(E^_C#1IRF([F*[8O,%.`/DN/.3`Z!1ZU^NW_
M``;K_P#!P!\'M:_8E\(_"/XO>.M#^'_C;X:V*:)9W/B"\2RLM8T^$*EJ8YW(
M3S$CVQ&,D,1$&&<G'WA_P59_X)*?#7_@K/\`!"'POXVCFTK7M&9Y]`\1V2`W
MFD2L,$8.!)"W&Z)C@X!&&`8?@#\>_P#@S[_:J^&?BR:V\'GP7\1='WL(+ZTU
M5=/E9>QDAN-NQCZ*S@'N>M`'ZS?\%//^#H[X#_L:_#ZXM?A;X@T'XS?$2X81
MVMEH]WY^E67(W27-U'\F`,@)&68MP=HR:^1_^#@G_@H;X,_X*G?\$)O`_P`3
M?A[>306]KXZLH/$>BS$-=:+=FUN08)L'IN(9'QAU((QR!\X_LK_\&</[1?Q/
M\76G_"SM8\(_#7PXL@-W)'>C5=09.XBBB_=[CTRT@`SGG&#^MG[2O_!!SP#X
M1_X(H>/OV</A%H^W5KBS76;/4+LJU]K6LV\B3I+/)C[TGEF(#[J))A0`*`/Y
MPO\`@B'KNG>&_P#@K?\`L^WFJ^3]A3QG9(QE("JSML0G/'#LI^HK^U6OX&=.
MU#6/A?XX@NK>2]T7Q!X=OEEB=2T-Q8W4,F01T*NCK]017]9?_!)/_@XO^"O[
M=GP3T.S\<>,?#OP[^+-G;I;ZQI&L7:V4%[,H(-Q:RR$(Z/MW;-VY"VTY`#,`
M?HW17S?^TM_P5X_9M_9-\%76M^,/C#X'C2V0LEEIVIQ:C?W;#'R100%G9CD=
ML#J2`":_-']CK_@\&\/?&W_@H+J/A/QQX9M?!?P9\23QZ=X7UB:7_3-+F#E5
MGU`YV".8$%@G$)"C+C<]`''_`/!UE_P7`\8_"+XCO^S;\)=>NO#KII\=SXRU
MK3YC%>$S@E+"*13NC'EE7D(P3YBKD#<#^/W[`/\`P2V^-_\`P5%\<:E8?"WP
MS)K$6ELK:MK-_<"VT^P+YV^;,_5VP2$4,Y`)Q@$UZ;_P<8Z1>Z5_P6=^.3WB
MN%U#5;>]M6+;A+;R6<#1NI_NE>1BOU^_X,X?VN_AFW[$6M?"-M:T71_B3I_B
M>[U2;3KB=8KK6+>:.+RYX@V/,V"-D*KG:$!.-U`'Q!;_`/!E[^U#-;QN_C#X
M-PLR@LC:M?$H?0XM"./8XK\W/VWOV0?$G[!/[4WBWX1^+[S2+_Q'X-FA@O9]
M+E>6TD,MO%<+L9T1B-DJ@Y4<@_6O[.OVV/\`@H?\(?\`@GU\+[_Q1\3_`!EI
M.AQVL+26^F_:$?4M3<#B*WM\[Y'.1T&`#DD`$U_&/^W3^U-??MM_M@?$3XKZ
MC:FQN/'.M3:DMJ7W_9(20L,6>^R)47/^S0!_09_P;?C/_!N3\4.%/_(U\-T/
M^A=Z_F;K^F3_`(-OQN_X-R?B>-H;_D:^#T/^A5_,W0!_<U_P3P\,6?@K]@3X
M(:3I\*PV>G>`M#MX4'.%73X!R>Y/4GN237L5>6_L-C;^Q1\'QM"X\$:+P.@_
MT"&O4J`"OX5_VZ?^3W/C'_V/&M?^E\]?W45_#O\`\%.OA_>?"W_@HK\<-"U"
M%X+JR\;ZL61^N'NY)%/T*N"/8T`?U-?\&S/_`"@Z^`__`%Z:K_Z>;^ONZOQ6
M_P"#6C_@K]\'=!_8!T?X+>/O'7AWP1XP\!W]Y'8P:W?)9QZI9SS272O#))A"
M5>2563.1@'&#7Z@^!?\`@HM\"?BC\:=.^'7AGXL>!?$?C;5H9;BUTC2]5CO+
MB6.)"[M^[+!<*">2,@'&<&@#^;W_`(/#QC_@K]T7_D2-)Z=_GN>M?7W_``8]
M+_Q2'[03;5S]LT<9_B^Y=?I7R#_P>'C'_!7[[H&?!&D]._SW-?7W_!CT/^*/
M_:".T?\`'YH_/_`+J@#][*_D;_X.M1C_`(+>?%#A?^0=H?3O_P`2JUZU_7)7
M\C?_``=:C'_!;SXH?*!G3M#Z=_\`B56M`'Z9?\&1G_)G7QGX7_D<K?GO_P`>
M,?\`G\Z\#_X/0_V$%\&_%[P)^T%HUJ([/Q="/#/B#8F`+V!6>VF8CO)#O3G_
M`)]U]:]\_P"#(P?\8=?&?Y1_R.5OSZ_Z#'_G\:_1O_@K_P#L46__``4`_P""
M=WQ+^''D1S:S>:7)J&@LP_U>IVZF6VY[;G7RR>RR-UZ4`?S[?\&CG[>,?[,'
M_!0>^^'NN:A':>$_BYICV8,TI2.#4K?,UO)R=OS()H^F273GC!^2O^"T7[<$
MW_!03_@H]\2/B`EQ+-H*Z@VC^'U9LB/3;4F*$@9(&_#2D#O*?K7S1G4O`OB<
MX-UI>KZ1<D9!,<UK-&V/JK*P^H(K>^`7P8UG]HWXW^$_`7A^(S:YXQU:VTBR
M7&[][-(L8)]ANR?8&@#^BS_@S0_88_X51^R;XN^.6K6?EZO\3KW^R](>1/G3
M3+-V#,O<++<%\^OD(>F#7[15PO[,/P`T/]E;]GGP9\.?#<"V^B^#-(M]*M@`
M`9!$@5I&Q_$[98GN6)KNJ`"OY#?VP_\`@A7^UUX\_:R^)VN:/\!_'&H:3J_B
MC4KZSN8HX=EQ#)=2.CK^\Z%2#Z\U_7E7\E/[7?\`P<+?MD?#K]JSXDZ!HOQP
MUNQT?0_%.I65C;+I.FLL$,=U(B("UN20%`')/2@#^A+_`(('_`;QA^S+_P`$
MH/A3X)\>Z!?>%_%FB07JWVF7@`FMB]]<2*&VDCE'4]>]>\?MI^#]4^(7['OQ
M4T'1+6:^UG6O".JV-C;1`&2XGEM)4C1<\99F`&?6O#_^"$/[17C3]J__`()6
M?"OQ]\0M=G\2^+M>@O7O]1FABB>Y*7UQ&N5C54&$11PHZ5]>4`?QC#_@W_\`
MVRSC_C'OQY\PS_JH?_CE?V%?L^:%>>%_@)X'TS489+?4-.T"PM;F*08:*5+>
M-74CU#`BNOHH`_.?_@ZU#'_@B'\4-I4#^T=#W9'4?VM:]/QQ7\S7_!*6WDNO
M^"FO[/Z1QO(__"P=$.U5W'`OHB?R`)_"OZ9_^#JRT>__`.")WQ*ABADFGFU3
M0DB2-"S,YU:U```]>GU(KQW_`(-K?^"`\/[#7@VS^-?Q:TN.7XO^(;4-I.F7
M$?/@ZU<'((S@W4BD;CC,:_(.2^0#]>***\)_X*??%?Q!\"O^"<_QP\9^$]2D
MT?Q-X7\$ZKJ>EWT<:2/9W,5K(\<@5PRDJP!PP(XZ4`>[45_'=H?_``<@?ML7
M6M6<4GQZUYHY)4C8?V1IG*E@#_R[?KUK^P7P[=27OA^QFE;=)-;QN[8^\2H)
M-`'X]_\`!<[_`(-=;/\`;;\<ZM\7/@=>Z;X:^(VJ,;C6M!O#Y>G>(9<`>=')
MG%O.<?-D;'/)VMEF_!WXW?\`!([]IK]G;69K'Q;\#?B-8S0L5,EKI$FH6[8&
M25FMA)&R_P"TK$>]?VY44`?P^_"7_@ES^T=\<]>ATWPO\$?B;J-U.`RF30+B
MUBP>C&6940#W+`5^R7_!'#_@T>U#P)X^T7XD?M0/I=Q_9,J7ECX"LYA=1O.I
M5T:^N$8QNBL.8(]ROT9RN4;]\**`/R;_`.#B_P#X-\[[_@I-::;\3OA&NFV?
MQ8\.V"Z;/I<S):P>)+./)BC$K%4CFCW$*SX4K\I*A5(_G6^*/_!.#]H3X$>*
MYM*\2?!SXEZ3J5JYC;9H-S-'G_9EB5D;ZJQ!K^XVB@#^-/\`8Q_X(+_M3?MU
M^,[*TTOX<>(O#.AR,INO$'BJ%],L;*(G&_\`?`22_P"[$CM[`<U[)_P4*_X-
MFOCS\`_VB3X5^#_PY\:?$[PC8:399\2P0Q)'J=XT(:Y8(9/W:B0LH3)P%'+'
M)K^LBB@#\M?^"%G[&/Q1_9R_X(:?$#X;^.?!.L>'/'&K?\)&+31;T(MQ<?:+
M79#C#$?.W`R:_`__`(A__P!LO_HWOQY][;_JH>O_`'\Z>_2O[.J*`/._V0_"
M^H>"/V3OA?HNK6<VFZIH_A+2K*\M)?\`66LT=G$CQM[JRD'W%>B444`%?BS_
M`,'(/_!NCXB_;6\<W7QU^!MG9WGC^2U2/Q'X;+I;OX@\I51+F"1V$8G6-0K(
MV-X1<'=PW[35^<?_``<^?MI?$_\`84_X)]:+XP^$_BRZ\'>)+CQA9Z=)>V]M
M!.SV[V]RS1[9D=<$HIZ9XH`_E_\`'?\`P3W^._PRUV;3==^#?Q.TZ\@<QNC^
M&KMAN'&`RQE6_`FOK;_@BI_P3S_:S\$_M_?"SXC^#_@OXZM['PKX@MKC5+K5
MK0Z/;?8"^R[0R7)C!S`T@"C))Q@'I7N'_!%7_@N=^U=^TY_P5"^#_@/QU\8M
M8\0^$_$6KO;ZCITVFV$:74?D2MM+1P*XY4'AATK^G:@#^=7_`(.=_P#@E5^T
M/^V-_P`%.&\7_#'X2^*?&/AD>$M.LCJ-@D9A:>-IRZ99P=RAEX]Z^G/^#2;]
M@?XQ?L.^%_C1'\6OA]KG@67Q%<Z8^G#4@BM=K&EP'VA6/W=RYSC[U?//_!S'
M_P`%AOVE/V'_`/@I1_PA'PK^*&J>#_"O_"*Z=J/V""PLIT,\CSAY-TT+OSL4
M8SCY>E?2W_!J#_P4:^-7_!0+PS\9;CXP^.K[QM+X;N]-337N;2VM_LHE2<R`
M""-,YV+USC'&.:`/U^K^:?\`X.+?^"1W[27[6/\`P5J^(7C;X<_!WQ9XK\*:
MI9Z3#:ZI91QF"Y>+3;:.3!9P?E=64\8RIK^EBB@#\G_^#3/]B;XK?L1_LP?%
M31_BQX%UKP+JFM>*(+VR@U)55[J$6B(74*QX#`BOU@HKSG]KW]HW2?V0_P!E
M[Q]\3M<9?[-\#Z'=:LZ$\W#QQDQQ#_:DDVH/=Q0!_(W_`,'#'PH\'_!S_@L#
M\:-*\$WD5QIMUK']J7D,2[4L+^Z1;BZ@7MA99&.!PN[;VKZV_P"#.?\`87D^
M-G[;NO?&35K'S/#_`,)]/:'3Y7'ROJMVIC3'/\$'G,<YP73ZC\GOC3\6-8^/
M?QB\5>.-?F:YUWQAJ]UK6H2$D[Y[B9I9#_WTYK^O7_@WC_8;;]A#_@EQX!T3
M4=/%CXJ\81'Q7KP9<3"XNU5HXW]XX!"FWL5/?.0#[@HHHH`_)[6/^#R']E/0
M]7NK&?P[\:O.LYG@DVZ!8D;E)4X_TWU%?S.?M-_$>P^,/[1WCWQ9I27,>F>)
MO$-_JMHMP@298I[AY$#@$@-M89`)&>YK[\\8_P#!J9^VGK/B[5+RW^'WA]K>
MZO)IHRWBS3MQ5G)&?WO7!K\Y/B)X"U+X5^/];\,ZU"EOK'AZ_FTV]B202+'/
M"YC=0RY#`,I&1P:`/W=_X(Y_\'.?[._[!'_!.?X=?"?QMHOQ2NO$WA2&ZCO)
M=*T>TGLV,MW-,NQWND8_+(N<J.<_6OOK]A?_`(.8OV>_^"@_[2^@_"GP/H_Q
M.L_$OB)9VM9=7TBUM[0>5$TK;GCNI&'RH<84\^E?SV_LH?\`!O%^U-^VK\!-
M!^)GP^\&Z+JGA'Q*DKV%S/XBLK6241RO$V8Y)`RX=&'([9K]`?\`@A5_P;X_
MM0_L.?\`!3'P'\2OB+X/T/2?"6@QWJWES#XAL[N1#+:R1IB..1F.68#@<4`?
MT.DX%?!W[>?_``<=_LP?L">*+SPWK7BJ^\:>+[!S%<Z-X5MUOY+208RDTQ=8
M8V&>5+EA@_+D8KY._P"#K3_@M3K'[)_A:S_9^^%^L7FC^.O%=DM_XCU>SE,4
M^D:<Y(C@B=3N6:;:Q)&"L8XY<$?A3_P3F_X)I_%/_@J;\>6\%?#>PAFFMT%W
MK&L:A(T=AHT#-CS9Y`&.6.=JJ"SD'`X)`!^V/B;_`(/+?@!\3KBUTOQ1\"?'
M6H:%;WL-\K7%Q97'ES0.)89?)+`%DD56&6X(!Z@5^AW_``3Q_P""X'[/'_!3
M*?\`LWX>^+GL_%:H7?PUKL(L-5V@`LR)N9)E&>3$[XP<XK\DO%/_``9#>,K/
MX>R3Z/\`'+P[?>*(XBPL[G0Y8+*5P/N"82,R@GC<4/TK\@?CI\#/BE_P3B_:
MCN_#'B:UU;P/\1/`]\D\,]M,T<D3J0\5S;S+C<C<,LBG!'XB@#^U+]M']KGP
MQ^PG^S3XG^*OC*VUF[\-^$X8Y[V+2H$GNV5Y$C&Q'=%/S.,Y8<9K\A?^"A'_
M``=>?LS_`+4O[#'Q<^&_AO0_BW!K_CKPEJ.AZ=)?:)9Q6J3W%N\:&1EO&94W
M,,D*2!V->E?"W]J/QI_P<*_\&\7C[PWX=M+#5/C=!'!X<UNQ^T16,5S=Q303
M)<YD8*B30C?R0-ZR*.F*_'SXZ?\`!M'^UQ^SC\&?%/C[Q9X'T&R\,^#=+N-8
MU2XB\36$[PVT$9DD8(DI9B%4G"@DT`?"&D72V.JVLS[MD,J.V.N`0:_J`T+_
M`(/*?V4--T2SMY/#WQJ,EO`D;;=`L<9"@''^F^U?R]VML][=1PQC,DS!%&>I
M)P*_1JR_X-1OVUK^SAN(_A]X=:.9!(A/BS3AD$9'_+6@#^BG_@EO_P`%F_A-
M_P`%=/\`A.O^%7Z=XVL/^%>_8/[3_P"$@T^"T\S[9]I\KRO*GEW8^R2[L[<9
M7&<G'#?&K_@Y0_8__9[^+GB3P-XJ^(^J:?XE\)ZA-I>IVR>%]3G6"XB8HZAT
M@*MA@1E20?6O`/\`@UJ_X)._&S_@E]_PO3_A<7A[3=!_X3C^P/[(^R:M;7_G
M_9/[3\_=Y+MLQ]IAQNQG<<=#7X`?\%A?^4J'[07_`&/FK?\`I2]`']A?PS_;
MX^$OQ6_9&L?CMI_C"QL_A7J-K->1:[JJ/IT0BBEDA<LLP5U/F1.`"N3C@'(K
M\Z/V@_\`@\L_9O\`A?XFN--\&^%_B!\1H[64QMJ%M;Q:=9S8ZM$9F\QA[M&N
M>W'-?SV_%?\`;G^(GQZ_9A^%?P.^V7L?@?X;Q3Q:=HUF[LFI7EQ=33FXD0?Z
MR0>=Y:#!V@''+-GT[X4?\$"OVP/C-X4AUO1_@3XT@T^Z3?"VJ11Z9+(O8B*X
M=),'J"5`(Y&10!_8UX:^)>FZU\*M-\7WDT&CZ3?:7#JLLEY,L<=G%)$LG[QR
M0H"AN23CBOSM_:O_`.#L7]E']FOQ/=:'H^J>)/BAJEFYCF?PQ9(]BC`D$?:9
MG1'Z=8]X]Z^6O^#JGX:?M):)^PO\*CX?O+R'X(^']!LK+QMI.EAUNH=16-46
M2]9"1):#"JH^XD@RV2R%?S._X)J?\&Z_[0W_``4M\-6_BG1=+T_P/X!N3^Y\
M0^)3);QWZ_WK6%4:2=<\;P`G7Y\@B@#]6O#_`/P>V_!N]U2./4O@[\2+"T8X
M::&]L[AE'^YN7/YU^A7_``3U_P""R_P`_P""FUK-#\,O&`_X2&U3S+CP[K$0
ML=7B7&2PA+$2*.[1,ZCN17XD_'/_`(,K?C7X&^'\^I^"?B9X'\;ZQ:Q&1M)F
MMI],>YQSMAD;>A8]@^P9_B%?DQX%\=>._P!CKX^VNLZ-=ZQX+\?>!=4;:Z%K
M>ZT^ZA8J\;#KU#(RG@@D'()H`_NP\:^,-/\`A[X-U;7]6F:WTO0[*;4+R58V
MD,<,2-([!5!9L*I.`"3VK\_/^(K+]B#_`**GJ_\`X2&K?_(]>H?`7]M&'_@H
M/_P10OOBRL,=K?>*/AYJW]J6L'2VOH;6XAN44=0OFQN5SSM93WK^,F@#^^;P
M%XWTWXF>!M%\2:/,USI'B"P@U*QF:-HS+!-&LD;%6`9<JP."`1G!%<I^U/\`
MM0^"_P!C#X">(/B9\0]4FT;P;X72&34;R*TENFA$L\<"8CB5G;,DJ#Y5.,YZ
M`FL[]AOC]BCX/?>'_%$:+PW7_CPAZU\Q_P#!S-_R@Z^/'_7II7_IYL*`,[P!
M_P`'//[&7Q/\>:)X:T7XF:K=:QXBOX-,L86\*:K&)9YI%CC4LUN%7+,!DD`9
MYKQ#_@\Q_P"45_A__L?+#_TFNZ_G%_86_P"3W/@Y_P!CQHO_`*7P5_1U_P`'
MF/\`RBO\/_\`8^6'_I-=T`?B)_P;N?\`*9[X"_\`8=?_`-)IJ_H5_;:_X.<_
MV=_V"/VFO$WPG\;:+\4KKQ-X4>&.\ETK1[2>T8RPI,NQWND8_+(N<J.<_6OY
MZO\`@W<_Y3/?`7_L.O\`^DTU?=O_``7$_P""`'[4G[9/_!3[XG?$CX?^`K/6
M/"/B2XLVL+M];L[=I1'901,2DD@9<.C#D=J`/AG_`(+\_P#!0_P'_P`%.OV]
MO^%F_#JS\267AX^'+'23'KEK';77G0M,7.R.21=N'7!W9Z\"O>_^#;K_`(+4
M_"+_`()*:!\5+;XG:;XXOYO&EQ82V!T#3X+I46!9@_F>;/%M_P!8N,9SSTKX
M$_;1_8A^(_\`P3]^,_\`PK_XI:+%H/BC[##J7V6.[BNE,$I8(V^-F7G8W&<C
M%=E^PA_P2E^.'_!2BT\13_"#PK!XDB\*R0Q:DTNI6]GY#3!S'_K77=GRVZ9Q
M^-`']!VD?\'D7[*6MZM:V</AWXU>=>3)#'NT"Q`W,0HS_IOJ:_6%6W*#ZC-?
MR2>#_P#@UP_;2TGQ?IMU<?#&Q6"SNX9I&7Q)I^=JN"<?O>N!7];40VQ*/0`4
M`.KX%_X.&?V*?CK_`,%#OV0-+^%/P73PW#;ZMJZ7_B2XU;539"2W@&Z*W0!&
MW;Y2KG.`/)'7-??5%`'\TO[%/_!H1\??#G[6'P_U3XKR?#^/X=Z1K-OJ.NII
M^M/=7%S;PN)&MU3REYD*A"=PVAB>2,'^EB"!+:!(XU6..-0JJHP%`X`%.HH`
M****`"OX6_V\/^3W/B__`-CGJ_\`Z62U_=)7\+?[>'_)[GQ?_P"QSU?_`-+)
M:`/ZLO\`@V9_Y0F_!3_KVU#_`-.-U7WE7P3_`,&R5U'<_P#!$[X,".19/*AU
M%'VG.UO[1N3@^_(K[VH`_BC_`."TOQROOVAO^"JOQW\17TTTOE>+[[2+?S#D
MI;V4IM(E'H-D*X';-??W_!O[_P`%WOV:/^"3?['NI>%_%WAGXE7WQ!\3ZU-J
M6M7^C:19SV\D2@1VT2R27,;D(@+8*\-*^,U^9O\`P4G^'UQ\*?\`@H7\</#U
MS"T#Z7XZUF-$9BQ\LWLK1G)Y.4*G)Y.:^Z/^"5/_``;#WO\`P5*_8WT;XN:3
M\;M)\+#4;Z\TZZTB7PS)>26$UO,R;3*+E`VZ/RY.%&!(!SC-`'Z;?\1GW[*?
M_0J_&S_P1V'_`,G5^3/_``<9?\%2?@;_`,%7/B?\._&GPJT'QEHOB#0-.NM)
MUV77M.M[4WT&])+7:89Y=QC)N`=V#B1>N./K[_B!R\2?]'&:'_X1DO\`\F4?
M\0.7B3_HXS0__",E_P#DR@#C?^#)?XOW&C_MB?%SP)YK?9-?\(QZUY7;S+2[
MBBW=?2\QT_+O^VO_``69_P"43'[2'_9.M;_](I:^.O\`@BA_P;::U_P21_:]
MU#XH7GQ>T_QM;WWAJZ\/MIUOX?DT]OWT]M*)#(;B0$+]G^[MY)!SQ7V+_P`%
MF?\`E$Q^TA_V3K6__2*6@#^*;PY_R,-A_P!?$?\`Z$*_O@\)_P#(JZ9_UZ1?
M^@"OX'M`E6#7;*1V542=&9B<``,.:_OA\(MN\*:61R#:18/_```4`:%?Q)_\
M%A?^4J'[07_8^:M_Z4O7]ME?Q)_\%A?^4J'[07_8^:M_Z4O0!^KO_!F]_P`$
MT/#?CNS\5?M'>+M+M=6OM#U(^'_"45R@DCLIEC22YO`I&/,`D2-&SE?WG`.#
M7]!]?F?_`,&DUC%9_P#!&7PJT:[6N/$.KR2'^\WVC&?R`K],*`.'_:1^(7P]
M^&/P2\1:M\5-2\-Z7X!BLY$UB373']AD@92&CD5\A]PR-F"6S@`GBORI^./_
M``>/?LW?`R^_X1OX:?#_`,;>.M/T=5MK>YM8;?1M),:KA5@WEI=HQC!A08'&
M17Y^_P#!V_\`\%#O$7Q\_;XO/@SI^J7=OX#^%,,,$UA'(RQ7VJ2QB66>50<,
M45TC3(^7#D??-<'_`,$,/^#=C6O^"M?@_6/'WB+Q=)X%^&^CZ@=+BGM;07-]
MJURJJ\J1AB%C1%=,NV<EL`<$@`^]O^(X;P7_`-&^>*/_``J8/_D>OQ&_X*._
MM3Z/^VY^V]\1/BQH/AEO!VF>.=274DTAIEF:UD,,:REG55#,\BO(2`.7-?T%
M6W_!EA^S2EO&LOC[XRR2JH#LNH:>JL>Y`^R''TR:_`__`(*O_LJ^%?V(/^"A
M?Q.^%/@G4M6U;PSX*U"&QM+K4Y8Y+N0FUADE$C1JBDK*\B\*.%'?-`'[R_\`
M!N9JUQJ'_!M_\1H9I99([*/Q9%"`<M&AM&;"_P#`F)^IK^9.OZ9/^#;\X_X-
MR/BARR_\C7RO4?Z%VK^9N@#^ZK]AK_DRCX/?>_Y$C1?O?>_X\(>OO7S'_P`'
M,W_*#KX\?]>FE?\`IYL*^FOV&)%E_8E^#K*Q=6\#Z*0Q_B'V"#FOE/\`X.A/
M%5GX;_X(C?&.&ZDV2:Q_9-C;#^_+_:EI+C_OF)S^%`'\J_["W_)[GP<_['C1
M?_2^"OZ.O^#S'_E%?X?_`.Q\L/\`TFNZ_G%_86_Y/<^#G_8\:+_Z7P5_1U_P
M>8_\HK_#_P#V/EA_Z37=`'XB?\&[G_*9[X"_]AU__2::O[*:_C6_X-W/^4SW
MP%_[#K_^DTU?V4T`?RJ?\'A__*7X_>_Y$C2>O3[]ST]OZYKZ_P#^#'H_\4?^
MT%][_C\T?_=^Y=?K7R!_P>'G/_!7X\M_R)&D]>WSW/2OK_\`X,>I%_X1+]H)
M=WS?;-'.WVV77-`'[V4444`%%%%`!1110`4444`%?Q7?\%O/V>]0_9E_X*K_
M`!N\-WUK);13^);G6+`E<+/:7C?:874]QME`..C*PZ@U_:C7P[_P69_X(9?#
MW_@KUX'L;B_OF\'?$KP_`T&C>)[>W\_$1);[-<1;E\V$L21R&0DE3R00#\;_
M`/@@'_P<I>&?^";7[/<WP?\`BQX:\0:MX6M=2FO]$U;1(XI9K!9B&EAFB=DW
MKOW.&4DC<5QC!'ZC?L:?\'0_P-_;F_;/\*?!WP?X=\:6<_BP7$=KK&L1P6MO
MY\<1E2$1AV=BX5P"<8('7/'XL?&G_@U]^-GPB\>7VBKXX^%NI+:2M&LYN[^$
MN`>"5^RMC/ID_4U](_\`!+'_`(-9?C!I7[0/@GXH:A\7O!/A>/P-K=GK<1T>
MVN]1NI)()4E$8$BP*`VTJ6+'`/W6Z4`87_!WY_P3*U;X/?M1P_M$>'[":?P;
M\1EAM-=DC4%=,U:*,("V.0L\:*P)S\Z2#(RHKYJ_X(2_\%W==_X)"^.-8T?6
M-'NO%WPK\6SI<:KI=O*$O+"X52HNK4M\NXK@.C8#A5Y4@&OZSOC#\&O"_P"T
M%\,]6\&^-M#T[Q+X9UZW-M?Z?>Q>9#<H>Q'4$'D$$$$`@@C-?A-^W_\`\&9-
MG;:QJOBCX%_$RST31'D\T>&_%%O-*MBK,!MBO(M[NHS@+)$6`'+L:`/LNQ_X
M.W/V-;KPBNI2>)O&-O>&(N=-?PW<&Y#`?<R,QY/KOQ[U^9/_``5I_P"#M7QM
M^U/H,W@OX!6.M_"_PO)(C76OS7`CUZ_V/N"QF,D6T9(&=K,[#()`)!^<[;_@
MV[^-UQJRVO\`PEGPK7=)Y>[^T;_UQG'V.OT0_8*_X,P-!TC6-+\2_'CXE1^*
MK!2)CX:\,VTMK;W(ZJ);V0B4J>ZI$AXX?G@`^XO^#=3_`(*G^-/^"HO['-UJ
MWC[PS>V7B3P3=1Z->>(4A6/3_$S^7N\V(#&V91CS54;`74@C=M7ZL_;P^"MU
M^TA^Q)\7OA_8KNU#QIX-U;1;08_Y;W%G+''_`./LM=Q\*?A1X;^!GPZT?PCX
M/T73_#OAG0+9;33].L81%!:Q+T55'YDGDDDDDDFN@H`_@-U[0[SPQKEYINH6
M\EI?Z?.]M<P2##PRHQ5T(]0P(/TK^B3]@+_@\1^%/A?]F+PKX=^,WA?QK:>-
MO#.FPZ;=7VCVT5Y::OY,:HLXS(C([A064C`;)!P<#U#_`(+4_P#!K7X7_;D^
M(NL?%KX4^(]-^'/CG4MUWKNGWEJ\FDZW-U:XS'EX)FZL55U<C)4,68_D/>_\
M&W7QNL]7>U_X2SX5MMD\O=_:-^,^^/L=`']#W_!)7_@N1\-_^"OGBGXB:7X(
MT'Q!X;E\!"SF$>M/"MQJ<%QYJF9(XV8*J/%M.6)_>(>,XK^6O_@L+_RE0_:"
M_P"Q\U;_`-*7K]Y/^#>C_@WP\>?\$V_C8WQA\3_%/0=1&M:+/I4GAW1;":2"
MZCD96#R7,I0@H\:D*L1SS\PZ'RK]M/\`X,^_&G[5G[6WQ(^)5I\;/#&CVWCK
MQ!=ZW#8S:!/-):B>5I/+9Q*`Q7.,@<^@H`^LO^#3#_E##X/_`.P[J_\`Z4FO
MTKKY=_X(\_\`!/?4/^"87[#VB_"/5/$UGXNO-)U"\O6U&UM&M8Y!/*9`H1F8
MC;G&<\U]14`?R#_\'/?P'UKX*?\`!9#XG7FJ02)9^.OLOB32YBN$N+>2%8B5
M/?;)#(A]UKZR_P"#:C_@X*^%/[`_[/6H_!?XT3:IX?TE-9GU?1O$-O927EO$
MLZIYL$T<2M*N'0LK*K9\P@XP,_L9_P`%<?\`@CE\./\`@KK\(+/1?%4UQX=\
M6>'][^'_`!-9Q>;/IC/C>CQ%E$T+8!,98<@$,IYK^?/]HC_@UJ^,_P`#?B9=
MZ#:^/OACK-O"`T5U+/?6CR*>1NC%M(%/L'/UH`_5O]N/_@[T_9U^#GPQU#_A
M3EUJ7Q6\:7$3QZ<@TRYT[3+:0CY9)WN$CD*`X.U%);&,KU'\R7QB^+6O?'GX
MJ^(O&GBB^DU/Q%XJU";4]1NGZSSRN7<^PR>!V%?LA_P3Q_X,\]>^--Y8^)/B
MW\4=!L?"<,_[[2_"T,UQ>WX4_,GGSI$L(/'S".0]>!UKZ-_X*"_\&?EK^TG^
MT&NO_"GQ]X6^%_@>UTBRTNQ\//HDUTUIY$01G\P2@NTC9=F;YBS,2230!ZC_
M`,&H'@^/XA_\$0-:\/S8\G7-?UW3WSTVRQ)&?T:OYE_CE\(M6^`'QF\5>!]>
MMYK76O".K7.D7L4L91EE@E:-L@X(R5SSV-?V-_\`!%C_`()L:I_P2I_8Q3X5
MZOXJT_QA=KK5WJO]H6=F]K'MFV838S,<C;USWKYD_P""W_\`P;1^%?\`@I5X
MTNOBEX%\1V?P\^)WV7&IFYM&GTWQ#Y8^1I@C;H90HVF1%?<`,H3\U`'RO_P1
MY_X.Q?AK\"?V0/"?PQ^.VD^*K35_A_IL.BZ=K6CV:WT.HV,$:1VXD3>KI*J*
M$)P58(#D$D5\C_\`!P1_P<,1_P#!572-(^'/P\T/5/#GPMT.^&ISS:GL6^UV
MZ52L;.BDB**/<^U=Q+$ACC`4<+%_P;3_`!NE\6KI7_"8?"L9F\GS?M]_^>/L
M?]:_5+]CO_@T6\%?!+]E[Q[#XI\66'C#XO\`CGPI>Z+I6L2Z<PTGPE+=6[1&
M6"$OOF==Y'FOM.,[50G-`'\^/["W_)[GP<_['C1?_2^"OZ.O^#S'_E%?X?\`
M^Q\L/_2:[KYQ^`'_``9B^-O@Q\>?!?C"?XZ^%[ZW\)Z_8:R]LGAV='N5M[B.
M9D!,Q"DA,`\]:_33_@M]_P`$O=6_X*T?LD:;\-='\6Z?X-NK'Q!;ZV;Z\LGN
MXW6**:/R]BLIR?-SG/\`#TYH`_F>_P"#=S_E,]\!?^PZ_P#Z335_937XC_\`
M!-;_`(--?%W[!W[<7P^^+>H?&7PYXBL_!-^;V33K?09K>6[S$\>T.TI"_?SD
M@]*_;B@#^9O_`(/3/V>M4\)?MX>`?B4(9FT'QEX2CTH3$$JEY9W$Y=,]!F*>
M$@>S&OE?_@@E_P`%D_\`AS_^T3K^J:UH-_XF\!^.+**QURRL9%6[MWA=G@N8
M0^%9DWR*4)4,LAYR!7]37_!0G_@GQ\._^"EO[.6H?#?XCV$T^FS2K>6%];,$
MO-(NU#!+B%B"`P#,I!!#*S`CFOYT_P!L3_@TW^*W[.GCEK7P_P#$OX>^(M$N
MI6^Q3Z@MYI]UY?!'F1I#,H;G'RN1QGV`!^C_`(P_X/._V;=+.GIHOA#XF:Q)
M=7$<5PT]G!:164;,`\C'S'9MH).U5).,<9S7Z\Z=J,&KZ?!=6LT=Q;74:RQ2
MQMN61&&58$<$$$'-?RK_`+,'_!J)\8_V@?%Z6%_\1_AGH-DIS-<6YOKZ5%'4
MK&T$08^Q=?K7]-?[)7P2U#]FO]F/P'\/M4\22^,+[P7H=KHTFLR6:V;:AY$8
>C60Q*S!/E4#;N;IU/6@#T.BBB@`HHHH`****`/_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>mccarthylogo_p2.jpg
<TEXT>
begin 644 mccarthylogo_p2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`$D`
MR`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HKXZ_P""['[4?CS]CO\`X)Z:YXX^'&O-X;\46>JZ?;0WHL[>
MZV1RSA779.CH<KQDKD=L5^/?PL_X.#_VNOB/\.-6\!:/JVH>-/B'XFO8UTS4
MK'P]:27]A;B-A)%;V]M`H>1V(.]U8J%XP>:!V/Z2:*_EI?\`X*B_MJ?L9?&&
M&7Q?XZ^*FE:TI6YET3QHEP\-Q'GH;:Z&%1N1E`I]"*^BOVD_^#@+]I']O6_T
MGP?^S]X=\3>&[C^S8I-5B\,Z<^HZO=W.P>=Y;HCO%"&SM*`/C&6[4#Y3^@RB
MOY?_`('_`/!:3]K#]AWXZ1V_C;Q=XXUQ;&Y4:SX8\;&:>1X\@LG^D#SH&V]"
MI&#U!&0?V,_X*+?\%P?"_P"R7^Q!X'^)'A.WM==\2?%>R%SX7TZY8^6BA%::
M:;;@[(F=4(!&YF`!QD@%8^]**_G0\#_MO?\`!2S]JGPY=_$[P7=?$#4/"]J[
MR1OHV@6:6!4$Y2&$Q9N`O3@2,,<G-?HC_P`$,?\`@JU\4/VU?!WC'3_C!X5E
MLI/`,1>[\7K9_8+%RF3)#<*<*DZJ"QV`#`)*K0%C]'J*_G]_X*2?\'*GQ.^+
MWQ2OO"?[/U])X3\)V]PUI!J]O:)/JNMG.W?'O5O*1OX0J[R,'(Z5XG=?&W_@
MHU\%=%'CS4=3_:0L='C47;WFJV][<V$:'D,\4RM$J'/\2A>GM0/E/Z;J*_+K
M_@B;_P`%Q/&G[;'AGQ9X;^(7@_4]<\6>"](EU9=5\/Z=^[U6.-2?)>,82.X<
MC"`$*YX`'2OACX[?\%N_VOO^"@?QFO/"GP9L/%'A2S65E@T+PKIQFU554D;K
MBX"&1".^THH[],T"L?T645_,IXS_`&O_`/@H)_P3SU?3=>\=>)?C#HMI=3`0
MGQ67U/3KLCDQ$S^9'DC/`(8#D8ZU^PW_``3^_P""KLG_``4`_P""<GC[Q]:1
M6_A_XB>`])OHM5MH%$D5M=I:/-!<QJ^X&-]N0K9Y1U.0,D"Q]RT5_.E^Q9_P
M<M_&KX;?$3Q!JGQB\6WGQ!T*'P_<KI.C1Z/IUDL^IF2'R&>6""-U0+YN>2,=
MB<5TO['G_!9K]JK]L[]OCP)#J&O:EIW@74M7"7.D:)HZ1:?%"5?"O+Y9D8;M
MHR\AYZ8Z4#Y6?J1_P7-_:F\:?L<?\$^-<\<>`-471_$EGJNGVT5RT*S!4EG"
MN-K`CD5X7_P;E_\`!0KXJ?MY^'/B9<?$[Q!'KLGAZYLX[$K:QP>4)%<M]P#.
M<#K7XZ_M5?M5_M<?%CX/76C?%[6/BA>>"9KB&2XBUO2WM[,RJV8LN8E&=W3G
MK7*_L7_'_P#:)^"EEKD?P+U+QW807SQMJH\/6#72NR@[/,VQO@X)QTH#E/Z:
M/^"K'_*-/X[?]B/JO_I,]?BW_P`&G_\`RD/\2_\`8EW7_I3;5]`?L4?'+X]?
M&S_@DU^V3-\=-0\:W]YI_A:5-(/B*Q:U9(VLKLR^6&1,C(3/7'%?F'_P3H_;
M\\3?\$\/B?XC\6>#M+M=2\3:YH,NAZ>;E3)':22S1/YI0??($9`7N2,\4!;2
MQ_7!17\N/Q6_X*._MU?"'Q/IWC/QEXV^,GA/^V&^T6']IV4MAI=X"=W[NV>-
M;=U]@A&*^_?AU_P6E^-'[7W_``2H\<>,O`^J6/AWXS_!F:WO/$/DZ;!<0ZWI
M;9#7*12HP0K@E@N`NPGH0*`Y3]D:*_)7_@WL_P""S/Q$_;>^,_C#X>?%_7['
M6-:.G)JWAZ>.P@LBRQ-MN(<1*H8X='&1G"/7Z8?M.?'72_V9/V>O&7Q`UJ58
M=-\):3/J,I8_?**=B#U9GVJ!W+`4$G=45^!O_!*O_@J[^UY^WY_P4"\+>#Y_
MB=.OA&2^?5=:M(O#NE!(=.B.]H?,%KO`;Y8]VX-AL@YYHH#8^[O^#G#_`)1/
M>)O^PYI7_I2M?(O_``:'_#;2+[6/BYXLFLX9=:L%LM.MKAT!>"*3>[A3VW%1
MG'7%?77_``<X?\HGO$W_`&'-*_\`2E:^8_\`@T$_Y$_XT?\`7YI__H$M!70V
M/^#O3PMI\OP1^$.MM:P_VK;ZY=V*7.W]X(7@WLF?0M&IQZCW-=9_P:9>`-)T
MO]C;QMXBALX5UK5O$9M;FZV_O'BBB38F>NT%F./4FL/_`(.\/^39_A/_`-C/
M/_Z2O7;?\&H7_)@'B3_L:I__`$5'0'0^4_\`@[K\#6.C_M(_"?7X(88]0UO0
M+NWNI%3#2K;SQ^7N/?'FL!Z5\3_MY:CJVI_LT?LMO=-,VEP^`+B"TS_JQ(FJ
MW@D`_P!K9Y.?;;7WE_P=_P#_`"5KX(?]@C5?_1UM7IW[.7_!*_1O^"HG_!"S
MX/Z0=0AT'QEX76^N?#^K2QEXX6DF820R@<^5)LCSC)!12`<8(,_2;_@GW/X<
MN?V&/A"WA(VI\._\(AI@L_L^-@`MHPP/^T&W!L\[MV><U\\?\%J_C3H_P[_X
M)2?&BY\`W>CB:^N3H.J2:4\8\BYGG1+M9?+_`.6Q0E6W?-A^>U?F1X0_X)/?
M\%&?V<])NOA_X)U#7;+PK=/(H_L7QG;PZ<P;.YTWRH\0;K]U&.>F:^BO@M_P
M;X?$3X.?\$W?CAHWB?Q<VM>/_'FDK>6?A[3;IYM/BNK5Q<1[F<#S;F3:8]X`
M`\PC+#F@1\]?\&J7[,GA_P",G[7_`(Q\::]9V^H/\.=(@ETR&9`RQW=S*RK-
M@]T2*0#T+@]J_H6N+>.[@>*6-)(Y%*NCKN5@>H([BOY@O^"%O_!133?^":/[
M86I2>.([RS\(>++/^Q=<*PLTNFRI)NBG:/[QV-O5@!D+(W&17[U>._\`@L)^
MS3\/?ANWBF\^,'@^ZTWR?.BBL;P75U<\9VQPIEV;VQ]<4!(]7^%'P#^'7[*7
MAS7Y?"?AWP_X,TS4+F;6=7EMHEMXW<@L\LC=`J@'J=J@'&!7Y/\`QT_X.3O@
MS^RM\6?%4'P)^#FG^)+G6]0>XUKQ$]RNE0ZM.#@R*%B>24'!P6V#G.#GG=_:
M&_X+@>&O^"C_`/P3A_:,\.>"[#6/"_B_1=/>6UM)N9=3T4W$2R7"LI(5Q&S"
M2/LIR"P)V_'?_!M7=_`VS_:N\42?&#_A%QJRZ3$?"I\0B,V2S^:?/*^;\GG;
M?+VD\@;\<T!;N)^WA_P<7^*OV]?V8?$GPP\0?"OP?IEAKY@>.^@O9Y;BPDBF
M259(PPQN^4KGT=AWKN_^#;?4YX_@O^UO9K(PMIO`;3.G8NL%X%/X!V_.OJ;_
M`(."O^"@_P`#/#7[%GB3X7^#;[PAX@\=>-/L]LJ:-'#-_9=ND\<TDLDD8PI*
MQ[%7.3OST%?*/_!MU_R2K]K/_LGTO_HFYH`^1_\`@D/^R/IG[;O_``4&\!^`
M=<#MX?NIYM0U1%.#+;6T3S/'GMOV!,_[5?U9?#_X<Z#\*/"=GH7AK1].T/1]
M/C$5O9V4"PQ1*!@`*H'Y]:_FW_X-F/\`E+3X5_[`NK?^DKU_3%0$C\^_^#F_
M_E$YXF_[#FE?^E*U\Q_\&@O_`"*'QF_Z_-/_`/0):^JO^#E;P_>>(/\`@D[X
MQ^QP//\`8M4TV[FVC_5Q)<KN8^PS7YW_`/!L)^WG\-/V6/%7Q&\*_$3Q+I_A
M%O%"VMWIM]J,@AM)GBWJ\32'A6PRE<]>>XY`Z'[#?\%6/^4:?QV_[$?5?_29
MZ_"7_@V:^!>A_&G_`(*4VEQKUE;ZA#X/T2ZUNV@G0.GVA6CBC?!&"5,NX>A`
M-?LI^VY^UW\,_P!J7_@FY^TE'\._&FA>,/\`A'/!>H1:B^F7`F2V:2TE*`L.
M#D*W3.,5^4/_``:?_P#*0_Q+_P!B7=?^E-M0'0_5_P#X+Y>!]*\:_P#!)_XM
MG4[*"Z?2;"#4;-W4%K:>.YA*NAZJ>H..H8CH37Y;?\&I-C:^*_VE_BWX9U*W
MCO-'\1^"FL[VWEYCEB:=592.A!5F!]B:_5__`(+D?\HG_C9_V`U_]*(:_*/_
M`(-*O^3UO'O_`&*A_P#2F.@.A\O"WUK_`((W?\%;$7=<B+X=^)OE=\AK[2Y&
MQD^N^W?G'!.:_2O_`(.C_P!NRSA_98\"_#/PUJ"3+\3/)\0WSPOD2:='MD@'
M'57E*M[^4*XS_@[/_8U,<G@?XY:3:KM<_P#"->(&1?F#8,EI*WM@2QDGIB,=
MZ_)K2-1\;_MG?%KX?>$+B]N]<U=HM/\`!^AQN=Q@MU?RX(A_LKO/X4#/VH_X
M-0OV.O\`A`_V?O%GQEU6V*ZEXVO#I&D%UY2PMR/,D'_728E?I`/6BOTW_9E^
M!6F?LR_L_P#A#P#H\<:6'A72X-/0H,"1D4!G_P"!-D_C100?/_\`P6_^'_PZ
M^)G[`6MZ3\4O'%Y\//"$FJ6#SZS:Z8VHR12K,#&@B7D[FXSVKQ#_`(-W?@S\
M$?A%X<^)2?!KXLZI\4H;RYLVU)[S09-+^P,%DV`!C\^X$].F*^7_`/@M-_P7
M'^!O[=7["&M?#WP+<^))/$-]J=C=Q+>Z6UO%LAF#OEB>N!7BW_!OW_P53^%?
M_!.'P]\1K;XCSZY#)XGN+26R^P6#7((C5PV[!X^\*"K:'[#?\%6?^"6>E_\`
M!4SX<^%_#NJ>,-0\'Q^&-2?44FM;!+MK@M$8]I#.N`,YSS6Q_P`$O?\`@G%I
MW_!,GX%:AX'TWQ3>^+(-0U-]3-W=62VK(655V;59ACY>N>]6OV`O^"GWPO\`
M^"DMOXJD^&TVM3+X.:T74/[0L6M<&Y\XQ[<GYO\`429]./6L_P#;>_X*Z?`_
M]@*[&G>.O%(D\1,@==$TR(W=\%/(+HO$8/8N10+78_-/_@[7\+ZEXW^/_P``
M=&T>QNM3U;5;#4;2SM+:(R37,SW%LJ1HHY9F8@`#J37Z<_\`!)G]FKQ%^R/^
MP#\/?`OBQ8(?$.E6327L,3;EMWE=I/+)Z%EW8..,@XKX@L/^"^/['GQW_:O\
M&^/O%6C>-M*U_P`'V=QINBZCJFF)+9Z?]H="\VV-W97^0#?CY037Z-?$3]L?
MP#\//V5]2^,QUF/6O`.F:<-4:_TL?:O.@R%R@'4Y8#'4<T#9D_MB_P#!0+X4
M_L$Z7H-Y\4O$;>';?Q)+-#I[+937/GO$$9QB)6Q@.O7&<UT7[+?[5W@7]LWX
M3P^-OAWK#:YX;GN9;-+HVTEOF6(@.NV15;@D<XQ7X-_\'!/_``5<^%/_``4@
M\$_#*P^&\^N37'A2^O[B^_M"P:U`6:.!4VDGGF-LUZU_P1,_X+?_``0_8._8
M8L?A_P"/+GQ)%X@M]9OKYULM+:XB\N5E*?,#UX/%`<NA]A_\%&?^#=/X4?MO
M^,[SQEX=OKCX;^--08R7\]C`)K'4Y#_RTE@)&V0]W0C/4@GFOD;PS_P:#ZT=
M>3^V/C)I:Z7N&\V>CR-<;>^`SA<_C7Z7>!/^"M/P<\=_L;7_`,>(]4U:Q^'F
MFWIL+BZN=/=9TE$BQ_ZH98C<P&:D^"O_``5S^`?QZ^$GB[QUHOC>"W\*^!VC
M76+_`%&W>SCMVD!**-X!9FQ@!<DGB@-2G^PW_P`$A_@S^PC\)-9\+^']"_MZ
MX\56KV?B#5=8`GNM7A==K0MQM2$@G]V@`YR=QYKX#_:5_P"#2/3?$7CJ\U#X
M5_$F/P]HMW*9(]+UNT>Z^PJ3GRTF0[G4=`6&<8R2>:^T_P!D/_@N/\&OVX?V
MHO\`A5OP_C\37^H-9W%]'J5Q8B"RE2'!;&YM_.1CY>:G_;(_X+G?L]_L5>)+
MG0=>\43:]XELV,=QI>@P?;);=QU61@0B-[%LB@6I\K_`'_@U!^'?@WX>^(H?
M'/C34/$WBK5M.FLM.O+>U\FRT.61=HN5BW@S2+DE0[!0><$X(]V_X)Z?\$*M
M#_X)_>&/BEIFG_$35O$J_$_06T*:2XTJ.W-@K)(OF*%D;>?WAX..E<G\+O\`
M@Z._9K\?^*+?3=27QIX4CN'$:WFI::K6Z$]V,3N5'J2.*^^;?XR^&=1^$<GC
MNQU>TU+PI'ILFKC4;-_.BEMDC,C.I7[WRJ3@<]J`U/@[_@G)_P`&\GA__@G?
M^U-IGQ0T_P")VL^)[K3;.ZM!87&CQVT<@GB,9;>LK$8SG&.:_1BOEG]EC_@L
MI\`_VS/C#9^`_`'BJ]U7Q+?037,-O)IDT"LD2%W.YE`X4&O?/CA\:/#_`.SM
M\)-?\<>*KJ2Q\.^&;1KW4+A(FE:*)<9(5>3UZ"@1=^)WPST+XR_#[6/"OB;3
M;?6/#^O6KV=_9S9V3Q.,,#C!'L000<$$&OYQO'?_``3&_9J^*_[5*_#_`.$O
M[2!M=4UC7/[%L-%UOPU>R2P7)F\OR/M"($;!R`Y`!QSZU^Y7[&__``58^"O[
M>OCS5/#?PS\1W>LZMH]@=3NHI=/EMPD`D2/=EP`?FD48]Z_GG_8J_P"4Y?@G
M_LK8_P#3BU!43]6?V;_^"'^B_P#!-_\`9&^/<GC;XO7DN@^./!EWIVNW%IH^
MZWTJV6-RUTB;B\CHI;Y>,CBN"_X(#_L\_LV_"G]L+6M0^$/QVUKXF>))/#4\
M,^F7?AB73$BMS/`6E\QC@D,$&W_:]J[W_@J3_P`%V/@3J/P(^./P6CNO$W_"
M:3:3JGAA4.E-]G^V&-X<>9G&W=_%Z5^7W_!"+]N_P'_P3W_:WUGQG\0I-4AT
M6^\.3Z9$;&U-S)YSS0N,J.V(VYH#6Q_1Y^VC^S+:_ME?LN^,OAC>:M/H5KXP
MLA9R7\,`FDM@)$?<$)`;[N,$CK7R_P#\$LO^"&.A_P#!+_XQ:YXPTOXA:MXN
MFUO2_P"S&MKK2X[58AYBOO#+(Q)^7&,=Z]#_`&%_^"R7P;_X*&_%#4/"/P\N
M/$$VKZ9IS:G,+[36MH_)5TC.&)Y.YUXKZMH)/A3_`(.,_BSX9^&?_!+CQE9>
M(;:WOKKQ9<6^D:/;RMAC>%_,61?>-(W?_@-?F9_P:S_L<_\`"XOVQM2^*6IV
MGG:/\,;1OL3.N4;4;A6C0^F4B,C>Q93U%?8__!P%_P`$Z?VC?^"C?Q5\&Z;\
M/=!T>Y\!>#[*25'NM;@M6N;Z<CS',;$'"HB*,C^]CK7U/_P1B_8'O/\`@GG^
MQ%HOA'7H;6/QIJEQ+JOB%H)5EC6X=L)&KKPRI$J#(XSN(X-!70^L****"3\!
M?^"NG_!`#X<?\$^?V+-6^)7AOQ=XLUC5-/U&RLTMK\0^2RS2A&)VJ#D`\5Y'
M_P`$./\`@D'X*_X*@Z%X^NO%GB+Q#H3^$Y[6*W&FB,B42JY.[>#TVCI7ZI?\
M'.'_`"B>\3?]AS2O_2E:^8/^#06YC_X1CXT0^8OG?:M/?9GYMNR49QZ4%=#Z
M)\/_`+)'@O\`X-W_`-B;XX?$'P?KVN>(K[7+*S,$>K+'A;R'SX[8*$`R"UT6
M8'J$K\D_^"37["TG_!6S]L'Q'JWQ.\67,/A_2Q_;7B749[L+>ZI/-(=D*.W0
MN0Y+?PJF`.1C]C_^#E7P]>^(/^"4'B_['&\GV'5--NY]O\,27`W$^W(K\0?^
M"7'_``3/\:?\%)->\6:7X'\;Z+X5U#PS!!<W%O>S31R7<4C.H=!'U"LN"3TW
MKZT`C]3?V]_^#=_]GW6?V;=>OOA%<1^&?'7A_39;O3T;6_M,&K21(7\F578X
M:3&T,N`&(XQFOCG_`(-^OB1-^TGIWQ._9)\6ZYJ</@CXJ:%+<6'E.&DTNZA9
M7E,(;(421@EAT)C4]2<]\?\`@UA_:`88/Q<\+_\`@3>?X5[9_P`$M/\`@WM^
M)W[#7[:7A?XF:KXX\&ZKI>A?:(KJWL5E,T@DB:,J-RX!R>>]`'QI_P`%R_\`
M@CSX)_X)=^#_`(=ZCX2\1^(M=D\87E[;7*ZF(@L(@2%E*[`.OF'.?05Z?_P2
M`_X(%?#G_@H=^QG9?$CQ-XM\5Z/JESJUY8-;:>(?)"0LH4_,I.3GFO;/^#P+
M_DE_P-_["FK_`/HJUKZ`_P"#7>ZCN/\`@E;IZQR*S0^)]420`\HVZ-L'WPP/
MT(H#H>?_`/!2C]A+P]_P3M_X(+?$#X=^&=6U36=,CU2VOQ<:@$\XM+>1$CY0
M!@8K\:_V!/V3_B3_`,%`OBO:?!SP1J$EKINI3?VQJAN)673[!(EVFZF5?O,H
M;8HP26<`8R2/Z!O^#B__`)1+_$7_`*[6'_I7%7PK_P`&@VBVLGQ!^,VH-"C7
MD>GZ?`DI^\J&24D#ZD#\A0"V/JC_`()\?\&Z/AO]AKXDR^,/^%F^*-8UR\T*
M]T.X%I`E@D2W40C:6&129(Y$ZJV>#@]J^=_@S_P;`^"_AI\5/$FL?'CXH6LG
MA".]?^Q((+]+&YU&#.?-N99/NMS@JF<D$YYP/U+_`&_/VHU_8N_8\\>?$P6L
M5]=>%]-::SMI20D]P[+'$K8YV[W4G'.`:_G7_9%_9E^-_P#P7Q_:<\22:YX\
MDEDTN!=2UG5=5D=[>R21RL<4,"84$D-M10J@(?2@%<^H/^"P'_!)3]F/X0?L
MIZQ\0/@GXUTNW\1>&&@DGT4>(HKY=3@>5(G\M22XD7>'X)!"MQG%;_\`P;J?
MM%:QXI_8!_:;^&FI7D]UIWACP]=:OI"2,6^RI<6=RD\:YZ)OCC8*/XG<]S7F
MO[??_!MQ:_L,?L=^+OBE=_%I=7F\+V\#KIYT@0+>2RSQ0A%<R$]9,CC/%'_!
MMU_R2K]K/_LGTO\`Z)N:!GF/_!LQ_P`I:?"O_8%U;_TE>OW%_P""S_\`RBO^
M.7_8KS_S6OPX_P"#9J58_P#@K5X3#,JE]&U95!/WC]D<X'X`_E7[<_\`!;_Q
M%:^&?^"4?QLGNI%C2?0/LB9.-TDTT42`?5G%`GN?E)_P:-_\GN_$C_L1W_\`
M2^TKYA_8J_Y3E^"?^RMC_P!.+5]/?\&C?_)[OQ(_[$=__2^TKYA_8J_Y3E^"
M?^RMC_TXM0/J?I-_P5&_X-[OAKIGPU^.'QV7QAXN;Q##9:IXL%B1#]E,X5YO
M+^[NV;N.N<5^:_\`P1;_`.">?AG_`(*4?M1:MX&\5:QJ^BZ?I^@3:LD^G!/-
M:1)84"G>",8D/Y"OZ)O^"K'_`"C3^.W_`&(^J_\`I,]?BQ_P:A3I'_P42\1*
MS*K2>#+L(">6/VBV/'KP"?PH%T/U/_X)N_\`!#WP!_P31^,FJ>-/"OBCQ/KE
M]JVE/I,D.HB+RTC:2.0L-B@YS&!^)K[8HHH)"BBB@`HHHH`^>_\`@J9^R#<?
MMT?L+^.OASI\D,.L:I;1W.F/+PGVN"19H@3V#,@4GT8U_-Y^SY^TS\>_^"-?
MQ[UI=,L;SPCKLR_8=4TS6=/+VU\B-D?*P`8`\AT/0\&OZQZ\C^.?_(RI_N"@
MI,_/?_@C[^W#\1/^"Q7A'XT?#KX\:/)>>%_$&BQKIU[9:0;.R@1B\<T2R8VM
M*"\4BY)(\LGFOSK^+O[''[2W_!#7]J63Q=X5M]8;3]-DDCT_Q/IMHUQI^IV;
M'/EW*`$+N`7=')P&`P3@&OZ2/@M_R*I_WZU/B-_R*%U]!0%S^>?Q1_P<L_M5
M?'?PXWA7PQI7AW3=8OH_L_VK0-&FGU!B<@E%9G"MSP57C'%?>'_!NQ^RC^TI
M\%M/\6>+/B]KFJ:=X4\7$W5KX:UAVN-0GO78,]ZQ8Y@!&05ZN3DA=H)^TOAC
M_P`C=;_[U>Y4"N?`_P#P<-?\$_/$7[=G[&UC-X+M?[1\8?#_`%%M6M+``>9J
M%N\92XAC_P"FF`C@?Q>65ZD8_$7]C3_@J7\?/^"5MKK_`(-\,^7I5IJ%T;F[
MT77M++?9KG:(S*J/M9&(10>QV#/2OZLJ\+^)G_(Z77^]_4T!<_,?QS^UO\6?
M^"B/_!`3XKWGCSP[K5UXUL?$%K!"UOHLD"ZE;-<0R(T,:K\RH"RDKG[F34W_
M``:9?#+Q)\/O$WQC;7O#^N:&MS:Z>(3J%A+;>;AYL[=ZC.,]J_83P[_R(\'T
MJ[X<^_+]!0%SR[_@H3^RZ_[9W[&7Q`^&MO<0V=]XFTQHK&>7_5Q7*,LL.['(
M4NB@D9(!/!K^;W]F3]ISX]?\$,?VB_$'_%+_`-CZIJ$/]G:II/B"RD:RU%(W
MW(ZLK+NVG)5XWZ,>QK^JBO*OCU_R%[;_`'*`N?@1^T]^U;^UQ_P6P^%.K7DO
MA%M.^&G@FREUZZMM&T^>#3[EHD)&&D+O<2GD(BEL$]!UKZ(_X-7?@9K>G^*?
MCEI?B[PSKFDZ;KV@VMBXU"PEMEN$=Y5=5+J,_*QZ>M?LI\,/^2>+_NFMKPY_
MK)/H*!W/Y5?CK^SS\:/^"-7[94>I0PZIHVI>%=2>;0/$26I-EJ<.2%=6(*$/
M&<-&3D;B#7M/Q@_:Y_:^_P""U?PCU;2Y]*:7P'X+TRZ\1:F=*TM[6RNS:022
M[6<`F:9MNU(ESEV'`ZC^ACX]_P#('M?]\U-\'?\`D1;CZM_*@.8_%+_@U)^$
M_BKP!^V?\1+K7O#/B#1+:;P4\4<M_ITUM&[_`&ZU.T,Z@$X!.!S@&OFO]C?X
M&>-M-_X+7^#-4N/!WBJWTV/XJBX>[DTF=8$C_M!CO+E-H7'.<XQ7],7AW_CZ
M?_<_J*@M?^0JO_73^M`<QG?M"?"&T_:`^`WC3P+?2>39^,M#O-%EE"[C"MQ`
M\6\#U7=D>XK^6B^\+_'C_@BU^UU_:D=G?^%_$WA^66"VU"2T,FGZK`V5)4L-
MDD;K@XZCCH17]8]><_'W_4V?X_SH$F?EM_P1<_X+7?'C]N+]N6P\+^/M-AO/
M!>K:5=Q)-I.B-#:Z==QIYR2RS`'`98Y$PS8W2+CTK]CZ\Y^`_P#J;CZ5Z-0(
*****`"BBB@#_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>oncolytics_logo.jpg
<TEXT>
begin 644 oncolytics_logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`&`!
MD`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HHI&<(,GI2;`"P'4@8I!("Q`/2O-/VG/VK?!_P"REX-AUKQ7
M>R0_:F:.RLX$\RYO9%&2J)GH,J"Q("[ER1D5\!?$/_@I]\9/VL_&9\/?!_P_
M?:'!&S.BV$8N]0EC##;)+(1Y<2\=```7P6;@UR8G'4Z3Y7J^R+C!O4_3CQ1X
MPTCP/I+W^M:IIVCV",%:YO;E+>%23@`LY`R3Q7,?\--_#7_HH7@?_P`'MK_\
M77YR^"O^"//Q?^-^I0:QX^\4VFCRW)19I=1NI=4U!8]@*\`X)4G;M:1<<^V>
M[_X<"'_HK(_\)C_[KKE6+Q4M84M/-E.$>K/OOP9\3_#/Q%-R/#WB+0]=^Q[?
M/_LZ^BNO)W9V[MC';G:V,]<'TK<WC(&>37YB?$3_`((:^-/`UO;:CX*\>:;K
MNI6C>>(Y[1])F2164QF)Q)("V=QRS)MP,9)XXVY_:*_:7_X)[>)H+7Q9)JFI
M:2S%(TUDMJ%C=ELMA+@'=N^4G`<'`/`')'F$Z?\`'IM+NM0]FOLL_6W<"<9&
M:6OG[]CS_@H9X'_:\/V#3?M.B^);>W$\VDWA!<CHYA<<2JI')`!P02HY`]_2
M4.Q`SD5Z-*M"HN:#NC-IIV8ZBBBM4Q!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`,<`G@8]:\6_;>_;"TW]D#X/2ZY-#;:AK=\YM])TZ2;RS=2\9
M<X^;RTR"Q'J!D%@:]AU+4(-*L+BZNIX;:UM8VEEEE<)'$BC)9F/`4`$DGH!7
MY):7I-__`,%6O^"@=W*T\T'A2S<RDN68P:7`X4*H^7:TI/8#:TI)SCGS\=B9
M4TH4_B>QI"-]66_V4?V2_&__``4K^),GC_XA:W>S>%(;MX[FYD=A+<E2&-M;
M)TCCRY&Y>%^8?>K]0/A'\%_#/P/\%VN@>%])M=)TVV4#9$@#S,`!YDC=7<@#
M+,2>*U?!GA#3/`OABQT;1[&WT[2]-B6"VMH$V1Q(!P`/\>222>:U`H(&!@56
M$P4:*=]9/=]Q3FVQ%A5"",@BG445W$",H;KFLCQQ\/M$^)?ANYT?Q!I=CK&E
MW:[9;:[A66-O?!Z,.Q&"#R"#6Q05!Y(I2BFK,#\O/VT_^"26I?!6*[\<?"_4
M+FXTG20U_<6$LICO=)2%`_G13;LRX*L<?*RX&"W)7Z!_X)A?\%#I?VF]*E\(
M>*PD?C71K82I<Y"IK$((!?':5<C<`,$?,.X'U^Z!$+`#('XU^1O_``4/_9HU
M3]AW]I/2?'?@X-8:)K%^VHZ7)%]S3[M&#R0$*`%0EB53)#)N'\)`\6O1>$E[
M:E\+W1M&7,N5GZYQ2>8NX$8-.KS[]F']H#3?VF_@IHOC+2X9+2'4T(FM7?S&
MM)E.UXBV!NP0><#(P<#H/0:]BG-3BI+J9-!1115B"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`/ES_`(*U?&.7X2?L?ZK:V\CQ7OBR=-&B92X.U]SR?,I&
MW,:,.>#DC!S7.?\`!%CX)'X=_LR7?B:YA*7WC>\^T[FCVM]FAW1Q+G<0PW&5
MLX!_>$<XS7F__!?#6KNVT3X7:9'.ZV%Y/J5U-#QM>2);58V^JK-*/^!FOLG]
MD30+/PS^RY\/+2Q@2VMAX=L90BYQN>!'<\^KLQ_&O)@O:8Z3?V4OQ-'I!>9Z
M+TP`****]5(S"BBBF`4444`(P)!`KR[]LWX*V_Q\_9H\6>&Y;2:\NIK&2YL(
MX2!(;N)3)"%SQDNH7GLQKU*FS()$VGN:SJ4U*#B^HT['YR_\$'OB>?\`BOO!
M4TH!'V?6K.(1_6&X)?\`\!@`?]KWK]&T(*`CI7Y4?\$^].@TS_@K)XBM+6&&
MVMK6_P!=AABB0)'"BO*%55'`4```#@`8K]5T78H%<&52_<<O9M%U5J`D4YP1
MQ07`!)(`%?`/_!</XD>)?AT_PO\`^$>\0ZWH1O?[5-P=.O9;7S]OV+;OV,-V
MW<V,YQD^M>?_`+(7[??BC]DGXFIX)^+6I7VM^&M9C@OK+5[F=[F>QCN$$D4X
M9LNT#HRDJWS*>0!AE+GF4(5G2EIY@J;:NC]/C(HZD"CS%Y&1Q5*SO+?5["&Y
MMIXKFTN(Q+%-$P>.5&`(92.""""".H-?F7_P3U\=^++?_@I'J/A#4/&?BS7=
M'T>?5K-(M2U2:X698"Z([JS;2WR@YQUZ8K>OBU3E"-OB)C!M,_4+(X]Z"0.2
M0!37P!G.,5X-^W3^W/H7['/@!995BU/Q5J:-_9>E[\%\<&:7'*Q*3ST+$;0<
MY(VJUHTX\\WH)1;T1[UYB^HP*-XR!GDU\&?![]G_`..'[=5A8^.O'OQ,USP!
MX>O/W^EZ1X>WVTLUO(.6R'7R_NQ[3()2PR<#.6[ZX_X)5>5%>R6'QK^,5I?W
M:EC.^M;U:0)M1Y%4*7```QN!(&,CC'-'%5):PA=>MBG%+J?6H<'H0:4G%><?
MLY_![Q-\(_#MW;^*_B!JWQ"U.[F#_;+NT2UC@0`@)'$I;;UR26)/'0`"NY\2
MZ[9^%_#][J>H3K;6&G0/=7,S`E8HT4LS''.``3QZ5U1J>[>2L3;4N^:N<;@2
M:-XP#G@U^=*?ME_$[_@HA\?=3\"?"G64\#>#H[9GFU22'==_9U8*\Y(^96<L
M`J*5_ARRG+#V?3_^"7DZ6$"W7QS^-4URJ*)9(M=,2.^/F95(8J"<D`L<>IZU
MRPQDJEW2A=+K>Q3A;=GU?YB^HH#@D@')%?!_[0G[./Q?_8S\)7GCCX:?%7Q;
MXETO2H/M.L:9XBN/M\S*C'$D>5*E`KL67"D;,Y8<+ZA_P3L_X*'Q?MF0ZQI>
MJZ/;Z%XHT&&.XDCMIFDM[Z%F*F2-6^9-C;5*EF^^I!.2%<,8N?V516;!P=KH
M^H:0R*#@L,T*X<9!R!7YGR_%KQ6W_!9<^'_^$G\0G0CXB\G^S?[1F^Q[/LN=
MOE;MF,\XQC-7B<2J/+I>[L*,'*]C],:*`<@$45TIDB,X3J0*/,7CD<UY3^UY
M^SO??M%?#=M/T7Q3K?@_Q#9;Y=.O["^FMT\P@?NYEC8;XVP`>I7J.X/PO^R5
M^WGXT_8W^+]_\-OC7+K%QIK7(5KV^F>YN=*<GB4.<F6W<8/4X^\.A!Y*^,5*
M:C-63Z]"XPNKH_3[<,9SQ1YB^HK@/CK^TMX2_9]^$DOC+7M2B;23&&LQ;,LK
MZDS+N1(`#ARPY!!QCDD#FOAC]G:Q^+G_``4S^.%YXTU3Q)XD\"?#?3Y?)%KI
M.I36R3HI)%M"R%?,;^_,1QGC!P`5<6HS5."YF^B[=PC"ZN?I-YBXSGBEW#U%
M5-/TI-,TV&UB+"*V18TW,SG:``,LQ))P.I))KY@'_!+[//\`PN[XW@#_`*F'
M_P"PK6=2:MR1N2DNI]4AP1D'(I/-4C.X8K\C?VDO#GBSX*?MNZ-\,-/^*?Q-
MNM'U&[TRW>ZN-?F-RHN716(P0N1N./E^N:^R1_P2\W(0?C=\;L?]C#_]C7+2
MQE2HW%0U7F4X);L^JE8-T(.*-X!QGFN7^#/PPC^#OPZT_P`/1ZMK.N_80VZ_
MU6Z:YN[EBQ)9W/?G&````.*\._X*V>*]6\$?L;:MJ.BZIJ&D7Z:C9HES97#V
M\R`R@$!T(.#W&:ZJM;DIN<ELB8J[L?3.\$D9&12E@.IQ7QE_P14\>Z[\0OV?
M?%%WK^M:MKES!XA:*.6_NY+F2-/LT!VAG8D#))P..37V3*04&<`$TL/7]K35
M1*R8--.P_>I`(((-'F+_`'A7YY_%3_@I9X__`&DOCB_P[^`=K8;)!*B:M<JO
MG7>Q&\R5/,PL<:Y!4D%B5!X!Q7IG@[_@F%XIO+"2Z\7?'SXGWNKW;^=+_9&H
M/9VT+,`70*[/N`?=A@$&,?(,5A'&N;:HQYK;O9%.%EJS[`W#GGI0'#="#7RW
MI_\`P3S\9>"K^!_"O[07Q*T^VGD4ZC'JGEZJ]RBGY1$SE1"V#("=K@[ER/EP
M?IS2M/.F6,$!EEG\F-8_,E;?(^`!ECW)QR?6NFE.;^*-B6ET+#,%ZG%!D48R
MP&:^'O\`@KG^VUXZ_9PU?P[X8\(+_8T6MV3WLVL^5YDCE9-GD1;EVJ5X9CR<
M2(/E'+3_``I_8<;]JSX4:%XG\9?&WQYXN77[2"?4+.PU&.#36!5':U>)-P+(
M<HQR"2I.%/`YY8V]1TJ<;M>=BE#2[/MKS%_O"A7#$X(.*^0H_P#@F;XI\#7&
MFR>!_C_\1M!6PA:`Q:D!JD`CVJJ+''YD21A5!'(;@KC;CGZ-^!G@+6_AO\/;
M/2_$/BN_\:ZO"7:?5KNW2W><LV0`BDA548`&2>.IK:E5G)VE&WW$M=F?$7_!
M?'1;NYT3X7:FD#M86<^I6LTW&U))5M6C7ZL(9#_P`U]D?LAZ_:>)OV7?AY=V
M,Z7-L?#MC$'7.-R0(CCGT96'X5Y'_P`%:O@Y+\6_V/M5N[>-I;[PG<)K,2J'
M)VIN23Y5!SB-V//`P3D8KG/^"*_QM/Q%_9DN_#-Q-YE_X(O3;[6DW-]FFW21
M-C:`!N$J@9)_=D\9`KA@^3'-/[2T^1HU>'H?8M%%%>L9!1110`4444`%-FD\
MM-W'%.KR[]L[XTP?`+]FCQ9XDENYK.ZAL9+>PDA`,@NY5,<)7/&0[!N>RFHJ
MS48N3Z#2OH?GQ_P3[U"#4_\`@K+XAN[6:&YMKJ_UV6&6)P\<R,\I5E8<%2""
M"."#FOU61]V#T%?G!_P0A^%$LFH^./'4K,L2I%H=L%92LC,1/,67KE0+?:>`
M=S=<<?H_$=T8!KSLJ35#F?5W^\NJ[R/SH_X+\`,?A,"`1_Q-_P#VPKV?XF?L
M,:!^V5^QC\.X97BTOQ5IOA:P_LO5-F2A-K&?)EQRT3'MU4DL.<@S?\%+/V%?
M$O[:[>"CX>U;1-+/AG[<+C^T&E'F^?\`9MNS8C=/);.<=1UKZ'^#WA"X^'_P
MH\,^'[N2&>YT+2+33YI(LF.1XH4C8KD`[25R,\\THX5RKU/:1O&2!RM%6W/S
M;_8K_;4\2_L&?$RY^$_Q8M;NW\/V]P(HI)26?16)R'0@'?;/G.!TSN7^(&M^
MP/\`\I=/$_H-2U[_`-&2U]L?MT_L,Z#^V3X'CAD:'2_%6EQM_96JA,E,\^3+
MCEHF/;DJ22.<@^%?L(?\$M?&?[*O[0]AXQUK7_#.H6%I:7%NT-D\YF)DCVJ0
M'C48SUY_.N26%KQJ0AO%.Z?;U+YXN+[GW8V1G/85^3__``6Y\.ZWIO[4FDZC
M?S/-I&HZ+$NF?(VR(1NPECW8`W!VWD`G`E7.,BOUB;)(`[UQ/QX^`'A7]HKP
M#+X<\6:7'J.FR2+*N&,<L#KG#QN.4;!(R.Q([UZ>-PSK4N2+UW,X3Y7=C?V=
MO%7A[Q/\$?"USX4E2705TNVCM$%PL\ENBQ*!%(RDCS$&%89R&!S7;I\P!!'/
MM7PYX0_X)J?%7]E_7YI?@W\6K:UT>^N/M%UIVNVA$895VH6V*ZRL<ODA(N%0
M?-QCOM-^&_[6<E]`+GXD?#."T:0"5XM(>62-,C<50Q*&(&2`67)XR.M1"O42
M2E3=UV!Q6]SZFYSG.1^5>:?MC>#+_P"(?[+/CS2-,N+JVO[O1K@PFVC:264J
MA?RE52"3(%*8&?O]#T-/]FWX/_$'X22:C#XQ^)[_`!%M;O:UO]IT1;*>S<<'
M$BS,&0CJI7J,@CD'U67A!CL:ZFG.#35KDO1GY=?\$+?B#IN@_&;Q?X>NK>W&
MI>(-,AGLKIS^]`MW<R0K\N2'64.?F`_<#@Y!'ZBJ/E&1S7R?^T9_P2XT;XD?
M$JX\?>!O$%]X`\;JXO89;6-6LY+I26\UD&&5G/#,I(ZDHV2#'!\-?VOM)T^S
M@C^(7PUO@FR$N]BYDV@8,C$P\].<<G/3T\_"0J8>G[*46TGHU9FDVI:W/??V
MB=;TSP]\!/&EYK,*W&EP:+>&YA:Y^S?:$,+@QB3!V%_N@X)!8<'I7YE?\$3_
M``]?ZK^UM<7EK=FWL]+T2XEO(M[+]J1G2-5P.&P[*V&_NYZ@5]0^/_V,?V@?
MVD;>WT'XC?%7PW9^$&8M?P>'[%UFO%W*VQ@R("/EX)8@9SM;I7T#^S!^RCX.
M_90\&RZ/X3L'A-VR27MY.WF7-ZZC`9WP,@9)"CY1N.`,FIG1J5\1&I;E4>_4
M%)1BT>EQ8P<?XU^6#?\`*<4_]C-_[:5^J(`4``8`KX,^,_\`P3,^*/B']L;5
M_BIX.\6^$]'N9=374-/^U&=I82(U7#J(BIS@@C)X-:YC2G*,'%-V=]!4WN?>
M7W1[4!@>!FOE8_#7]KO!_P"+C?"SG_J&R?\`QBN[_9[\'?'70O&,]Q\3/&/A
M#6=$6V80VVC61BE:8LN"Y:)?E"[NASG'49KIC7DY6<&B+'MKQA\Y)YXKP;]N
MC]AK0/VR/`H@E:+3/%6EQG^R=5$>3'W\F7'+1,1TZJ26`/(/O,3$J<G)%*5!
MZ@'O6E:E&I%PFM&";3NC\8?V"_@#??MT_%C2O!_B7Q)J(\*>"+&2^%HTC.4@
M,R!X8<G"%W=<MV"\?PX_8SPAX.TOP#X:L=&T:QM].TK3(1!;6T";(X4'0`?U
MZD\GFOD7_@G)_P`$YO%G[''Q9UK7]>UOP[JEKJ>DMI\<>GM,TB.9HI,G?&HV
MX0C@]<<=:^S<_-BN'*\,Z=.]16EK]Q=6=WH&/QHZ=^**0]3CD^E>FS,_*[]O
M;G_@KIX6]#J>@?\`HR*OU04<X[5\:?M)?\$X_%OQI_;>T?XGZ?K7AZUT?3KS
M3+A[6X>87+"V="X`6,KD[>/F[\XK[*A8L,YS7G8*C*%2I*2T;-)RNDD.Y&`!
MUKY7_P""R?\`R8[J_.<ZG9?^CA7U3GYL5XM^WE^SEJW[5/[/5_X.T6^T_3[^
MZN[>X6:]+B$+')N(.Q6.2/:NC%0E*C*,-6T3!^\CP;_@A&?^,;O%F>G_``DK
M?^DMO7U[\8M&U/Q%\)_$VG:*[Q:Q?:5=6UBZ2F%DG>%UC(<?=(<J=W;K7C7_
M``3@_9#UW]C?X4ZWX?\`$&HZ1J=SJ>K-?QR:>TC1HAACCVG>BG=E#VZ5]$$`
MMSR:SP=*4</&$]'8<Y7E='Y)_P#!&N^TCPG^V-?67B&,6FLR:5<6FGI<J8WB
MN@Z^8F#C#^6LHVD9ZBOUL3[@P3BOFS]K/_@F=X/_`&F?$Q\3V-_?>#?&JM'(
MFKZ>NX.Z$[7DCRNYAQ\RLK?*O/'/)>"/@7^UMX$\,VNEP_%'P#?PVB[(YM0M
MYKFX*@#`9V@RV!QDY/U)KGPD:N'3IRC==&OU*E:6MS[!.<<=:7.,9(KY3/[.
M?[2_Q`/_`!4'QQT/PN+3_CW_`.$>T(7'VK=][S=YBV[=J[<;OO-TQS].:#:W
MMCH=C!J%XE_?PVZ1W%TL`A6YE"@-((P3L#-D[03C.,G%=].JY[Q:,VK&3\5/
MA/X:^,GAQM'\5:'I^NZ:YW^3=Q!Q&PXW*>JM@D94@X)'>OD?Q-_P18T'1_$(
MU7X>?$3Q9X#U$R'#K_I0BB*X:-&1X9`2<'+.W&1CG(]B_:&_9J^)OQ7^)<>N
M>&/C3J/@/3K>T^RPZ9;:&ERBY*EW9S,H=F95P2OR@8!P3GSF/X8?MA>$M"L[
M>V^('P]UMXY$B9Y;0F?86YD=GB4,%!)(')`X!/%<F(C&3?/3;\U;_,N+MLSR
M#XK?#W]J+]@[P7<^)++XBQ>,O"^DM*\YN':YDMXV=5621)P6).[.%=PI!YZ9
M^A_^";/[=M_^VKX=\3+K.B6FD:SX7EMQ,UF[&VN(I_-\LJ')96'DN&!)'((Z
MD#S_`.+G[!_QV_:PTB+1/B5\5?#%EH-DQN(X=$TF207,V5V^:A,((49()9L'
M^'G(^DOV8OV9/"W[*G@!O#OA6WN8[6:;[3<SW$IEFNIBJJ9&/0$A1PH`&*SP
MU*JJMXW4%T94Y+E\ST'4K"#5-.GM+J&&YMKF-HI8I4#QRHPP593P5()!!ZBO
MR1TS5[__`()2?\%`KN)H9I_"EXQB(D#*9]+G=6#*?FW-$1V)W-$0<9X_71@2
M,<'ZUXM^V_\`L>Z;^U_\'Y=$FEMK#6[%_M&DZC)#YAM9>,H>_EO@!L>@."5`
MK;'8>52*G3TE'5$4Y6=F>J^#?%VE^._#%CK.CWUOJ.EZE$)[:Y@??'*A'!!_
MQY!R#S6HN-H(Y!K\EOV4?VM/&_\`P33^),G@#XA:+>P^%)KMY+BWD1C+;%B%
M-S;/TDCRA.U>&^8_>K]0/A'\:/#/QP\%VNO>%M6M=6TVY4'=$X+PL0#LD7JC
M@$95@#S583&QK*STEU03A;5;'544T2`G'(IV?8UVW("BD9PO4&J>O>)-/\+Z
M5/?ZG>VNGV-JN^:XN95ABA7/5F8@`<CK0Y*UP+3,I7`()K\KO^"F_P"TP?VS
MOC?X7^&7P_G&M:;IMYY*R0#,6HZA(?+WJP)#1QID!A@?-(<L,$=/_P`%`?\`
M@J?/\1;B;X>_":3[;IFJQ&QO]32`RRZGYR[/L]NA&0,,1NP68M@``$M[5_P3
M"_X)XR_LR:5+XO\`%>R3QKK-L(DML!DT>$D$IN[RM@;B#@#Y1W)\;$57BI>P
MI?#U9M&*BN9[GOO[*/P$M/V9O@1H'@^U9)9=.@W7<RDE9[E_FE<<#Y2Y..!P
M!WKT;IP*;&@C7:`,"G5ZU.FH145LC%NYXSX[_P""@OPB^''QMU'X;:EXKEE\
M>:191:E>Z'I^CW^I7EK;2;=DSI;0R;4.Y1N/&6`ZFNS^"'[0_@C]I+PO<:SX
M%\3:7XEL+*ZDL;LVLG[VPN8SB2WN(F`D@F4]8Y%5QD9'(KX3^+W_``3^^*F@
M_P#!97QW\>M(T[Q1J_@CQGX"LO#\)\(>);/2=5MKN&6'<DXNF16B*PEOD+<L
MG<''J7_!-3]@#XD_LD_'WXM^,_%GC&POM&^)EU'>?V%)J$WB;4X)T2-4DDUN
MX@M9F@0?:%CL_L^R+SV97Y*UH!]FU4UW7K'POHMYJ6IWMIIVG:=`]S=75S*L
M,%M$BEGD=V(545026)``!)JW7G_[5?PCOOCS^S%\2/`^F75K9ZCXS\+ZGH=K
M/<EA!!+<VDL".Y4%@H9P3@$X!P":`-?X*?&OPK^T7\+-%\;^"-:M?$7A3Q%!
M]ITW4;8,(KN/<5W+N`.-RD<@=*ZFOF[_`()$_LX>*?V0?^";WPD^&?C:VM;/
MQ7X1T=K/4H;:X6XBCD\^5\+(O###CD5](T`8'Q)^*WA;X->%Y=<\8>)=`\*:
M)"Z1R:AK&H0V-K&SG"J996506/`!/)Z5YQX>_P""A_P1\2>-8_#D?Q,\+6&M
MW7V<V-IJMR=,DUA;B1XX)++[2(Q>1R/&P5[<R*W&"=RY\N_X*I_\$Y]3_;FN
MO@YXG\-ZAI\?B[X*^,K7Q3INFZU?S6^AZJBRQ&>.Y6**8^;LB'DR^6QB9FZJ
M[JV-^W_^S7\7?^"C?[)GBSX-ZMX#^''@ZS\4I!9WFOWWBN75#IDB3QR&\L+5
M-/!N=J`A?.DLY"^X85<2,`?9ZR*W0@FE)`Z]ZYWX4>`#\+?ACX;\-'5=4US_
M`(1W2[73/[1U.;S[W4/(B6/SYY,#?*^W<[8Y8DUT$B&0`9Q@T`>(_'W_`(*/
M?!O]ELZB_P`0O%EUX3M-)G2VNKZ_T'44L(Y'QL47(MS"Q8D`;7.3QUKO?A)^
MT!X8^.`U`^'9M8D&E^7]H^WZ'?:9CS-^W;]JACW_`'&SLSMXSC(S\R?\%ZOV
M%O&__!1'_@G#XG^&GP]&E2^*KO4;#4+6&_N?LT5P()P[H)""%8KG!;`XZU]D
MI#D;L]><4`2URWQK^-?A7]G3X6:UXV\;ZU:^'?"OAV`7.HZC<AC%:1[@NYMH
M)QN8#@'K74U\W_\`!7?]FWQ3^U]_P3>^+'PU\$V]K=^*O%ND+9Z=#<W"V\4D
MGGQ/AI&X4;5/)H`[3X7_`+<OPU^,]]H\'AK5->U)/$")+I]S_P`(OJL-G=1N
MF])!<26RQ;&7D,7"D$8/(KUROA']DV\_:ETOX^:"?&WP6U_2/"L[O!J6H:A\
M=;?Q!%I\;(W[W[$NF1&9@P``$BXSGM7W;&I5`#R10`I..3P!7EOQ<_;:^$OP
M+\4Q^'_$_C_PW8>)YWBCBT"&Z%YK4S2#*;+&'?<N"`3E8R,`GIS7J+#<I'K7
MP[^RS^R1\9O^";7C;XHKX<T[1?CAX'^(WB__`(2E;N^\0MIOC*SDGC"7"SF>
M)K6]6/RX5C)GMV6-,8;Y0`#[.\$^--/^(?A6RUK2GNGT_4$\R$W%I-:2D9(^
M:*95D0Y'1E!K5KGOACJ'BC5/"D<WC#1]`T/6VD826FCZO-JMJB`_*1/+;6SD
MD<D&(8/&6ZUT-`'+?$/XU^%?A/KOA72_$6M6FDW_`(WU3^Q-"AF#;M2O?)DF
M\A,`C=Y<,C<X&$/-97QS_:C^'_[-'_"+?\)WXHT_PU_PFNMP>'-$^U!S_:.H
MSY\JV3:I^=MIQG`XZUX;_P`%-_V+_$/[9OC#]GF/1KB_L=*\`_$B+Q+KM[I^
MJG3;ZRM(]/O8A)!(#N+^=+$"HSE2V01D5Y'_`,%*/^"3GC?]HGQ3^SQ<^#?&
M7BCQ#%\/_BKI/BS7!XJU_P`ZVM+"T$CO)$FP,TQ;:B@9^^<X&2`#]#**1&#`
MD'(S2T`%%%%`!7!?#']J#P!\9OBGXZ\$>%_$]AK/BOX9SVUMXHTZ$.)='DN5
MD:!9-R@9=8I"-I/W3TKO:^,O^">O[#7C;]FW_@H3^V)\4_$PTN+P_P#&[7]$
MG\-Q07/FW+06-M=+)+*H&$#-=`*N2W[MB0`5)`/LVLKQSXWTKX:>"M8\1Z[>
MPZ;HF@64VI:A=RYV6MO#&TDLC8!.%168X!.!6K7FW[97PVU7XR_LB?%/PAH4
M<4VM^*O".K:/I\<D@C22XN+*:&)68\*"[KDGIUH`N?![]J3X=?'[X)1?$CP?
MXRT#7/`DL$US_;D-TJ6<4<.[S6D=\>6$VL6W[=H!)P*U?@K\:O"W[17PMT7Q
MMX)UJU\0^%?$,!N=.U&V#"*[C#%=R[@#C<I'('2OA*__`."/NJ>"OV?M!\1^
M`GA\/?%.[^%]AX(^(?A5+T6^@?$J&'3H[6:VNI44F&Z5//C@OHP3&9`65TR*
M^A_^"17[-WBG]D'_`()N_"7X:>-K:UL_%7A'2&L]1AMKA;B*.0SROA9%X8;6
M'(H`^CLXZUS_`,2/BSX5^#?A:77/%_B70/"FB0.D<FH:QJ$-C:([G"J9965`
M2>`,Y)KH&!((!P37R=_P4:_85\:_M+?&#X"_$OP!XETJQ\2?`KQ+/K47A_7;
MB>#1/$45S$D,PFD@1WBN(XU;R91'(%\V4%2'-`'M7P1_:W^'W[2%Y<1>!]=E
M\0P6Z22B^M]-NUTZY1)?*9H;MXA!.-^0#%(P."1D`FO1P00".AKQWX;?$CXR
M^(O%4=CXE^%7A'PU86UV\=_J,?CE[^*:'&8Y;%%L%DF;@B1+A;7;E=C2@MM]
MAB&(P,YQWH`7..M`8'H032,<*3SQ7%_`WQ+X\\3^%[BX^(/A/PYX.U=;J2.&
MRT?Q)+KL3P*<+*TSVEKM9N3L"-A2N6#$JH!VM(ZAAST%+1UZB@#S+]IS]E+P
MA^U;X-BT7Q7923&U9I+*[@?R[FRD88+(^#P<*2I!#;1D'`K\_/B5_P`$SOC)
M^R-X[@UWX/:WJ>OP74CQ)+IS"TOK9/O*D\9;RY%[9!()7)5>!7ZGE`<D@'-+
MM'''2N+$8&G5?-+1]T7&HT?EQX/_`."ROQ8^#OB&73OB+X-L]6F7]ZUO<02:
M->QJRC8/N,`N1GF,EL\$8KK_`/A_V?\`HDP_\*?_`.Y*_0;Q1X.TCQQI+:?K
M>E:=K%@[!VMKVV2XA8@Y!*N""0?:N9_X9B^&O_1/?`__`((K7_XBN=83%1TC
M5T\T5S0ZH_/OXB?\%RO&GCFWMM.\$^`]-T+4KMC`))[M]6F>1F41B)!'&`V=
MPP5?=N&,$<\;<?LZ?M+_`/!0GQ-#<^+8]4T[20Q:-M:5M/L+0J2N4M@-Q;+$
M9V$X)Y(X'ZH^#?A?X9^'1N3X>\.Z'H)O-OG_`-G6,5KY^W.W=L4;L;FQGID^
MM;GEKP<=*3RZI4_CU&_):`JB7PH^?_V//^">G@C]D'-_IHN=:\2W-N()]6O`
M`X'5Q$@XB5CU`).``6/)/O\`'$L9)&<FEV#.<#-+7HTJ,:<5&"LC-ML****U
M$-\I<YYXI5C"G(SG&*6B@`HHHH`;Y0R#DDCFG444`%-:(,223S3J*`"BBB@!
M&C#$$D@BE4;0`.U%%`!2,H<8/2EHH`;Y*\'GBG`!0`.@HHH`*1EW#'2EHH`1
M$$:X&<"EHHH`:L04@@GBE90PP<XI:*`$5`F<9.3FEHHH`****`"FM$&)))YI
MU%`!0RAA@Y%%%`#?)'<DTJJ$4`#`%+10`4C('QG(P<TM%`##"#CD\4]0%``Z
7"BB@`8;@0<C/I34B5&)`P3Q3J*`/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>oncolytics_ex23.jpg
<TEXT>
begin 644 oncolytics_ex23.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`@$"
MT`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W\HHHH`****`"BBB@`HHJOJ&K6NDP^9=7$-N@[NP6LJU>G1@ZM
M:2C%;MNR7JWH5&+D[16I8HK@?$G[0NCZ3N2R2;4)AW7Y(_\`OH\_D*\_\2_'
M+7-?++',MC"?X8!@_GUK\&XQ^DKP1D/-2IXCZU57V:*YE?SG=0];2;78^@P?
M#&.Q&KCR+O+3\-SVS7?%VF^&HM]]>V]OZ!F^8_0#D_A7!^)?VD+6WW1Z7:R7
M#=!)-\J_EUKR<6]YK$WF".XNI'/WL%R3]:UM.^%?B#5/]7IEPH]7&P?K7\VY
M[])3C_B23P_">`E1@]G"G*M4_P#`N7E7RA==SZ;#\,Y?AO>Q=3F?FTE]V_XF
MQI'Q2UKQ7XTTN.XO'2![N,&*+Y$(W#@XZ_C7O%>-^#/@/K6GZ]8WERUG#';3
M+*R&0LQ`.<#`(_6O9*_?/HVY=Q;0R_'8CBZ-55JM2+BZS;DXJ/12=TD^EEZ'
MSW$U3!RJ4XX.UDG?EVW"BBBOZ4/F`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`)VB
MLG4_%:V89;:SO+^4<;88^/S.!6M17#F%#$UJ?)AJOLV_M<JDUZ7=K^J:\C2G
M*$7>:O\`.QQ&IW'C;Q`66UM['1H3T9Y/,E_P'Y5C']GZ^UN?S=6UV29SRVU2
M_P"K'^E>H45^9YGX-Y)G%3VG$-6OC.O+4JR4%Z4Z7LX+_P`!];GJ4L[KT5;#
M*,/1*_WN[.#T[]G?0+/_`%QO;L_]-)=H_P#'0*Z#3OAIH.E$&'2[4,.C,FX_
MF:W**^@R?PPX2RJSP&6T8-=?9Q<O_`FG+\3GK9KC*O\`$JR?S?Y$=O9PVB[8
MH8XP.RJ!4E%%?;TZ<81Y8))=EH<#;;NPHHHJQ!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110!S_P`5]3N-%^&'B*\M9&ANK73;B6*1>J.L;$$?0BOR#_X;[^,7
M_0_:U_Y#_P#B:_77XU_\D>\5?]@FZ_\`135^%5`'L'_#??QB_P"A^UK_`,A_
M_$U]&?LJ_M9^.OVEO@UXH\"_\)9>VOQ&L8VU30+\,BR:@$Y>V;C;].G4>E=-
M^S!^TE^SQX5^`'A33O$Z^'_^$@L["..^\[1S+)YHZY;8<GWS7NGP`^,'P.^*
MWCM;7P);Z#)KEG$URK6^E?9Y(T'!(8H/7'7O0!^;TO[>GQGTR_:.;QSKD<UO
M(5DBD5`593@JPV^HP17ZA_LK_M*Z;\?/V>]/\727$,$EO`4U8$X%K-&/WF?;
M^(>QKX5_X*S?LK_\*L^)Z>.-)M]NB>*I#]J"#Y;>[ZM]`X^;ZAJ^>OAS^T-X
MD^%WPW\6>%=+NO+TOQA#'%=J<[H]K9+)Z%ERA]0?84`>L?'_`/X*0?$7Q;\8
M=>O?#'BK4M&\/M<F.PM8-FU8E^56Y4\MC<?<U]?_`/!+Z[^(_P`1/`=YXT\=
M>)-6U.QU)C!I-K<;0K(IP\W`'5AM'T-?GG^RQ\`+[]I7XTZ3X8M-\=O/)YM]
M.!G[/;KR[?7'`]R*_:CPGX7L?!'AC3]'TVWCM=/TNW2UMXD&%C1%"@?D*`-"
MBBB@`HHHH`****`"BBB@`HHHH`\B\0_'37(/C9JOAFSAACL]+-F/,&@:CJ+2
M^<NX[I;<&.+'3Y\>IX%+?_M@Z38SW2KX8\7W$-JU\#<10VOER)9.4N9%#3AM
MJD'J`6[`GBK?C_2?!/ASXBSW^I>*-2\/ZQK*PF:*WU62W2<1_)&S(O`'49.`
M:T=%^$'@SQ%I]XMCNNX5;4K"<QW3-M:ZD9KI"<_>WD_[O:DKVT\_^!^.Y6E]
M?+[NOS['*>,OVU=)TR/5H=%T76-6OM-$14E(HX9MSQ*?O2!UP)E(WJH;G:6P
M<:W[2W[0-Y\$]'T&2QL[*>]UBY\MX;N3F",+DL0K<#<40OG8I<$DBI];_93\
M$W\T]Y>PW[!;<QJ7OY-MJN$RT?/R'$:\CTK6\9_![PO\;-*T^XO6N+R!;1[>
M.XM[MT^U6\NTO&[*?G1]BD@]2`:<NEOZ_K_,F-_M%SQO\19/"G@BV\10PPWF
MEP[)]0:)C(8K8CYY8RO#!/O'&<J#BN1'[55KHEA)=:QH^J);^4-2D>TA5AIF
MGR/M@GN=[JVYQ\Q6-6*@\@8)KN[/X:Z38_#;_A$XXIO[%^PMIPB,I+"`J4V[
MNOW3@'M7-^+/@OX,\5>([*POC,+U;!(C9QWCQB^M86&U94!Q(BMCKZT/XG;;
MI^/^2_$/LJ^_7\/\W^'F5+W]J[P_;:+;WD>GZ[=_:[6TNX888(S+(MS<&WB4
M`R`;MXYR<`<Y/2JT_P"U[H,5HLD>B^)KAX4,FH11V\)?21YYMQYV90IS(K@>
M47X0GIS3O"'[/W@"+5]0M=-FN+NZTR6U2>!M1DE-B89OM,,84GY%#G(7T..E
M4/B/^R':^+M2MFTG5%T.S:1GU`+%-)<7P-Q]H*;Q,J;=Y8@/&^-QQ3C:ZOW_
M``Z?\'\`?6WE_P`'_@?B=V?'\Q^,%OX;6"/[+-H[ZEYQ)\P,)50+CIC#9KD/
M$G[0=]H_P/U[Q0MOIMO<:3K<FE)]H9OLZHM^+7S7P0>%.XX(Z5UGBKX/:;XL
M\36FL27FLV.HV=L;-);&^>WW1%@Q5@IP>0#S69'^S?X?1;R(W&NO9WUZ=1EL
MVU*4VWGFX6XWA,X'[Q0>/<4NU_/_`-*O^6@?YK\M?QU'_`_XIWGQ*&L+<2:5
M?PZ9<)%#J6EA_L=Z&0,0FXL<J3@X)&?RKO*JZ9K5IK0F^R7$-Q]FE:"7RVW>
M7(O53[CTJ34M2M]'T^:ZNIH[>VMT,DLCG"QJ!DDGT`H;!7V)J*9;7,=Y;QS1
M,LD<JAT8=&!Y!%/H`*\_^.OC?Q-X"M=+NM#_`+">WO+V"PD2^AE=P\L@4,"C
MJ,#/0C)]:]`KB_B_XD\'Z>-+L/%6HPV;2W"WUE$SLKRO`RMN`7DA25SVY%'5
M>J_X/X#[GGU[^VWI,6L6^A6JK?:XNI0Z9-.JJMG-)YZ0S^6HD:9-I+;?-50V
MW@L.3ZCXQ^)=KX#\!W.N:K:W-@L)\N.UE:-IIY2^R-%V,RYD8KM^;^(9QSCG
M[7]GOPEK=Q'JD/\`:4EK<W2ZI!`M]*MK'*9%F\Q(L[5W.-QXY)/K787'@W3]
M2T(Z;J%NNKVC.7*:@!<[B6+#.\'IGCT`%#OR6?Q=?P_X(M.:ZVZ?C_P#Q.P_
M:S\0:[X2M-4M=*T6%K71WUG58))7EVJMTT'DQ,IQN^1B6.1TXYKNO`_Q7UK4
MOBW<^&]8L;&WCDL#J%G)`DR94.H"!Y`%F;:RLQB&$)VGDBLG5_@-\-?#TVGZ
M-))_8[0V5PZV<%\UO]JM1*)I?-52-\:N0>>F<4[PIX@^&7AB=_%%KXDCN(XW
M>RAEN;^2:.S,F)&CB5L[`P"MP.@':J35_O\`QNE^GW!*_3R_2_Z_?Y"^.OC-
MXL^'^NZI'-HNEZM;PV%U?00:>\KW%LD9`C,Q(P0^<X501@@;L9KDK;]KW5]>
MU'5--T7_`(1C5;KP_9W&H7M['YWV.ZBB1&"0X8D,=Y!)+`8Z'I7;:CX%\%^`
MK75-<OM?U:&Q\4%_.:;5I7AN#*,CRP#D8'W=OW1TQ6'<?#[X6ZY-96I\07$M
M[JD+R"Y35Y//U&&95!620'YE94`"L>W%1K:WE^.OY?B-VW\[_+3^O(W/C9^T
MC;_"OX8Z?K%M:QWFK:Q;K<V=C))Y>8]JO)(QXPJ*PSW)*@<D5'\2OV@M0\`Z
M_:1_V+%)I4^BW>J?;&N`3-)#")/+1%R0O(!9L=>`>M:;:=\//VC/"]QI<:Z-
MXALK&(6QV(KO:H1QL8C*Y"\%>N*3QE;>`;SSEU2\L$7PM:MIUQ$)]JV<=U'L
M\ME7NRC@=?2G/K;Y>G3]/ZT%3^S?Y_>O^"<?:_M"^,+GQ3;^%_L7AM?$5UY,
MZ3[9_L:PR6[RX*[MQ<%"N<X.<X[5ZE\*?''_``LOX:Z'X@\G[,=8LHKIH@=P
MC+*"5![X.>:\N7P;\*[?2-.N!XFNE?5)U-GJ/]L2_:F**8`@DSN50"4VG`R?
M6O1_AWXF\+6JKX5\/WMO(WAV$6AM8BS&W6,!=I;ID<`\YJM-?P^6_P"A.ME<
MZJBBBI*"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@#F/C7_R1[Q5_V";K_P!%-7X55^ZOQK_Y(]XJ_P"P3=?^BFK\*J`/J3X0
M?\$I/&WQD^&>B^*-/USP];V>MVRW4,<S2>8BMT!PI&:^D_V"?^">/BK]E;XP
M77B'6M6T6^M9[![0):,Y<,S*0?F4#'%?&WP__P""B/Q8^&'@S3?#^C>((;72
M])A%O;1&QA<H@Z#)7)_&MG_AZ;\:O^AHM_\`P70?_$T`?I[^TA\'M+^._P`%
MM?\`#6K+_H][;,T<H&6MY4^9)%]U8`^XR.]?B#?VIL;Z:`G<89&0D=\'%?LY
M^RE\1]6^+G[(GA_Q'KUPMWJVJ:=/)<S+&(P[!Y%'RJ`!PHZ5^-/B'_D/WW_7
MQ)_Z$:`/TT_X(]_!'3?"/[/;>-,+-K'BRXF1I".;>"&5HEC'U9&8GOE1VKZ\
MKYY_X)7_`/)CG@__`*ZW_P#Z6SU]#4`%%%%`!1110`4444`%%%%`!1110!Y;
MX@\(>(=`^(?BB\T_P[IOB2Q\616P+7-VL(M#&GEM'(&!+1$#>-@)R6X[UQ+?
MLW^)M!N];U'1[6QAU357UQI#]L>..=;C!M5;:P8`'/W2"N<Y'6NL^//C_P`4
M>!/'FFMIUY;_`-E2Z5J,PLQ!NDGGAMVD0LQ[`@8"XSSFN!TWXE^*)O%>C^&V
M\;:A+9ZK'9W4VKB*T\Z%I+.:9H5/E>6%9D4C*E@,\GK4K9ORM\G=?I_3*;M;
M[_NM_FBK\._V3_$EQXCF3Q%I\+>'U@OFMK2>[B=(998K=8_W<6%X9)#_`!$9
MR22:JZ?^R?XSMY=/`6_LUL]/M[:T2SU.UA@T\QQ,LBG="\I#O\V(W4,&PV,9
MK2\/?&_Q9K5G8ZI-X@FADL6T:$6"0P"+51=7`BED;*%\E3D;&4`CH:]J^.?Q
M"O/AW\/+B^TRQOM0OIF$%O\`9;*:\$#-G]ZZ1*S;%ZG`[8JJFD;OT^[_`(?_
M`#%33O9>OW_\,>,ZG^REXBM]8\*M9OJ$-I86%JDJ6.H6T/V2\63?/.[30RNQ
M<8&8R&.W!X.1T?P6^"?B+P/\6)M8U#2X/.CL+N"?4_MXE?5YI+CS$<IU3Y<#
MGIC`X`KDK']JKQ-=>%/A6`-:W:J;)M:U-_#]SY=\TC,C11D0[%.Y2QZ?*5*Y
M!S79?`3XD:_XC\<V(U#7)]2AURTO[J:R>.%4TQX;QHD1-BAP-O!WEB2M6TU*
MWG)?AK_P/QZ$75OE'\]/GW_X<R=,_9X^(&B0:U>1ZOI,E]XNTRZAOTMX7MI+
M.Y<F2%C+YC>;MRT6Y53@J<'%0WOP=UOR/"=JOANTAAL7O)#H)\2NK!V,&R[$
MF<C80^53.WS1CDFM[4O"&K?%SQ)K6A_\)0?$7AF2+;J"W-O"+>*X6YC<00^6
MH9@(U=7W,W)7D'(J'X*_LOS?`OQY)XBO-0TB2QL;*\B,R1.EP8I&B=4=B=OE
MPK$54#H&[5$6E9O16_*]O^!OI9KH5+7;5W_-+^O7YG-77[.WCORKAK>&./4X
M'EGNK[^U"?\`A(F^U)-$I!Y3:B[<L!CH.*?K7[./C#QO+XDU#4+..WO+RWU&
M;2H3J6[['=2^6;=LJ<!E*GYAPIZ5?^'_`.U3K#V?B>^U*UOIH5C&N6$%UILU
MCY-@)2DL<;.BB8QQ!)=RE@3(1G&*EU[]LC6%:QFT?PS;ZA87EO)J:3RWL=ND
MEB)S%'(&E=`"ZC?GD`,OK3BGHO*WW[_EZ:.P7W?G?^O+5?>KG+^-?V8/&4]A
MJ5CI>CV:QWFHWU^+F*\C61I95B\J3#DH-N)`6*,X."N,FM#4_P!E/Q-KGA^Z
M>XA@?6-3GO4NY)+TOYMO)9>7&AYP5\X`X['FMN\_:]UO1[Q9+W1-*CL+R>YB
MM76Z?>BP7MO;.TF1@96?<,'@K2>+_P!L;5M.O/L^C^';75)%N=2WR&]BBA\B
MTF2,G?(Z+N;>">2%Q2CJK+JOP5OZ]!ZK7L_Q=_Z]0^%'P*\4>$/C58ZS_9ZZ
M?I:VL44R27ZS+`BVL<7E1"/:PPZ9V/YB=64@L0/H"J^E7IU+3+>X9/+,\2R%
M-P;;D`XR,@_4<58JI-[,B*5KH*\W^*7P<N/B+\8_">J22WUOI>CV5_#<266I
M36,X>7R-@#1,K%3L;(SCI7I%>4?M"_M!:M\)?$6EZ;H^@QZO->6<^H3O-=16
M\<<43(I&Z1T&3OSG)P!R*G[2_KH_TN6KV.*^('P/\::E\=)];M=,2^TJ.8HH
M_M)8_MMH;/R_*D9RT@;S,Y"E5Z-@MDUWWP'^'.M>`M+M;7Q':QZOJ\,TSOK?
MVC>T@95P=K'<.`$P.R`]Z;X`_:!NO&7Q/E\*S:9#:W^GB6?4,2[A#`0C6SJ>
MC>8L@Z'&4<#.*YK3/VK=5U?1[*:.Q\-QW&O:FEAIT3ZD=]HK/,N^[3&Y/]20
M,=68+UIQ=DDNMOS_`,Q2UU[?Y?Y?H5OB5^S)XK\2?&"Z\06^M:9>VVH:7J-D
MWFV31SVB2I$(H%?SB"NY6.X(,'=D,6R)+#X8^*9M'\02W_A5'_MV&TT]K*#6
M5M[B&.&V,1F25,`;F;!&X':._2LWPW^V'XH\7:I)#9^']#$,>KIH1D>\D.^X
M:&63S%(7!B!C^I!]J]J^$_C=OB1\.M)UR2W6UDU&`2O$K;E1N00#Z9%)1O"R
MVT7ZK\'^/<<G::;WU_R_3\.QS%YI/B_P9\%O#NFZ7IFGZUX@L[:&UGE#QQ):
M83:TL:OA68=`.`?IQ7FOB;]EC6-6BT_2]#M-3\-Z3/\`89KP'4[>:,M;.7_>
MKY9D,A(&#%($)8DCBOI.BB7O/F?>_P#7YBCHK+M8\A^`/PT\2>&KJ]N-6LX=
M%FCT&PT2WV3I<^8]N)<SX7`P3(,`\\<XK!\`_!?QQ\%+[QK?6L>A^+KK639R
M6Q:'[&]S.N_S)Y2\S_,N[..-QQ@J!BO?**J4FWS/^M;_`-?\,))+3^MK?D?.
M-W^SMXECO[74M+L]1L=0NK=XY]^K1HL%VUV9Y+F9(SLF1RS'RP"!P-O`([KX
M7?#?6O"'Q.O+B"QN=%T*9[N:[ADUF2_@U":64.DL4;L?)/WRP`49;&"`#7JE
M%).VWG^/]?U9#>M[];?A_7]784444@"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@"OJVE6^NZ7<65W$LUK=QM#-&W1T88(/U!
MKQ__`(=W_!;_`*)_I'_?R;_XNO1_BWJ$VD_"WQ'=6TCPW%OIEQ+%(APR,(V(
M(]P:^)/@C^T?XP^%[:7KFJ:CJFK6M]X,O-5:VO==2_AOKB$HP8JJAK;"L>"3
MGI0!]*?\.[_@M_T3_2/^_DW_`,71_P`.[_@M_P!$_P!(_P"_DW_Q=><_&7]K
M2XUOQI!I=C$T*Z7JUO;07=CJ+*'>?2)KHEP`0X1QMVDXR`>HQ7"Q_M9>./%6
MA_#O2;:ZL['3].U+PC::I=27$@U35Y+N**:1@/NF%@2&R,D]^<4`?:'@SX?Z
M/\/?!MKX?T6PAT_1K*-H8+6,DI&C$D@9)/)8]^]>8S_\$]O@S<S/))X!TEGD
M8LQ,DW)/7^.O'?#7[;GBKPU\.[>;2]$TN[TW0-.AU34VU._FFO)XIK^2W\N)
MPH&X8R&;(`&,&O1/@?\`M?Z[\5_C!;Z9/I>A6N@:M>:E:62)</\`VG;?8L!F
MG3E<.2"N,8'K0![1\.OAOH?PE\(VN@^'-.ATK1[,N8+:(L5C+N7;&XD\LQ/7
MO6Y7SKI/[:6I:E^U1'X-AT_3;SPW<ZE/HJ7D<4T5Q#=0IO?<S?(X'0A0.H.X
M]*Y"[_:_\4_";XW>+TU!-/USPR/%$FE);>>_]I6JK:B1?*0?+Y0(.<Y/S$]N
M0#ZYHKXIO/VW?B5\2O`UC>V&BZ+H]O+J^DR+?+<3P1&*XG4?9G+H<],.XPI5
MB0*V+K]L?QQ\,KSQL=4MM!U"XF\60:+I:+<S7$=BTELDA)1$#M`%&05Y9W(X
MX)`/KZBOG?X.?M1_$+XS>/\`1M*M_">AZ1:1Z9#J>MR7MS+YRH\\\.+=`/XO
M)$BE_P"%L'FOHB@`HHHH`****`"BBB@#@?%/Q<TFT^(W]B'P[JVM7VFK$9[F
MVMH)%L%GR!P\BRL"`=WE(^!UQ6+\1]5^'/PGT+5M-U+P?IO]G6=HNL26<&D6
MS17K>9Y2A(S@--N(`R!]X<U?^*?P)OOB7XD^T?VUIMI9[H64G2-VH6NQ@Q$%
MTLJ;0Q&2'23&3CCBIOB%\"I/B7XJ\-ZEJ&KQQKX?U!KEH(+,JM]`"'BAD+2'
ME9%1RP&&*_=7-+6R_K3^M?D/K_7]:[?,E\!ZEX+^*FJV]_IV@V$UQH]I;26M
M[+I\.ZU26/S$CB?EE*J1D#`&:KGXC:/\,9I_#>E:'KVKVVBA6U&2P@CEBTT2
MDN/,W.K.2#NVQ*[!2"0,C-CX-?!27X*Z!)I]CJL=Y'<:E+>3O<6A+F!MVR!,
M2#;L&P!CN&%(VC.0:M\*-<M?&NK:IX=\36^BV_B!HI-1@GTO[7)YD:B/?`_F
MH(V9%"G>L@X!`'.;=F_+^O\`@B6BU(_%7QB\!^#;-=/DN-)N)M+E@$>EVRQ-
M-;,SHB%8B1MV^8IXP0#4_AKQA\-]-U?7+S2;SPC:W\(:?5Y[4P1S`!B&>9EP
M3ALY+'KFO./'7[$%YXY\<MJT_C"-85U)M0CC.DLTV&9&,;/YX0XV`!A&IQC.
M[%9_@K]F3Q9?+JVE7=TNB:3:Z0FC:3<S64+7#(ESYP,JQ7#^:"H"EMT3')PJ
MGFICJM=]?R_ST\_D/3Y:?G_EJ>C:%XU^$/A'5(]3TR\\!Z7?:J&5;JU6VAFN
M07&X;U`9@7`SD]<=Z[Z#4=-\3PWMK'+:7\<#M:W<0*R*C8!,;CIG##(/8UXK
MX1_9%E^'5OXFOIM03Q-<:OIUU;"QM[,699IG60[7EF?'*_Q-[D\5UW[/_P`.
M_$7PQ\(6FD:A-;SM)9-=7EZXWS/J$DC%LD-AE"X[#D<$YP#2WR_ST^Y?>T)W
MO?S_`,M?O?W)L=K?QO\`!\%QXF@GLI+IO!JI!<C[&C*Z2[4982Q`902$<<`$
M8YI/#WCOX<?$6S7?!X?5_"LDXBM[Z"`2:8MM*T32(O/EH#'P1CC'3I7,7W[%
MENVDJEIXGU2*_N(Y8]0GN`UQ%=^;,)Y"L1D`CS*-WRDXSBH;K]B?^VM.U6RU
M+Q,;BSO/[1:T2'35A>U:\N/.;>P<^:JD*,$+G!YY`!K;SM^*V#3\?PZG4>)?
MBQ\*++PT]W>ZAX/N;&2&X*QX@D^T)PTRJO\`%N(7<.YQGM4GA[Q!\+/&%GH6
MFVT/@^3[8B:AINFO;V^]"Z[@Z18^5R.<CGBL'P9^R%'X9U*]O)M6T\W&H:7>
M:=*++2C;1@W!A_>`--(V5$6,,S$[NH`Q6:G[(>MV/B32M8_X2RQO9M#DMKJ"
M`Z,Z>9)!`(0@/VG:J-MSRI8$GYL<4XV6_E^;_P"`PU>WG^2_X*/>@,"BJNAO
M>2:-:MJ"PQWS1*;A8<^6LF/F"Y)XSGN:M4GN"V"LWQ#X/TGQ:+<:MI>FZH+2
M3S8!=VR3>2_]Y=P.UO<<UI44`<WIGPGT73_$FJ:M);_;[_5IHII)+P";RO*S
MY2Q@CY%3)(QR"2<U:D^&OAV:VU"%_#^BM#JS^9?(;&(K>MUS*-N'/NV:VJ*`
M,NT\$:+8)&MOH^EPK"R.@CM(U",JE5(P."JDJ#V!QTJ]I^GV^DV<=O:P0VUO
M$,)%$@1$'H`.!4U%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`8_Q`U*ST?P+K%WJ-K)?:?;64
MLMS;QIYC3Q!"64+W)&1CO7SGX(^+_P"SOX42\CT/0-&M1?Q1V=X(=/3F"6VD
MN&W_`/3,)&X;MN&*^H;FW6[MY(I%W1R*48'N#P:\"\'?\$W?AWX,UB2[M[>[
MF$VGWFG/%*P9"EPSEFQC[RJ[(O\`LT`<KHOQ7^!N@Z4JV/P_N[2\_M*`1:8F
MAE+N66:WD$,Z1]U:(R*&'N*Q=%^*OPZ\1^(/%BW7@?0+?Q1\/DNGT16TXL^F
M6FFVZR0//@[EVOP%7!^7`Z9KU[PE^Q;HOASQ7I^NW6N:[K6L:;=VUQ%=7CH6
M$=O$\<4&%4#8!(Q]2>IJIK'[!?A/5/&7B#7X[K4K35?$S:B+^>(J&FAO8?*D
MA/'*K]Y<]#0!QV@?&OX-QW47AN^\*K;K?BRT6^NDTLKIQEEC%Y%`6)X!9BP!
MZ$U)\`)_A[\5OVJ+KQAX<M]8LM0CT:2]M8'TF*TM[N*1Q`]RLH7S)MQ7`W'`
M.2*[.?\`89\+W-@UM)?:HT3ZY8:ZPWKS+:6PMT7I]TH,GOFL_P#9L_9<U;X*
M?&C5M0>]EF\+V.C)H6APW%PLTR0B<S8^5%VJI.`&+$Y/-`'/:5\>O@3)\1(?
M$%OH-K#XMNB]ZLPT\+>&4W36;9_Z:&16SZJ,U7E_:(^!>G>)]6\:?\(K)_;$
M.^[CU,Z/^^U53*+9Y8&/^L&Y@N1S@UV%O_P3Z\!P?$P^*O)N6U%M>?7B"5V%
MV4CR<8_U88E@/4U3?_@G=X3GLGM9M6UZYM+>,V^F0S2HRZ1";D7+1Q?+G!=0
M"6)..*`/.=.^,?PWT/Q;XN\,W_PSMM/\/W2Z8UOI*:/_`,3#4KV9YV4/%T&W
MR=R^F,YYKU+]G'PUX1_:*^$UUXDU;P3H%M-XAGEM;N#[(-TD=O*R1*^>=RA1
M]"*T_B-^QGH7Q#^(FH>*FU76--URZFLKB"YM73-G):B0(RAE(.1*X(8$=*[7
MX+?"6S^"7@"W\/V5U=7T,,LLYGN<>9(\CEV)V@#JQZ"@"]X3^&/A[P).)-&T
M>PTV1;6.Q!MX@F((RS)'Q_""[$#_`&C6]110`4444`%%%%`!1110!Y'\1?A%
MHNL_M"^'-2N/#]O<Q36EW+?7`MBP:1%C\HNP'WA@[<\\<5Y3JWA6Q\8QR2>$
MM%U*&SN-7TVV?2-2M+V*.]1;@F2YNFD0D[LX+?,VWENM?65%$=&O+_.__`"6
MJ:[_`.5CR?3_`(5:AX*^"7B[3[BXCT\ZHL\D-OH\$EU%I:,@7;"C;&?H6P-N
M23BO&]3\.O,?"ME)I>FVOA[3;^]1;X^$+R6TO@;6';+)9"3S%??N0,S8)4D5
M]>44=7Z)?=_7^=P_X/XGR_XOT+4U\7^&V\.0QWDDT&G1V4J:/=V,>G)'<M]H
M,"$,L0=,[UD<'`7&[/'U`.E%%.^EO-O[Q6UOY)?<%%%%(84444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`45POQS_:!T?X#:
M=I9OK/5M:U?Q!=_8-'T;2H4EOM5N-I<QQB1TC7"J27D=$4#)85P__#?7A6U\
M+RS:AH'C+2_%<>L1^'T\'W%C$VN7.H21^;'!$(Y6MI`T8+^:LYA558M(H5L"
MUV_K;[]U]Z[H'IO_`%O^&C^Y]F>Y45\]^-?^"D7@_P"%_P`'?B%XJ\5^'?&_
MAN_^%]A'J>O>&KNSMY-8BMY,^5)$(9Y+>=7PP!CG894@D,"*W(?V^/AW<:/X
M"U*.]OFTGXB:-?:[IUZ(`8;:VL[=9Y_/^;<CJK8V@,=RD<4Y*R<GLO\`)O\`
M)/[@OJH]7_P/\U]Z/:**\'\,?M[:7KW@;5/%5Y\/?B=H7A6ST&X\2V6L7VF6
MSVFKV4,1F+1-!<2F%VC&4CNA`[9Z9!Q-X*_;:D\2_"K5/'&J?"GXG>$_"6F^
M'9/$R:EJKZ+(M[;+#YX6*.UU">7S&CY`=$'8D'BIDU%2<M.57?EOOV^%Z;Z,
M(ZV4=>9V7GMMW^):[:H]RHKY_P#`7_!2+X?_`!1^#?PQ\;>'[7Q)J5C\6-5_
ML31K(6L45[!>?9;BY,-RDDJK$P6VD7EB-Q3L=PD^#_[==S\8?C5K?@6'X-_%
MC1-3\+S6T.N7.I2:#]ETC[3%YT+2&'4Y'<,G/[E)".A`-6X24G![K3\O\U]Z
M)YDXJ2V:NO2[7YIKY'OE%>9_&7]J#3_A/XRT_P`+V'AWQ1XY\8:I:O?PZ%X>
MCMC=+:HP5KB1[J>"".,,0HWR@L3A0QS7$ZY_P46\+PZ3X3;0?"OCGQ=KOB[6
M+S08?#^G6]G;:E87UI$TMS!<B\N;>*-HU1CGS"&&"I8,I,K577]:V^Z^C>R>
MA4M-_P"M+_EJEU6J/H*BN5T7XG33_"NX\4:UX9\0>%#9VLUW<Z5J36DE]`D:
MECG[-/-"20N1ME/49Q7C_P`/O^"GWPS^(O[0/@GX;6Z^(K'7_B!X2A\8:/->
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M*@D(/V@MD`;<FL&__P""FGAN*;2=+L?`?Q&U?QIJ6OS^&9_"=O#IL.JZ7?0V
M@O'2=I[V.V"FW9'5XYW5@XVD]CE>R_K;\+M)OHWJ']?G_D_N9])45\]_%W_@
MHWX5_9UC^&Z_$;POXV\#77Q-UMM"LK?4(;&X;2Y1]V6\DM;J:*.%LJ`ZN^"X
MW!><6/BW_P`%#O"?PG\3Z]H0\/\`C#Q%KV@Z[I/AS^S]*@M!)?7FI*6MEA>X
MN(H]N`=S2.@'O1RM[:ZVTUUNE;UO)+YH)>ZKRTTOKVUU]-']Q[Y17SYXA_X*
M.>$_!?P[\::MKWA?QQH>O>`4M)-7\*7=M:?VPB7;^7;/&4N6M94D;(#I<%`5
M8$@@BG_%+]OZW^`?[/OBKXD?$#X6_%#P9H?A58&>WNDTF^O=2\UQ&!;QV5_.
M&*L5R'9"=PV[N<*UM7_P-?/KN&[LM_Q^X^@**\;O/VVO#-[)X1A\-:7X@\;7
M?CSP]+XET*#1A:@ZA:Q^42H>XGAC60B92`[@<-D@C!J_LQ_MIM^U!XDUFQLO
MA=\2?"]GX?OKG2M0U/7'T<6MO>P;?,M\6VH3RLWS##+&4.#\]/DES.-M5?\`
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M$:NX"<J,C-C2/^"A/A75I]-U`^&_&UKX#UJ^73=-\;3V=NNAWT[R>4@4"<W:
M1O)\JS26Z1,2,.002XQ;M;K_`$OOV7=Z('I>_3_A_P`M?378]ZHKYS\0_P#!
M2+1?#_B#X@+_`,*Z^)M]X7^%NI2:9XF\4VEOILFFZ:\5O'<2R>5]M%[)&D4J
M,QCMF/7`.#6[XE_;KT.S\?:AH/AOPCX\^(3:';VMWK-YX9LK:Y@TF*Y3S(69
M))XYIRT9W[+:.9\?PY(%)1;2?>S^35TWV36J;T8/2Z]?P=FO-IZ-(]OHJ.TN
M5O;6.95D59D#@2(8V`(SRK`%3[$`BI*0;A1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`?/O[8/@W6M+^-/PE^)>FZ-JOB+2_`-]?)J^GZ9`;F\6WNK8Q>?%"
MOS2F-@,H@+D,<`]*XGXM^(/&OQ:^(7P[^*UK\-_$UOX9^&?B.X<:?/$RZYJV
MGW5B\$EZFGLBR1M#(RXB8F5T#D+G:K?7%%4I.R7;;[[_`#Z_>_*Q+WM^UOS_
M`,_P7G?\^?VN_A'XQ_:KTCXV>//#_@SQ79V.K^!].\):)INHZ7)9ZGK,L6H-
M=33?99`)410X1?,52<.0,8);IG[-?CGX)_\`!1'PKI-CX&U?Q)\([/3_`!!X
METZY@C0VNG37]I''<:1(7(5"\\9DCW$*1<,N1LK]"**?/[J@MDFO_`M_QU_#
M9M"J7GK+>Z?W62_\E5OG?>Q^=OB#X:^)IO#7BS0?@YX3^+7A[P;J_@W7;/7_
M``IXFTZXAT^QN7LI5MHM-\[.Z1IFVXMW>$KWZ5U7P-TMY/V$/%7@'3M.^/=]
MXLN_AQ+9-9^+]%U2.UANET\Q&WM9+B%(\F0[51&.X#C(%?=%%95(*<)P?VTD
M^^G-;_TM_)+4M2M*$U]AMKY\M[^?NK7S>A^:^F?LE_$/X0?M'_LTP:+X3UBZ
M\":KJVF>*?$30P_)X2U2UT.ZLKGSQ_`MQY\)!Q_K(G!^\*^K/V=/A]KGAK]M
M;]H;7-0TN\L]'\27'A]M+O)8RL-^(=.,<IC;^+8_RG'0U[Y16U2JYMR?=O[[
M:?)127D8TZ?+&,?Y8J/W-N_JVVWYGS;\4;;5O@)^VY-\3I_#GB7Q)X3\1>$8
MO#T[Z#IDNJ7FEW,%R\R$VT*M*8Y%E(+(IPR#.`<UX&/V.O&WQ-^/G@OQ9J&G
M>-/".G>+OB3K7B>X&EW)L]0\/V3:-]DMVGDC)\EYFB4E<Y'F!3AL@?H=16=/
MW5;U7R<N=_C^&AI/WK^=F_E'E7X?B<7XZ\&S:?\``#7-!LYM3UBX70[FT@>Z
MF-Q=W;F%U7<YY=R2.>YKX%^'O[#/CSQ>]G,^@ZGX?\1>&?@[X6_X1Z_NX3$E
MMKUA?ZC.;4MV;;(BN.RS>]?I=11&ZFZB>NGR:4DG_P"37^2*4DH>SMIM\N:$
MK?/D2]&S\O\`]DW1?'WPGTOX`^./&WPO^(VDR6GB#Q[J.MZ99>'KG4K[1SJ6
MI7$UN)8;='<*ZN"&Q@@@]ZTOC%\!?%VN_&?P[\4=4\,_$_0_#_B'XFW.N2P^
M%[*ZDU_2-/709[*&XEBMT>6)I9BH90I(5P&QR!^EU%;5*SE+FLM-%Z.2E^:T
M\C-QO?SN_O37_MS/BOX\?#SQ)^T'KW[,UQX!NOBEH-OX3\8:A)J&OZWH+C5M
M-A_L:_B$T\>H0\K))(D8=XR"7&.<&N3_`&K_`-C1OA'\1OA;K\-S\7?%$E]X
MUOO$'C+Q+X9LYI]:,KZ2;2*398Q9CCVQPQA8XPH`]R:_0"BI=1WNOZU3MZ72
M?K8I>?:WYZ^OO,^+OCG\$+?]KS7O@;IS>'?'VK>![=-<TC79_$NF75IJ$,,M
M@85EN!<(DH9F/RR$#+`$5\X>"_A%\9O">N^)-4\>>!_&FK7?@_XI>#M^IV&E
M2WTOB73M,1XWU2".)2\@:,HSA5)#EQVK]8***=5PES1[Q?SC-37XIKT?=*Q5
M2J4G2GMRN/HI)I_FON7F?G3^VC\)/&'[4.D_&CXB:+X-\<6&E:GX5T+PQI%B
MVESVNNZH;;4Y+RYN4M"OG($64*FY0Y*N0,8)[;XXZ%-\8OV)/$'A+P;I?QL\
M1:E#KNCWK+XTT;48;R5!?6[.(6NXD+QHD3,0N0N23UK[@HHIU.1JRT33^YIZ
M^K_,)7E+G>^WX**^Y*Q\&?`?]F[QS\"/^"GVEZ'!X:U6;X0Z+HVL:IX>UM(\
MV>E_VA+#)+I;'^$QSK,\8Z>7*%'W*]W_`&"OA]KGP^L/BLNMZ7>:6VK?$35M
M2LA<1E/M-M(8O+E7/5&P<'OBO?**F,W&*7]UQ^3DI??HEY[O4S=-.3EWDI?-
M1<?QNW^6A\(_M&_LC_%K]LS]I#XN:E9WGAOPCX9M/#"^`M!'B7PW<ZA)>+)M
MN[J^M&BO+<1[IQ`FYEDS]F!XQ@V?@YXG\=_#?XK_``^^*?Q!\!^.I)+SX:#P
M?K46D:%<:E=V6J6U_O+O!"K2^5,NYDD"E<`9(R*^Y:*5.3@DET_533?SYY/M
M>W16+J152_-UM^#BU]W)%>B\S\Y?A7\./%W[.7Q%^#?C3Q%X(\<3Z?)KGCK7
M+^WTC0;G5;O1TU?4'NK..XBMT=E<QNNX8PK9!/%=)??L_P#CCQ9XYT#QT?">
ML6,/BCXYZ7XH_LZ2`BZTS2K?3YK;[5=1_P#+(LP!*GE0R@X/`^]J*OVEW!_R
M-6]%-3L_G%*_;SU"I[ZFG]M2OZRC*+:_\";MWL?-FD?!G7M=_;8^/EY-8WVG
MZ)XN\#:#I&GZHT9$,TZ?VHLJHW=H_.C)`Z;QZUY'?^%_&'CW]B?PO^SNW@'Q
M=IOC+36TS2M1U*72Y%T.TM[2ZB=[V.^XAD#1Q;D1&,F7`*`@X^[Z*F,N62?^
M'_R5MK\W<?7F6^MO*Z2?_I*?KY:'YQ>,/V3?C'+#^T5>6-]XID\%^(_B#+<:
MIX*M[&V@G\8:&^FV<-RUC=-'YRS.%D"@.%<QE!M+;AZ+^TYX1TTZY)J'@?P#
M\9O!OQ'M]&MH?#.N^&]+E-IJ@2+]Q;7H7="B1G",MXJ%1G!K[8HH<FXJ/915
M^ONQ4=_E==%=Z6>A]IR[WTZ:RYMOS[V75&+\-VUQOA[H9\3+:KXC-A!_:@M?
M]2+KRU\W9_L[]V/:MJBBB4N:3EL3&/+%1"BBBI*"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBFSSQVL+22.L<<8+,[':J@=235==;LVN+>$7EJ9KQ#)`@E7=.HP2RC.6`R.1
MZT`6J*BL[^#48C);S13QABA:-PP#`X(R.X(P1VJ6@`HHHH`****`"BFS3+;Q
M-)(RQQH"S,QP%`[DTV.[BFM5G22-H67>)`P*E>N<],>]`$E%1VUU'>VZ30R1
MS12#<CHP96'J".M.FG2VA:21ECCC!9F8X50.I)H`=15>/5;66:&-;FW:2XC,
ML2B0%I4&,LH[CD<CCD58H`**CO+R'3[9YKB6."&,9>21@JJ/<G@5(&W#(Y!Z
M&@`HHHH`****`"BBF7-S'9V[RS2)%%&"SN[;54#J23TH`?14(U.W,T,?VB'S
M+A2\2[QNE4=2H[CD<BIJ`"BBHK>^AO&E6&:*5H7\N0(P;RVZ[3CH>1P?6@"6
MBBB@`HH9MHR>`.23VK*\+^.M%\;K>-HNK:;JRZ?.;6Y-G<I,+>48)C?:3M89
M'!YYH`U:***`"BBB@`HILTRV\322,L<<8+,S'`4#J2:2WN([N!)8G22.10R.
MAW*X/((/<&@!]%17=]#81"2>:*%"P0-(P4%B<`9/<G@"B*^AGNI84FB>:``R
M1JX+1YZ9'49P<9ZXH`EHHJCKOB73?"]JL^IZA8Z="S;%DNIUA4MZ`L0,^U`%
MZBJND:W9^(+);FPN[6^MV^[+;RK(C?0J2*M4`%%1?;X?MOV;SHOM&SS/*WC?
MMSC=CKC/>EFO8;>>**2:..2<D1HS`-(0,G`[X'/%`$E%%1W=[#81!YYHX4+!
M0TC!02>`,GN:`)**B2^ADNY+=9HFN(U#O&'&]`<X)'4`X/Y5+0`445GVGBW2
MM0U66QM]3T^:^@_UEO'<(TL?U4'(_$4`:%%1V=[#J-JDUO-'/#(,I)&P96'J
M".#0U["MVMN9HQ<,I=8RPWE1P2!UQSUH`DHHHH`****`"BH[>]ANWD6*:.1H
M6V2!&#&-NN#Z'D<&I*`"BBL_7_%VD^%$C;5-3T_35F)$9NKE(0Y'7&XC/X4`
M:%%0:;JEMK-C'=6=Q!=6TPW)+#()(W'J&'!J>@`HHJ.\O8=.M9)[B:.WAB&Y
MY)&"J@]23P*`)**IZ+X@L?$EG]HTZ]L[^WSM\VVF65,^F5)%1WGBS2]/U:+3
M[C4M/@OI^8[:2X19I/HI.3^`H\@-"BBB@`HHJ.VO8;PR>3-'+Y+F.38P;8PZ
MJ<=#R.*`)**BN;Z&R:,3310F9Q'&'<+YC'HHSU/!X'I4I.T9-`!145G?0ZC;
M+-;S13PR<J\;!E;Z$<5+0`45%=WT-A&KW$T4*,ZQAI'"@LQPHY[DD`#N34M`
M!145U?0V**T\T4*NP12[!0S'@`9[GTHBOH9[F:&.:)YK?'FHK@M'D9&X=1D<
M\T`2T444`%%%%`!1110`4444`%%%%`!1110!D^//"EOX[\#ZQHEVBR6NL64U
ME*I'#+(A0C\C7Y$^'?B_)X.\3>"_BKJEP?)_9/MK#P#J)$I/DM=O?6MV).<?
MZL::YSS\HK]C*\]O?V3OAEJ7ASQ5H]QX#\*3:7XYOO[2\0VCZ;$8=:NOE_?7
M"XQ(_P`B?,V3\H]*(W4KKR^]77W.,II^I7,G'DEL]/D]7;SNHOY'YT?L_P"M
M?%;0OAYXSTG0IO%UCK7PYTC2]:TJ*SUG3]+TF[O-2C;4KBYOUN9XVFCFEG:'
M)5E40MCYLU]F_M<^/O$5SJOP7\)PZOJ/A.T^(VM&SUO4=,N1%<PJEG).+>*<
M9V-)(H4.O.%.#S7IWCC]ECX;_$OQ#I>K>(/!'AK6-2T2-(;&YNK!))+9$.45
M21]U3T'05O?$?X4^&OB_X4DT+Q1H>F:]H\A#-9WMNLL61T.#T(]16E2:ELNM
M[>7_``>UK?(SBGU>MK7\VM_D]?F?*;3:IXJ_:-\/?")?B]XNN/"NG^'-3U@Z
MS9ZHD&IZC=PWB1"VDNHP&?[,A^8=6W#?G%>0_LZ?%7XD?M:_%35-+UKXF^--
M'TG0?AK)J$7]B7*67]K7,6KZA;17Q=5+`M%;QY"$*_<$8K[BUW]C_P"%OB?P
M+I?AG4/`/A6Z\/Z*Q>PL7T^/R;0GEB@Q\N>^.O>NAT3X*^$?#6JM?:?X;T6Q
MO&TM-$,T%HD;FQ1F=+;('^J#.Y"],L?6LW\-NMI:]VU*S]5=+KM>][6VC-*^
MF_+\DG%M?]O).^VKM:USX*^"O[1_Q*TCPAX#^*7Q$UOQ-K_@GQ#9:##%>^&M
M7AC_`+"NY46*2+4=.8#SEGF97\Z,LP$H&Q0H8R?`_P"/7Q>\;^!/"7Q*6Z\7
MQR>,FUP:_;:GKVG+I=C&D=V84L;03F9)K9XHXR!&';#EQFOM+3OV0?A=I&J:
M9>VO@'PK;W6C)#'8R1Z?&IM5BXB"<8&S^'T[5-IW[*/PUTCQYJ'BBU\"^&+?
MQ!JRRI>7Z6$8FN!*")-QQ_'D[O7)S55VIJ?+I?FMY)[+_-^F[NWG1]VW-K;E
M_"]_ZUN^Q^>1UKQY=?LQ_!&;6OBA\0?$DOQN^$VM7/B-;O40JM-%HL=Y%+`L
M:J(I`Y92R\NK'=DG-?57[*OPZ@L_^"3GAW28=<\27JZAX`CE-U-JDDUW`TEB
M&VQRD[D5>BJ/NC@5[O8_`?P7IMIX:M[?POH<,'@VSDT_0HULT"Z3;O$(7B@&
M/D1H@$('!48Z4[X6?!#PA\$/#,VB^$/#>C^'-)N)FGDL["V6&%W;AF*CCFJQ
M<HU57A%64]O)7FTONE^%O0H7I^RD]7#?STCK_P"2_C]_PG^R+8:DOPL_9E^%
M]KXZ\;:5X9\9>$+O7M0OX=<?[=/<00VRQ64-P?GAC`=Y-B8^X>V:]0\-^,M=
M^/G_``3!^-%KKVM:IJ4VB?\`"7>'K+6[:;R+K5K2QFNH;>?>G5F2-49EX<JQ
M_BKW)OV'O@^_A*XT'_A6_@_^QKN].HRV8TZ,0M<$8,NW'#$<9&*[_P`.^!M&
M\(^$8-`TO2[#3]$M83;16,$"QV\<9&"@0#&#D\=\UGC/W\*D=N9-?-NZ?_;J
M]U=UJ]0PG[CV=OL-/ULGI_V\[2?9JVJ/SK^%?P4_M[XO_LE:)8^./&ME!<_!
M[5[V:_M]6,E^ZNFCGR4N&#-'&&*D;,$!``<$@I\)_P!HKXF?'./X8^";S6?'
MUW%)X8\1:I/J6@ZI::=J6J7-CJD=G`TT\\L098HB7D12=YD4L,`U]U?#;]E/
MX:_!V_L;KPKX'\-:!<Z9%<06DME8I$UK'.4,R(0/E5S%&6`X.Q?2H?$O[(OP
MO\8^#['P_JG@/PO?:+I<\EU:64MA&8;:61B\CH,?*68DG'4]:Z,16527,MO>
M=O.3FUK_`'>=/S<>E[F>'I^RHJGU7*K^45%/3^];7LGUL>"?M!>/_&.J?\$;
MO$&O>*FLXO&7_"*AKZ6UG@NX7F615,BO&7B;<`&^4D9->*>,OB;\1-.^&WQZ
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M.-0\07U]=7RW4VD7<$NFB&]M201#')]JF3RP-A.W`^4Y^\+S]E[X<ZA\2V\9
M7'@GPU-XID5E;5'L(VN&W*4.6QU*DC/7!Q5#P_\`L:_"GPKI&M6&G?#WPE9V
M7B)1'J<,>G1A+U0P8*XQRH8`XZ9%8T_=24NR7W1:?WMJ3\UW]XZ%)*HI>;?R
MYDU_X"DXKNGKIH?/'Q`\$ZWI'[1_P3^'O_"U?B7;Z-XNTO6-4U27^WS'>7\\
M<-L402XW(BL68(F`-QQQQ7!_LR?&WQQ^U-\1=/\``'B;QYXFT?0_#MEXB>UU
MS2KW[!>>)_L&M3V,$SS*/F"01HSA?E=CN/!KZ6_:)_8CT?\`:/\`V@?AYXB\
M0Z?X?UCPKX.T[4;.XTF_@,AF>X6(1L@QM`7RSG)'48KMO%G[)WPS\=>#]'\/
MZQX%\+ZAHOA]=FFV4MA&8;%?2,8^4>PZU:DK7:[Z?.23]8JUEMZ:6QCHG'TU
M]$KKTD]WOZGQ7^P;\:O&W[4'Q3\2:OXW^(7B^TT?P+X<LK^"#3KD6MGJ+17=
M_&;V5$7,BS16Z,R9V-G..E>9_M!_%3QEXK^'EU9_\)-X^O/!OQ=^&?BW5Q-J
MNNHUS?&TBMY;>X@M(05L8RLK+L60EU;#*I6OT_\`#?P@\*^#M2N;S2?#NCZ=
M=7EE#IT\EO:I&TMM"&$4+8'*(&;"]!N/K7+>$?V,?A/X!UE]0T7X=^$=-OI%
MN(VF@TV-6VSKMF7..%D4`,!P0.:B>K=MK/[W??[UZ6VVM5&3C)2?=/Y*VB^Y
M^M[WWO\`%WQ+\>:U^RUX$^#^I^$[[5?$NH:'\)/$6M6@U.Y.H3SW$=C;S1J7
M;+%%8\*#C:`.E9?[9GQI\>?LO?`JZN/!_P`4?%OB*\\9?";6?$MSJ%U?BZ?2
M[VWMX)(;ZUXQ`C/*P"*-G`P.*^\_`7[+7PY^%T=@OAWP3X;T==+6X2S%K8HG
MV9;@*)PG'RB0*H8#@A16?HW[%_PE\.Z)X@TVQ^'?A&VT_P`56[VFKVZ:;'Y>
MHPO]Z*1<89#GE>GM70ZL74<Y+1W_`!<W;_R9._\`=7E;.C3Y$D^C7SMR:_\`
MDKT_O/SOY'\`[GQ/\,/V[QX(O/''BKQ=HNN_#F+Q+<+K=RLYAOEO1`SPA541
M*Z-RB@+D#`%>!:KJ6K?"R/\`:<^(WA_QIXATW7O"_P`4T6UT:WO@NGWIE@TZ
M-HI;<#]XTBL0I;)!&5QS7Z'1?#S0H/&D?B--)T]=>AL/[*34!"OVA;3>)/(#
M]?+W@-MZ9YKC=4_8_P#AC>^/)O%__"O_``C+XM>Z;41J4NGIYTEWM51,[XR6
MPB#=R0%'I6,96FIR[27WU%-?=%<O_`*Y>C[Q?W4W!Z]+R;E??YGR]\$OCQ\0
M]6_:=\*?`?6/$>K2^)/`>NZAKFOW[OMFUKP^T7G::TA_B#&Y6!SQF2T>NZ^+
M-YXD\<?\%%[[PW'XR\8:3X;\/_#Z/Q#%I&CW_P!EBO+T7CJ&D(&Y@50*5SA@
M<$&O1/@/^SOXBTO]H/Q=\5O'G_"-KXL\0:9:>'[.TT266XM=.T^V>60?OI8X
MW>2624LWR`*%51G!8^K+\/\`0T\<R>)ETFP'B&:S&G/J/DK]I>V#%Q"7Z[`Q
M)QTR:KFTC?>SOZM-)^OPMK92O8I[R71VMZ)J37I?F2_NVN?G#X=^)OQ6^)_[
M/&C>+;G4_'4-G\2?"^O-XF^W>);"&WLB+*>:!],@BN&GBD@EC6)E1`=LC,^"
MM1?`'PAJ'PR\-_!OX8^"_P#A.]-TCQ)\-)O'6HWGA_5K2QU#5-4+6L0:6XN)
M8O,BA5RQCRV?,7=\HK[WT;]DGX8^'O%&K:U8^`_"UKJVO0RV^H74>GQK)=QR
MY\Q6..CY.X=\\U/XX_9;^'/Q*\):/H.O>"O#>K:/X>18],L[BR1XK!%`4+&,
M?*N`!@<8`I<RULK7M]UI]?)RC);:Q2TT8Y.^GFW^,>GFDXOR=SXX^"/Q$^*7
MQ4^,.L7?C#Q7XDAO_!/PJT;Q(WA[0-7B_L_4=4\V_P#,=G@++*LP@C!57*$'
M'.*X.^^/?QFT']CJ?XA6/B#QA&WB[X0ZOXDU'4-5U[3I5M-46P6XM[K2[:.=
MY(HTD9U*;`%`3<`<U^CWACX1^%_!>N2:EI'A_2--U":P@TM[BVM4CD:TA+&&
M`D#_`%:%WVKT&X^M<KI?[&GPHT5O$!M?AYX1M_\`A*K:6RU<)IL8&H02@B6*
M08P4<$Y7H:)R3Y[=;V\K\_Y\T>NG(K7Z73FHU83:T7+==[*"_.,O7F=SXE_:
M!^-/Q(_90\1Z38Z9\1/%VO\`_";?#1-7O[O6)TN!I5W_`&KI5HU]`@4)"%AO
MIF95&WY%..*[[XW:EX@^$WQH\!_"OP_\1OB5XRTWQEJ=S/JJ6VO6JZWI@BL#
M-%;1WDTD119V_>X+[ML;!>#BOL#6_@CX/\27\5UJ'AG1;VX@TJ70HY)[1'9+
M"1HVDM@2/]4S11DKT)1?05R\'[%/PDMO`5QX7C^'7A%/#]U<B\FL1IT?E23`
M8$A&/O`<9].*<I)K1=7]SFVE_P!NIK[K;'/3C)+?HOOY4F_FT_OON>;?#GQ7
MXTU'_@G7X[F\:3";Q!H^G^([*&Z:]MKV:YMH&NDM9)WMWDB,_DK&)`&.)%;/
MI7S1\*=>\=?$KP'XR<?$SQMH&G^!?@SX;US2K#1[M+2&*^;2Y)FF8A-S`M&N
M8\["!R*_1'0OA9X;\,?#X>$].T/2[+PR+9[/^S(;=4M?)<$.FP#&UMS9'?)S
M5#1O@'X)\.V=_;V/A70K.#5-,AT:\CBLT5;FRAC,45NX`^:-(R5"G@`D5G.[
M]KR[R44GV:4U?[Y)_+T-H-*4&UHN:Z\I2INR\DH->C]3Y$_;UFO/V@/^"8OP
MC\0:SJVL:;?ZMK7@S5+VXTJ\>R+23W=IYC$I_"#(6&>%8*>H%</\<O"FM>"/
MB_\`M<^)O#OC[QIHMY\/O!7A[4+`VFH`->W$%C>.DES(5+S`[<,K':P)R,\U
M]]Z]\&O"?BCX8?\`"%:EX=T>]\(_98[$:1-;*UF((P`D8C(V[5"K@=L"LS1_
MV9OA[X?\.ZQI-GX-\.V^F>(K"+2]4MDLD\O4+6)&CCAE&/G14=U"G(`8CO6M
M2<7.;@K)R<EY744E\N73U\C.G%J-.-37E23\[.[^_P#K<^(O&?[0GQ>^*?B3
MXFZMX?F\5VNL?#?3]"FT&WM];T[3-"N9)[""\E>^2XGC:2.>25X=Q5@@C.T[
MLUZ9_P`%4HX]2\=?LR_;/`LGQ"CD^($S2>&D6RE;4#_8>I'8!=R1VYVGYOG<
M#Y.,G`/T3XK_`&3_`(9^.?$>DZOK'@7PQJ6IZ'''#87-Q81O):I'_JU4D=%[
M#MVKJ?$GP_T/QAJ^BZAJNDV&H7OAN[-]I4\\*O)I\YB>(RQ$_=8QR2)D<[7(
M[T_:1NK+K?\`+\[;6TZ"C%I6?\K7S:M^'XGYG>`OB/KUU\4]/M_!NB^(/AWX
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M_%/XW>'_``;)H_CB&/Q]KGP2-U#K>LSK']INAK"IF2<(2C2(#&'"MM+A@I(Q
M6SJ=XGQH_;0^!_AS7-4^+GA+Q-X1\6ZK9:KINH^)Q.UFSZ+-<1>1=P'$T<BJ
M2"Q#[2RE5Z5]C_L]?L)>!_@M\`?"G@O4-%T7Q'<>'_#4?AFXU"YL4WWML&$D
MD9!SB-I<N$S@<>E=#?\`[&WPIU3PBN@W'P_\*S:.E\NIK:OIZ&-;I05$PXSO
M`)&[K@XKJJ5(>TO'97M\YN5__`7MW[:WSJ+GCII>W_I"5OO7_#GRMI7Q&UC3
MO"W[07Q!\2_$[XB6L/A/QE?^']%M-/N$E@L8G$$44<5NVV-Y#))\K2MA"V<@
M`UXO^T!>^+O%FD?$3X<^+->\:6.F^$/$W@75['S_`!6U]J5E]ONI4F2:Z15[
MP*XC!=8V;*N1@#]+C\`?!+>$M<T$^%=!.B^)IGN-5LC9IY&HR.`&>5<89B%7
M)//`KG]&_8O^$WA[POK.BV/P[\)6^D^(K:&TU.U33H_+OX82[1)*,?,$,CE<
M]-QQ7/%Q7+?7E4/GR\K?WM/77?;OI6O/FY=.9R^2EI\[+2VGJ?'O[0?Q/\1?
M"3]LCQ%X7T+Q%J>GV&K6G@GPY=:[),LU[86UQ=7L<TYG<$F5]BQ^8Q.&DW#F
MJGQ?^)/Q`\'_`+4FB_!S0?B9XTB\._\`"P]#L&UEKM;K4X[>ZTO49[BP>>16
MW@M!&P+`LNX8/`K[=M/V6?AO8Z'>:;%X(\-+8:AI\&DW,'V!"D]I"6:&!LCE
M$+L5!Z%B11X3_99^''@32M)L='\$^&].M=#U$:OI\<%BBBTO`CQBX3C(D"2.
MN[KAB.]5&237-K:5_5<R=G]S^;:VO?24D[M*UX<J\GR./-]]ODK[[>6_L/>(
M]:/BCXW^#=9\2:WK^F^!?%?]G:9?:M=?:+V&VEL+>X*O,>6VO*^">0,#M7AG
MP[^%FF_LF^(_!^AZWH/@_P`;:)XVOKO2?#7Q,\-S_9?$Z3W"3,%OE`)GPN5^
MTQS$`@$Q)C-?=?A_P!H?A35-9OM-TFPL;SQ%<"[U.:&%4>_F"+&))2/O-L15
MR>R@5RO@O]DWX9_#GQS-XFT'P+X8TG7[AF9[ZUL$CF);[Q!`XSWQBLY6DDG_
M`"I/SLK/[W=WO?O?8S5TFEW;7E=MK[NVWIHSX2_8X=O!_P"P#^SOX)T7Q9\2
MKKQ#X\MY[E=-L->%O+(ELK^:GVR4YLX(SAF6(,[-P%/-9G['.N:]\<?VL/AA
MXP\6>*/$T_B#1_!GB>WVVNN2?9]0.G:XD$:/M"+,K(J[R5'F$!B!TK[JO?V$
MO@WJ-O<Q3?#/P;)'>7YU29?[-C`>Z)),W3ASN.2.N36@?V/OA;]DT&W'@#PJ
ML/A>[DO](1=/C4:=/(_F2218'RLS_,<=3R:U=2]3VCT=V_2\7'3TO\[=+Z*M
M%2@X+R^:4N9I^MEZ>=M?@J7]HCXS2_LXV?Q0T_5?%]M=>*-+U]M;.IZ]IPT^
MU$5K=/;MIUJ)VFCF@FBB!41@E2Y<<#&U80?$)_$MOH\OQF^)\EOJGP2;QW=2
M?VDBS'58F54DC8)^ZC._+1IA6*C(ZY^VT_8]^%<?B36-87X?^$_[3\00RVVH
MW/\`9T>^\CE!$BOQR'!(;U!.:Z!?@EX02]CN%\-Z*+B/1SX>23[*FY=.)!-H
M#C_4D@?)TXJ)N\&HZ.SMY>[-+[I2C+9;>2&OB3>MGKY^]%O[XJ4>UGYL_/71
M_P!IGXQ?'OP?KVM:7J'BJW\1>#/`'AS7-'-GK&GZ7HMQ?7>GBZEGU!+B>,RP
M22_NS\I50&QAJO?$?XH?$A?A9^T1\33\2/&=AJ7PU\86J:'HMO>QC3+./;8F
M2WD15_?QMYL@(9B!G*XZU]N>(/V/OA9XJET%]2^'_A2];PO;16>E>;IT;"P@
MB`$<2#'"*``%Z#%;6H?`3P3JN@>(-*N?"NA3Z;XLN1=ZS:O9H8M3F&S]Y,N,
M.W[M.3_='I6TJD'4<TM-;+M[R?Y)KRZ:7,Z,91HQIS=W97?>RL_QU\[NY\X?
M\$X_AU!X>_:(_:.U3^WO$UY<2>.Y(#97NK23VJ![*SE#B%C@/S@-UV\=*X'X
MF?&SQH_@7XP?%./QMXATSQ)\._B&?#6C^%XKH+IKVD=Q:PQP2VW262Y25I1(
MWS#S5V\+7V?IGP'\&:+\4[OQQ9^&=%M?%U_;BUN=7BME6[N(@``KN.6```Y[
M`50UW]F#X=^)OB;#XTU#P7X;O/%=N5:/59;%&NE90`K;\9)```)Y&!6--\KA
MVC%1^[EU7JHM?]O/=;U&-HR3U;DY>M^;1_.2U_NK:^GPUX7^)WQ$L_AVGQ-N
M?B5XTO-0C_:`G\(1:1-=(-+CTF3Q&U@;5H54;PL+?*S$LI48.!BO3_\`@H9X
M/OO''[=W[.]CI_@?P'\0K@Z9XH?^R?%U^UEIK`0V69#(MG>'>O\`"/)YR?F7
MO]1CX!^"1H']E?\`"*Z%_9IUK_A(_LWV-/*_M+[1]I^U[<8\[S_WF_KOYZUK
MZIX!T76_%^E>(+S2K&YUS0XYX=/OI(0UQ9),%$RQOU4.$4,!UVCTHBTHQ79O
M[O9QC;_P)-_.^YLY_OIU%M*^GK*37W)I?+L?#WC7Q5XDA@^/UQ#X@N/A:WP'
MT^S/AOPWX:O%@T=&;3UNVDDC$48NHI9V:)=\:C$1PJL37$)\7_B-X\_9Q_:T
M^)]YX^\<:/KOP_21=`TNUO\`R;'1F;PUIUVV(@OS$3W#L-^=IZ8R<_>OQ"_9
MD^'OQ8\7V/B#Q-X,\.ZYK6FA1;7MY9)+-$%.5`8C.`>0#TJ]<_`GP9>Z)XJT
MV;POH<FG^.9&E\0VS6B&/67:%(&:=<8D)ACCC^;/RHHZ"KISBE+F6\;+R=XM
MR]9)._:^A.G-%]$[OS5MNUET[]3X1\:6?Q`T#Q5X^T=/C)\3GM](^$">.HY#
MJ2++_:JI+B16"?)"2@)A7$9[C%?0OQB\&3_MA?\`!/KP?#JWBK3?"VL>)K/0
M=7%Y>Q!["\O0UO<K:SP[T\R">1?+>,,"RN0*]OO?@OX2U&]O;FX\.:/-<:EI
M/]A74CVJEKBPY_T5CCF+YC\AXY-.\0_![PKXL^'*>#]3\/:1?>%XX([5-*GM
ME>U2*,`1H$(P`NT8QTP,4I23O9=8M>5I3?Y.*[>[VL8TXRC*+OLFGYWC!?G&
M3_[>[MGS3^S%\==)^!OBKQYX+U7X11^$O&'A^XTV75X/AUIT^L:3J27:3K;W
M4<<,*O!Q;R"1)(U*?)EG#!C\X?M1Z5>^(;K]IGQ?IOAKPMJGAWP[XKM)-3\7
MZS?-!XM\+&WL[![B#2K80,'C50&CWW-L3)+(-C@`M^C_`,)_@?X/^!6B2Z;X
M-\-Z/X;L;B3S98;"V6%96QC+8ZG''-8?C/\`9$^%_P`1/B`GBK7?`7A?5O$<
M;(XU"YT^.2<LF-A+$?,1@8)SC`I1E:HI^5OQB_\`VW9-;Z62LZ^RXKO?\^OS
MZI^:;U7D?[>7C/6#K?[/6BZ-XNU_PIIGCKQM%IFJ7.G70M+F[M6TV[F$1<@E
M2SQITP0<8P<5X+)\?OB%<?'BQ^"\&N^/M?\`#,?C36-.76],U6VMM:O8;73H
M;B*Q^V3R1C<LDSLS!O,9;<KR-U?5O[8G[(</[5^O?"U;^/1[K0/!7B<ZUJNG
MZA$9$U"W-E<V_E*H!&[=,K?-@84\YQ75W?[)'PQOOAA!X+F\!^%Y/"EM-]IB
MTLV$?V>.7G,@7'#')^;KR:>EF^[>G_@-G\K.W>[VZOK%=DK^OOK\;I_);]/C
M_P"$'B'XH?&#]J;X8^`_&7C;Q=H-A#X3\47MW%I&NVQFU<V>K6$%G+<S6K2+
MYHAE8.$?.2P/4BLWX,?8_P!G7X:_M,:LOC;XB0:E??%>ZT"U6#4?MUTTT_V$
M1"&.=A%'/+Y@3SG("J0<X45]U>$_@/X+\!ZGI-[HOA?0]+O-!T^72M.FMK-(
MY+*TE=))88R!E4=XHV8#@E%)Z5C^)?V1OAAXR\1>(-6U7P'X7U#4O%4*P:Q<
MSZ?&\FI(H4*)21\V`BX)Y&T>E',KIV^S*+\^:HIWZ_97+UMV:5G,HM_^!*2[
M*T'&W3K*_G:VE[KX)OOC!XZTGXT:7X)US4-3:'PI\7M`BLDU+6!K5];0W.DW
MLSQ27+1J2P=`<#.W.`Q%;WP,^(?Q!T#P'^S'XTU+XE>,_$E]\4]>U+0]=LM2
MND>PEM?[.U2XCVPJH59(Y+2+$GWB,@D@U]J>%_V/?A9X*%O_`&3\/_"NG_9;
MR#4(C#I\:E+B%'CBF!QG>B2.JMU`8CO6U:_`7P58Z/X<T^'PMH<5CX0N&N]$
M@6S01Z5,T<L320C&$8I-*I([2,.YHYH\K7FO_25%_?8O>2?11:^;<FG\N9?=
MZ'YR_L6ZSXV^-L*:%)\2/&GAO0=#^#UOK\5EH=U'9K)?OJNJQ^>65-P(6",%
M5(#`#<#BND^&W[0'CK]IWX::M=Z_X_\`$_A2Z\'_``7TKQ?8R:-??V>=4U"Z
MM[MI[J4X_>JC01KL/R@L<CD5]Y>#OV>O`OP]EDDT/PEH&DO+IJZ,[6MDD1:R
M6221;<X'^K#S2MMZ9D8]S7A/[6W[!MY\7-#L_#OA/PI\'_\`A'+;07T'3CK6
MG2QW7A4,K)YUIY2.LJJK#$#>4`R`[\'`G%S]I"I&"UE>S[-^T=__`":*_P"W
M>EDUM3<?;*<MER_<O9W^_EEY^\][M/RW]M"UO/C3_P`$M/@#JVN:_P"((]1U
M'Q!\/;R_U"SOWM9IY)]1TX2S.ZX^;,A<'^%P&'(%6_BCXX\4&W^/VKQ_$CQ9
MX?N/@9#;P>&[--1_<W*K91S":]5O^/HSR$KF3TXYS7UKIG[.WA4?L^:3\,]8
MTJR\1>%-,TBUT9K/48%FBNH;>-$3>IX)_=J?8BLV]_8S^%&I:AHUU<?#WPG/
M<>'HD@TZ233XV:TC0Y55R.@[`]*WQ%2,IU%3T4IRDGVNHI.W=*.B_O/:VO%A
M8RC1I*IK*,8I^=KMJ_FWJ_);W9\^?\%,=(G^,O[)WP?U'5+W7O#MU>^,O#-U
M=KIE^]D\#S31APS+_=+G&>C`'K7CW[1.D^(/AGXP_;.\<>&?'OC#1=1^&_A[
M0M4TU;2^`2\N;;2"ZO=,5+3AMNUE8[2"3C/-?HI\1/AGX>^+?@ZZ\/\`B?1=
M-U[0[T!9[&]@6:"4`@C*GC@@$>F*P;3]F/X>6/A/7-"A\&>'4T?Q-91:;J]F
M+)/)U*VBB\F.&9<?.BQ_(`V<+Q649I.32M>3:^:BOPY?Q\C5+^&IZ\J2?GJV
M_OO_`%<^,?"WQZ^+?Q.\:Z]XRTR3Q1'?>&_B-9^'5L)M<T^R\.-I7FVJ3Q26
M\MPLK7$D4LLD;B,L7,87(R*_0BN!O?V6?AQJ/Q(M/&$_@GPU-XHL=GV?4VL4
M-Q$4&$(;'50!@]1@5WU#DN112V_R2_%INW=O?<F,9)WD[_\`#M_A>U^J2"BB
MBLS0****`"BBB@`HHHH`****`*NMP7-UHMY'9S+;WDD+K!*R[A$Y4A6([X.#
MBOSQ;4O%G[/O@S6M&\=>(_B]X/\`BYJ?A_5H=.\1W?BF\USPIXLO$M9IMUO!
M),8K*=4C:5(HDMF&TX9PI%?HE?V4>IV,UO,K-#<(T;@,5)4C!Y'(^HKQ;0OV
M!?!ECJ]G<:MJGC#Q=::2DZ:5I^OZNU]::1YT3P.85(#;C%(Z!G9R%8X(S6<H
MM\R75-?G]V_H^NR-:<U%Q;Z-/[N_?\UTW9XI\!OC7\6KOX9_`'X?1^-M+OO&
M'Q`\+3^(KWQ3J6BO<&WM;>&VQ%Y)G_?3,\ZYD:09&XXS4?P<_;5^*W[4'Q*O
M/AOX?OO"OA7Q7X,76$U[5KG2I+ZSU&:QU)[&,01>:A1)=@D8[F*9*C.,U[)I
MG_!/+PAHG@O0='LO$'CRUF\)2R-H.J1ZSC4-%ADC6)K6&39CR"B@;'5NF<YP
M:=<?\$Z_A_;:)I-KHLWB;PO>:7#=6SZGI&J-;ZAJ,=U,9[E;B8AC)YLS-(QX
M;<Q((KJJ3C*HY6T=]/-WY7Z1T375ZZ[/",;4U%;Z:[Z+XE;SZ/IMH?-?@O\`
M;0^(6D?\%/\`Q%\';C4_(O\`Q%>://)?Z@+FXT'3(XM-\^ZLK`,P075PRN4C
MR#L1Y"&*X/T!^U3K.J>/_P!J_P"$_P`)_P"VM?\`#WA?Q5I>MZ[K$^BZE/I=
M[J'V'[(D5HEU`R31*6NS(QB=7(A`R`36QJ/_``3K^&>H6&L0K9ZO:OJUUI-\
M+B'4'6XL+C3%5;26"0Y9'54`8Y.\,P.0QKN?C7^SSH7QVLM'_M.;5M.U3P[<
M&ZTG6-+NC:ZAILK(8W:.3!^\A*LI!5AU'`P5)0?+I>V_2_NI)_)ZVV=KW]YV
M<+IM]U]S_P"#WW\M$?'GQ'_:*^(?[+7Q:\9?"WP;XAFU:SL_$?A*'1]1\5S7
M&N3:5;ZN;F.XM7GDE\^<H;7S4:61G`G`)(`K'_:1_:!^-$_QD\/_``SB^(5C
MHNO>%_B5H%I/K>F:-)##K5CJ%I<R)'/;BX`PCPN&CWLKC8>"*]>_:E_X)]G6
M_A'H6@^#$U_5-4U#Q]I/B+Q'K5QJZKJURENRJ]RUPY7+1QH@5$'`7"J><^@W
M?_!/#P+J7@[4-/O+[Q9>ZQJ6M6OB&7Q)-JF[6A?6PVV\JS[<+Y:955"[=I8$
M')RJ<HV4I:VDOFE[-_I+7J]];VN5DK1ZQE\F^=:_@[=.GGXI<_M8>.O#7[0'
MBGP#I.HVTGB#Q5\1K+PEIFI:@MQ=6>DQC1'O[B<6S3;1E;>0+%&R*6<9SR33
MUO\`;:^,<?[0WAWX.V.I>#?^$F7QU<>&=5UZ?2)?L]U9_P!AOJ<4T=NLWR3`
M@*4+LIV]1G(^@;_]@3P+J>G:LLTWB-M5U;5K37CK(U$C4K34+:`01W4,H7Y)
M/+!5N"&#L"""14W@_P#8/\">#O$_AO75_MS4/$'AG6[GQ"FJ7U^9KK4+ZXM'
MLY);AL`2?N'*@8`7`P.*=%P6E371+YI0U\EI+3S^[&SM[OG^+G;UWA]S^>%^
MRO\`';Q9\6?@-\2AXJNM/N/$G@/Q%K?AA]1TVW:SCO?LG^KN%CWL8V*NN0&.
M"I(-?)_[`7C#Q!XX^&7[..N>!]8^/NM>)M4TRTNOB1?>+;WQ/=:#=6SZ>[32
MQ/JK&T:0W)C,;61P03@[*^_OAW^S]X=^%VC>+K#28[M+?QMK%[KFIB6<N6N;
ML`3%#_"IVC`[5<^#/P<T7X#?!KPWX#\/QW$?A_PKI<&CV"3RF65;>&,1H&<\
MLVT#)[UG3E:F^;XFJ?WJ,N?Y.36EM5VL:5+-M1VYIV\HMKE^:6SZ/N?`_P`/
M/VV_B3X4_8Y\(WNC^+(];\0:7X4OO$>HVMUI-SX@U2_$5W<!3<S-*B6L!2/:
MLDCEF*D*K!375:A^W5\9?'NA?&/Q5X=O_!>A^'?ACX?T7Q!;65UI,MW=7YNM
M+2]FMW?SD55RQ"N`2,_=->TK_P`$M_AK8:"FEZ7>^,M#L)-&?0+^'3]8,0U>
MR9Y7$5P=I+;6FDP5VD!L9(KJM`_80\`>&_!'C;P_;6^J_P!G?$#2[/1]7#WI
M9W@M;-;.((V/E80J`2.IYJN9<LWUZ>MW^%K:>N@4]'%2VM9_^2_CI+7S7RR/
MCY^TKXBT'X<?"U/"\>G6/B+XK:E9Z;;W5["UQ;Z6);=IY)3&&7S"JJ0J[ER2
M.17RK^U%\1OBI\>/C3X9^!&J>/4T/[/XZBT?6]3T.TNM/'B"RFTF>^AW?9[J
M*:$AXF5HXYL-\I)(RI^YOB1^S1X9^*/PQT?PKJ"ZA;VOAUK>72;RTN3#>Z;-
M`NV*:*7'#@<9((.3D$&N8\*_L(>!?"VNZ'K#-KVJ:_H>O/XE.JW]^9KS4+YK
M5K3S+AL`.!"Y4*`JC`P*<73]HVUI>Z]+QM]UI7[W6_3/]XJ:5]>6WSM*[OYW
M7I;[^4_:CGU"S^)7P+^$.EZYKWA_PWXQN[Z#5K^PU.>#4KBVL-/:9+1+S?\`
M:(WE<*6D63S2L3X<$EJ\6^-_Q_\`'/[$OQ%^)W@?P/KEYX@L]/TKPOK&AGQ?
MJ5WKCZ1+J.IW%C<027,TK7,D;+"LB>9(S*2^#MP!]C_&WX#:#\?-!L;/6EOK
M>YT>\74=+U&PN#;WVE7*JRB:"4<JVQW4Y!#*[`@@XKB4_8)\"W/@_6-+U2;Q
M%KMUXBO[+4=4U?4=1,VI7\EG('M@\N``B$<(JA?F;C+$F(2]Z\^]WYJZ_+]/
M[S*E&T'&.]K+R:=_G=:?/^ZCP3QG^VK\6OA9^T=JGP;U#4O">L>)=8NM`71-
M=BT=[>WTV/4?MWFB6#SF\XQ?8F*G>F[>`0,5W^J?%#XT1?&G0?A'_P`)/X,M
M_$EUIE]KUSXF30I)(I;.*6.*&,6AF`65F=M_[TA0H(SFO1OBA^P[X$^+?Q`U
MKQ5JD.J0^(M9MM.M_M]K>&*:P:P>>2VFMS@^7(K7,N6YR#@@BLN?_@G]X0:T
ML)K?7/'5GXDL9KB?_A)8-:8:Q<&XV^<LDK*5*/L3Y`@4;1M`-',K*Z[W\]+1
M]+/5]^M[Z5+?W=K+[_M>M]DNFZM;7Y;\#_MF?%KXM_%OQCJ7AV>%?$WACX<W
M3_V&\DTNC7NH6&N3P32QP;P`\T4)57Y9=P&2%P:O[3_[:OQ&_:0@6_\`A;XT
MM_!G@W2?$/@O3Q>06,DUW=W]_(9KNWD=9HP8HXI;16C_`(BSJ2,\?5VG?LO^
M%_V5,^+_``'X&\0^)M>T_0U\/1:3IVH6J37MN]VUQ(Y:\FAA,AED>1W>4%AG
M&3@5P_[,_P#P3GT?1?V/;WP/XPTUM%O_`!1XCN?&%[%I-V%FTB^ENOM$/DS+
MD;X<1J",K\G&150E'2^O+9]KOG;?R<7Z)I(TJ27.W':6G>RY$OO4E;O)-LX'
MXF_M8>/OAG^V_P"*?AWINJ6MUK&NP^$=&T^^O$N)+"PGNDU)[FZ%F9C$I*VP
M(5-A8[0SMM&.V^/7QG^./[/.F:'_`&Y=:;?:!&;YM9\7:#X2N-4^Q(@0VS3Z
M?',98T.7,CQF0*$'`!)'H6M_\$^?`?B75]3U;4+CQ->>(M4MM+A?6I-1_P!/
M@DT[SOLMS&X4!9A]HERV,-NP1CBKT'[$^AV7AC^S;;Q7\1+:6=[B2^ODUYS=
M:HTX"R&<LI0\`8VJNW'&**DE]G?\'HK:=-;O3NM'LL_M+M9>NBUUZWT_%Z=?
M._\`@HW\6[RX_P""9FK^+/"_B#4KB;4K;29[?5/"6IRV,]['->6P8VEQ')&Z
M>8CL`1(IPV"PYKYN\3_&_P`5?!/QYXUT6SD^+7@G1[M/#%QH7A[QWXJO=5U2
MZ8ZJ8;^]M[O[;<2"W*S6L30_:6&[!,85OF^Z?'O[(?@SQ]^S+'\(VM[[2?!U
MM:6ME;1Z=<F">U2V='AV2$'#*T:G)!SCFN1O/^"<G@;Q)=R7OB;5?&7C+6&%
MO%%J>M:KY]W:0PW,=RL,15%5(VFBC9@%RVP9/`HBXQK\R^'FOYVTM^*ZZ6O;
M6QC4C-T7!;VMZ.^_W=M>CTN>4ZG^VY\1F\`ZO\6K:Z\/0^`-+\>R^#!X<?3'
M:_E@BU7^RGNS<^:,2&8-((O+QL`&[)KS?X&?M7?%3X1?`95USQU)XMUSQY\8
M-<\&Z5?7'AVZU"30HH+V^>24012R2SHL5L5C@7:$!5<[5)KZQO/V"/`MYX_F
MUII/$"Z=<ZT/$<WAU-0(T6;4@P?[6;?'^L,@#D!@I?YMN<FJ5S_P3O\``DKZ
MYY-]XKL8=7UQO$]M#;:IY<>A:HSM(]Y9#;F&1V=RW+*=[`K@D5-.44E=>O\`
MY)=?.T]=-UMTZ)R34DN]UY:5$ONYH7WORO?KY#X._;(^+7Q,^)/A_P"%%K'#
MX:\6:E>ZQ*?%6L^$+VSM;_3;".V99X+&X:)R\LEW$A^<JOER$$G`KD?%_P`5
M_CYX/_:6^-S6_C;PW#<>`?A9H6OW5I+:7-YI<MTLNL,YMK9IE6`SI`HD<$M\
MD8^8**^F-0_8/\)ZCH&EQ-KGCA?$&CWL]_:^)AK3-K4<DZ>7,!,RE1'(@"F,
M($^52`"`:E\)_L&?#_P9!XL2SAUIV\;>&;?PIJTEQJ+S23V<!NRIW-DB0F]G
M)?ON'H*KFM!V^*WWNSU\EM=;-ZVZ!3Y>9<^UU]W,FUZV3L_E?J<!^VE\<-<U
M7_@EE?\`C[2+Z_\`#>N:KHNDZDEQIMT]O-:-/<6I<)(A##AV7@\@D=Z\Q\9_
MMN_&;P[H'Q9\<1:EX,7PG\+/B+9^&$T@Z1*]YJME+-812;Y_.`CD7[6S*P1@
M=H!`ZU]8>-?V7_"OC[]G1/A;J$-\WA..QM=/$<=P5G\JW:-H_P!YUSF)<GOS
M6'K/[#O@/7OA_P"-O#-Q;ZF=+^('B"+Q-JZK>$.]Y');R*4;'RKNM8OE'H?6
MCFBJLY1V^S_X%!_^DJ2^9E%/V48RWTOZ6:?XV?R./_98^+_Q2_:-O[?QW'JW
MA2U^']WK>HZ8=`?3)%OX;>WEE@2<77F$-*TD0)0QA0K'G(KW/XH>,E^'7PT\
M0^(&3S%T/3;G4"G][RHF?'X[:\Z\.?L/^#_"?Q#&O:??>*+:WBOKC5;;18]5
M=-)L[V='66YC@`&'82.>6*AF)"@X->B:5\.['3OAR/"\TU]J6G_8VL9)+ZX,
M]Q/&RE6WR'EB03R:PK*3HN-/25M/6W?U_KH;PE%5N:2]V_X7V^[3Y?-_"/[&
MVJ_%+5OVP/AHUU\3+RXT;Q5\+?\`A,]<TJXMI+B&]O+F[C>0J3.%C8>8J1L$
M_=QQA`,5G_LQ?MB?%CX-_`OX'>(O%WB/3_%GAGQYJNN:3<VUQ!//JL:VT6I7
M<4[7DDK%VQ9^64*8"D8/&*^D?@I^P3;>"+/P)<ZQK6JQ^(OAG:2>']+U/2+Y
MH#JVCK*KP07B,I#$*D88`\LA((#8'4Z-^PK\/]$\&_#W08[/4)-,^&.IW.K:
M+%+=E\37$5S%)YO'[Q2EW,-I]1Z5UUIP>E/1:V]'*37W1:5NECFA&7->IJ[*
M_P#B44G]\E>_5/Y'C_[&'[9_Q$^-7CCX?W&M:??:KX7^)N@7&L>9;>"M2TR#
MPG,J130027DR^3<)+$\BAP5RZ#`(:O<O'?P&U;7OBQ_PE=CXX\5:9;QG3Y6T
M>&^E^PNUJ]P7`BW[`)TG"N,88PQL<E0:J_!7]C?PS\"/$MK?Z/JWBZZM=+M9
M++2-*OM7>;3M%@D(+);PX``^4`%]Y4#`(!->M5G5E%V=/3>W6VK:OWLK?=\R
MXIZJ6M_^!MVOY6/C_P#9(^'>L_M-_!+PO\8M2^)'CW1?&6NZI+J;QPZ_=_V-
M:VJ7TB#3#I9E%F0(4$32&(R[\MNSQ7-R_MW_`!.TWX->&OC'/<>&9?!/C+Q2
M_ARV\.KICB]TZ*2ZGM+:Y-SYO[Q_-CC9XS&H"LV#\M>[']@'P&?$S7'F>(O[
M`;5CKQ\+?V@3H/V\S&X-Q]GV_>,Q,FW=LW\[<U7M_P#@G?\`#Z#Q&MT9/$<F
MDVVH7&KV7A]]2)T?3KV<2^9<PP8^60F:5AEBJLY(`-9RV2CIY=EI=?-)I/H_
M>W;MIIS-^O\`[=9_)M-KY;))_./P9_:X_:(^)=W\([.Z\2_#FUF^+GP^U'Q?
MYL7AV9AH<EDUG\JJ;C]^)/M:Y#%-NTX)JQ\#_P!MSXV?M3:Q#%H&L>"O"\=E
M\+-/\:7*W.B27AO+^6\U""2('ST\N%EM%_O,NX]:^I/!/[%_@?X?WW@2XTZ#
M4ED^'/AJ[\*:-YEV6"6-T;<RA^/G<_98L,>F#ZUX#X>_X)=0:/\`M3ZE#8W7
MC/P[\,;7X:Z9X5L;K3-?2&:_D34-1FN+68<R%?+N(SO*K]\A6R&`VJ2A*\8:
M-\UGV_BM7^3IZ=6NO6H\O+*4O[NG_;U-.WRY_1-O0XWXN_\`!4GQJGP#L?B;
MX3N-):UTWP1IOC'5?#<&A3:A.HN%\R1+J[\R..S4KGR\[Y&P3L(%;7Q3_;8^
M,WA[0OCQXUT[4O!=OX6^#7B6WLK;2I-(EEN]7M3':/*DDWG`1O\`OWVNJMR!
ME:]B^(/_``2]^&7C[2=:TM)/%'A_0?$FBVV@:MI&C:H;6RU&VMHO)@\Q-I.Z
M./"A@1P!G-=9XC_8B\"^(OAW\1O#=S;:I)IOQ0O!J&NHMX5DFF5(D'EM_`,0
M)Q]?6JE*ESN45I=M+UE%K[HIKY^9C34N11GO9)_):_-OKH>-Z'^VWX^U+XD:
M%\+YX]#C^(LWQ!FT;42MHQA708[22_%ZL>_*EH!%&&R0)'Z=JU?VB?@AXB^`
M/[+_`(^\8K\1?&6N:YX3\.1:EISWFISM'%<6$EQ=R2E"Y4M/YOEMD?ZN.-.B
M@#5^#?P!U;QU^WQKGQO\1^![SP0VF^$H_!FC6VHW=G<7MZ/M+3SW;?9)YHU0
MA84CW,)-H;<JY`KU3]JWX0ZG\?O@AJW@G3[JUL;?Q.%T_4[B8MNCL78"X$8`
M.7:/*C.`-V<\5B_@CR_$_P`'LGY)I*371R:Z%T[>T]_X5:_G]I_<WRKNHI]3
MD_VBOVGM5^''[,'AGQ5X?M+.77O&E[HVE:<+P,;>UFU&:*(2R`8)6,2%MH(R
M5`R,U\N_MX?'/XP:5X+\6?">;Q[9Z?KT.L>$5_X2?1=*ET^:ZT[5M7BL9X-J
M7&^"09;YXI0Q3(!0G</N+XD?`7PU\5_A+_PA6M6;3:&L<"PK%(8I;9X&5X98
MW7E)(W1&5AT*BO/Q_P`$^_`M]H&H6NL77B?Q%?ZMJNEZQ>ZOJ>I&;4+F73;F
M.YM$,@4`1I)$OR*H!!.>N:J/LW5O)>[SIM=X7C[OX2OW3L_*(<\8+7WN6W_;
MVNOST2[-7,/XK:WK'['WP?\`A/\`#KP9>1SZ[XMUZW\*6FK:P]UJ,=IF">XF
MN7$\\DTA"0/M1YC\S*-V*X/2_P!MKXA>%?CO9_#/7)=`U35M)^(=EX8U+5K>
MP:WBU.PN])^WQR)%YC>3,&)1AN<84'^+CZ8^.'P*T+]H#PG;Z3KGVZ'^S[V+
M4K"]L;@V]YIUU$28YX9!]UQDCH002"""17G=[_P3Q\"W_@MM-:^\6+J\FO)X
MGD\2+JA&MRZBD2PK<-/MP2(46/;MV[1C%3&3<G*IKJG\KP^[13];KY%2*Y.6
MGI[K7S][7\8_<WZ^&W_[;?Q<\>_M8W7PU\.ZEX2T.W;XAZMX82_NM(DNY(+*
MUT>SO$8()D#R^;.^22`5P,#&3[7^VK\8?'GP.^%WP[A\+ZAH+>*/%7C+1O"]
MW?W^GM):A+IRDTJPK("IX)4;B!TYZU8^%/\`P3N^'?P>\>VWB;2QXBN-:M]<
MO?$?VF_U22Z::]N[:*VGD<MRP:.%,+T!SC`P!Z1\6_@IH?QK@\/1ZY'<R+X8
MUVT\16/DS&/;=VS%HBW]Y<DY7O5/E_=+LZ?-YVY>?[[2[7OJ55;:FX;\LU'R
M;YN6_I>/I8^0M?\`VV_BUX=\9>.+.QDD\62?"W5[71;O3=*^'^I7,GBIWCAD
MGD2>`R16A19L*A+YV9)`(I=-_;;^+=GX-\5?$K4-2\+2>#_#/Q/N/!A\/)HD
MD=Y+8B_CM$E-P9CB93("5\O#8[5]%^,_V+/"OC'XD:AXD74O%>BR:Y-#<ZU8
M:3JKV=EK<L*JL;W"*-Q8*JKE67<%`.:\=_9A_P""=7V35?&>I?$!_$T,-Y\3
M-6\5:?H`UE)=(O(VNO,L[IX4+?-@*VPLN"`67-%&2O'GZ*[];PO]ZYK+I?2W
M1U%^ZER[\VG>SC4M]SY;OJ[7OUS_``W^VS\2+[P7X5^*]S<>'6\`>+O'9\(P
M^'$TUQ?V=L^I2Z=#=&Z\SYI3(B.\?E@*K,,\5Y-\6/CW\?OC!^P##\2(?B7H
MOA&2^\?6&CV]MHN@RQ3Q0+XGBL1NG^U!B'C`\Q``KKN7HYQ]>Z1^P/X$T7Q]
M;ZS#)XA;3[/6I?$=IX??42=%L]2E=Y'NH[?'#F21WQN*AF)"@U=E_8>\!R_L
MSW7PG^SZFOA2YNY+]2MX1=V]PUZ;X31RXRKI<8=3CC:.M%.4%%-K523^2Y;J
M_5W4M?/IT6O/?I_^UKY:..GD]]WYA\2/VF/B)\#_`-H.TT/QMJ=IH'@EAIMO
M8>)7\+S7&EZ[<2Y6X2XN(I6&G/OVJ@E!0[E^<DXIW[9.L?$&+]NK]G?2_"?C
MR3PSH>M3:L-4T_[$US!J0BM?,'F*)D5^,A=P.QCN&3Q7HWB+]B+P[XTL(;+7
MO$GCO7M,_P!&-Y87^L&:VU-H&#(TR;.3D*3LVAMHR*Z'XY_LQ^'_`(]ZEX9U
M#4+O7-'U?P?=O=Z5J.CWGV6ZMBZ&.1-V""CH2K*1R/2BG)1:;W3?W-67XW=M
MK6T1,M;I;.-OG_5M=[WU9\[>%?VU/B1?>$O"/Q4O+CPZW@'QCX]_X0^+P['I
MKK?V=O)J<NG071N?,.Z0R(CO'Y8"JS#/%;_[06L?$,_\%1OA'HN@>/)-#\*W
MW@W7;_4-&-D\]O?-;W.G@EQYR*9"LI"2%28\O@'>:]#T#]@7P+X<\>6FLPS>
M(I+'3]9D\166@2ZB6T>SU*1G=[N.#'$ADDD?&XJ&<D*#72_&/]F#P_\`&CQ[
MX7\4W=[KVC^(O"(GBL;_`$B]^RS-!/L\^WD^5@\3^7&2I&<H""*5.2CRM]'+
M[G#E5^]I-RUW7W#E=N79I?>I-_*\;+R:^;^.OV6OVH?BY\.OA/\`"OQ%XD\3
M:;XE\,^,?'6H^&;BSO()[C4UA,]X8I_MDDI.Y/)5?+V%=O`(P*[O]E3]NSXA
M?&[Q3\/==FTV_P!3\(_$J>Y5[&U\%:G;IX6A42-;RR:BZ^1.KA`K$;0&<;21
M7NNB?L2^!=`\#^$/#MO;ZE_9O@?7V\2Z8KW99EO&>5R7./F7,S_*?4>E-^&'
M[%?A7X1>,;74M'U+Q9'INERS3:9H,FK.='TIY22YA@`'!+-A79E7=\H'&'&4
M;OF[Z>EEH_-N^O3HQUKRG*4=G^=Y?DG'UM]_GG[4_P"U'XV^!'QZMX=2EB\(
M_"]K6T>/Q+/X?FU33Y+EYBLT-Y/$X-@@7;MFD0QY?EAC%>*_LV_M.?%SP!X`
M\&^)=9\5:5XB\*>)_BYJ7@Z6ROXIKB_6UFO[R.&47DDIVB(QH!'L*[!@$8%?
M7?QP_9.\/_M!/?0^(-4\4-H^KVRV6IZ-;ZD8].U.%6R8Y8B#PV2&VE2PX-9M
MI^PK\/[+X<:)X42SU#^Q?#_BAO%]I$;LY%\TTLQW'',>^9_DZ8P.U13]U*_=
M7\X\T6__`"5-+MIL]1UGS4Y1ANUIY-0DE_Y,TWZ=M#YGUS_@HQ\0O"7C&&1+
M_1?$V@>*-,\23:7<VWAZ:TT^RN=-M)+F+R;J27=>HPC*NRQJF?NN:UK?]KOX
MN:9X8^$-CJ_BC0QKWQ@THZW]LTKP/>ZE'H,,5JDLD:VT$CR3EWD0!VV!1GKQ
M7K%A_P`$P/AU:?V7#-J'C2^T_08-0M-'T^YU@O:Z1!?6[V]Q%"FT84QR'&XL
M5(&#VKM?%O['/A/Q/X(\':/!<Z_H<_@&!;;0=6TN^\C4;",1")E$I5@0R`!@
MRD'ZT_=2LO+_`-NO\]8_=;;=2N_)^]_[;;Y:/YN]CY1\!?M!?&_X\?M0>&;6
MTU*X^'NHKX&UC^T[/6M(O4LYY[35#!%?1:=,\1Q/&BNK2894EP":Z7X"?MM_
M%;]KG1+6'PW>>%?">H^'_!EMXCUF>ZTM[Z/5+N66YB$$2^:GDQ'[,S%\N1O`
MP<5]'>`/V/\`PA\.?&FG^(;-M;NM8T[1I]#%U?:C)=23PS3^?*TA?):1I,G=
MP!G``&!7(Q?\$W/A_I/A_2=/T6\\7>&QI>F-HDEQI6K&"?4K%I7E-M<-M/F(
M'D<@@!AN(##-$OAY8^?WWF[^FL=-M-M+-R=Y\RVTT\DHW7KHU??7?6Z^7_"O
M_!1/QAK?Q,\8>*-/FFCF\3>"_`D&DZ1>W$TVE:/J.HZCJUM-<+#N`&?+0L1M
M+B*,$\#%[Q-^UC\4/V;?VFOBKX=UWQ9_PD^L:KJ7A#0=&N(=(NY[#2?M=M>2
M37$>FQ22-O(B)*1'YRJ$GCCZDO\`_@GI\,+U-<C72;JUBU[0M*\/R1V]TT:V
MEOIDD\MFT'>.6-[B1M^22=N>E9UA_P`$WO`,+>)KJ]U#QEK.N>*I].N[K6M0
MU=I=0M[BP5UM9X)-H$3H)&'RK@YY!R<[3J4W)M+2_P"%T[>3M?7S2OVA)VUW
MLOO44K^EUMY7MJ>,I^V/\:=<^(G@WX?VK6>CZCK?B^\T)O$VL^#+[3X=5L4T
MQKQ+FWL[AHV#K(I1AN9<KU&:[?X&_M-_$33OVE8?`OQ6U*R\/WU]?W=EH]M+
MX8FM;/Q/%%%OCFL]0$KPF<JKR-;-APH?`(0FO4/"_P"Q9X4\.^(?#.M7.H>*
MM>USPMJEQK%MJ.K:J]S<37$UNULYDX"[1$Q`5550><9S5Q_V2?#M]\4=)\5:
MCJ7B?6)M`U.76=*T^_U(SV&FWDD3PF:*,C(81RRJH+$+YC8`XQG%I25]K:_<
MM5^/EKLM&IM)I_A^._EMUOIZI\'\7/C;\0O&/[3WB;X=_#_5/#_AL>!?"=GX
MGU"\U33&O_[3DNYKN.&V0"2,1H!9R%I/F(+J`.M>`_LZ>,_%'[?G[<?@OQ=K
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M8/K4TM$U+M;YJ-6S_P#`I0=_+RUJI:5:,NBW_P#*5_PC/[_,\]_9"_:/^(/C
MGXN#PWXMMM0UK2]5\,Q^(+;7(O!6I:!9Z=<^:J2Z>SW*[)6VR(Z.K`L$DRHP
M*^FJ\U^"'[+NC_`K59KRSUSQAKLS6B:?;?VWJSWB:?:H<K#"F%55!`^8@N<`
M%L5Z56E247;E\_S=ON5E\MV]7E%25^;R_)7^]W?SZ+1%%%%9EA1110`4444`
M%%%%`!1110`4444`8_Q"\7Q?#[P%K6O3QM)#HMC-?.@ZNL:,Y'XXKYU^"7B[
MXM>(OA1X/^,FJ^/M-G\.Z[IZZ]KOA:YTN"&RTS3)(&F'V.>*/[0;B-?+SYTC
MH_SC"9!'TQKNBVWB31+S3KR-9K.^A>WGC/1T=2K#\037S[X*_8:\0>'_``WH
MO@O4?B=J-]\+?#2-#I^AVFFFPU"YM_+>-+6]OEG(N+=%?`1(8BVQ-[.`05K:
M5M]+7VZWNO/W;>CU6Y7NV2>VM^_2UGTMK]ZT=CC]>_X*>:]X#^'&E^,_$WPR
ML]-\+^,-&OM5\*RV_B8W-W>-;6<EXD%[$;1%M6EBC.TQR7`!ZX/!S]'_`."E
M/Q2UW5+/38?@7HD.J:UX('CS38I_'X6);(!3)%=.M@QAGRP"+$LR-GYGCYQL
M:O\`\$Q;_P`:^`=/\(>)OB1)JWA7PEH]]I/A2VBT);>YT[[3:26@FNY?/9;M
MXHI"$")`.[!CR.^T;]B"VTCQGHVL#Q%/(VC_``];P`(OL8`E0[/]*SOX;Y/N
M8(Y^]5U+6FX>?+_X#.U_/FY$^EOFRH\MHJ6_VOOAMY<O-OK?Y'E7AG_@J;XH
M^*FFZUK7@GX3Z?J_ACP[X/TGQI?W.H^+387KVM]:M=&&"W6SE5YXT4C#RQHY
M_C6M?XN?\%15^&DVC:Q#X5T6\\#:I#I5S]NN?$WV?6)XK_R]DMMIZ6THDC0R
M`,TL\&2&VAL<^2_`G]@;QYX/^*WQ#^&NA^.+C0?!UIX%\->$;K5+OPK]H;6X
M(+*2"62TD,R)#/MX)/GJA890GD^E^*O^"4+3Z5XD\.^&_'EOH?@OQ-)IDT]G
M<^'A?ZE;M8I`D445X;A`L!6W7,9B)!9B'&<5T5%1]L^7X+IK_#=WO\K6ZZ.Z
MU,)*:BEUY=?7EB[KY\U^FNFP^7_@IMXK6U\0:]_PJ>RC\#>&?B!+X"O-5E\6
MA;R=Q=I:I=06JVC;DWNN]9)8RO.TR`9/6_##_@H0_P`2=2^'^B#P:;'Q=XH\
M0:MX?U[2'U7<?#+Z;Y@N)=_DCSU)$)3*Q[UG1LCH5U7_`()_647P&\5>$I/%
M-UY&N^/)/'\ETFG!G@8WT=Z;98P_S#,>S=G)SG;VKROX;?`K5?C+^V#\8/BW
M\.+C6O"<.KZ'9:+H>HZMI3V\:ZDY"WVH0VMU"#O6".!,NA1VB7@@$G&CRZ1E
MO:[_`/`8_@Y\R?RM9%UOBDX:*[MZ.4DK=;J+C+7HG?5GU!^U#^T#_P`,Y_#J
MSU2#26\0:SK6L6/A_1M,^T_95O;Z[G6&)7FV/Y<8+%G<(Y548A6.`?GWP'^V
M_P#%+2O$?QPC\4>%?"[ZCX)\1Z3I&FZ5_P`)*EOI.G1W-C#+)++J36JRM%O=
MFR;9I.0HC/2OH+]I?]GR/]HKX:V>C_VM/HNKZ+JMCKND:JD`F:QO[.99H9&B
MRHD0E2KIE=RNP!7((\+O/^"9WB/6=?U[Q1J7Q0L;[QKK'BVP\7QW#^%0-'BF
MM;'[$L$EC]JW30E"7&9PRN%.XE>9IV7-S[WT]+T_Q^._E9+5C[6[?.]I;^7P
MVMUNWI8XU/\`@I/\3/C#XS^$,?@/PKX*@CUKQMK/A'Q397OB>;[.\UC`S_Z-
M<C36=X2N)%D,<3$A4*`$LO=:-_P5,T_4OB5;0RZ'X>A\#WWC"Y\#6^K)XI63
M5CJ$$LL#2/IOV<;;5IX7C63SRY.TF,`YI^C_`/!-?6/#&GV>I:;\1K>/QMIO
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M&7_!.G6/AY\0/A3,WQ'6]\%?!?4+^Z\-Z$/#ZQW`AN;.XM5@GN_/;S/)6X.Q
MEB3*J`P8_,+/[3__``3:M/VD_%WQ(US_`(3+4/#NI>.]"T72+2YM;%)9=!FT
MRYNYX[N,LV'9C=E=I`QLZG/&G-!-./2^_G=:]+V>EM$[/H*4;N2O;16MWYKZ
M=;6[ZM:'CO[+/_!1CXG>/?&GQ_UK5K/1=>\-Z->Z5=>!M,FNH='M['3+N2[A
M26ZO#&S;7%LLQ;9(RB0*JL>#UO@__@JQXB^)7B_0?"/AGX9^']7\9:EXBU/P
MW>(/&4D6C6<MG9PW8G2[-AYLT+I.@S]F5U.?D8<UM>)O^"55C-J=]?>'_&#:
M/=;/#9TZ"XT@7EC`^C1SI']HA\Y/M$<OGDLFZ,J5!#&M3X1?\$WY_A]^T%:_
M$?5O'*ZUK*^(+_Q#<P6^B+8VTLMWI]O9-'&OG.8XT%N&7)8_-@DD;B+V?,T_
MA2LOERI/Y^]>_76^NA'5<SW=W;M=/3Y.UK?\/>\#?MD_$#XJOJE]H_PSTO\`
MX0_2;^[T.^UJ+Q3YMY:7MM&WG2I9O:(LMHDRF/S//60XSY.,XXS]CW_@H!X^
M\9Z5\$;/XB>"[&W@^+UK=P:?K]OK*/=37EM#)<-YUBENL<,4D4;%62=VRN&1
M<UZ-X=_8N\0>"/%&J6GA_P")%QH_P^UC6;O7[G08M&1KQ[FY#>;%]L,N/LK2
M.9#&(0^1CS0,BCP5^P7:^#=-^`]NOB:XN/\`A1TUW-"QL@O]K^?9S6I#?.?*
MVB7=QNSMQQG-31Y=ZG:/WV=_QM;\;F=12YK1V][\_=^;6_X6,W_@I3\4_BE\
M$/A/:>*O`7B#PWH>EZ;J6GPZFEYI#7U]>B>_@@,<3-(L42[)&RS([9Q@#J.A
M_;1\2>)?`GP_D\56_P`0M1\`^%M!LI+G49-&\/0ZOJEY,<")%6:*9!'UW!8M
MY)&&4`UUG[57[/D/[4'P9O/!\VJ2:/'=WME>&Z2`3,IMKJ*X"[2R_>,6W.>,
MYYZ5'\:/A1XY\6:O8:AX)^(4'A.:"U>SNK+4]#_MC3;Q&Q^\\E9X'69<8#B0
MK@D%&K&5_9\JWYGKY65OE>^G3>QT)KF3?;]27]DCXBZ]\7/V:/!7B;Q,FG)K
MVM:7%=7@L7#0%V'5<$@9&"5!.TDC/%<Y^U]JGB+PMHD>N0_%"#X7^$=(M)I;
MZZM],MKW4+^[)001)]ICDC$>`X*(AD=F4*RX.9O@%^S7JW[.-AX)\+Z#XDFD
M\#^&=,ODU&WN((FN-8OYYTE28MLS$B$W!"1E1^\4'(45E_M-?LK>,/C7\:/!
MOB[0/''AK1[?P;;7"VVCZ]X4DURR:\E9,7H$=[;$3)&A1"VX*)'(P6R-*]I3
MO#1-OY;]/R]4W;6V=&\8^_JTE\]OZ?SM=V/+_AK\>?C!^T9XE^'O@.[U:3X6
M^(KGP*/%_B:^L],MKF\\U[C[/!!'%=))'&&PTC@JS#A05ZUROQ@_;!^-D_\`
MP3T\8^/_``_KO@_P]XD^%U]K&C^(;F316O'U6XTZ]:V#VR-*(H%F55D;>)=A
M8J`<;J]^\8_LN^,-;\8^'?'6D^.]#T7XG:7H\FA:CJG_``C+W&DZM:O(LI4V
M)O`\95U#(1<MM);.X'%4_$7[`VDZM^Q%XI^#-KKU];KXPCO)=3UV:!9KBXO;
MRX:YN;HQ@JN7E=B$!`4$`<"M.:/-S/NW\^=M6\E#1JRN[:$QZ)]X_=RVDM]W
M+5/73J<]^VG\;O%OA3XL_#WP[HNO>./"NAZEI&IZQK6J^&/#4&M7>8#:)!#M
MFMIT13YTKL=F<1<'&:]T^!WC#3_'OPDT'5M+\22>+[&]M%>/6)8XHY+_`+%W
M6)$16R#E510"","N?^,/PG\<>)M5T_4/!'Q"C\(W%O9O875IJ.B_VQIMVC%2
M)1")H'2=<$*XD*X8AD;C&5\#?V<-4_9WL/`OACP[X@D_X0GPWI]__:L,\$;7
M6M7LTD;QR%MA\M%+7#E8RO+(.0*SC;E:>]_UD_EI9*WW=C6T;]%^B^]WOWTZ
M]Z/Q?_:D\3Z'\;[CX?\`P_\`!&E^,M?TG0T\1:N=3\0MHUO:6LDKQQ1QLEK<
M&2>0QR;4943Y.9%KPW2?^"OVN?$KP=XX\4^!/A)!KGA7P!X6LO%VI7NJ>+!I
ML[VTUM)<36\<*VLQ-S$(G4*S+&Y'^L2O=OC#^RUKWB3XRS>/?`GC:W\$^(M4
MT5?#VK-=Z(-6@O+1)'DB9$\Z$QSQM))M<LZ_.=T;<5P?PV_X):^'_A)\(_BA
MX+T/Q)J$6D_$;PA;>$D:>V66;3DALI;4W!;</.D<RM(PP@W9'?B-51F_MV?*
MN[O*R]+<OG>YO'D=6*E\-U?T]WF^=^:UNGF:'[??[3_CKX6_LG>%_''PMLM#
MN=0\0:_X?MRNLWK6B):7UW!&5RMO<99A*J$[1L5V<%F0(W!^//V[_BW\)?C+
M\;HY_`OA_P`2>'_A?X<T37KVU7Q&+*'3%F@N9+M+>?[&TMW(?*!0210J0GWD
M)Q7N7QP_9+A^,G[+6G?#==>FTNXT5=+ET_5A:";R;K3Y89H)6AW`.ID@4LF\
M9!(W#K7+:A^PG?>+=*^,C>(?&D5]K/QF\-V6@:C=6>C?98+%K>WN(?.BA:>0
MD-YY.POQMQN.<C6?*G/DVYFUZ6BDOP;?KINS"ES2A3531V7-;O?5_HMUY;'$
M^,_^"L^E^'_$&O75CH&AW7@WP;<Z99^(K^\\3K9ZK;2WT%M./LMAY#BX2&.[
MA,C--$1E@H<J:]E_:)_:1U+X5^*_!OA/PGX;L?%GC3QU)<_V;97^KMI5C%!;
MQB2>>>X6"=T4!D4!(7+,X&`,D><Z)_P3HO/`/BK49O"?C>QT71O%$FGW7B*W
MN/"\%_?7-Q:VMO:F2TN))-ML)H;:(.KPS8()4H3FO3/VA/V<+SXL>*/"/BKP
MWX@A\*^-O`\EQ_9>H7.F_P!I6CQ7$8CGAGMQ+$9%8*K#;*A5D4Y(RI*G)IRW
MWU[[+Y6YKVZ\N^M@IW^UV_'_`#[]+[:'F=[^W;X^N-4\0:7I?PAL9=9^'^DQ
M:MXQM+[Q<+<6`D$CK!9/':2B[E,<1D`D^SKM=,LI)`XVY_X*QZ]XCT3XD>(O
M!_PIM=;\%_#*QTS5M0U6^\5BPEN[6[L(KUA#`MK*3/&DA&QF5&VC]Z"=H[2Z
M_8&\76-_KNH:3\7;J'5O'FEQZ5XRO-0\/QW;:FJ>8%EM`DT0M)5CE:-2WG*%
M5,JS`L9-"_X)GZ'X2^$WQ@\&Z3XBO+32OBKIMEID>^T$CZ/';:;%8*0=X\XL
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M=S><PNI8[=F12B0`[B2"3FIJ13A)+>UE]TKM]FWRV2T3O=VL12;4HN6W7[U9
M+NK7O?5Z65[GFOPS_P""G'B+0].TF3Q!9R>)-5U3X>^#=2LK))H+*#4M9UFX
MFMPNY8"T*LZ*6;+JJCY8P0=W5^"?VV_BII'C[XZ6OBOPIX7%YX$U'0;+3-(C
M\2I%I5BMY9"66:34GM4D,6\[LFV,@Z+&>*MI_P`$F],CTNU5?&EXNH:3X5\,
MZ!I5V--7_0;O0[B2XMKXKYF'WO)\T1(&T$;N<@U3_@F?XD\2^(_%/BG6/BC8
MZAXT\1>(=(\1QS_\(H$TBWFT^U-LD+V7VHM-"RDMAIPRM@[C@5U8N5*563I;
M<S].5R5K+NES7OTLEJ9T[J*OV7WJ.OROVZW;NCC;_P#X*4?$WXJ^)/AK;^`/
M"O@>.ZNO'VH>#?$]E>>*9_L4\MO9_:%^S70TUI&A9'1Q(88WR-I3!+#MO#__
M``56TS5/'VG_`&K1/#]MX$UCQ1=^#[+5HO%"S:M]NMS.A>73OLZ^7;O+;R1I
M()V8DH3&H;-36/\`P38UK1HIM8LOB1:Q^./^$]E\?6VIR>&@VGPW$UC%9RVS
M6:W*EH2D9*XF5ER,EL$MM?"W_@G[??"W7%T^T\9Z:W@'^U;O6Y-'3PO`-1FG
MNGDEFA:_>1\6QFE=PB0K(O"^<5&#AIRJV]E?M=QAS+OH^9+[]58=G>3?G;TO
M.WSMR?*ZNF<?X9_;K^(WQ0^.O[/[6_A;2?"_PW^*^H:L8+A=7&H7VIVD&FW$
M\'GPM;1_969XUD`BEE!489@3BO1?B/\`MMWO@[]JUOAA:^&]!$D=I8W:7FM^
M)#I,FJBY>566PC-M)'<M%Y?SJTT;990`<YK`^&/_``3SUKP!\1?A5=W/Q(74
MO"/P9N+]_#FBKX?6&X,-S:2VRQW%UY[>88EEPK+'&"!AE)^8=A^U'^R/JG[4
M$S:9J'BW3[7PC--:7#V,GA])]0LY()5D+6EZ)4,)?:H):.0CG:1G%5+DYH);
M7U[VOU\_3T'K>7IIZWZ?+N>2_LW_`+;/Q@U;X#?$3Q5XQ\)>!;ZXT'QYJ_AS
M2C#XM:TMTC@U*6V`NI'L$$,,*J!YR":64#/E!CMKEM7_`."F7Q,^*'C'X367
M@'PMX)ANM3^(U_X+\3V=WXGF:QNV@TJYO%%O=?V:TGE$(L@D\E'W1A"FURZ]
M_K/_``30UI8=2L=%^)%I9:''XWF\?Z)I]_X:^W+9ZA/(\L\=T?M2"[MF>61E
M3$3(2IWG:*=;_P#!-+5].,.N6OQ&MX_'5EX^?Q_9ZH_AL-I\-S+8-8S6[6:W
M*EH6A=]N)E925.YL'<4)05G4[1^_W$[]_MM_@VV:5K.4_9]7.WH^?E]/L6[>
M5@\3?\%1[3PWX_U2-M`\.R>#-`\31>$-2U(^*E35TOG=(FDBTXV^)+5))%5I
M#.K]2(R!7.?#S_@J1\0OB0GP[GL_@AID-G\5+S4=,T!Y?'*B07-GYI+W*BR(
MBMG2)F$B-)*#P8>A/H>@_L$ZIX0\=:E<:+XWTS3_``WXBUG_`(2'6+'_`(16
M"?4)KUMIF%O=R2LL$$KKN*&&1UW,%D7@B?X7?\$^;3X9Z7\&[6/Q1<7@^$.H
M:CJ$3-8A/[3-VDZ%6^<^7L\XG(W9V]LTJ?)9<V^GY:_CMY;H)6]ZWG;\;?I?
M\#@O#'_!5VY^(&A^'+/1/!?AF#QMJ$.KS:MI>N^,QIFGZ;_9FH2Z?<+#>?9)
M&N&>>)O*!AC#+@L8^E.T/_@J;KWQ=2\N/AI\+;/Q)ING^"K3QK->:MXK72D2
M*;SM]IM2UN&\]#"ZC`*,1RR#!.CX5_X)?3?"R>QU?P?XTTRT\66MUKAEOM:\
M,+JMG<6FJ:I-J30FV^T1%9(9)MJ2"3!"DLAS@=[X,_8?B\)^(?%FI2^*[W4K
MCQ9X0MO"EQ)-I\,+J81/FYQ#LCW.9B=BHBC&!4U+<K<-]?OM*R7E\.^MUVN3
MI[2WV;KUM>-WZVO]^U['C7[,G_!1+XD_%_QE\8?$EUX.T6^^''A;0M,U[1K.
MRUB236D6YTQ;M8!`+)4D:0D[B9_W9&%$@YKW_P#9`_:=N?VHO!5UK4NG^%K.
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M'_!+;XA_%SX[_"36OB5\2M4L99/%%Y=)H^B6.I)<:=IL=O<S0X3_`(E]O-'D
MQ@'?)<;@-V5)V#4T;_@G?<:7=:5X?D\<--\*]`\4OXPTWPU_8X6\BO&NI+Q8
M7OO.(>UCN)6=(Q`KC:H,C`8KU7]E7]GV']E[X%Z5X)AU236(]+FNY1=O`(6D
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MZB:VM*_KS2Y=/3E_SN<%XH_X+`7WP^\->/+K7?A[H)U+PMX*OO&MAI^D>,O[
M0:ZCM2`]G=R?8TCM;C+*"(FN4!W#><<]1XI_X*7ZU\'M3UZT^(7PSA\/W%KX
M6@\4Z+;Z=XD74YM26:[CLTM)@;>)+><SS1+\CS)A\[^,5@>)/^"2>I^/_A_>
M>'M?^)6GO:_\(!??#VP.E^$EL!;6EP(P+B5?M3^;.OE@L045R3A4KT[]H/\`
MX)\:/^T5XSN-4U37[ZSCF\'KX6CBMK=?,MY([V*\AO%<DC>DL*$(5(..O:M)
M<J4;>=_3W[->;]WNOQ,KMI]]+=MZ=_.UN?L_P,3Q9^U5\4/"?Q*^%VA^+_`M
MEX,F\6>,!HS_`-D>(H]9L]1MFTV[NN));.&4,KP*K($C(;!61UR#S]W_`,%+
MM8G\9:MX4OO"^@>']2O]`UK4="N+'Q*-8N[::PA9RE];BU2*!S@,%CGG'!#8
M-=EKG[#_`(K^*'B;PKK7C[XJ3Z]?^%=>_MBWBT[0ETRSCC_L^YLO*BC\^5XW
M;[29&D,CY9``J#@<CX+_`."7>IZ`/"]GJ'Q%L;W1_!.CZMH>DP6GA=;.XD@O
M[8P&6ZF^TOY\Z9W%U6,.<Y4$YK&M%RIS4=[.UN[CIKT:E\M7LM]8RBI4WZ7^
M4G?3K>-ON74Z+7?VUO$'PG_X)X_#'XH76@P^-/%'BZT\+VLUE]M72X[F[U62
MU@:3S!%(J*LEP7VA,8&..HS-:_X*-^(/!_Q#?X;ZU\.M*A^+E[J]GI6C:-9^
M*'N-)U);FVN+I;AKYK..2*..*UG,G^BLP*84/D&LK]NC]GG6O!__``3O^'?P
MY\+7&I:IJ7A/Q!X*TR#4+;33<2HEGJEBC7C0#<-J+&9&!)4!3DX!-;FJ?\$Y
MM5\5^-)/B%K?Q"@NOB[:ZM9ZKI.OVOA_[/INF?9K>>V2#["UP[21/#=7"R`W
M`9C)E60@8[*OLY3G4C\/M))?X;0:LOF[WZ:+5(X\/&I&C"-3XN17Z^][RU?J
MEM^5S(\6?\%1;_P/?_V!K'@;0]'\7:?XCE\.:V=0\4R0^'M)D%DMY#*=1%DS
ME)XW41[[>/+;@VW'/-_MJ_MX?$KX7:5XS;P99Z/#JVD_#&V\700W6J0S6-K/
M)?F!V25+64S$)]WD(P[*>:]9T/\`8J\2>'-&\1W$/CS1;WQ1X[U1]3\576I>
M$TN],U8FW2WBB2T-P'A2*.-`G[]OXMV_/')VO_!)OP_;?#Z\\-?\)9JYT^\^
M'0\`!OLR^=$!=/="[4EB,AVP(L;0J@9Q7-I=/M:_G^[E?Y<]K7[]$FS:5[6C
MW7W<Z_\`;+_\%NQ5\=_\%`?$?P'^(6H1^/-#MXWTOP!;Z_+HVAZJM];W.H3Z
M@+2""&>6TMY6:1GB7<P1%+D;#C<3XU_\%,?%G[.%KK&E^,/A1I[>-[--'N].
MTC1O%OVRUU6UU#4XM.W"ZFLX/+FBDE!:-HBIX`DP=PVO%G_!-RY^,5WJE_\`
M$#QVNL:MJGA*+PPUSI&B#2UMI(+Q;NVO8D>>?$D<B1G:Q96*YX!VB/Q[_P`$
MX-6^-]_>:UX^^(D.M>+)GT:&VOM.\/\`]GVMG9Z=J<6HB$6[7$I,DTD0#R&3
M'0J@`P=O<<X)[7][?;F>WG:U[]-M1T](OFWTMZVC>_E\5K:WWT/0OV=/VG/$
M'Q2^,7C[P%XP\'Z?X1\2>!K?3=0*Z?KK:O:WEI?"?R7\QK>`I(K6TJNFU@,`
MAV!K@5_X*)ZS<64/BN'X?V!^%M]XHD\(V>O2^(V349+M;M[)9WLA:E$M&N4*
M"07#28(;RL5Z]X*_9[A\&_M,^//B0NJ27$WCG2=(TI[`P!5LQ8&[(</N);?]
MK.1M&W8.3GCRVQ_X)Y7%G<6OAW_A.&?X4V'BA_%]MX:.CC[:EVUT]YY+7WG8
M:U6X=G6/R`XX7S"!BLM'*/;2_P!ZOYWM>W2^_04N91E;Y?\`@+^5N:WG8P?^
M"9WQ)^,7QW^&'BSXF?$#4M-D;7-0U&TT+P_9ZJDVF6`M+RYM@H/]G0S19,(!
M9I+@L/GPA/ECRGX:?M]_'[6?V>_@?XBU7P_X4N]>\=_$ZY\,36NEZN)%U:R2
M+5#MD::SA6UV26L7SQB1F2,M]YC'7V+^RO\`L\0_LQ?!*U\%PZI)K,-K?:C>
M_:G@$#-]KO9[LKM#-]TSE<YYVYXSBO(OA]_P3COO!`\#Z;+X^CO?"_PW\<S>
M,]!L1H7E748FCOEDM9[C[0PE&Z^8K((T($8!5B2U:1E#FMTO'[DU?SNUO?1Z
M^1<?AFWO[]O5QDH^EG;M;?IID_\`#SW4H%C\.7G@GPSI?Q,D\6WWA,Z7?>,3
M!H<;VEJEW)<G4C9[_*,,D>!]EW;W"[?XJ[C1?V^=+U[]A7QA\:(]*53X*L]8
M.HZ5%>K<HEYIKS130).J@2(9(3MD"C<K*V!G%87B;_@F['<^/=3\9:+XKM;+
MQ?)XNO/%>FW&HZ&NH6-I]KLH;.>UFM_.C,\92%6#"2-@P4]N?5_#?[.MM/\`
ML]ZIX`\8:@OBVV\16UY:ZQ.MA#IT=VEUO\Q(X81MB0*^U1EF`4%G=LL<=Z.O
MQ<J_\"Y5>V^E[[]=M`I.U5<_P\S_`/`>:5K[:VY=NF^NWD]QXT^*'[-_PG'Q
M=\>?$&Q\3^$]-\.7&O>+-#.DP6BZ;MM?.5=,>&,2-B0;-MS(^X'.\$8./\3O
M^"E/BCX!^%]:F\=_"W3]+UI?!EYXV\/Z?IOBLWR:M!:M`LUK-*]G%]FN%^T0
MDA5F3#'#G%=%J7[`WB#XD_#MO`OQ!^*FK>)O`-OHEQH-MIUCIO\`95W>02VQ
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M+QO$UQ:GXB?#VQ\`2(+$-]A2V:](N@=XWLWVP_(<`>6/F.>/`/AG^PKXS^(O
MQ._:/\"77BRX\/\`PU\0:KHFDZC#/X:+W'B"SB\/Z=#,UG=&55B#[&B=MDP&
M&`VL":N/LG)KROY?$EKU^%K;75]M%%>[=^5^^T=O._,M=+)>K]:\=_\`!22Z
M^'GQ^T7PQJ/A#0U\.^(-?B\.6-\GBGS-8>::!I8;A]/6V*1VSE=@9KD2<@^5
MCFN?^'__``4[\<>,?#GPUUZ[^#5CINB?%B>_TS0"/&0N+U]0M[6[NHXY85LP
MB03)9R`2B1G5BN8L'-:3_P#!,"^C\36D=O\`$"WB\)Z=X\7Q];6+>'!)J37.
M]V-O+?&X_>0`2,J`1*R`*"6`Q716O[%&E_"'X2?!F&Z\3:A<6/P#U:?Q#YL.
ME---JP:SOK<Q^5&S,N!>%AL#DF,#'/'/3MR7GIJONLKM]+IW\G9:$OF]I:*N
MN5_.5Y67>S7+Z7>O4U/@A^WE:_'GQO\`#?1='\-R+)XT\,7OB75G>^^;PV+>
M:*W^SNOE_O7:XD=`28\"%S@]*Q/CW_P4+O/@#\=+;P[J7A+0V\-S:WINA&_?
MQ/MUB22],:1SQ:<ELZFW620(6EN(F)5BJ,`"</\`X)P_`BUT?XU?'#XJV>GZ
MSINB_$#78X/#5KJ=M+:R6^G0J997C@E57A2>^N+J7:R@D;3CH!:^(O\`P36U
M+QKXZ\37%K\0K6Q\-^*?&>G^-[JSF\."ZU);NTDMG%N+TW"_Z,?LRA8S#N3<
M<.1\M;14?:T^=63LY>5Y)\O=6@VN]X[:Z*5^6:AJ]5%^B:OVUDO2SOT.K_9F
M_;=O/VB_BMKWA\^&]$T*'0[Z^L9;>;Q'NUV`VTYA66?3VMTV13!=Z/'-*-K+
MG&>*'[:?[>6I_LBZG<S+X1T+5M!TG35U2_N;_P`4?V;>7$9<JZ6-JEM.UQ(@
M&6\UH$^90'))QOV7[(FJ:M^T?X>^('B;Q;I^M2^$'OFTE+7P^FGWS)<H8_*N
MKE)2L\<:'"J(HP2%8Y(S7*_M(_\`!/;4OCCXW\?:AI?CRWT#3_B9HL.BZU!=
M^'QJ=U;QQ(RJ;*<SQBW#;LNK1R!CR-IYKGDWRQLM;:^;UW]?+;\3:/+SROM?
M3TNMO17WW\AO[#G[37Q,^/OQ[^-FG^)-)\*Q^"O"/B.&QT2YM-7DDOH(Y-,L
M;I(F@^QQJZL+AI#(TVY68QA650Y^GJ\1^`7[(^I?L\_&3Q5KFD^+K>X\,^-&
MM;[5-&N-'S<?;X+&"R\Z*Z$V$B:.WB)B,3'<"0X!Q7MU;U>3W5#I&*?JDDW\
MWKY]=;F-/FU<N[?WZV^6WY:6"BBBLBPHHHH`****`"BBB@"GXBOI-+\/WUU'
MM\RWMY)4R,C*J2,_E7Q7\+?VO?BSX1_9^^&'Q<\:>(?#7B3POXZUBSTO5=+M
MM#_LZ;1DN[AK>.:*83/YNR0Q[E91E2Q'-?:VMZ?_`&OHUY:!O+^U0O#NQG;N
M4C./QKY1^%G_``3Q\9VWPO\``GP]\>>./#&M^`?A_J$.I6UGH^@SV%YJDD$C
MR0+<RRW4RE%=E8B-$W%!SCBBGI.[[Q]+7?,OFK?HT$O/:TMM[V7+^/R[W-[P
M5_P4KT?Q#JFBZAJGAV31/`7BR2]B\/\`B)]2CF-Z;5))'::W"AH%=(9&C)9M
MP`R%)Q4*?\%%M4TSX8V?C36OA7KNF^%_$T%G)X5NEU2":75Y+R:.*T@GCPIM
M9)#*C8)D55W$D%<5D?"+_@F##\-H+?PS<7'P_O/`>FQWL%KY7@^*/Q#-%<+(
MNR:_9V!V+*P#QQHY`&2><MUS_@G7XT\?_!71_A[XF^(VBZCX7\%0V"^&H8_#
M@WR36,L3VTNH>9,ZW'RQ!&6-8E97;@'!%>[?RNO6UWS7_O6M:VE]T$KW]WS^
M_3E_[=WYNO9]"WXF_P""G%QX1O\`3_#MU\.;ZZ^(5WXML_"4V@6&M031PR7=
MI/=07*W+*BO"4@;=\H9>>"0`8?!O_!3^^UJ^TUM9^%NJZ#I;>-1X`U6^;68+
MA;#56D\N/RD50T\)?:#(?+*EOND`FKVD_P#!/G5;OQ-X+US5-6\`Z7J7A7QG
M;>*9H/"_A%-)L[F*"RNK46X'FM(6)N=^^1WQMP%`/$UY_P`$[[FZ\+S:=_PE
M<"F;XK1?$GS/[//")<K/]DQYG4[=OF=.<[>U:4E3YE[3:ZOZ?N[_`(.H_5+R
MN5K<G[O?E?W_`+S_`"I_)ZZWMQ_P5_X*=ZYI/PJT_P`6_%3PM;Z3X/O_`!!J
MNACQ/:WJ"..2WN[J.+?:X+)&T<`'F>827S\@!%:GBC_@J_;_``\^%6L>+/$G
MP_O]+M_^$,N_'/AZU75X9KC7+*WC61HI`%`MKC8Z'82X`;[W!K)A_P""5>O>
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MU#8:8UEH,-F)F#0VZPB51@@A<;@/UKP/3_V2?'GBSXQ>`=>\>>/-%\0:;\,]
M0N=2T8V6A-9:I>236\MOMNYS,Z,@CE.5BCC#,JD],4_=]K_=U_)_CL]O)6,8
M\WL?>^+]?\NF_F[[-GP4^.GQ,U+]NGQ?\._&R^$X]&L_"5IXCTN+28Y6EA\Z
M^N;?;+*Y^<E(02`H`)[U]$R%@C;<%L<`]S7F>G?L]RZ?^V'K'Q4_M2-XM4\(
MVGA@:;]G(:-H+NXN/.\S=@AO/V[=O&W.3G`Z/X3V'BZU^&T*>+[[3[GQ1,UQ
M++):18M[</*[0Q*!C<(XRB%C@L4)XS6,;^R2>ZO?_P`"E;_R6WZFDOXLFMFX
MV_\``(W^7-<^?+_]HOXF?!O]HCPOH'BC7O"OBQ->MM2U'7="T;36BE\'V%O;
M2S17;W'F,71Y$B@_>(FYI<KG::Q_!W[7/Q.TKP3\+/BCXBO?#MWX'^*FMV>F
M'0;?3C#<Z'#?,R6DRW/F'SFW&/>I11ASCI75?LL_LA_$SX*/J-IXJ\4?#7Q5
M9>*)KF?Q-J-OX9O;76M::57"YG>^D153<JJOEE51<``G--\&?L&>(M/LO`WA
M/7O&>EZK\-/AKJL.K:)IT.DO#J<[VY9K:*ZN#,T;QQ,P(V1(3L7)/-;4^52C
MS;>[?TN^9>MK)/?KIT*FTN7L_OM[K\M=6MMM'JS2^''QS^)Q_;_U+X=^+E\)
MQ>&;CPC+XATN'3(I6N8BEZENOFRN<,65B2JJ`#CDU@^)OVX?$6J?\%#_``3\
M-_#-IILW@&Z?4]-US5)$+R3ZE;6R3>1;L#@"(,!(<'YFV\$''KDG[/4DG[8<
M/Q4_M6/R8_"+^&/[-^SG<6:[2X\[S-W3Y=NW;WSGM7EM[_P2I^'FE?M*_#_X
MA>&8;KP^/!NI:EJUUIZ:E?RQ:C<W8W&0*UQY<?[TL[`(0Y8@BE2LO9\_12OZ
M\TN5OO[MOG;LP>]2W6UO_`5>W;WOPOY,]`_:M_:@U']F_3[6YL_"<6N6K6T]
M[>WU_K<&C:?91Q!3L,\H;=.^3LC"\[6RRX&?)Q_P5,F\9:AJ4?@7X9:MXLM=
M)\"Z;X^NKR36+>QABL[PW6(?F#,9@+20@*"K<Y9<#/;?M.?L?>(/C+\:-+\9
M:#XB\/6<EGH-SH#V6OZ*^J6]JL[[FN[4+-%Y-SCY-YW`KQBN7_9]_P"";MW\
M$=,\56\OB^WU)O$GPWTKP"K+IIB\AK+^T<W1_>'<'^W#Y.,>6?F.[C)7]E-_
M:L[+N_>LO1^Z^F]K[FGN^T2Z:7?SA?YI.?W>ARO[1/\`P5(UM?V>O'WBGX2^
M#&UP>"_"EKKM_JE_>1PPZ7/=VRW,$/D$9G9871Y`'3:'7!8G`^H/'EUXOUWX
M2V\GA"XT6Q\17R6Q^UZE&TEM:1N5,TOEJ0794+%4)`)P"0,U\J^(?^"4_B[3
M?@AXP\!^$?B-H.DZ3\1O#&GZ)XCDOO#TEW*;JTLTLQ=6VVX01B2&.-61P_W`
M00<U]"?M3_`KQ5\9_P!G";P3X2\56?A74+K[+;W5_<V<MQ'<6D;*9[?;%-%(
MHF13&620,JN<'.#6U7DLU#NONZ_+\;>9C3YO<<^VOK9?COY7\CY^@_;E^(6G
MR:EX1L=2\.^+M6U/QUI_@?PWXPATTV^FW4TUO)<7C&%9&61K6."8$))AG`4D
M'->F_#'XU_$Z/XI?$WX5ZE<^&/$?CCPCI&F:]HFK/:OIUGJ-K?-<Q`3Q(SE&
MCEM)`=K'<K+T.:+[]CWQ?XN^$.AZ#JNM?#_0]4\!:S9ZYX.G\+^'+BQL]*FM
M@RA)8);J4R1NDDD;!60E9&YSS78_L_\`[.VL^`OB?XN^('C+7-,\0>-_&-K8
MZ;<2Z98/8V-E9V?G&&"&*265Q\]Q,[,SDDOV``HCRV:E]_=<L;6[/FYF_+J]
M!R>SCV7W\SO?NN2R7GK9'$?LC?&SXJ?M!?LI>)-0NKGPBGQ$TSQ7K?AV*Y2T
MECTQ%LM3FM5D\O<7;$<><%AN;TS4O["W[2VO?'+QS\1M%O/$6C>.M#\%WD%C
M;>)=/TTZ:MU=%6^TVQ@+MGR6"CS`=I+$=5-;OPI_91\0?!KX#^*O"^@^-1I^
MN:YXJU?Q/9ZLFG!DM#>ZA+>"!XF8^8JB3RV(92PR1M.,8?AW]F/XF>$_%GC+
MQY_PE7A.Y^(WC&/2M*:73]'DL=+LK*WN`99?)DEF>6?R7FP6?!(0?*,T*2<O
M5)?.R_6]]N][*S=2WO<O\SM_AYG^EK;]K7=U[#\;_B3>?";X<7FMZ?H%WXEO
M('CCBL()TM]Y=U3?)*_RQQIG<[G.U5)P3@'YMT7_`(*OQ^*M4\/:#H?@"3Q%
MXOUKQ7?>#Y['2O$5K<65E=VU@+XR?:\!9(3$RY95W*2?E)&*]G_;(_9SOOVG
M?A-9Z!I^L6>DW6GZS9:P@O[)KW3]0^S2B3[-=0*\9E@?'S*'7.!Z8KQ_X2_\
M$V-<\&?M!:7\0-8\9:'=W5GXRO/%LUCINAO9VW^D:-'IGV>(&9RBH8_,!.<@
M[<?Q48>,7*7M79:V];QM]Z<M^WFB:C=ER?/[I:??R_?ZFUX0_P""C-QX_P!-
MTC2='\`W5Q\1M0U_5O#USX=EU>.."QETQ]MU(UYY95H\%"I$>6\P#`.<9OPL
M_;+^('C;_@G%\1/BG)H>E-XV\,3>)TM--DD$%O$-/O+J&)9&&\,R1P@L1PY4
MXV[LB72/^">?B#X?>.I/&7A7QEI-MXNC\8Z]XCMI-1T>2XL3:ZJR&2TDC2='
M9DV*1(KKR/NXXKL?@-^QA<?#+]C_`,3_``MU[Q)'KD_BR?7IKW5+6R^R`?VI
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M0]<\":KXBL]'N=`OY?$_A(:K9W%M)?S7D4D41F5HIHFN)5SO96#?,IP,=F(E
M!M>SV][_`-*J<J^[DOY:)KIAAHM4OWK]Y<OH](\W_MUO/5IGN_C7]LCP[X<_
M9GT'XF:;;7>O6/BY;!-"LK=E2;4I[UD6WB!/RKEG&YCPH#'G%<G>_MJ>,=.\
M3Z5X-G^$E[#\2-8-S/;:0^O0_P!GR6=N(S)=B]$9^3,JH`8@Q?(Q@;JZ7XJ_
MLCP_$']G#P[X'L]2M=&U#PC<:?J.DW]MIL<5O;W=FZR1M]FCVH(B5(,:;0%8
M@$<&N.U+]DOXJZG\1M(^(TGQ'\+R?$31X[JQA5O#DO\`82V%P(MT`@%R)]P>
M)7#F<G<2,8XK&7+SRMM=V]++E^?->]_L[68X\W(N]E?UOK\K6M;[6^AD:-_P
M4VNOB%XXTOPKX-^&.L:]XFO-%U'5+VUN-6M[&'1Y;"\2TGMYI&#'[[C:R*VX
M$<`$D+\,/^"HUC\:/%7AG1_#O@^1M0U[0;;7Y+;4]:@T^;RY;F:V>*T608NW
MA:!S($*A0T?/SBM7]G;_`()[-\!_C1;^-'\4+JU]/X>U73-44V/E&\O;_4(K
MV2Y4AR$1?+V"/!.,'=QSR5[_`,$R-=U#]G#0?A?=>*O!^HZ%I$0V7UWX99]4
MTVX^U-.;FQG$X\B0JP7)#X*@C@D54.7ECS;]>V\]O*W*UU>UT[V-6Y]K^[Z6
MB[OSOS+LM[.R.PN?^"B<,.HW&LKX-O'^&-GXI/@V;Q5_:,89=06Z^Q.PM=NX
MVZW683+OSN4G;CFN#^%7_!1;7+OQ!X;_`.$K:P@TV^UWQQ;7LMM:;5CL]$G=
M83DL2&\M?F(SN.>!706__!./6K/1)/`D?C33V^$<_BW_`(3&32Y-)=M7-PU\
M-0>W^U^=Y?D-=9?F$OABN[%0Z#_P2ZCM[W1UU3Q5'?:;8ZAXQNKN".P,;746
MON[>6&\P[3"KD;L'?UPM3HH7CO:6_?EC:_GS<WRL=$>2[4MN9?\`@/O_`*<E
M_/\`#,M/^"B7Q`U3X\>!;5OAK<V/A'Q=X$UKQ=8V<=Y%=ZGJ_P!GDTX6H'W!
M;L4NG+HVX#<OS_*16)\8O^"J'BV'X=^)(?!_@_PTWCSP=XAT'3]5L#XFBU"Q
M6TU*8I&RW$4>/,.R1&0J#&1GYAC+_'G_``2O\?\`Q4@\-VFN_%;118^"_!E]
MX-T@6/AZ2&:>&>:P=)+IC<D2?+8B.14"!UD.-O?7U'_@F-XF\3P_$"]U#QEX
M1T_6O%MMX<73H]$\-/9Z9I$VC3W$T7[AKAF>.0S`%=ZD8.&Y&-)>STL]$_G;
MVC>OGR636WH<LN=P:TYK?*_*EIULG=I[^IU_Q*_X*+O\+=5\1+?^"6FTOX=V
M]C+XZOX=;B*^'WN8UE*0H4#77E1NLCD>7A&!`)XKF/VE/^"BGBKP]I-]>?#_
M`,(P7?A[1O'VB>"[[Q'>7B-&9;G4[.WNECM<!F58[@H)0_$A'R$`FK/B#_@G
M'KOB#XB>)/$EQJGPLO;[XB"SE\5OJ7@9=187$$"6[/8>=.PA5X8XU*3"8`KG
MJ31\2/\`@G'XJ\11ZMX>T'QUH>D>`M:\=Z=X]GL;C0GN+^*YMKZUO)8(YA.J
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M]B:[:"YM9EG41'_3'5E=7RJK@@\UG3MRRYM^GW/[K-+O>_9,TE;2WE?_`,"C
M^:O]WF8/[0?_``5;\4>%/@M\3E\/^#M`L?B1X)T*V\00V$OB.'4K>.UEN!"3
M.8D!CG0G#0G^]D.<5ZI\0?V]]:^'E]?:;-\.QJ&M>$]#3Q#XNMK7Q!%LT>V<
MOM6!VC7[5,4C9PF(QCC=FO/]1_X)5ZYXX\.^++'7_%WA+3H]?\!#P1:0^&O#
M+Z?;:?Y=P)XKK8]Q)N.Y5W+D!NQ%;WBW_@GSXL\8?$&\\9WVL_"G4?%GB;2H
M-(U^74_`YO[/9`7$<UG'+<LT,FQR")&D0D`[>U5*R2Y=]?U2^_1O7KHUK;.G
M=R;GMI;_`,EO_P"W)>FJVO2\:?\`!6N+17\9ZIH7PUUGQ-X-\"W.E1:AKEOJ
MUO#]HCU""":%[>%AND8"=-RL4&#D,3P.BE_X*2-HVH^)/#NM>`;W2_'VCZUI
MNC6.A'5HI8]3;4(&FMI#<A=L2[8Y?,!5MAC.-P()I^(/^":4FI^`/BSH-KXI
ML[.'XE:GH]_`8])$<>EK806L7E^6CJK!_LV1M"!=X`!QR_XX_P#!-5/C!\7?
M%OC1M<TAM2U;4=#U72;74M'%[96D^FV\\!6XC,@\^.59SD#85QP<\U53V::Y
M=M+]_L7Z;_$MOT(7M/GKZ7UM\MNOZC9/^"F\T_BGP_X2T_X<:GJGC[5/$%]X
M9U#1[?6(/)TB[MK6.[WM<L`)+=X98V$BKNPWW,@@<GX+_P""E'Q"^*G[7?@7
MP5HOP\TRTTJ\BUZT\46MWK0-S87FG3VD;M#(L6)$5)]P&`9-X'R%3GT#X?\`
M[!.H>'OBAX#\77^K^#[74/"NJZAJ=Y9^'?"Z:38W7VFU6V6.-5D9AL"9WRM(
MS9QD`#&'H'_!.?Q)\.?CQ:_$3POXXT>'6XO$&NZA+#J.BR7%N]CJIMFD@`2=
M&$T;6J%9,E3DY0TZ7(IISVY7?_%9)?*[;\K;Z:ZU=8>YO?\`"\F_G912]=5O
M;T3]E7]LO_AJC5M0;3?#D-CHME+<VQN?[9AFO+6>"<Q&*ZM`!);NV"R@[N!S
MCC.=\9_VY+GX=>-O&VG^'_`U]XNTWX7V$&H>+[^'48[;^S4EB:<101LK&XF6
M!1*R90!73YB3BE\'_L=:Q!^U=I7Q2U[6/"S:AHMC?6`DT/0FTV\UF.X*;%OY
M?.=9UB"`H`BX8EO:L[XS?L3^*/%/CCXDW?@WQII7AO1?C%8P67BJVO='>\N$
M:.V-H;BSD6:-8Y'M]B'S%D7,:D#.:QE>RY=[/TO?2_E;MJM%W9<.7G?/\-UM
MO;2]O/U_R1R_[,?[2_Q1_:D_;8\<+;R:-H_P?\"BU@M8X'2YN-<-W917<,[E
MD#1Y293A3A<8.[K5YOV^=;\/_'/QQX);0X?$VO?\)=#X:\(:5;2"S^T?\2S[
M=.]S.V\)&B)(Q?:?X5"DD5Z/^RS^R/;_`+,'B[QY>6.IK>:;XLFTQK.T\CRV
MTZ*RTZ"R5&?<=Y80[L@+C.,'K7`^+/\`@GQJTOQMU?XD>'O%]AIWB\>*E\3:
M*UYI;7%G;!M-.GS6UPBRHTJ21LS91HRK!?3FO=4DE>W+\[WB]?E?Y;=#G]]Q
MYG\5]NGPM:?.WSWZE?4?^"GUII^N:1X:F\(KIWC>]UB_T*\TW5-<AL;*SN[2
M&*8Q+>,A21YHYD:%=JF10YP-IKK="_;?E\3_`+15]\.K/PDL>J:+%83:I%>:
MY;6U[&EW%YHEM[=O^/F&/E6E1\;U=1DJ:YP_L(^)'\">*+*]U[P+XCU+XAZK
M<ZMXJCUSPL;O3;N22&.&'R(?/#Q>2D:A=TCD\YR<&LO5?^";>KZWX'\`^$[W
MQ9H>H:/X!?3)=.U>YT-F\26;6C*SK!>B8;$E*X(*,0KLN2,8=/ENN?\`NW[:
MKWK>2?S?=%RO9\O:5OO]WYM?);ZGKW[3W[16J?`+3["73?"L.O+=+++<7=_K
M4.C:=81QJ#^\N)0PWMG"H%YP<D`5X[H'_!4V3XJ7>GP_#WX9ZMXL%_X&MO'9
MGFUBWL(+:VEDE0P.Q#GS08GV[596(Y*CD^A?M)?LI^(/BU\9_"?C30-?\/6M
MQX;L;G3S8>(-'?5+,"8J3<PHLT7EW*A2JN=PPQ&*XO\`93_X)N77[-A7SO%\
M&L[?A];^!\KII@):*>YE^TG]XW47`&S_`&2<\X&<;\DF]];>MI67HWR_U<TT
MYDNFGYQO]RYOZL<[\4O^"I.J>)O@'XJ\3?"?P3-KLGAGP=!XEU*\O[V.WCT>
M2Z@>6W@\HC_2)`J%G4,@"E<$EL#VGQY^U.WPM^`W@GQ!=:7)KWB;QL;"PTS2
M[:06XOKZYC#[=[9$<8PS%B#M5>AKP:Q_X)5>+O`/P8\0>#/!OQ&T'3K7QUX3
MM/#?B2?4/#TETTDUM`\$=W;!;A!&6C<*ROY@^12,'.?=/C!^RC<?$/X0>!-'
MT[7(=-\2_#F[L=2T?4IK0S6[7-M%Y?[V$.I:-U+`J'!P>&SS6TN37MS1];7?
M-;Y6MU[ZF?O>[_AEZ7M&U_G>_3L8-]^VAXMM]>TCPC'\*+X?$K4TN[EM$GUV
M&.SBM+=D5KH7@1MT;M(JI^Z#$@@A<9KSF;_@KN-?N]<A\*?"[7=>D\)^&I/$
MFO"?5;>Q_LQ8+JXMKBV.X,7F5[:0J%&UQ_$O!/<WW[)?Q/D\?:1\0XOB)X9F
M^)%C!>:?-)=>'9&T5K&X:-Q;QVZW*S+Y;1AE9IF)+'.17*?#/_@E?_PK1OB%
M)%XR%Y<_$+P?/X?O9I=.PPO9[J[N9KO`?!0M=8$8P0$'S'-1]AM[V?\`X%9\
MJ]-K^>VAI[M[>:^ZZYOGO;RWU(_%/_!68>"/"VKZEJWPQUNS9?"MEXQT&U.J
MV[3:U8W-TEJ`^!MMY5>6,E26!5P=W!`UOB'_`,%,+[X/-JFD^*/ACJ5IXRM'
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M0)''S;T/&5-9&N?\$U6O_@)\9/`]KXHLK.+XIO:FWFBTA8XM)6"W@AV^3&ZJ
MP/DY`38%#8`P*SH<M[U/Z][_`.1VV>^KO9;5E[T5#:^K\N7])7[WTTTUV+O_
M`(*,:=%XVN&A\,S3>`;'Q*GA&Y\2_P!I1J\>HLZQ\6FW<8%E81F7>"&S\I`S
M7/\`@C_@J!=>*;+PKKEY\+];TGP7XK\2W?A2VU9]4@FG-Y#-<0JRVR*6:%VM
MV`8LK`G&PCDR>%O^";3^`_B7J%QI-U\/9/"^L>(F\2W0U+P=%?:Y%.["22*&
M\>38L1D&03$SIDX88&-+1/\`@GK>:+\"?AWX.3Q9#YW@/QO-XP-X-..+H/>7
M=R(`GF?*1]I"[B2#LSMYP%'EM&_E?_R6[^7O6MY;]37F?:SMZ^];[_=O^G3F
MM4_X*8W_`(Q_8U\3_%3P_P"';73M/T_3X+VQF&K6^HSPL]RD36]W;#:UO<*&
M^:-B=K9!.5Y[V;]O[3[?0WW>&=0_X2!?'\?@$:1]I02O,S;S<AL8\I;8/<$8
MSLC8>]>=_%K_`()?:U\;Y_%^H:SXJ\)Z3KGBC0ET2>\T'PVUBNH$7<5P+F]3
MSV$\H$052-NW>Q'!P/1)/V$XYOVWU^*TFN1MH/V)YCX>^Q]=6:W^Q_;_`#M_
M&+5I(]FS.9"=W:G[MT_73T:=F_[R36BT<D[:-@[WE^'S5MO)M/?51>NI6^&/
M_!0RS^(GCGPU#)X7FT_P=XZU2YT;PWKYU*.5K^Y@$IQ+;!0T*2"&3RV+-NP,
MA<BL_P"+?[=EU\#/VG?B!X?UBS74?#_A[PSH-YI-E9PXOK_4M1OKJU6'>6V[
M6:.(#(&WYB2:@_9Y_P""=DOP`\9Z+#:W7P^G\(^&K^XU#3R/!\0\0N9&=ECE
MOVD880R'#1QHY``+'G.E\?O^"??_``O+XQ>,/%Q\3_V7<:]I&AVFF*EEYC:9
M>:7>SW<5PQ+XD1FE"E,+PI^;GA>[>/:^O>UONYNW3;3<TZ5$M[+E[7YE\[<N
M_7?NDL7QW_P4Y_X5!XCC\+>-/`__``C?C:XU"QLX[6?7HCI`BNQ+Y5Q)J!C5
M8TW0M&=T8/F,BC.X&M_5?V]KS3_BKH7@C_A"88_%&K:*FMO:W7B2UMTGB:X,
M)2RE(*7CKM+D*4PK)G&[BO!^QUX\U;Q?X@\8>(/%7@/7/%GB2TM=&N[6?PM)
M)H3Z9"9&-N;=[EI"SM(6+&7&5`QC(KD;W_@F-K$_[.4?PQ_X2+P7=>')3//M
MO?##32:%<2W!E\S2V^T`VHC5BL8._854@]05&VEU_7;]6^KNM%J3Z?UW?Z)=
MK/5Z'V#$_F1*Q4KN`)!ZBOFC6OV[/$7B;PKXRUWP?\/;[4/!NA'6=.M?%!OX
MF4WNGK.DLCVA`?[,+B!X]X<EBN=H!!KV7X1>&_%7AB[UVV\0:E;7^D0SV]OH
M"*N9X[6.VB1WG?`+RR3"5CZ`J/6O%M*_8=\;>$/"WB3P/X?^(6EZ9\-=<N]9
MOX[%M$:74XGU)KB:6![@S;&MUGN'=0(E?&%W]ZQQ,9<DE3WY7;IJ[6OU3_7?
MH:4)*\7/^97]-;^3UM\MC*_9Q_X*)>(O&FB?#^T\:?#K4]+U;QQX#/BW3);.
M\AGDUB2"W@DN(A;KGR&8S*8P9&R&`)4@BL_5O^"M=KX1\/>.O[:\"O\`\)-X
M(T_3-5DT32?$-KJ4EQ!?7?V6-&D4*L-PL@.^)^G'S$'-:/Q._P"":%Y\1/A[
MX`T.'QW<:++X)^&^H>`3?6=F5GF>ZM+:W%W&?,_=[3;[MG)._&X8S7,:C_P2
MM\2>+O[>DU;QAX+TUM6\.:-X=@M?#_A>2QL[--/U+[:)!&URY)D!*D9&#S[5
MW5O8NL^5^ZV__2IV:_[=Y=//H[G'152.&3E\=EIYVA=-^O-UZ;O0[35O^"E4
MO@?Q5XD\*^*OAYJ6B^-M-&CMH^CQ:K%=C6UU2:>&U'G*H6%A);2B0$,$"Y!8
M56C_`."EFI67Q"USP'J7PVDL?B-INJV.D6FD#Q##):7\ES9M>>;]J\L>7%'$
MIW,8R<X`6LO]MO\`9#T^;XE>(OC!J7BRXT5HK'P[#ITD.BR7RZ/=Z7>WEPEU
M.J/E[=OMFUP`NU4)W<\>2?!K]D[6?VT/C1\1OBC=:YX+UR\L?$FEW'AS69?#
M,DWAO6C!I0MKE5M99C))`#+LWB7/F1MAN,5A'EDM-UOY*\4GZN[O?Y'14]V2
MMM;\>5MKT3T77OIJ>Y)_P5!T_4=2T'0[+PM%'XNU2[U/3;K3M3UZ"PMK2]L&
M19;6.Z92DTK^8CQJ`I9&W';@BO3/VNOC[J7P)_9HN/&5I:M:ZA'<:=&;>5$F
M:'[1=0Q,IPVTD"0C()'&1FN$UO\`8>U_5O@=<>#9+GX2W%KKC74NLV4W@1$T
MMII@`DEO!',C(\>!AG=V.`2<@&ND^(_[&4GC7]BK1OA##XGNM^CV^EVXUB^B
M-S-<?8IH9"SKN!+/Y6,[N-W?%'NV5][Q^[[7HE\VUUW,Y<VMO.WZ>M_EZ'!Z
M'_P4\N]6<ZI)\,=7L_!-OXYE\!W.N2ZO`6%TMV;5)HK=5+/"9``2Q1E)X#`9
MKZQKYAM_^">%S!\!Y_!?_"5P&2;XCR>/?M?]GG`5M3-]]EV>9U`.S?GWV]J^
MGJ6EK?U\,?\`V[F+UYG;;7_TJ5O_`"7E"BBBI&%%%%`!1110`4444`1WMY%I
MUG+<3R+%#`ADD=CA44#))^@KQ?PE_P`%!OAGXM:^?^T=4TFSM-*N-<@O=4TV
M:SM=4L+=E6:YM9'`$\:%TR4S]]>QKU+XD^$/^%@?#S7=!\]K7^VM/GL?.7[T
M7F1LFX?3.:^%=#_X)H^*/&'P9L/`VN>&/[,O_!W@^\\.Z7XGO/'FIZG'<S21
M11!H+%IFBABD6(&0.N5PH0<9"_FOT6GGI+\FHZ;N[L6HI\M^KU\E=?FK^EM3
MWL?\%0OA;:RWT>I?\)=H<UAHL?B%H]3\/75JTMA)=1VL<\89?G5I94`QS@YQ
MBMO]HW]N7PS\`H=8M,?;M>T>TTS4)K2?SH(?LU]?QV4;^:D4GS;W)VA3T&2H
M.X?'_P`=OA/\2OVF_P!IG4O!.K>&=(\)^)F^#'D:=#_:RW<-[+;ZU:2$ET4"
M-':,*,Y(!R1Q7:_'3]CSXS_M+>)_&6N:AX9\.^&_[:T'PYI=A9?VXMU*KV.L
MQ7EP975`H_=JQ7;G/`X-=$80;I-[2;O_`(5*<4_GRJ_;R,N9JZZKET]5!O[N
M:5GY+<]<\$_\%/\`PWJFH?%AO$GA7Q?X5T7X4^(%T.[U:?39Y;6X5F@C$Q;R
MP(P&G!(RVV,>83MZ>X^&_C9X?\7?%7Q!X-T^ZFN-;\+V5G?:B%A;R88[KS#"
M/,QM+$1,Q4'(!4G@BO#?`W[.6M>'?'WQV\.^+=%TV\^'/Q6O9]6&K_V@@:,2
MV<4#VSVY&[</+9@X.,8[US__``1]\`:]8?LV:[XL\07ZZEX@\::O/Y&I,AS=
M6%F!8V$C`]<PP(Q[$L3WK*%G"[W48OUE9)KR=[OSZ::FE6RE[FSDUZ+=/S5M
M'V=CU.R_;]^'MUXMN-)D?Q%8[(KZ6UO;O1KB"RU3[$K/<BVF90LS(J,2%Z[3
MC-9?P]_X*8_"GXC'39K?4=:TO3=9T*;Q'IVIZMH]Q86-_90QB6:2*650K&-&
M#,.H%?.$?[!WQ>\8^*?".H>(]!T^X\2>'UUZ/6?$]UXD^U-K9O+&X@A-O`1B
MVA#2)^Y4*J@<`\FND^.'_!-GQE\;OV=_@YX%DN=/TMO"_P`-M2\(:U=)<;OL
MEU<Z3%:(T8`_>()4.2,?+]:<8JSYGLE]]IZ]'NHZ:/7I?0LO:QA]EWN^UG%)
M?-.3Z['M7P<_;]TKXX_M-VWP_P!(\,^(K&UNO"K>*(]3U>TFT]YH_M*PHL<$
MD8+QN&WB0/[;>]=-XJ_;5\$^$OBG<>$Y?[?O+RPNH+'4;RQTB>ZT_2KB8!HH
MKB=%*1LRLIP3P&&<9KS;X%?"GXI:U^V1I/C[QIX3T?POI.C>`3X6*VVLI?27
M-W]KCE+JJJ-L1521D[AT(J32OA-\6O@E\3?B1:^"]%\.ZQI?Q(\1?\)!#KNH
MZAL&B;X(HY8Y;?!>4J8B4V'&"`<8J796ZZ2^;4VHKHE>&O397U9G%R=[_P!W
MY7@G)^=IZ:=WT1UME_P40^&DM[J"7MWKFBV=CI]YJL6H:II$]G9ZC;6@S<2V
MTKJ!*$')V]N:YWXN?\%*_#OPT\+>$=9C\-^)IK'Q/XFT[0'_`+0T^XL)HHKR
M*22.YA0Q,;@?(`$7&2W48KQ?X=?L1_%"X^*?@/Q!XL\%:+J^I^&=+UNQ\1ZE
MJ_B7^T!XKEN[?8FV,JWDVS-D>2%54!`"X%6-&_8+^(L7Q+\'W&BZ6?"/P\\.
M^,-%UZ/PE>^)7U:+2S;Q7"W,MH[EO)C/F1*MNA"?(2%7OI&$>:,9/JKOI;FL
M^SLX_-7U2W5*6DG;I*W>_+[OS4M^CZ7V?UM\#/VD/#?[0FDZU<:"NKP7'AV]
M;3]2L-2T^2RO;.<*'VO#(`PRK*P/0@C%?,7PS_X*N>*OB5\8888_A<NE_#V^
M\;KX$L]3U*]NK34GN@\ZR3^4UKY#1J8&^1)RPW+NQG`]Y_9P^"6N?##XU_&3
M7=46U6P\;Z_;ZCIABEWNT26<4+;QCY3N0\>E>)Z/^POXXB\!>$]+N(]-232O
MC!>^,[LI=_=TV:6Z964XYDVS)\O;GGBLX_%&5ND+KS;AS?<G+TWZ&51R]E/E
MWO*S\DI<OWM1];^9ZM+_`,%'/AG#-<2-<>(%TM1=BSU;^QKC^SM7DME=IHK2
M?;MFD`CDPJ\L5.,U<U/_`(*$_"O2-8U2QN/$$BS:/X,7Q]=-]DD,::04,@E#
M8P6V*3L'S8[5XG\/OV+?B%+X%^%/PIU_1M'M_!WPGUM=2;Q%'J2ROKL$/G"&
M-;?&^-V$H\PL<<-C.:\BTS_@E!\5O^$&TS3;K^P9+E?$<?A2]<ZAN\WP-"L,
M"`G;\T[00',?8RGGBKC&#;C?KH[=-KM=-6FU_+&3[&LFD[_?]][+1W]U-7M\
M4H]K/[=_9\_;.\&_M.FVE\)Q^(KC3[Z*6:TU&YT>>WLKKRGV2*DK*%+*V05X
M.0?2O,?C9_P4/U3X?_MD2?"_2O!Z?V+X6T6#Q+XO\3ZR]U;V6GV$S3JIMS#;
MRJ[_`.CR<RO&I8;06.=K?@W^S!XH^'_[6EGXF\/^&8?AKX5D_M)O$]A8>('O
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MK^RGFG+JH$<2QVIVHPW%F[5]4_M:?`B;]I7]D_Q]\.8K[^R[CQEX<N]&CNP3
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M)J`LK&XM+F*>Y;/[UO.WJ[%@6QD\42Y>:W33[N9*_G[NMM[WTM:^47+ENUKK
MIY\M[>7O:7O:UM;WM[5XE_X*;>&]$^(?@?1[?PSXLO+?QE%JH9/[+N8]6LKF
MQ\O=;FQ\HNS-OZ[E``SSFO6_A_\`M,>#?B3\!O\`A96GZLL/@^.TN+RXO+N-
MK=K)+<NMP)D8!HVB:.165AD%"*\JT#X3?$SXB_M0?#CXB^+-#T#P_!X=M-<M
MKFQM+_[3+:1W/DBV5FP!)(1&Q<IA1D`9K$^'W[#GB*^_X)L_$+X-:]=6NE:S
MXSE\5)%<V\OG1P)J.H7L]NY(Q_!/&6';D4-)4FW\7W]7]^EOZU*IZU;2^'F2
M^5M_E^OR+OQ=_P""JW@?X:_!;Q9XJMM"\9WVH>&]$_MZUT:YT:>QNM8M#(D:
MW$'F+\T&^1-T@!VA@2.F9/%G[<WB[X)_L!77QC\>?#W_`(GENJ3_`/".Z++=
MR,L4DRI'O:>VCE1@K`MF+`(X)!S7E?[2?['7Q=_:^T"^O-6\.:%X3U30?A_J
M'A'2[2/6$N8]6N[R:S>28NJ@1PJMF-JL-V7Y`Q7T=^U_\!]8^/'[&_B7P+I$
MEK%KFI:5'!;>>^V%IHRCA6;L"4QGMG-54C&,.9/6_P!R4G^+BD_*]K%4;2E!
M3VOK]T?P3<O6VYPNN_\`!3G0_"?Q9M_#NJ>#?&=O;W'@Q/&"F'2KFXU*)#</
M$\4EFL6Y`BIO+EN0?N]ZZKQ)_P`%$OA?X=T[3;]-2U35M+U#1K;Q#+J&F:9-
M=VFEZ=<+NBNKJ1%(@B9<G+=@3VKE/`GP-\?^*?CWJOCKQ!X?T_PXNJ?#4>%?
ML(U-+R2&\2ZE899``4*,K;ATSCM7@'PB_P"":'CWX.?#+3]&U#PO_P`)LWB;
MX=Z'X2UJSM_'E]H=EIMQ9V1M9A,+:1/M-NX<GY07P#CK1&*Y&WNGHN]Y5-+]
M+*,-?/75F-.[E[VVG_I-.[7S<].ZTVL?=GQ-^._AOX0Q>%Y=<O)+>U\7:O;Z
M)I]S'"TD!N9U8PAW48C5RNT,V`691U85Y[XK_P""AWPX\+>+M8\/QR>(M:UO
M0KZXL;NRTG1KB]F0V\<$EQ*%13F&(7$0>0<!FV]013_VMOA3H=S^P[X@\-ZA
M<0Z/9Z#H"SV5P)G<Z=/9(LL$J/(2[&.2)"&8ECCDDFOE+]GC]B;Q]8>#?AK\
M6)M&O/%7BGQ/X5OQXJTNQ\57?AF4WNI7D=]]H66*1"R#E&C8DX"8&5J='*26
MROKZIN/?=QDGVYHN^C9HK^SC)[NUUZ-<VKMLI)KO9]T?5_Q$_P""@?PX^&^A
M:?JUQ=:YJFC7VCIX@DU'2M)GO;2PT]NEU<2(I6*/J<MT`/I57Q?_`,%&OAGX
M)\5^+-+O+CQ#(G@6W6[\0:C;Z+<2Z=I,36WVE7EN`NP!H^F"<D@=:^9?CM_P
M3S^)6N?!K7/A[H_A+2=4\)WWPX'AOPWI*>+;E-.\):DR7'GR2BX9I+W<TD6R
M24NR",X"@G/N?P8_98\2>!+'XU?VYX?\/^(;;QU:Z?%9Z3=W0:VU)8=,CMIH
M)SM(56=67)!!!S52C%<S72]O/6R7W:NU[]!;.">M]_+1._WMK6UK'N'PD^,N
MG?&/3;FYT_3_`!!IOV5E5XM6TR6QE(90RLJR`;E(/45XOH/_``5`\#R:G;:3
MJEIJ_P#PD6J:KKNG:7IFB6%UJLU^NDW*V\[#;"FU\NAVX(Y.&8#-:7[#WP&\
M5?`_6?&$=Y;7WASP/J#6I\/^%[O7I-;_`+%=8R+@Q3NS&.%V*[80VU-AP%!Q
M7F?[+O[#?COX3_M1>'O%FKPZ4ND:;>^.)YC%=B20+JVI6MQ:87'.8XGW?W3@
M<YJE&#E;I9OYVNOQT_X(X_!>6]_PL_UL>R>/_P!N+P[HO[#WB+XY>&=/U+Q7
MHFBZ+>ZK#8102074[VWF+)!(I4M"RR1NCDJ=FUB0<8KB;_\`X*=Z9I'B3X56
MEYX&\7V\/Q/T*_U>*$V,[:E;26RV[>2EH(B\H<3,0^4&$S@[N'?"S]CGQ+8?
M\$X?'7PCU>:QL->\5IXL@AFCD\Z&%=3O[^:W<D8Z1W,98=CD=JI_"SX#_$C7
MOC?\$_%GB;PWIOAR+X>^$M4\.ZG!'JR7C/++'9)%)&5491C!(><%1C/6E347
M4DGMT_\``9_?[RC^'2X2TIQMO>2?R<.7[USO^D=O)_P46^&LO@WP_K6GS^(-
M:7Q%:7-_!9:;HUQ=7UM;6T@BN9IX%7?"D4A",6`PQQ3_`-K']N/2?V;OV5H/
MBKI6BZAXYTF]FL4M(-,#%IX[J:.-9,JCD`!\\KR<+QG-?-/P[_X)W_$+X-Z]
M9>)FT.;Q5=76FZQH=YH^F>-;O0#`EQJTM[;S^=!)&)$*2LLD;9((0C.#7MWQ
MI_8YU37O^"=5O\+?">G:9I.K:3;V,MEIQU*XN;59+:YCN/(%S<%Y6!V%0\A)
MYR:4>2RE+NK];+F=_/X4GIW?70J<;57".JUL^^BL_+6ZU[)[$'B/_@J/X;\#
M?&#Q!X;UWPGXPLK/0?"5AXMDGATNYN;V*WN&N!()[58MT`A$&YF9B3N^Z,<]
ME:_\%"/AOJ?Q"U#P[8W&N:E-I%E:ZEJ-_:Z1/+ING6ES`9X9YKD+Y:1M&,Y)
MXK@K;]G3X@^/?B+\7_%FK:'I^@3?$+X;6OAJSL#J:736][']O!5W4;=N)XCN
M'')]*Y'X&_\`!/#QAI?P8^+_`(0\17%EI8^(?@/1O"]K=6=T9&@GM]'^QSL=
MH!`60\$=1SQ2:7)4?6*NEW;E-6^24=NX2Y?:PBOAE:[[>[3N_FY3^ZW0]N\*
M_P#!07X:^)M#UO4)K[6-#MM#TI-=D_MC2YK%KO3W;8EU`LB@S1,V%!7/+*.X
MKK/@=^TKX;^/T^K6NDQZSIVJ:$83?:9K&G2Z??6\<REH93%(`WER!6VL.#M;
MN#7R+XB_X)T>*OC9\-=2L-6\)MX5\3:7X4BT#3]7NOB%JNL&_9+JTN7CBC:=
MDM[:1K1.<"53@#`W9]8^#?[*GB;5/%7B;Q-,GBKX->(=6L[#3#JEAXN'BK5K
M^WMGGD\I_P"U([RVCA#3MM"1B3YVRPX%6XPOH_ZN[/YJUUNM=-KXJ4K:KM^2
MNOEK9[/17W/2M9_;6\`:!H?BJ^NM0OHQX-\26_A34[?[#)]ICOYWA6!%CQN=
M9/M$3*Z@J5;.<`U5\"?MV?#WXB>-!HMA>:M']H6\;3]0N=,FAT_5_LA(N?LL
M[+LF,>UB0IZ*2,@5\_\`[0'P#?QK_P`%1_AU9:3J@FT76=._X27QC9KC=/<:
M7NAL+E]N%#%YV4C`R8E_NX&?\"_^"?\`XX^&/A/PCX6_X1_;JGPML]27P[XR
MOO'6I7EM]IDM;BWMYXM+,QA5BD^)%D38,L5!.TC%?P^=[V?SLK-_^!)M*^J:
M6Z9J[<SBO+?SUMUV32;MW=K6/<V_X*6_#"S\->(M6U"7Q-HUGX;T1O$<IU'0
MKFV>^TY9!&UU;(R[IHP[*,J,_,O'(KT7P'^T)HOC[X6ZEXPCL?$6EZ+ID<L\
MAU72Y;*:6&.(2F6.-P&9"AR&`YP1U%?"/B/_`()S?%?XAQ:A=3>%=/TG6+SX
M77_A&_O]0\4G4[K6M4FOM/G%PTC`E8F%O,0O`3(4*!@5]T?&2PDTK]EGQ3:S
M;?-MO"UU$^#D;EM'!_E2Q35+#2JIWDD_31R2?S23Z;]-BZ,54JQCLG*WG:T/
MQNY+KM\WP?@3_@I5\*_'.CPZD]]KGA_2;S0I/$EC?Z[I$^G6VHV$48EDF@>1
M0)`B,"0.1GI3=9_X*5?#'PMX`USQ%K4GBC0[?P\UA]JL]0T*Y@OVCOKE+:UF
MCMRN^2.2615#*".N<8KY)T/]C+XC?\%!/V*/A#H^HZ;IG@?2/#OPT-IIVI+J
MOVIM7N+K3H(X3LC"O%$`N7#'=S@>M>B_$K]A?QG\9_"^J7P\!Q^&O%#W/ARW
M2YU7X@:AK\UW;6.MVM_<!?/EDBCC"1.R#`<L<'`KKJ481K^S;TYK>BYFK_=:
MZW6]NAS8>I[2E"H^J3?:[2=O35Z[=.C9[KJ?[??AO0/B+H^EZO8WWAO2=0\+
MZMXGGN=;@GL+RUAL+BT@;_1VBP5;[4"&,BMPNU&!)72T+]OGX=ZGI.NW6H7.
MM>&6\/Z:NLW%MKNE3:?<S63ML2XACD4-+&SX0%<Y8@=2*\O_`&^OV%_%'[5_
MQJL=2TFXL++28?A[K7A\W$TQ#+?3W^EW5NI0#)C86<@9ATXX.:Y;X[_L6_$W
M]L;6;OQ)K^DZ3X%U/P_X6CT31M/75%O5U.Z74+6^>25XP`D!-I&BJ<L-[$C@
M9RBH.,.9VOS<W6UI3L_-M*.BUL[];K62LW;RM]T+^F\M?+Y/VWX`?MOV?[07
M[1'BCP+8^%]>T6/PWH5CK)N=8MY;&ZF^TRS((S;21@J`(@P?<=V[H,5J)^W)
MX`?XI_\`"*?:M7$S:F^B)J9TR;^RI-01&D:S%UCRS/M5ODSR1CKQ7'_LW_#'
MXBW?[7_C3XD>,_"^F^%-.USPMIFB6=I#JZ7\_FV\T[R,Y10H4^8,8)XZ\UYA
MX1_8$\0>'O%]QX;U3PK-XD\._P#"=3^-+77[CQ]J5O:VI:[-Y%_Q+8Y@C7$<
MI"C*^6P`W9&0<H[Q4MM;_P#@=O3X=4M+V6H=)-;Z6_\``+OS^/1[[NQZ[\-_
M^"FOPJ^*6JZ!#IMYXAAL?$UU<V&FZK>Z)<VNFW-U;B5I;<3NH3S`L,C8SR%.
M,UDVW_!3SPCK7QG\&^'=.TG6%\/^*K+5-1/B/4[:;3[-+6Q@$K7$!DCVW$3#
M(W!EP!GFO-#_`,$\O&^M_LA_!/X?WATVUO\`P?XIN]1UN6*[R(+6:#48]\1Q
M\[@W49QQW]*P/%?["/Q:^.7AOX?^!]?T71?#.A^"?!NN>$KC7+?6%N'O7NK`
M6L%Q%"JAE0XRRL0P]^M:-14II?9;2\_=;O\`^!65NOWCLKQ3V:U\O>:M]ROY
M?-'TIX<_X*#_``UUS0-:U2ZOM7T&RT32?[>=]9TN>Q^V:?G"W5N'4&:-B5`*
MY)+*,<BH?@%^W!9_M`?M&>*/`=GX6\0:(GAK0K'6FN=9MI;&ZF^TR3((S;21
M@J`(MP?<<[L8&.?GOQ#_`,$\_%WQA^&%YIVH>$5\,^*-!\.VVFZ5J^H^/M2U
MR._N;>YM[D1I!)*\<-K*]JH.Y=ZAL`<&O:?V=?AK\1M1_;(\:_$KQIX6TWPG
MINN>%],T6SM(=734)_.MYKAY"Y10H7]ZN,$_A5<L.:WK^MG\]--T_)F3<O9W
MZZ?G&_YRUUT\T<M9?\%%_&R^&?&WC:\^&.@?\*S\">);W0-0OK/Q9+/K0CMI
M_)DN_L36*1;`?F*BZ+!0<9/%>JZW^W=\/=!^('_"/R7FJS&&YM;&[U.#399-
M+TZYN422"WGN0/+CD=98R%8Y_>+TR*^?M'_9?^,4GPF^*?PF;PKI.GZ)\1/%
MFJ:C_P`)2^M131P:?>7/F-BU"^89?+RH!X!/6G7O_!/;6O#_`(\\;:"?"LWC
M3P?XX\46GB*.^F\=ZEI-KIB1PV:-%/8V\RB9T>UWHRK@@HK'"U--1<HI[6CZ
MM^[S+RWDTW975NQ52Z<N7O+Y+7E:[[)-)WUN>\G]OSX<Q^+]4TR2\UB*QT>:
M\M;G77TJ<:*D]FKM=1?;-OE;XA&X89X*$=1BL/5O^"G?PK\->!=4\0:Q<>)M
M#L])6PE>&_T&YANKB"^N4M;6XAA*[Y(GE=5#*"!GG%>377[&GQ4F_9=\=_L]
MVVGZ#;^$?%#^)`GC&34BTWV?4YKNXB06RCS!,DERJ.Q;:50D<G%8/C[]@OQQ
M\7_#45Q)X#A\/^)M+?P_:1WVI?$'4=<>[M[36K.^NA&DTKQ11;+9F0%1(6PO
M`)R4XQ<HIO1\MWMH]W;RTTO=*[U+E9/YO[DU;7S5WMNEL>W0_P#!4SX5&]U"
MWN/^$PL9M$U*#2]86[\-W</]B23[/(>Z+)B*.3>I5SP0<U'X%_X*5^%]:^(G
MC#P_K^BZWH$?A;QG+X.75EM9KK2Y9`D#0O+<B-8X&E:<*$);D#YN<#A?CI^Q
M!XZ\?Z-^TE#I\.EM)\4-?T/4=$\R["[XK2WM(YO,X^0[H7P.<\>M86M?L?\`
MQ:U[1OBG\/I/#NB0^&/B1\2%\4IXB76%9[&Q5K%R#;[0YF8VK*NTX&X$FJI1
M@Y1YNL=?5NE]UDZGW;71%:Z7N_S?A:?3K=J.VOGJSZ)LOVY/`&H?%(^%([K5
MO/;4YM$BU(Z;*-*N-0A5FELTNL>6TRA'!0'.5(ZC%7OV:_VN_"O[5^E2:EX0
MM?$TFCJA>+4;[1I[.TN\2-&PBDD4!RK(00.G'K7S?\+/^"?_`(A\`^++?PUJ
M7A:;Q'H&F^/+_P`:6/B.Y\>:E#;0>?>3WL6-,CF$9N(WGV<IY3`$G.2#]"_L
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MYENIT@BN(K`6QC:'>X)_TD2!%9MG&*]=^&7BC7O%2Z])KFB)H<=GJ]Q9Z:OG
M&22]M(R%2X<8&S>P<A1GY=ISS@?.OA[X??%#6OVKM2\6>//ABOBBWL=4>U\)
MW:^)[46'AS3CA/M$=HP#&Z<%B\AR^#L4A<@YP^./;1^JTT\FT[:VMJWJK$RT
MA+OM\]=?32^SOHEO<O7G_!1+6+?1+CQS'X"LY/@_::^?#\NO_P!O$:IN%S]E
M:[6Q^S^6;83<;OM(?`)\O%=;XR_;%UKPC^U_X-^&DGP]U&/0?&#7,5OXHN-2
MACAEDAMOM!$-NH:1UQ\I9S&`>F[%>277['?Q''P/O?@3%I.E'P+>>('OU\5?
MVD@DBTY[[[88#:[=YG'*;L[>^:]H^-WP'USQO^TU\%O%&F):G1O`=QJ+ZD9)
MMLBK-:&&/8N/F^;KZ"M:?):+E_2Y5OVUO_PV[E\4DNSM][M;U5N_WF;^UE^W
M79_LS?%/X;>#[7P_-XFU;QYXCT_1KL170MTT*UNYQ`MW*=C;OG.%CX+X/S``
MFO?*^-?VM_\`@F?XC^)WQ/L?&'@[XH>/+'4-2\>:#X@U:QD&BM:65K8RJ2UL
M\VG23@Q*"R1-*R%F8E3FOJ'P7XG\0:SXV\36.HZ*MAHNDRP0Z7?M-NDU7,0:
M5R@`"JKG:,'G!.!6=/6E>7Q<S^ZT+?BWKUU[645+JM9?#RK[[RO^"6G16[W?
M%2?MN>!X/BM'X2E_X2""XFU)]&AU*72)TTN>^52S6R7)7RVEPIX!Y(Q7._"S
M_@IE\*_C!?\`AM=(O/$*:?XNEGM]*U2]T2YM=.NIX=YDA$\BA?,`C<X[A3BO
M#O$O[&'Q8\=?&'P_J6O:'9:QJ'A_XBCQ(?%%SXBW1MI0:41VUK98Q;E(V16"
MA=Y4L2Q)-:>E_P#!/CQM??LA?`+X?WYT^UO_``+JES+K\D-WN$$$T%[%OA;'
MSL/M"'''?TI)/V//]JZ5O5*[\K-V^1I[O-);+IUZRT\[V7W_`"7J'@O_`(*0
M>'?BA^T1X!\$^&M!UV\TOQY8:CJ-KKUY:S6-K-#:K$5EMM\>+B.3S.'5E``!
MY!JKXW_X*-P^#OCI\5_`_P#P@?B>XD^&7AN/Q`-3,,J6-_N@GE,3R^65A4^3
MM5R6WEB`/EYXG]G[]FKXM:+\8?@%_P`)-X9T'3-!^"WA:^\-W6IVVKK,=6=K
M>V@AFB@"[D1A`6*L<J3CGK6]\>OV;_B%J/QV^+FH>'=$TW6-"^+7@B#0/M<F
MII:R:1=6\=THWQL"9$?SDP5/!!R,5IB(Q22I.^D]>^LN5M=-$M/O)I-MIS5O
MANM[;<ROUMKJOD=-\%_^"FWP[^*7AC3;S4O[6\)W-]X4_P"$NVZG83PVLUFB
MQF=K>=T43B)I45BH!^93CFO0O@?^U/X7^/FKZAINDQZYIVJZ;;Q7DECK&F2Z
M?<O;2Y$5PB2`%HG*L`PXR*^8?CW_`,$XO&GQM\&_"_0UN-/TZ/PS\+M2\*:C
M<+>,IBOY?[-:$*4PQC+6D@9U((!&.M>L_LE_L_ZMX7^*UYXN\1>"+CPSJT&A
MQ:#%>7GCK4/$5S=QB02,%2:9XHH=P!7C?GT%:5(T_:-1V][\)22^]*/6]G<C
MWE2C+[3M?[HW_.7W)'T;1117.6%%%%`!1110`4444`%%%%`!1110`%MHR>`.
MIKS'4OVT/A+IWA[Q?J@^(W@N[M?`-M)=^(1::Q;W$FD1QYW><B.60\8PP!)X
MZUV'Q3T+4/%'PR\1:;I4XM=3U#3;BVM)B<>5*\;*C9]F(-?GO\,OV?/$^L?"
M'1-'NM'^+!\8?#OX9ZUX;NH;CPS!IVDO-<6T<;6R7'EH]\9)HEDC,!D4%279
M2P#2[VE;HKKSTD_P:2?^)>CTIQBY1OU:3\E=?G=V]&>A>'_^"R_P;\8^(/".
MM:;X6CO?&OCJ:32/#$:ZSX>_M+5-,62,O,LYOML<)E./L[R+,9(R!$2IQ]8>
M"?VCOA_\2-?U?2=!\;>$]8UCP^#_`&M866L6]Q<Z61U$Z(Y,>.<[L=*^8-'^
M!/C:Y\<?L\_9]'U339-#^%FLZ->WLD#+'I%]-:V20I*?X'WHV`>?D/I7A:?L
MB>//BE^RSI/@'3[+XH:7\1/!/PWU/PR8[O0[?2=#2ZFM%B>W^WF-3>+-(I*2
M0M(/FW.5.:VE&*E*"^S>S[I.2OI_A3?=STMHGC3O)QD].:U_+X>_D[+MRZ]S
MZO\`VH/VYOV8Y_@!?:KXZ\4_"_X@>!X=:L-(O+1[O3M9M4O)KE(XA)%(YCS&
MQ\UL\HD3OCY:]&\&?M3?#6XUV3P[I>O>';*QT^'3$L)XM0LTL+T7PD^R16VR
M4DEQ$P5=BAOX-V#CYM_:<BN/V@_V7];A\%_!GQGH^H>&IO"]W*]YX?;3[V_B
MT_5[2ZFL;:%U$LYABAD*E`8W)`1FS4/Q%^"7B#]HOQW^T!XDTSPWXFTQ-:T#
MPOJOA6;4]*FL;B>_T]KN<(L<JJZR*X12I`(\P9ZT6C%.^W-K_A2CK\_>MZ6U
MW%S.2C;1O3T;Z?*ZO^FQ]<>-/VBOA_\`#BWUJ7Q!XX\(Z''X;>&/5GO]7M[9
M=,:9=T0G+N/++KRH;&X<C-4O$7[5WPO\(^'M/U;5?B-X%TW2M6M&U"QO+K7;
M6&"\MEP&FC=G"O&,C+*2!D<U\30_`_XB3Z5\/_C/JNB^+]$U/6_'.I>+_%>F
M66B?VEK.E1367V+3P;(H[2-!#%"K*BLREF8#K73?LT?LMWFE?M3_``Z\2/X6
M\93>'HXO%>KQ7/BC2+>WFTJXOKR*5-L4:XM1*3*Z1L%E57(95.5![/7E;UMK
MY-1O;SN[I/R^XJ3Y8J4==5]SDU?RLDF]+^]K:VOUCK?[6?PM\-:#X?U34?B1
MX$L=,\68_L2[N->M8X-7SP/L[EPLN?\`8)K2N/V@O`=IX^C\*2^-/"D?BB8*
MR:0VK0"^<,I<$0[MYRJEAQR`37YM?`S]FSQW\'KKQ3-XL\/_`!(L_#OC#2]7
MT"PM=!\*KK%PBOK.H2_9WC:-_LT<L4T4B2MLB(QN88%>I:3\"]?^!FNZ!IW@
M'0_BE>WVI7FE0>*]#\2Z-%>:3J]NMK'!-?"^0&&"ZC@0#*2KF1,;3N!*Y4]N
MNWS;6OHK-OSV2U+EI)Q[7^=DM5ZNZ2OTW;T/M?X>_';P3\6M2OK/PKXP\,>)
M+S3/^/R#2]4ANY+7YBO[Q8V)7YE8<XY4CM5;7?VC?A]X7^)-GX-U+QSX1T_Q
M=J`!M=$N=8MXM0N,]-D#.)&SVP*^>?V)/"?B3X9?&Z#PWX?L/&DGPGL/#LL<
M8\8Z";&_\-W*W"B*QMKED5KF%E\QB`TBKY:D.=PSYK\:/A%XLE\&_'KX91^!
M_%&I>,_BEXY77/#7B*WTN2;3(;=VLS!=2WH'E6[6?DO^[=E<^4-@;=3C%.<5
MT:OY_$HV\G9N7566]G=2VU%OSMZ*S=_1.T>CN]NA]%_#'_@H5X*^-G[6GB#X
M2^$%;Q!J'A!)!KNIVNIV!M]+G3&86@,_VICE@I=(3&&.TL#G'3Q_MG?#:R&J
MG7/%WAWPJ-*U6\TACK.L6=L+B6T56G,?[XY"*ZE@VUE!RRKQ7)_L:_#[7/!7
MQ?\`CQ=ZOIE]8VVO>,DO-.GGB*+?0BQMT,L9/WEW*PR.X-?//PE_9@\32_MP
M^&-:USP3J$FB:;\2?&FLB[O-/W06\=Q9VZVMR&884.RL$;N0<5G2]Y13WY+M
M^;Y7^";5O+4J>D937\]DO*TOU2;?F?2/C#_@I)\%/!/C;X=Z)=?$+PK,WQ2\
M\^'[ZWU>TDL;L1<$^;YN"&?]VI7=N?Y>M>@Z=^T7\/\`5_B+?^#[7QQX1NO%
MFEQF:]T:+5[=[^T0#):2`/O4`<DD#%?#?PQ^$?C#X(>/OAWXLU+P3XNDT7P[
M\4/'4US!INCS7EU;6NH7-Q]CN%MXE+F!]RG>HV@."<#)IOP4_9Y\56<GACPC
MXDLOBH?%'@_QCKOB-I[/P[!%HLZW4M\ZSOJ3QCSHYXKA`84D:8.0I4!,BJG*
MH*4=[-_DTODGKW\A\MIN+Z.U^]G)7^;2MVON]+_8VF?MR?!;6[59[/XN?#2Z
MA:2.(20^)K)U+R1O)&H(DQEHXI'`ZE8V(X!J\?VO?A0/AB?&W_"S/`/_``AH
MN#:'7?[?M?[.$P.#'Y^_R]X/\.[-?(O@/]E'65_9`_8G\-W_`("F\SP;XITV
M_P#$>G3:8#_92QZ7J`:6XC*X7;/)'EF'#LO<U5\3>!O'/PV_:$\9WO\`PAOB
MBU\'ZQ\4IM4?6M'\./JVI6,']B6L4<UG`J.P66<2Q/.B-LPW3)87*FE.<4]F
MTGWLX+\>9V_P]>A4M'EMK=7]/XFG_DBO_B^_[#TK]J7P?XB^*OA?PGI.H#6K
MCQAHESX@TO4-/>.YTZXM8)(HW83*Y!),JXV@@C/(Q6GXT_:)^'_PW\;Z7X9\
M1>./"6A>(M<94T[2]0U>"VO+\L<`11.P=R3P-H.37Q3_`,$Z/@+XX\#?&+X7
M7^N>%_%>F:?I.D^-[>:;5K1HI+87/B`3VBR]E:2##J.XZ5Z9JNEWOPH_:=^+
M?_"1_#'Q)\0X/B9?Z/-H#V.D&\LFAAB2-HKBX(\JU$$H:;,S*"&RFYN*4HI.
M*[W_``DTEZVU^0I;/RM^6K]+_P##GT/-^TE\.[?XG?\`"$R>._!\?C'89/[#
M;6+<:CM`R3Y&_P`S`'/W:PD_;?\`@W<7$UO;?%3X>WEY#8S:D;6W\16<D[6\
M08R2A!)DJNULMT&#DBOD'Q5\&O&%[\%=:^$,7@?Q2_Q`O/B<OBJ'Q&-*D_LI
M;0:JEY]N^WX\KS%ME,(BW>:3\NS:2:=\+OV4/%'AS]ES]F'2K7P1>Z7K6A^,
MKR_UV-;#R9;%9K;44:>XP,J':2(%FZ[ES63O[#VBWO%?^!):^D6[/T>SNE3Y
M5-KHN9_^`W_]*25NUUOI?Z:^$G_!2KX&_&'X'Z+\0K+XF>"],\.Z[E87U36[
M.UDAF6/S7@E!E(69(R&9,DA3D\5VT7[5GPPF\7Z1X?3XB^!VU[Q!!'=:9IPU
MRV-UJ,4@#1R0Q;]TBL""I4$$$8KXO_9I^$_B34_#W[)/AW5O`/BRSO/@Y>W=
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M#PSKOA[0FU+RX;F&)2)K;:YDM[@*`"8RF8^64XSZ]\9?AU\1_C9_P31T[3-5
M\.VT/CAH-/O-4T&P18%NT@N8Y9K=(^%5I(D/[O.-QVUE**Y4T_Y+^7,DV_EJ
MWM;;S*?QV\Y?@VE]ZM9['MW@S]JKX8_$>RM;GP_\1/`^N6]]?#3+:6PURVN$
MN+L@L+="CD-*0K'8/FPIXXIWCG]J?X9?#!KP>)/B'X(\/MIUVEC=#4=<MK7[
M-<.H=(7WN-LC*0P4X)!!QBOCOXX?![Q)^TO\2O&7Q2\&^"_%6@Q>%?#6DS:/
M;ZIHTNEW^NZOI]Z]T(H[:95EPL&^W#LH5C<84L!FN;\*?`GQUX"^)N@?&+Q!
MI'CK3X_']CKE]K-II'A@:UJFC75]<QM;6\]IY<DB?Z%'#"S*N$:-@Q`.:5M$
MWIO_`/:_^!6E;>VF]]3O\O\`[;_P&Z3VO9[6=OL3XT_$#X">,=>\/Z'\1-8^
M$NK:FLUMJ>AV'B*XT^XF664LMO<6T<Y)#.0P1T&6P0">:R?VQ?\`@H'X'_8L
MU/PEH>M,-3\6>.+EK70M`M]1L;&YO0F-[A[R>&%57(`RX+,0J@DXKQO_`()_
M_LNZI\&_VI+N]O/#WBB'0[?X9Z5I.G:AXAM8!=1-_:%_,]HSPYB5D1X<QH?E
M78#R*]<_:-^'^M^)/VTOV?M:L-+OKS2?#UQKK:G=Q1%H;$2Z>8XS(W1=S_*,
M]36E2FHM)/2[;^5_Q=E=^?S(YF^9]DK?-)_==O3_`(8WO#/[=WPMU/X<:7XE
MUSQCX9\%V^JQ74\5MK^N6%O,J6UPUM,^4G>-E65=I978`D`X/`W_`!1^UG\+
M?!&@Z#JNL_$CP)I.F>*$5]&N[S7K6&#5E;&TP.SA90<C!0G.:^//V&?V7O$G
MAOXX_"'5/%'@B_MHO#?A_P`81/<W^G\:=/=:^\T(W,/D>2$[EQ@E3GI7FO@_
MX4_$;PE\!)/!NM>`_'FD6UUX5\1:=ICZ%X9>\O=1GGU._>.QN9@C?9+?RFA9
M`VQ'$GWN`*QJ:0YUOKIZ.6GJ^56]=F:0CJDWV5_6VOHKN_YH_0SQM^UM\*_A
MIJ\FG^(OB5X#T&^C>&)[?4->M;:5'F7=$I5W!!=>5'\0Y&:O>)_VD/A[X*\<
MZ7X7UCQUX0TKQ)KB"33M*N]8MX;V_4\`Q0LX=P>Q4'-?#'P8_97\5)\&_CM<
M:QX%U,>(_$/PO\/Z-82W6FG[9?31:*(YK9&8;F*S\,HZ-[UUO[,OA36_@%?^
M+-%\<?"WQ7XUU3X@7N@ZCI,L.D-=VB6\.EV-N8KFY9?*M7M9X9WV2LI.[*;B
M2!O4HJ,Y0O?EM;SN[67G;6^UOO,N=\D96W6OEHG=^5W:V]_N7TQ:_ML?#&U^
M%NE^,/$'C+PUX-T/6;NXLK.;7M9LK19Y8)Y('57\YHV.Z-N%8D#J`<@;6B?M
M%^&_$?QRD\`6,ES=:Q'H$/B1;F-5>REM)96B0I(&^9B5)X&,$'-?"_PL\!^/
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MFOPWT?5]"DOM'NM#GM=5U5[2WOHY+V/3W43R>0UQ`H^3>XC)0,%7-J#X`>*O
MB/\`M;^"_'T7@?7K/P7JWQ>'B*.RU'2FMYK&WB\.WEN=0N+=P&M_,N3&!YBJ
M^X(2`2*VITU)V;M^FL?S3;7IZV*DN6]M=+^NDG;Y-)/S?I?Z+\'_`/!4'X)_
M$7QGXY\/^'?'7AW7M6\`Z>-3O(;'5K*7[=;^1Y[/;'SL2*BX#L2JH2,D=:ZU
M?VWOA':VMBVI?$CP+H=Y?BV5;'4?$%E#=127$230Q,OFD>8\<B,H!.X,",@@
MGYW^+_@?Q)X>^+_[46D)X1\5:@/BMX7MW\.7FG:3-=6-R\.FRPR0R3HI2&7S
M``$<@OO7;GG'F/@?]D;Q5;_LP_M1I=>`=27Q/XI\,:'I^CF33?\`3-1\CP]9
MQ-#$<;FV7"R+M'1P>]3",7!R[*+]7=IKY?A;Y&TH+F44][_^VVO][_K4^Q-3
M^)G[/G[)WCW5$O-<^#_PV\3^*6_M/4A)=:?I%]JY8_\`'Q-RCS$D_?;.2>M>
MA_$[XP^$_@GX8.M>,O$_A_PGHZNL9OM8U"*RM]S=%\R1E7)[#-?FU^UII6K_
M``0_9C_:9T7Q9X1\4:E??$*;2M4T;5[71Y;RS2W6RTZV%O/<`%+:2":&7Y)"
MI/F`IN)-?6W[5V@:KX6_:;^#_P`29M!U[Q-X1\'VNK6>HVNCZ;+J=Y87-U%"
ML%VMK$K2R`".6(F-69?.SC;N()0245?Y]%[J=O5/W>U_(YX3<I.ZZ7\WKO\`
M/?O;S+G[2'_!3+X9_L]W?@;3X=4T_P`7Z]\2)#_PCNFZ5K6G0G485(#SK-<W
M$4/E@D`8<L[?*BL<XZ3XQ_MI_"WX3?&#P?\`#'QQKVC:/XA^(]G/)9:?J=W;
M)'+&H"F.4/)SYC,8U`#!V5@.E?-?[-'[/7C?P[^U#\)_$]YX7UC2_#LVL^.M
M86WFMRG]@6M^+0VD4Z](7DV.P0X()(Z@BO9OVKK#5O"G[8'P1\=1^'O$>N>'
MM#36-,U&31=-EU&:RDNX8EA=XHE9Q$60@OC:N03@<U*BFXQEU;OY:.T?6^E^
MKZ#E)I2E#IMYV?Q>EM4NW5G3?`_]M+X/^+[B/PCH7B'PWX9U#3-8O_"FG>&[
MJZM;"ZEETZ9[:1+6U5\M$#$=FU?N@<#I7=:!^T'X#\5_$B^\&Z7XT\*:EXNT
MM2]YHMMJT$NH6JCJ9(%8R*![@5\4:)^R_P")M/\`@+-]G\$:A:^(+S]HRX\3
MS%=.V74FGG7I9%O6.-QC^SD'>>-A]*?^R7\`/$WA_P`:?"_PSXJM?B@GB;X<
M^+=7UNYN8/#UO;Z$RW'VT-,^I/&OVB*=+A/W43O*'*;E4(2*IKG2<MW:_KRP
MDW\G)I^G3I5>U.K4IP7NQ;MZ*4TE\U%6?][TO];_`!E_:BTWX3>,['PO8^'?
M%/CCQ=?V3ZFNB>'8+>2Z@LT=8VN96N)H88TWL%4-(&<A@BMM;%73OVX/A4_@
M/P_XAUCQMX?\(VOB9GBL8/$=]%I-U),CF.2'RIF4^8CJ5*C/([UY_P#$*'5/
MV>/VZM8^)EYX;\5>)/"7C+P;8Z`9O#^E3:M=:5>65W<RJCV\"M+Y<R79(D52
MJM"0Y7*D^;ZGK/B[3?V@_&'Q$\=?"/Q=>:=\2/A_:^'M&TG2[!]=FTV6&ZU!
MI+6Z$28MC<QW%L[,_P"Z4HRM)\@)SVAS+5Z_>N:T5YNRMZW5[I&CBN=J^GN_
M._+=_P#;K;OTLK.VK/IWQ-^UO\*_!?BN/0=8^)7@+2M;EFAMTT^[U^UANGEF
M4-"@C9PVYU(*C&6!!&:9%^U]\)Y_"&H^($^)G@%M!T>^CTN_U$>(+4VME=R.
M$2WDEW[4E9V50C$,20`,FOSL\._L$^/_``S^QE\9O#/B#P5>:YXNU#2/`VFQ
M2K9?:7U3['%9BY2)\$RI$4<,1D?(373_`/!0;X>WWPT^('Q"UZX\)ZBWA6_\
M=_#(6$5KI^^/4_(U:W62*!.%D9?E7:/85M&E%UXT>;1RC&_2TI15_ND_ZWRI
MR<J,JMM8INW>RV_KHO/3[SL/VJOACJOPSN_&EK\1/`]QX/T^0Q7.N1ZY;-IU
MNX(&UYP_EJV2!@MGFJ]Y^U_\)]/\):;KT_Q-\`0Z'K,4T]AJ#^(+1;6]CBQY
MKQ2&3:ZID;BI(7/.*^//'FG>,];^*?CCXB:#\/\`Q=I_@?Q=XL\/+*\_A6:7
M7+&.RLYQ/JMOICQF8R>:;>$,8RX52X4@`UE?L;_LT>)E_:K\+:YKO@OQ4VA:
M=XU\:ZO:WOB+2C'-;Q7<=FUK<.&4>6TI\PC@'(8<$$5E37-+EVTO]RB[?/FT
MVV?G8K2Y(*6]VE]_-K\N77_$GII?[P\#_'WP+\38XV\-^,O"NOK)IZZJAT[5
M8+H-9LS*MR-C']T65@'^Z2I&>*M2?&/PC#\,U\:/XH\/KX/:V%ZNN'4(AIQ@
M/243[O+V'(PV['-?F?\`%3X(>/OV??V:U\3>'-'N-#\;>)/'GBWP!%:7*_9Y
M)=.U_7+Q;*YC4CYEB:2*X4#K&6(K[(_:U^'^H_"7]C;PYX5\#^&Y-9T[P[>:
M+ITL5KI7]J76F:=;S1![NWM`#Y\\*QAT0*QR-P5BN"W%./,GNXKT;U=]ME*#
M;T6KO:Q4O=J.#UMS/Y+16W^)J5DKO1;W/2%_:Z^%+^`+3Q6OQ+\!-X7U"<VM
MMJXU^U^PW$H&3&DV_8S``_*#GBNT3Q=I,OA==<74M/;16M_M8OQ<)]F,.-WF
M>9G;LQSNSC%?G3X"^!E]/KWCSQ1JFG?'?0]17Q[/K'@_Q'!X:DN+Z)9M'MH9
M9)[(QEFAF82(5,.`RD-L.,^Z?%?X;?$SXZ_\$M[31]5T"VM/'UQ96-UJ6AV4
M26JWB074<LMLL>0J-+#&1Y9.T,^W.*IQ7+=NWP?+F2;O_AZ[/R%"[E9_WOG9
MM+[UZKS/1OB7_P`%%_@K\,_@'X@^)4GQ&\(ZUX5\.,L%U<Z1K%M>!KACMCMU
M*R;?-=B``S`#DD@`D4[[]O71M`_9#L?C!J?A7Q$FEZG=6EI::5I]WINI7EW)
M=W<=I;^7+#=-:,KR2I\WGX`SD\8KY>_:Y^&'BS]J`_$#Q9X*\!^,]-T>;POH
M>@BQU#0Y]-OM6NX=:MKABEM*JR,D$*O^\V[2"=I(!-?1_P#P5*\,ZOXI_9(D
MCT71=:\07ECXH\.:E)9:58RWMV\%OK-G/,R0QAG?9%&[$*"<*>*F,5>/-UDE
MZ+FLW\UKV2MON73]Z=NWXNR=OD]'W:Z;':_"K]KC0_B'XHUKP]K&C>(OA[XH
M\/V":O>:/XG2VAF%B[,@NDE@FFMY(@R,K%)24.`P7<,[?AG]J+X:^-/`FJ>*
M-'^(/@G5?#6BLRZAJUIK=M-96)7J)9E<HA'^T17QW^U[\(/''[=GB?Q9XN\#
M^'_%7AW3]%^'MSX9L/[;TN72+[7[JZU&TNIHX[:Y5)!''#9;0TJJKM<8&0":
MP_&_P/\`$'Q2\2K\0-)T/XL:K;Z%=>'?[>TS6O"\.C)J]K87$TABMK/RXY[B
M:`29W;"CJ%6-G(P*C%24>9\K>_\`=]YI-^323Z;[HF6G-;6VWG[L79>=VUUV
MM9ZM?:-Q^V3\([3X?6?BR7XH_#V/PMJ$YM;76&\0V@L;B8=8TF\S8S#^Z#FI
M?&7[77PI^'5]#:^(/B7X!T.YN$@EBBO]?M;=Y$GSY+`.X)$F#M(X;!QFODSX
ME6^L>(_VG]*^*^E^`?B/X1\$MIVI:3+)8^"Q>ZM?7<WV<_;)=.:)[F-)40P[
MWC#?NANVJ03Y_P"'_P!A_7O#OPE^.VFP^"?%FH?VM\)K71-`;7-/MY-2G8M>
MR&R'D`Q[DWQ#RT)VC8#R*RE*U-U+;*]NNB>GJ[*W6SVTUI)>TC"^C:5_5I7]
M%=W\UOV^U_B+^WE\*_A]\./%7BB/QAHGB2Q\$S06^N0Z%J%O?7&F/-((T$R+
M)^[R3GYR.%)YQ73^%/VG/AQXZ\$ZIXDT;QYX.U3P_H;,FI:E:ZS;S6NG,HRR
MS2JY6,CN&(Q7P9^US^RYXNN(O&Z:!\/=:OM/N/A'X1TN*TT[3-RWEU:ZO<RS
MVJ(`%:1(F!*GH&YP#6E^T?\`!WQO^TA\4==\?>#/"/C+P_X7TFW\,VVH65[H
M1L]1U]["^FGF,-E<(#,((W0*2I$A!5-V!6\J<597WDTWV2=N9^3MWZK6RN9W
M>_E%V[N48RY5YKF:Z_"].WVJ_P"U]\)X_`5CXJ;XF>`5\,ZE<-:VFK'Q!:_8
M;J949VC2;?L9PJ,Q4$D!2>@-:?BOXZ:#X>^$#>-[&2X\5:')#'-9MX>C_M*3
M4Q(P6,6XC)$FYF`#9"CJ2`"1\2+^SUJWQ#_:*^'OC:QT'XE:OI5_\4;76M5?
MQ-X;BTJ.$6^C7D'VQ;01I+"OF&%2\Z*6=4*Y&"?N7XO>-+[X;?#R^U?3/#>J
M>*)K,H7TW2]OVR6(N!(T2G&]D4L^P?,VW`R2!45(J,.:^K_#17_%[VLK7?DX
MWY^7R_5K\E^/W\7\/?VRO#OC'2?&4FK:+XJ\&ZK\/UADUW1M6LHY]0LXYD,D
M$BI9R7"2K(JMM$3NV5((!&*U/V8?VHO#O[6?@C5->\-V?B#3[71]9N]"N(-:
MTYM/NDN+9@LF87^=1DC`<*WJHKQ__@GSX(U#PU\8_B]JFGZ3XRL_`/B6XT^_
MTV\\86-Q::W>:ALF6\4K<JL_V6-1;"+S%`!,@7Y>:G_9@O\`4?V7?A3\9]>\
M3>&_$6VZ^*.M:C865M:@W>IP75W$EN\"NR*RN6&&+!<9.<"IC_$Y9?R7_P"W
MN:"M\^9V]+BE?D3COSV_[=<9N_R<4GZV]??_`(K?$RQ^$'@2]U_4+75+Z&T*
M(EIIMJUU=W<LCK''%%&O5F=E`R0HSEBH!(\OM?V_O"&G>%?%U]XGTCQ5X)U3
MP3]E.IZ%J]K!)J7^E-MM?*6UFFBF,S_(@20DMP<&NH_:R^+WB#X)_L_ZWXB\
M+>%]7\6>(HEB@L-.L+&6]D$LTBQB:2*$-(T46XR2",%BD;!0217RGX@^")^*
M?P`UC5O#>G_$?Q-\1K'Q9X?\7^(+KQ+X6OM!N/$0T^]BG-K:1W<42[%CC<1Q
M(2`=NXY;)*:4I6D[*Z3?9-J[^2;;OILEK<OHN^MO/31?-Z+[WH?2G@G]MGPW
MXA?Q1:Z[H?B_P-KOA&PBU?4-%UO3TDU`V,K.L5S"EG)<+,C-&ZXC9G#+M95)
M`.U^S#^U%X>_:R\#ZIK_`(;L_$&GVNDZS=Z%<0:UIS:?=I<6S!9,PO\`.HR1
M@.%;U45YK\'[;5/CG^W'=?%.W\/>)O#?A71?!/\`PB\!U[2IM*O-4NYKX7$A
M%O,JR>7"L2`.R@,TS;<@$UC?L_?`_P"(!^`7QZT#2[Z;X>^)_%GQ"\1W6B:O
MJ&FO<+!!<3KY=VD6^,NK+N*D..<'/%+7JM>23MYJI&*U_O1?-_PPGTL].>*O
M_==.4F_^W9+E_#<]7^!'[8W@K]I#XH?$+PGX5N+Z\OOAG?Q:;JUR\&VTDF=2
MV(),GS`I5E8@`!E(YP:]"\1>,=)\(-8+JVJ:?IAU6[2PLA=7"0_:[EP2D,>X
MC?(P5L*,DX/'%?$_[%OPC\<_L/?%GX\:YXRL]'G\#Z%X?TF2P?P]X=N;,ZH+
M.TE+_9_/NY?,D`R&!8EI'!++DU[A^WIX:USXE_L?7FL>&]`U2^\6>'9+#Q9H
MVD*@-\]W9S1W*6X5"P\QMK1D*Q!+$9(YK2LHPY6M5:-_GO9=]VETT3"*E*3B
ME9N]O6RM=^K2;T.S\<_M;?#GP%\-]>\57'B_P_>:7X=GN+*[^QZE!-(;R!&>
M2R4;P#<@*?W1(;/85C:!^WC\+?%WPXU;Q%H_B[0=4DT'P_\`\)+J.CV^JV9U
M2PM/)\[,T1E`B.WC,C*H/5@.:^!=*_8M^)%HVI>&)?!_B-]&UCPE>_$>ZG^R
M-Y,OB*YTNXT]M//_`$\[FBEV=<Y->A?'S]E3Q5'\"O`>D^&_`NHQR:?\"_$.
M@7-K8:=L\F]FTZ%8[5E4#$CRA@%ZEL]ZFI'DC*^Z73NHSO\`^31LO)I]3:BH
M3G3[2E9WTT<H6]/=E=^=UT/MB_\`VJ?ASH>J^'=,U;QOX3T/7/%EO%<:3I6H
M:Q;07U\)5#((HC)F0G./DW`GH36!\%/V[?A;\=[ZST[2?%VBV?B#4+N\M+70
M=0O[>'5KAK65XI62V\PNRAHV(('W>3BOGCX/^%M6^!GBGQ;IOB_X5^*/'%QX
M^A\.MHXMM'-U:*EO9V\+PW,[#RK0VTR/+^^9<_P;FXK"^&/[+WB3PM^SW\(;
M>+P1?:?K>G_'.3Q%JBQZ?Y=Q!:-=W^;N4@9V&.1,N>JN.QK1TX^U4>CDE?M>
M45_Y+=M][=.G+&;^K.JU[R5[=[0E+\6DEVOUV/T#HHHK$T"BBB@`HHHH`***
M*`"BBB@`HK)\>ZS_`,([X'UC4/L]W=_8;*:?R+7_`%\VU"=J?[1Q@>^*_':]
M^)/AR[MM2U#P3JWA&QM?&7P:\5WWB33?#U\]U?PW<4VG/$-5N-Y:6_C$TP.]
M5D3+CD$5/-=M=DW]T92_'E:OT+4&TGW:7WM+\+WMU/V?HK\=OVD]<^'=M\(-
M3_X4SJ6E/X-;X90O\0F\-W9>VCU#^T=.%N;MHF)6_*&Z!W$3E/O<;:Z7XXZ]
MX?M?B+>P_`>Z\-S_``.FBT'_`(6(^C7C'0893?-Y_P!IDM]P1FCVBZ_B\LGS
M>,UT.C:2C?=M>EFU=]D[:/S1$=:?M/*]NNT7;U][;R/UDHK\O]3\7^!?#?P_
M31YM;^%FK_!WQ9X\C33)8=3FC^'_`(:\NPDDEBGF8+;W,$DJXC@5O)\]E!PP
MQ6%^R'X+T']H;XY_!'PSXJ&F^,?">DR?$6WL[,*XTN6""]TU;=1`796A16/E
MH^Y5&TCH")ITW*5EVO\`=%2?SUMV>]Q77Y_^W6_+U78_5VLN'QGIEQXOGT%+
MI6U:VMEO);?8V5B9BJMG&WD@C&<\5\-_LOR^'/@9^VGI_AG0;SP9\1F\2:CK
M`?5M.E>#Q1X:`)E-OJD(;]Y;IA(8WD"[0(@J]#7'?\%4UDU#XQ?%:Q^U7UO#
M=>$_"$#-:W4EM*BR>)HD8I)&RNC%21N4@CL14PCS2I17V_PT?^7^7<;T<D^C
M7XR2_7;[S]*:XB[_`&DO`MCI=[?3>)M,CM-.UM/#=S*7.V'47=8UMCQ_K"[J
MN/5A7@W[-/PWT3X(?\%&?B=X3\)Z?#HGANX\':/JLNGP$^3+=O/=1O<,"26E
M=44,YRS8!))YKXY\=_#'X6>&-(^+W@R+3_"^@>/-6^.>F3WMA8,FGZU-I,FJ
M6;Q2_NBL_P!G9G)5P=NYC@YS54X\U2$/YDO_`$N,7^;?X^144N63>Z:7R<'+
M]$O73S/UVHK\O_C[X<D^"GQ(^-/@WPC9Z?HGPOL_%_@^\\0Z=)+)#I-G8W-I
M*;V2;;DQP2M%"9B/E(W%NK$_4/\`P3>ETG2?"7Q"NO#GB7P?J_P[_MH7&AP>
M&))9M$T:,6T?GPVD[*(WA\Q2^(28T9W7@@@1&SBYWT2O^$7KV7O:/K9[&=W=
M)=?^#^.FWF>XQ_'KP;-\:7^'2^(M-;QQ'IW]K-HP?_21:[@OFXQC;N91USR.
M*ZZOR=M/'WQ`MM1L_P!K)O`NWPZOQ`?6Y?$*ZQ$9)?!\J'2S&;7;OV",QW77
M&8E:M'P]\.M!T?\`9W\+_%#38I&\;3?'`VD.O-=RS745I-K$D,EO$[,?+MWC
M.&B3"-G)!/-.,;J*>^B?=-N*2MY<R3OUC*PYM*3BM=[=M%*^O_;MU;I*)^J-
M%?EG^SE\*M'\"_`3]E?QQI%K<1^-/$WC*YT_4-8DNI9[R[MI?MVZU,DC,1!E
M5Q$,(I`(4&L/X>_M5Z#H'[.'[*^AVNK:AXB\9>`;+7!XET#2)WDU6SN+72+W
MS+2;;DPW)9<*DF&)P0".:*D>2,F]XNWX7;]%I]_WW*-I<J^7S;2^;LS]4?'O
MCW1_A=X,U+Q%X@U"WTK1-'MVNKV\G)$=M$HRSMCL*QOBO\??!_P/^'D?BOQ5
MKEOI'A^62"&.\='D65YF"Q*JHK,S.S```$G-?DS=^)O#<7@3XN6?@?6/`<V@
M:]\"KG4]2LO"=XUY"M_'<JN;RX+MY]\J2%9)'"R9/S=J^UO^"DC:HG[%7PW.
MBI82:L/%GA3[(MZ[I;M)]K@QYA0%@OJ0":KV;]WSE%??.4'Z_#=#ARR:M_>_
M"$)KT^*S]#Z)^#W[1_@GX^?;5\)Z]!JDVF[3=6[0RVUS;AL[6:*54D"M@X8K
M@X.#Q7;U^5?[4GB3QGXA^.VN:E\2!X;\,^)--OM)T+7]$@FG71+WPB;F29M1
MEN2H>:V>8QQS90"$*RO\KY-779OAKI_C3X9_\))XL^'>I?`F\^(M^]K;Z==2
MGPGI</\`8C^9;K/(%MY+3SAO(4F!69E.,$"8QYHJ7?\`S7YI_)IQ>J,JC<)-
M;_\`#-_FOFFI+1GZO45^5?PJUGP3-\9;:#XF:AHJ_LIK?>(_^$-DURY1?"TL
MXEL?LP#R'R6C"&Z^R@G;G=Y?(6MK]E_X86?QW_:L^#.E>/M-F\2>&[;P1XQO
M-"L]:,DR2V*:YIJV$LD<A_>;8&4H7!P-I'(!K2E1<W%+[2;]+1E*S[2?+HNS
MO?H%27)S?W6EY.[2NGU6NK[Z'Z0>#?B+H?Q!EUA-%U*VU)M`U&32=1$)S]DN
MXU5GA;_:4.I/^\*VJ^+?^"9?@[X8?"+]HK]H7PSI6F>#?#OQ#_X3V^N3IUM!
M!;:J^DR6]I)!)L`$C6K,S%6QLW%N<YKQ7X@:QHHU#QE)/>VJ_M6)\68H_#L!
MG_XGW]D?VO;B%8(R?,_LPZ=N,NT>3@R%OFK*FN;V2_GC&7SERW2]'+Y6?8'=
M*HW]F<H_)<UF^R:COYI]3]/*\\^-?[5OP_\`V=];T?3/&'B!-)U+Q!'/-IUH
MMI<74]VD'EB5E2%';:GFQY)&!O%?GQ\,OA?HO@_X(?#/XD6%O/'XZN?C\=-?
M6Y+J6:[6SGUNYMYK1&=CLMWC)!B7"'KMR`:^COVO=!\6>(?^"E_P'A\&^)-)
M\+ZH/!_BMFN]1T5M5B:/S=)R@B6>`@GCYM_&.AJHTW)1?=M/Y4U/_P!N2^3T
M-I14:LZ3^RKW_P"WI1_]MO\`,^JO!WB_3_'WA:QUK2IGN--U*%9[>5X7A9T/
M0E'"LOT8`UI5^9?[5VHZ):>)_P!HY?'^IV#?'2SEM5^$&]_L^IRI_9=H;=M'
MB+%_FU`W/FB$L>HD)4"N;^(GPFTG5OV*/VXO'&M:7#-X^T[4=9LH]69V-UIZ
MG2K,21V[YS"I9FR(]N3@G)`JZ='G3<?Y>;[W%)=-5S6EV:ZF?*U*,7NY<OX-
MW]';W>_E8_5BL;Q_\0M%^%GA.\UWQ%J5KI.DV*AI[F=L(F3@#U))(``!))P*
M_-7XU?LO^!O"OC?]HBQL-$\BQ\-_"S2?$>FV_P!KG:*VU5A>`ZCM+D&\/D1_
MZ0<R?*?FY.?L'XT_M+^%_P!G?]A;0_'OQ`.FW]M#INF,@U2>*&&YOI5C$.^6
M4A(\RL"78@+R>U9U(\J>NUOQ<E]_NO[T9TZG/*,;;IO[E%_E)?<SOO"W[6/P
MY\8_#_5_%-CXLTW^P]`.W4KBX#VK6!Z@2QRJKINR-N5^;(QFM+X/?M!^#?CY
M8WEQX2UVWU<:>XCNHQ')#/;,1E=\4BJZY'()4`]LU\(>+X_#GQ0^&VH?%*T^
M(G@7XH:[?>-_#6K?$&'P9JL&J:=H6DV<C"&WVP.[%(=QE>23YGVNV`JA1ZQX
M*^*__"T/VX/&'Q$^#=KI'Q,\.0^#;'2+FZTG688].U*^^UR.%2[&Z)WBA)W`
M$D;@IP:J,$W9_P##6BI7\TV^5=+]65)V5UY/UO+EMZI>]WM:Z1[IXF_;;^&'
MA'XGWG@R]\3_`/%3:=+%!=V-OIUW=-:O*H:-9&BB9$+*0>2.#FO50=PKXP_9
M.T;QYKW[?/Q^U*Q\0:+X=T:/7-&?6-$N-&.H7,[G2H"R1W:W$:QX^[GRGZ9[
MXKI?^"BU[H%O\3_@]'\2;C3[7X,S:CJ'_"4-JTJQZ,TXM#]B6^9R(_),F_'F
M'87"9YQ4RCRQC?=I/[TGY]]-==-AW]Z5ME?\+_T^WF>X?';]I+P=^S;H5IJ'
MB[56L$U";R+2"&VENKF[<#)$<,2L[8')P,`<FMO4/BCX?TGQ1H.B76J6]OJ_
MBB*:;2K23*RWJQ(KRE1C^%64G.,9K\U/A5\)_"OQ:_:A^#,FI>'])\2>!;/Q
M[XN7P%-J=HMVHT>.WBD@^SM*"?LZ7(G,!!VB-8RGRA:]X_X*'>#?AMIW[<O[
M.?C+XE:9X0AT&P?6;%]9U^&!;6VN6@BDM(VFE&U7,B.8P2"7'R\FJY+*#E]K
M7S2M=)K^:^C7?0K=R2^RG\VFU=>6ET^JUT/K?P'\1]#^)VEW-]X?U.VU6UL[
MR:PFE@)*QSPN4EC/^TK`@U3^+7P>\/\`QP\+1:+XDLY+[3X;VWU!(UG>$B:"
M598FRA!X=0<9P<8.17YJZ7\-='\'_!G1?B1H=IY/CQOVA5L+?6/M$CW$=M<:
MPT,MO&68A()(V(:-0$;.2"<&N@_8=G_MCXS?#NZN/$G@?2?C-'K6HMXZL(+B
MYN/%&J0'SPT.HPA/W<*?NFB>8B-0J",_,`2C3<H1GL[KUORPE=>2YE=[JW4R
ME+275:_-<TXV^?+Z._0^^_B_^T9X*^`<=I_PEFO0:7)?;C;PB&6XGF"_>81Q
M*SE1D9;&!GDUTG@[QCI7Q!\,6.M:'J%KJNDZE$)K6[MI!)%.AZ%2*^8_B%\3
MO#7[.?\`P45UCQ5\3-<T?PKX8USP19Z=H&M:U<I9V$5Q'=3-<VPGD(C65P\+
M!,AG"<9Q7C/C7Q9\&?$OQH:\^(VDZ7X.^$EYX0>Z\"6/B*U32;&74GO+@W%Q
M:PMM7[;)F.2,KB8K(&4`L:RB_<4N]_E;FT]7RZ;;_,VE&TG'MR_._+KZ)NSW
MVWZ'Z*45^,.D_#.\\>?LW_M!>+/B!#K5UX]\*^'_``Q+I5[?7MRE]H[_`&<&
M*XC!8&&Z,93=*`)3R"W45WW[6'ACPW\%/''QD\+VJMH?@62T^'&M:E:QW$JQ
M/<7&I7T5W=.0V\R2QP1"1\Y<1@L2>:Z)4&G:_5+[[?Y_UN1-\L.?I:_GTV^;
M5OZ1^A/Q%_8M\!_%7Q^WB+6K76KB:XGM[J[L(]:NXM+U&6W*F&2XM%D$$S(4
M0@NA^Z/2O5Z_*SQ[\1_ACX<^(_B[2?!__"&W7[.^O:KH-M'?'5A;^`M-U3R[
MM[MIY(CY#Q%5@$D6X1O,R!\-FL;]D'P1H'Q__:N\$>#?$$VG^+/`^BWWCJWT
M_3[-Y8=%GM8Y-,,,2VXD*R6H\URD3EX\%2!PN%1HN;Y([)2E]R3?S>ENZU\A
M5I*&KUV7WWM]UK/L[KS/ULK'^('Q!T7X5^#M0\0>(=1MM)T;2XC-=74[;4B7
MI]222``.22`*_+S3_$VO?LL?LM:+\7?#?]IWD-C>^(?AA?64):816EQJ$R:3
M(%Y/^C70CC']V.Y?L!7O_P"WM^SWH_@[_@D-9^"=:TZRUF'0HM#@E2]B%PKS
M"]MA(Y#YY)9^?]HUG&//%2B]W%:_WO\`*+BW_BM?2YI9*IR2\_\`R73\7=+R
M5[:V/K;X1?%O1?CCX"L_$OAZ2\FTF^+B%KJSELY3L8J<QRJKCD'&1R.1Q735
M^8W[1^A_#KX=:A\>M%\3QZ3X=\::'H=I#\$].@*VMY;*-,!@&AQ#!\_[?Y@<
M6XW<*&^6O:?V$O@_IOC3]J[XO>+O&6BV>I>/O#^J:4D-[<`ROI4[:1")_LX8
MD1;F9PQ0`L#@Y%5&,9-\NR5_OLK>JO[RZ:;W,JDG!1OO)M>EE?7R=_=?6ST5
MCZJN_C)X7L=9\2:?-K5E'>^#[*/4=9A+'=IUO(KNDDG'"LL<A&/[IK6\)^*]
M.\=>&-/UK1[N'4-+U2W2ZM+F(Y2>)P&5Q[$$&O@#XP>%/AG\._V[_P!I:\UK
M3O!^B^./%7P[M+CPS/=P00:EJI^QZA'>-:,P#R,`$$NS)`V[N,5X]\2OAQ>_
M`/X$?!>^^$MEJ&F^+?&'PIU%-7N;.YN)+[5XX[>S<M))EI9'C1I3&>63HF.E
M9QUAS/R^]J;_`/;=^FNC-;;+N[?+W-?_`";Y^1^N%<K\7O@OX=^.GA[3]+\3
M6<E]9:9J]CKENB3O"4N[*X2YMWRA!(66-&VGAL8(()%?+?\`P3?@\-GXU>)+
MCX=>)/AS=>"Y=!M$O]'\&7$UY8VVI*[9GEEVB%+ID)$B9\TD`N.AK@?C7X0\
M0^&_VT+'X#:?'J$GA?XD>*HOBA!,';RK:WL$:YN[7=V#ZA%8_)T*W#=LUIR\
MM2%O5/JG%WNO1)S5OY>C>F?->$GV_%-;?-M1MY]M_P!#**_*#X->,8_#6GZ-
MXD76/#B_%?28-<N/B%HFAW=U+XQUZW\BYS!?HB9MPD@A>&64@+L`C/SX/G/C
MWQ-X=N?"WCC3/`^N>"?^$;\4?#6PO]4M/!-\[P)?+KMG$QN+I9,RWRQRLLDO
MRRC(W?PX*=-SFH+K]VTG]WNNS[]%UK3\4O/62CKYJZ=NW7>WZS^*_P!FKPOX
MY^+FD>--776-0U3076;3[:;5;AM-M9E5E6=;3?Y'G!78"39NP>M=]7@'Q^^%
M]Q\`O^"?WQ,L/@IH%OH?B1?#&HWFD6VE0;))-0:U;$J@<M,S`'<<LS8)R37P
M3\3;/PO?_LV?$3_A7/BSP./#=UX5T:VU_2O!FH7<SIJ!U>T`NKJ<!1#?,C2K
M(&83DX+=,U,8WE[./2WWN_W*ZM?6^FA,Y<M-59=?R3C_`/)7MY/Y_KK6'H_Q
M)T+Q!XYUKPS9ZG;7&O>'8;>?4K)"?-LX[@.868>CB-\?[IK\YOVF/`EK^SU\
M>/C%X7\#VEQX?\$W?A3P;J_B6TT^60*]O)J]_#J%VYR6,CVL8$LF=S*F6)QF
MO-O&.I_#^T_:1^)H^%-QX*D^"<VJ^"T\2RVMX1X96R^S:D7$LD6Z-;0R>5YF
MW]UG.[JU5&%U=>GXI7?E=Z/K;H5.\4[]$G]Z4K+SL]OS/U^KEM%^-?A3Q%X(
MU;Q)8ZY8W.A:%+=07]ZC'R[5[9F6=6XZH58'Z5^=&@3>%=,U[P=#XR\5>`]6
M_9@O/%>KRPB"=_\`A#],D^R6YM+3[1.%AEM5G^T-$03"'<(IRJ@>G_L8MHY_
MX)1_%X^'W630_P"TO&)L6#NRF'[1<[""_P`Q&,8)[5C5O&#DOY7+T?NZ/L]?
MFK-.S+A%.<8]Y*/R][5?^`_+8^H?@Q^V=\,?V@]5AL?"/BRSU2\NK?[7;0M!
M-:O=PX!,D(F1/-4`@DIN`!![UZA7YHV_QDT?]HK]G+]F+2_@KXA\/^-OB-X'
ML(=2NI-`OX;]O#T46B31R)=-$S"$R2/'$(Y,%F/`.TXXGX9W6L_\*BN=1^$O
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M<3332M]V-%!+,?8`$U3\%^,]+^(OA+3=>T.^AU+1]7MTN[.ZA.8[B)QE77V(
M.:_*?P+\/-*^'GP9^"_B328KBWU[4_&/BOPY<WSW<LLTFEQV6J^78;G8XMD\
MF(K$/D4H"`#S7.Z!X@TW2?V5?AK_`,,TW5I/\47^'%__`,)O'X=G,NI)&-.'
ME-?*I,BW"RX\CS!O[)\M3&THRDNEOQ4I:^5DKOIKN;2@XSC#NI/[I*-O5N]E
MUTU1^QU17M[#IMG-<7$L<%O;H9))';:L:@9))[`"OR0^,&E^%M5^!GBR/X>^
M*/`+>#]2C\*V>NZ-X(OKJ:-;Y_$%BK7%Q<*%6&\:-G212PG)Y;D9K]1/#WPW
M\(_`7X7WVFZ#X;L=*\.6<4US+INFV0*2Y!:3$2CYV;G/4L3W)JJD.6'.WU:^
MZWX:DP]ZUNO^2_'I_F9?PH_:R^'?QP\076E^%O%-CJNH6D)N6A$<D)DA!"F6
M,R*HEC!(!>,LHW#GD5>^'?[1?@'XR>,=>\.^%_%6A^(M8\+^6=5MK"Y6X-B7
M9PF\KE<EHW&`<@J0<8KY2^#/Q3\,?&+_`(*3^&-9\)^,-#^)F@R>$-3L;73M
M+BBA;X8Q[K1W@NDB)Q)=,BILN-LB?9\(@&\GO/@-X>TKP+_P4[^-%KIMC8Z3
MIUOX%\,R>3;0K#%'^_U0L=J@#U)IQBN52EI=-_<Y?HOOZZ:G27+K;E_%Q7Z^
M6VQ]0ZEJ5OHVG7%Y=S16UK:QM---*P5(D499F)X``!))KS_X6?M;?#GXU7NH
M6_AGQ58:A-IEO]LN%9)+?$'3SE\U5WQ?]-$RO(YY%6?$'QS\$:A^S9J/Q$O+
M^TO/AX=!FUNXO)X2L$^GB%I'=DD`.QHP3AAR#[U\,'QSX?\`V\OAI\0/&GA?
MX@_#G5/B'-\.=1T?PAX&\*>(;.^OM#TN8PR2FX2"1G:=S'`I`4)%P@Y8DY.Z
M<T_LIM]UI*U_5JWDKOI8TC"_+TYFE^*O]R=_N74^X/A;^UI\.?C3K]WI?AGQ
M9INJ:A9PM<O"`\1DA4[6EC,BJ)8P2`7C+*,CGD5H?"W]HOP+\;O$&OZ7X0\5
M:+XDOO"\D<.JQZ=<BX%D\F[8K,N5R=C="?NFOE/P]\0_!O[1W[0/[-=G\,]0
MT?6Y/`=G?_\`"4PZ=*DQ\/6+Z9]G-E>JN?)D>=H@(9,,3$QV_*37;_LVZ'!X
M*_;X_:4M/#VE6-NMIHWA<VEC`JVT+/\`9+PJORC"@M@$XXSFMZE-1N^R?SL[
M7]&OQZ]^>,FTGU=OE?2SVU6_I;0^@5^,?A.]^*\W@%=<TV7Q=#IPU6;2!)NN
M$M"^P2LO92W'/6NBU+4K?1M.GO+N:.WM;6-I9I9&VI&BC)8GL`!G-?G1^QYX
M;^(_@7_@J;;W?Q$\%VNG^+?%'@2\U'Q%JD.O17D1)OE*")0H(@B4)"B=0!N/
M);/UO^T;XC\,_'O]ASX@7UG]EU[PYJWAK4D'GVS>3<A(I5.4D4$C<IY(P<9&
M1@UA6O"@JJWLV^UU*2_0Z*<%*O[+I>*^]1?ZD_A7]O#X5^,?#=]K-KXH\O2=
M/%T\E[<V-S;P/';1++-*CO&`\:QL&WKE3V)KU;1M8M?$.D6NH6,R7-G?1+/!
M*GW948!E8>Q!!K\HOVA/`.A_"[]C3X%Z;X;TC3=!T^\^$?BN\GMM/MUMXIIW
MT6!GD94`!=FY+'DFIOB+,=7\8>++3Q1XB\#^$_&$6A>&A\*]1UVZN1JEJ@TZ
MW<R:3!$I:=S>><LR0Y9E"JXVXKKG1BIN'9V_%IV\]+I=K]CFIU'**EW3?_I+
M7_I6K[GZB?$7XDZ%\)/"5QKWB34[;1]'M9(8I;JX)$:/+*D,8./[TCHH]V%;
ME?D_^V_J7@N[T;XV+\3+K11\9(O'>@)X3BNY]FI'1OMNEF,V:9WFU+^>9-HV
M;OO\XK]8!TKF2]U2[_JD_O5[/LU8TO[SC_6[7W::=PHHHI#"BBB@`HHHH`**
M**`"BBB@`KD?CU\([7X]?!GQ-X+O+NXL+7Q-I\NGRW$*AI(5D7:64'@D>]:'
MQ2TO4-;^&GB"STF]GTW5+K3KB*SNX3B2VF,;!'7W#8(^E?F/:_\`!0?XG:Q+
M+K\/B:__`+,\1>'%^'FFVJL`B>+(HK25[F,X_P!:S/>(1_TP7BB,/:-T_+\[
M_JE'UDNEVGS<MI7MKWMM;]+OTB_(_0#XU_L\Z)\;/V;IOA?=Z[)96<D-GI[7
M4)C:X5K=HI%&T\;F$:Y'HV:].TZ2%8OL\4T<K6@6)P&!9#@8##L<8/XU^6GB
MOP->^._VJ+C3=6\5>)[-M%^/]GIGVK3;_P"PR2;O"FG,7=D`W.7W89LD;R.G
M%=#\5CXF^%VJ?MC?$CPWXZ\4:-?>"/&&CWEC8VDZ+9W;KI>EA_M(VDS+(C%2
MI.!U&#S6_*Y:M[I2_P#`E2?_`+D_#STSBU&+@EI%:+YRC;_R0_2Z:\AMI(DD
MECC>9MD:LP!D."<#U.`3QV%$%W%<O(L<D<C0MLD"L"4;K@^A]J^0_P#@I'\/
M4\>_M*?LH>;KGB318Y/'MY`TFE:BUG@G0=2<'*_Q$H%SW5V7O7A_Q`G\3?"K
M3_VH/B/X<\<>)M)O?"?Q&M)+/3[6=$L;DF&P23[0NW,P='((8X&,C!J*=/FD
MH][_`(2A'_VZ_P`AU)<O+;[5OQ4W_P"V?C]_Z85&UY"ERL+2QK-("RQEAN8#
MJ0.O%?`OP&^.?Q:^*?B70_'D#>+"U_\`$&^T#5+"]UG3+?P_!ID5U-;B&&V:
MX$_VE%C1\^7O<EN"I%>V_%H_9?\`@I[\(I9/W<<WA+788V;@.^^V;:/4X!./
M05,8-N*?6_RM'F_R7W]B9U$DVM;6_&7+^&K]#Z-M[R&[,@BECD,3;'",&V-Z
M'T/M3;F_@LWC6::&)I20@=PI<@9.,]<`$_05^;&D>(/%#_M`VOA_PWXNUSPC
MIOC_`/:#UG3M3N]*9!)?6D7AVXG:(,ZL,>;;J-P&5*Y!!%8_CWQCXH\1^.M!
M\#:IXJ\0ZQ:^'_B1XO\`#EKJ-S.'U1K1/#5U-&IGV[MZLV`PP2``<TI1:AS=
M>3G_``BVOODE]YT<MI\C[M?^E_\`R#^]'ZA6]Q'=P+)%(DD<@W*Z'<K#U!IS
M,$4LQ"JHR2>U?FE^SYK/B3PK\%/V9?AKH6L?$[4=%\9>$KO7[^YTG7;6/4C-
M!#;K':Q7%U+$(X5WL_EJV?D/&,UU7@/XB_$KX[S_`/"'_$+Q=K'A&;POX`OM
M6>;2-5M=VNS1WMQ;)<3RP-)"X\B*)Y(E8H'E8'IBGB8^RYK:\O-Y7Y5*_P#Z
M2U]QCAY>TC"3TYN7SMS-)?FC[^74K=K#[4+B$VI3S!,''EE?7=TQ[U'I&NV/
MB"W,UA>6M]"IVE[>59%!],J2*^-_@?\`"2'XZ_\`!$KX6^%)O%%OX1.K>#=!
M6'4KD!K?S4^SR1Q3+N7S(I601.@8%UD901FO,_'GQWU3]F'2/$WP[TGX::#\
M.?B)=:KX;@U:_P#A_<0C2[_3;^\EMEN[<3"%+6X_=2J4F`*ET/F.,$:U:+A7
ME06K4N5>;O;_`(=;VUV"$N:DJO2UWY+^M%TOIU1^CU%?G[I/CSXI3?M':-\&
M];\0>-/#?@O7=?G:RUBZUZQN/$@@CTQ)S82W%K+-Y;>?O=68AVC8#H,UZ9X"
M^*FK>#_VN?#?A-OB1>>+O"MO\/\`4[R6_NYX=MW<P7XC\R1D`5I(DS&S=]I)
MY)K%JR3[IM?*+D_3:WKY:E1UOY6_&2BO7>_IYGUL3@57MM7M;QXUANK>5IE+
MH$D#%U!`)&.H!(&?>OSE_83^)OCK]K#X@Z5'X@^)GC-M+L?AO:^(?(L+Y88]
M0NWU2_C\V5E7+J8X44J#M8=<\5S?[#/A*3QY^U/^S9KNH>(O$EG._P`,?%,Y
MAM+\VMK,T.MZ>!&8U`4JP?+K_%L0GI6\<.W+EE_>_"-1_C[-KY_(S]I[CDO+
M\>7])'ZA6MY#?0^9#+'-&20&1@RD@X/(]",5POQ5^`5G\5?BA\//%%QJ%U:W
M'P[U&XU&V@C12EVTUM);E7)Y`"R$C'<5^?O[.WQ=\>?$2T\,^`]/N_'-GI\.
MC^)O$"S^%K[3]-GGNT\0W5O&9'N)H5:*)`"R+G=O!;BO1)/C1\7/`-AX-^)7
MQ2OM8?PA)H^@#5_^$+UVSE3PWJ#N([F2[M02EW:SR.A#P/(RJ3A#C=65./-:
M6VJM]\E^<7^'5V')IJ2?1:_<G;[I)_>??E%?/G[<7C>Z.N?#_P`$Z+K'BZS\
M0>+[ZZF@L/#UW%I]QJ$%M;EY3+>R?\>\,9>-V*!I'(50I!-?+G[,OQ9^)?[5
M/Q3^$'A77/B1XLT&QO/!GBRXUC^Q;Y%FU.>PUBRM+>1KCRPV]4D;YT"ELG(P
M2*BG[\N5;^\_E&+D_P#TEKU+E[L>9^7XNR_S]#])7=8D9F8*JC)).`!5:ZUV
MQLM+^W37EK#9;0_VAY56+!Z'<3C!R,<]Z_-?X&?&SQQ^U?\`"^;1?%WQ`\2Z
M+!X:^&%[K`N[*Z2UDU^Z%_J%FTUPV,2+'%:Q;EP%+39/:M[XW:=)JW_!!7X'
MVD.FZ9K4ES9_#F)+#4I/+L[\MJ&E`13,(Y-L;YVL1&^%).QNATIT^>]G]J$5
M_P!ORG&_R<-NM^@2]V:@^TF_E&$K?-37H?H/HWB33O$<;MI^H65^L9PYMYUE
M"GWVDXJ[7R;\;O#>I?LY?L-^,/$6G>'/A[\#?%FDRQ:I##X'N?MEEJ4L,J&&
MVE?[#9M+]H/[DIY.<2<,37D'[._QD\;_`+3_`(F^'OA[Q%\1O%'AF+QCH'B'
MQCK+:;=_8[G2]0M[VUMUTA'9<I':)*Y=",N1D\9J8QYI.,>G_P`BY>FREZ-)
M.W,@>D5)]7;\4OS:^]M:)GZ&I>0RW,D*RQM-$`SQA@60'."1U&<'\JDK\R?B
M7I6N0_%[]I[Q=X>^*GBA;[P7\)?#^KV6K:3/#"-9N;>VU.6*XF*H0ZDIR@PC
M!CQTK4^*7[7'C75I-.^('A;Q)XKN8]"\6>$/#^LI)J$-CH4$E_/81W=I'9@/
M)=.T=V6,C^6$+#:S;2*TC1<JBIK>\5Z<SY4_2_W:=78)74.>VFOX1C)K[I:=
M[/HKGZ145^<'B'XI?$?2OAM\2OB<OQ,\927O@_XPQ:#I>C^?&NF+I[ZE:6SV
MTD03,JE)GP6)*G&"*K>+OC[X]3X/>!?BY#X^\7#Q%KOQ,;1+[PU#>JFFK:QW
M-Q']A%MCA@L2;FSN).2>:S2VOUY?ES*+7_I2OZ/RO7*[R2Z77W<U_P#TE_>O
M.WZ453U;Q#8:"L;7U]9V0E.U#/,L>\^@W$9KXE_8:^*?Q2\;Z]\)/%E_=>*]
M0TGXD:1<7OB0:WK6F-8+*8A)$^G6T=PTT:H^49!&,+RP!S78KX`\,?'3]OCX
MN:7\3M)T?7=/\.^']*?0++6(DGM[:UD68W%S$D@*J_F#!D7YEVCD54Z<HOE=
MKJ]_EH_Z[:]"(2C*/,MM+>=VK?G_`%<^M%<.H92&5N01WI:_/G3OB`_B?0_C
M!)X-^)WB/1/"?P1T"SD\&"SU7S(-0C-HT_VFY9\M=1M(/*`<X`C('-<#XW^/
M?Q8\?>!?C;X_7XC>,?"NH>"Y/",FD:-921)8V$M[I]C+<AXV0F16:=SL<E0>
M<9HC3<G9>3^4G9?/NNA<8M_C]ZM?\UKU/U$HK\T/BE\3?B5X/_;&C^$FG_%3
MQO'HM_XJ\+L]_+<QRW\<5_8ZB]U`CE,+$S6J,J@?(2=N.*T_"/Q"^(G@>\L]
M6D^)_C;6H_#_`,=HOA[#9:A=))!=Z3-(J,EQA`9I!YN5D8[AL7WR_8RNEW:7
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M^U_IM_JVN?$/QAX5%G\(-+\3"RT*5+*.749!<DW6=I8*_E(WE@[2&`(-547)
MS7^S?[ESZ_\`DCT]/.Q*+4^3KHOF^6W_`*4OQ\K_`*25P/[1WP"L_P!H_P``
MVN@7U_=:;#:ZM8ZL)8$5F9[6=)E3#<88H`>^#7SWXN_:/\8Z_P#L`?`?7/[;
MFT?6/BA?>&]+US7+9522QBO54SS(3PCN1L#?PM*".E>5_&CXL_$/P/\`&#4O
MA/H/Q)\6_P!CZ;\0_"NG0>('GCNM2A@U"WF>ZT^25U(D*^4DF6&X+<J.PK7Z
MO+VWL^L9\O\`V\G#7T7,G]_71X^TBZ=WLXN3]&I?B^5K[F?HL.!56WUNSN[!
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MJ,.G:'IDLFU_)>+#RWTLD3J=K*J*"`'#$BO:/&?QF^(%IIW[47CZ'QSXL$_P
M[\6V>C:!I<=RHTS2H+C2M*>65XMO[P(UW++AR0I7/<UT^Q?O1CLKOMUA%/Y\
MT?*RWM8B/-+EE):RLOP;:^6OG?I<_0JXO(;0Q^=+''YK!$WL%WL>@'J?:I*_
M/_\`;#^%=QX=3X5>';/XO>*]>O-0^)'AVYQJ%W!?7VC;XKK,L;LN0LH!P&!"
MXRN*]W_8>\2:];_$KXS>"]6\1:UXFT_P3XC@MM+NM7G^T7D<,UI%,T;28!8!
MV;&>0#BLU&Z?E?\`#DO^,_P*J-0Y/[R3^]R_^1_'YGOL?B/3Y=6:P6_LVOE&
M3;"=3,!Z[<Y_2C_A(=/_`+6^P?;K/[=C=]G\Y?.QZ[<Y_2OCM/@?X=^.O[1V
MGS_"[PS9Z)9^`O%9U?Q-\074?;]9NXRQDTFVEYEFC+,%F9V$2*-BAFSL\?B\
M*Z:?V"+#XGBSM?\`A=\GQ`42ZN$']KF_.MF&2R,F/,\H0Y3RL[`@SCO2I1Y^
M5/2[2^]I)KRU?GHGM)!/2]NGYI2;3\U97[7[IGZ85X[\.?@9;:+^T=JOC77_
M`!LOBSQ4]@^E:;:M#!;?V+8M+YS1+&A)9F8)ND;DA%]*]8TK5K?5H)/(N+>X
M:W<PS^5('\J08W(V.C#/(/(KXQE^">A_&;]H*QU/X4^&+'1;/X=>)KG6/$/C
MQE']HZ_?(DP?2K>7_630F20"5G;RT";$4MRDJ7+-/R>O9:)O[GZN_*K\U@>M
M-_EW:NTO6Z7DMWHC[,B\0Z?/JC6*7UF]]&-S6ZS*95'J5SG]*F;4+=+U;9IH
M1<.I=8BXWLHZD#KCWK\W?#?A/1M(_8K^$?Q*TNVMQ\8]4\>Z>EWK$:`:MJ%S
M-J9BO+2:7'F/&(3(IC8E55`<#&:]L\7?![0?A[_P5N^&6MZ;;W`U3Q1X9\1W
M&H7$]U+.TA5K$(JAV(1%R<*H`&35.-I<K[R3]5%2T\G<GF]WF79-?.3CK]WZ
M=#ZKD\7Z3%J_]GMJFG+J!(46QN4$V3R!LSG]*T:^"I_#G_#-GQIUKXL:IH/P
M9\>V/C7XJQZ8MW9Z<USXFTDW,L&G6^R[<8#P;$\R!4&T>81(<8/WA;WT-W)*
ML,T4K0-LD".&,;=<'T/L:(J].-3OOY.T6U\N9:[%2TFX=OQ5VK_.S\R6BBBI
M`****`"BBB@`HHHH`****`"BBB@`J.\LXM0M);>>-989T,<B,,JZD8((]"*D
MHH>NC#;5%?2=*M=!TNVL;*WAM+.SB6""")`D<,:@*JJ!P````!T`JQ110VWJ
MP225D%%%%`#98EGB:-U#(X*LI'!!ZU7T/0[/PSH]MI^GVL%E8V<8B@@A0)'$
M@X"J!P`*M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%``>:\\M_V2_A
ME:6%C:Q^!/"\=MI>O-XHM(UL(PMMJK%BUZHQQ,=[_..?F->AT4+1W7]=?S5P
MOI;^MK?DVO1G`^,/V6/ASX_TS7+/6O!?AW4K7Q)J2:QJB3V:M]NO4BCB2X?N
M9%CBC0-U`0#M5F7]G#P'/X;\0:/)X1T%]+\5M$^LVK6BF/4VBCCBC,P_C*QQ
M1J,]`BCM7:T4[M;?U:UONLON0;[G+_%;X+>$_CGX:BT?QAX?TOQ%I<%PEW%;
MWT`E2*9,[)%S]UADX(YY-4Y?V<_`D_AC6=%D\)Z$^D^(ITNM3M&M%,5_*@14
M>0?Q,!'&`3_<'I7:44HMK;^MO\E]R#>U^FW]?-G`VW[+?PYL_BA_PFL7@OP_
M'XJW;_[3%HOG[L8W9_O8_BZ^]:/Q;^!'@WX\Z1;V'C+PWI/B*TM9/-A2]@$G
MDMTRIZJ?H:ZVBCI8-G='&:#^SMX%\+Z?X9M=/\)Z'9V_@VZ>^T1(K15&ESO%
M)"\L7]UVCED0MU(=AWI8_P!GGP-%XECUA?">A+JL.ISZRET+1?-6]FA,$UP&
MQ_K'A)1FZE3BNRHIN3;N_P"OZL@\OZZ_YO[V>4O^PS\'W\)3Z#_PKKPJ-'N+
MUM0>T6R58_M##!D`'W21QQBM'Q7^R-\,?'&AZ+INK>!?#-]I_AR(P:9;R62>
M791GJB`#A3W'0]Z]%HI;Z/\`JVGY!_7W[G*M\#_![_">'P(WAO1V\&VUI'80
MZ,;5?L<4"`!(UCQ@*N!@#I@5B^%_V2?AGX+\#:IX9TOP/X<L]!UL`7]DEFIC
MO,=-^<EL9.,GC/&*]$HHDVVV^N_GZAM:W3;R/,H_V,OA3#\.6\(KX!\,KX<D
MN?MC6(LU\MI\8\PGKNP`,YSCCI4OB#]D#X7>*M*\/V.H>`_#%U9^%%*:1"]B
MFW3U/++&,<`GDCH3US7I%%&^_P#5@.-^'O[/'@7X33+)X9\)Z#H,B:>FDJ;*
MT2';:([R+`-H_P!6'DD8+T!<^M9M[^R7\,]0L?#-M-X'\.-!X,EDGT)!9JHT
MIW8,YAQ]W<P!('!(%>B457,WK_7]:A9)67]=/RT/-?$G['7PL\7^%]/T74O`
M7AF[TG29YKFSMGLE\NWDFD:65EQTWR,S-V)))JWJW[*WPWUW7M-U.\\$^'9[
M[1T@CLI6LT_T=8/]2JC&,)_",<=J[^BI6FWK\P_X8Y'XM?`;P;\>+"QM?&/A
MO2?$4.FS_:;1;V`2&VDQ@LAZJ2.#CJ*@\"_LX>`_ACJ6FWGA[PCH.C76CVMS
M8V4MI:+&UK!<RI-/&A`X622-'8#JR@]J[6BA:;?U=6?X:>@/7?\`KK^9YCK_
M`.Q;\)_%.@Z3I>H?#WPK=:?H8F6PMWL4\NU69B\JJ/[KLS$CH22:VO$_[.?@
M3QG\'+;X>ZKX3T.^\#V<%M:V^B2VJM9016Q0P(L?0",QH5Q]TH,=*[2BCI;I
MN%W>YYAX8_8N^%/@[1FT[3?`?AVUL&O[?5#;BVW1FZMVW038;(WHW*GL>:F\
M5?L>?"WQO8W5MJW@/PS?0WVI2:Q.LEDO[V\D"B2<X_C8*H8]\#.:])HH_K\O
M\E]R[!MM_6_^;^]]SC(OV=O`D%GK=O'X2T&.W\2:7%HFJ1K9HJW]C$CI';2#
M&&C5))%"G@!SZU@:G^Q%\(M:\2KK%U\._"<^IJ;9A</8(6W6Q1K=O3=&8XRI
MZC8OI7J5%5S._-U#IR]/^&_R7W(X^X_9^\$W7AS4M'D\*Z&^EZQJ8UJ]M3:J
M8KJ]$B2BX=<8,@D1&W'G*@U\Z^(_^">FJ?$7]I31?$VN:+\+K'3]!\3+XF.O
M:/!<0ZWJQBW&"WF@9#$F"PWS+,Q?;]Q<\?75%*,G&:FMUM\K6^ZR^ZVP2UBX
MO9[_`#O?[[O\]S@_`O[+_P`//AEXXO/$OA_P;X?T?7M0W>??6MHL<S[CEL'^
M')ZXQFIOBO\`LV^`_CG=V=QXO\)Z)XAN-/\`^/>6\M@[Q#.<!NN,]NE=M12[
M+MMY!W??<\\\9?LF?#/XA:MI5]K7@;PSJ-UHD206,DUBA-M&GW$'&-J]@>!6
MGJO[/W@C7(/$$5YX5T.XC\62V\^LK):*5U)X%1(6E&/F*+&@7/0*/2NPHIW?
M]?>!QNI_L\>!=:\=KXHN_">A7'B*.:VN%U&2T5KA9+9)$@;?C.8UEE"GL)&]
M:>WP!\$O"T;>%]%,<FN+XE93:KAM34@K>=/]<"H._KP*Z^BCF?\`7R?YI/Y+
ML)I/1_UNOR;7S9YQJ_[(/POU[2;6QO/`OAN:SL7GD@A-FH2-IW,DV`/[[DLP
MZ$G-6],_9>^'>B^,H_$%IX-\/V^M0MOCNX[15>-M@3<O8':`,@9Q7>44AO7<
M\RU_]C'X4^*/#6AZ-J'P_P#"]SI?AM#%I=LUB@CL4+;BB`=%+<E>A/:NIMO@
M]X5LM3OKR'P_I,-UJ6G1Z1=2);*K3V<88)`V!S&H9@%Z#)KI**-]PZW.7O/@
MKX1U'X71>"9_#ND3>$;>U2RBTAK93:1PH`$14Z`+@8QTP*R?#/[+'PY\&^'=
M/TG2_!?AVRTW2]236+2".S4+!>(,)<#OY@'`8\@5WU%5S._-U_IATMT,?0OA
M_H?ACQ#K>K:=I5C9ZEXDECGU2YAB"RZA)'&L2-(W5BL:JH)Z``5SFC_LP?#O
MP_?:%=6/@OPY:W'AFTNK'298[%%?3H+DYN(HCC*K(3E@.M=W14_U^GY:`>1Z
MC^P7\&-5DMVN/AGX/E^RVB6$0.G)M6!/N1XQ@JO;/2NXTOX.>%=$M_$4-KX>
MTF"'Q;-]HUI%MEVZI)Y,=OOF&/G/DQ1ID_PHH[5TE%%W:W?_`(</,\W\(_L@
M?"_P':6\&C^`_#.GQVNHQ:M"(K)08[N(,(Y@>N]`S!3VW'%=AH'@#1/"VM:Q
MJ6FZ78V-_P"()EN-2N(8@LE](J!%>0C[Q"@*">PK8HHN_P"OE_DON0?U^?\`
MF_O9Y'X9_8,^#?@SQI'XBTGX=>&=-UJ.];45N[>V\N07#,7:7@XW%B23CDFN
M@'[+OP['Q1_X3;_A#?#_`/PE9?S/[3^R+Y^_^_G^]_M=?>N\HH3M:W38'K>_
M7<Y_X=?##1_A7I-]9Z-;-!%J>I7>KW3.YD>>YN9FFE=F/)RSG`[*`!P!7!^$
M?V#?@YX!\:1>(M%^'7AG2]:AO7U&.[MK;RW6Y=R[R\'&YF8L3CDDUZY10M&F
MN@2U33ZZOSO_`,.S@](_9>^'>@?$V7QE9>#?#]KXIF9G?4H[11.6;JV>S'N1
MS72:AX`T35O&FF^(KG2[&?7M'@FM;*_>(&>UBFV^:B-U"OL3('7:*V**.B78
M.MSS]/V5?AO'\4_^$V7P5X='BSS?/_M3[(OVCS<8\S/]_P#VNOO77:#X-TKP
MM>ZE<Z=I]K9W&L7'VN^DB0*UU-M"[W]6VJ!GT`K2HH6BL@W=PHHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`(
MS<HK=>AP?:O*_P!K+]MGX;?L3_#F;Q)\0O$NG:/;A&-K9O<Q)>:G(%9A#;QR
M.OF2L%;"@\X-=-\8?B_X:^"'@V\\0>+-:TW0-%M,F6[OYUBC7"EL`D\L0O"]
M37X>_!OX@_'K]J;_`(*'_%CXVZ%^S['^T%X3;6SI_P`/]9\3:B^E:?H.FQS.
MT$MK`Z'<'C*/Y@4G._\`O&@#]B/V`_V\O"'_``49^`,?Q&\$Z9XHTG19+^;3
MQ;^(+*.SO!)%MW$HDD@VG<,'=SZ"O;*\^_9F_P"$G/P@T>;QIH'AWPOXINX3
M<:AI>A3O/8VCN[$*LCQQLS;=N[Y``V0"1@GT'</6@`HI-XQU%(LJOG:RG'7!
MZ4`1RWBQ3&/:[-MW<#K[?6@WJ"55Y8L<<?P]>3[<8^M<O\;?BAHWP/\`AEX@
M\:>(K^/3-!\*Z?-JFH7+GY8H(4+N?7MT')Z`$FN:_9"^*VL?'G]G/P?XVU[0
M9?"VI^+-/35FTN5PTEK'+EXE8CC<8FC8CL21VH`]3HJ*>]AM;=I9)8XXXU+L
MS-A5`ZDGTI;.\AU"VCF@DCFAE4.CHVY6!Z$'TH`'NDCW;CMV]2::]_&B;N3]
M/\_A^-?G;_P6*_X*L?'+_@G-XEUC4/"OP,M?&7PYTO1[;4+KQ1/JYMX[::2;
MR#'Y85B2'>(>_F>U>B^#OVWO&/[/'_!'^/X[?'N..W\96?AO^V+RTL+5(W:6
MY8"S@6([5$CL\"X)'S-@F@#[+L=4M]2,@@FCE,+;)`K!BC>AQT/M5BOE?_@C
MI\+_`!;\._V']!U?XAR3-X^^(5S/XP\0>=(7>.YO6\T1GL-D7EI@<#;7U.'!
M[B@!:*3>OJ*19E8\,IYQU_&@!U!.*3>N>HK`^*GQ*T7X._#37O%7B34H=(T'
MP[83:A?WLOW+:&-"[N1WP!T')Z"@#<-RH')Q['M3?MJ'U+8W$=Q]:XS1_C1X
M9\1?!.T^(D.J6Z^$-0T1/$,>H3?+&+!X!<"8^B^6=W/3%<Q^T-^U[X!_9=_9
MW_X6?XSUE=.\&XM2EZL+R>;]I*I#M106)9I%XQ0!Z\DRR8QGFG5\U?L>_P#!
M5?X'?MN>/[SPM\/?&L&I>)-/M_M5SIEQ;RVMT%_V5D4;@!R=N<#FOI6@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_#
M'_@HO^U+HNL_\%K1X7^,7ASQ%\0-&\)Z%*WPZ\"Z>Q6S\0:S)?;(GN1T.$0D
M,QV@QC@@D'[6T+3_`-NJ/X9_V]8-^SOX1DL+(C3O!\FBWSV\4/)BCEN5OE0.
MJX!9551C[M>&^'?^"=7@K_@IO_P4&_:0OOC!?>,]/\??#3Q)#8^!IK6]N-.D
MTC16$TEK>6S@CS`UT+L?*<*8!ZBO8/"__!#WQ5;WJV_BK]KC]I+QAX8DWQW>
MBS>*;RVBOK=U*M!)(LY9E*G!!!R..AH`Y/X<_P#!=N;XO_L-6^IZ+H6FV?[0
MWB#76^'VD>&I=[6%UXB1O*>52'W?88S^]9]^0N1N)&:\D_X)D?\`!4#X@_`7
M_@G=XBTWX@66J?$3XYVGQ)U7PEH6G?:%D;Q/?_:09/*9<?N(6W[FX&!@8K[;
M^!/_``1Q_9]_9P^/UO\`$KPKX'M['Q1868L=-!?-GI"F(1.]I`1LMY'&\O(@
M!9II222[9X?]A/\`X(;?#7]B/XJ^,/&MEJ^O>(_$GB!]073+K4Y,GPQ;WC^9
M-%:C)VON8YE7#')!ZF@#XLO/^#G+XF>!/"Q\/^)O!/@AOB)X1^(,/ASQYJNG
M0W3^%]'TV25(TFC<SE_.;]Z@R[*&A+;2&Q7;^)_^"\5U\=?^"B_A72_A9XHT
M^'X=Z#XBT[P_-H-Q`8K_`,>QW_F"XU&%WP%MK/R]P(`W8)R00!]P_`3_`()#
M?`;X#?LZZQ\-?^$#T#Q5H?B2ZCU#7Y==L8;^XUZZCD,D<MRTBL961B2I<DJ6
M..M<%^U[_P`$$O@'^V=\:/"GBSQ5H5UI\/A'0!X<M-,T.3^S;=;2-W>%!Y6!
M&(O,<``8P:`/R#_:T^#?BO\`;D_X+!>&/@?IOQN^(GQ!\#>,/$,FA^)==:[B
MM[-$MEDN;BRM@D2Q-)#:PNA=D=3+C(.,']UOV.?V%_!'[!WP]U+2_`MUXCUN
M_EMX[>>XUW6Y+V:X>)2(E.<)&3O`^5%'/3`KQ_\`:2_X)$0B+X/7W[/NKZ7\
M(O$'P;ENHM/:'2TDM+J"ZMV@N&EB`"O*Y.XR,"68EB2>:^E/V5?V<+?]F#X;
MR:$NN:UXJU.^N7U#5-;UFZ:YOM3NI`H:1V8L0O&%7.$7"C@"@#\1/VJO^"[/
M[6GBGQUXQ_9S\<_`^U\.:_\`$"8Z'H$7AZ*>VUAX))0I,<LLTL4DKPJVQU0*
M"0Q4CBOVE_X)\6OC:P_9GT6W\<>&+/P7>6J+;Z7HD5VUY<:=IT<:1VZ74Q)$
MER54EV4*N2!M!!)\3_;._P""<WBS]J?_`(*6?L\?%U?$FGV7@CX)O<7LVD&)
MA<W=Y*P)D##Y2I6.W'/0*WK7VI9]&'S=N"<XX_S^E`'YF_\`!QU\4-&T?_AF
MKP/XVO+73?A7XV^)]C-XVN[@RK#]@LFCF,$K(1B.3>P;OPI!!6O@7_@LE_P7
M/\.?M,?M+_#WP_:^&]:U[]G?P-,WBFZMH89+.3QCJ-JL@MUD9L_Z`MP(U^Z-
MP9R&!V%?UY_X*\?M$_"OX)?`NST_XA>`-%^+^N>)=0BM?"'@:\TF/59M=U,D
M*GEPNC@>6KLQ?'`!&<D`_'7_``2+_897]L+PC^TM??M":+X>O_$'B*]_X5V-
M.TWR9;'PMI=O"LG]GV+)E(ECF=<B+`WV\9ZH,`'D7P`_X+F_M$_L]?%#5KSX
MC>&F^*VA^*?!EMXRDT'P[9_9S\.Y9VFDM[`R%G'EFS196#[G'FK\P"D'ZITO
M_@NC-I'[.'[/*>((_"G_``O#X]WVG36GAW3F=K/2-)OKUC%<W&9"P9+#83\X
MS-OX"_+7T]^S!_P3>^'W[)G[*VJ?"GP[9R7&GZ]97-IJVK7`#:EJ_G1-$7FF
M^\Q2-A&FYCL5448``KY@L?\`@V.^!NE_LR1^"X=0U:+QA'J%I>/X\EC277H8
MK<E4MH)B=]O!Y!2(HCA<1@XH`G_;5_X.`M!_9H^,&GV^A^%]2\8?#'PYKXT#
MQ[XPM;9Y+/1+EUE5+>`AAYTJS)\V,C:C+U(8<[^RA_P<+Z3XDU?X\ZE\<=#M
M/A/X7^'-SIUUX9M[F.1=4U>SO()Y8$>,NV^=U@:0!0@`=5(R#GZL^(7_``2T
M^%OC/X%?"[X6V^AV5A\/?AGXDL?$2:'':H;?6)+2.<1I<C&)`\TBRRE@?-(.
M[.XFO"_^"JO_``0W_9O_`&M;7Q;\3_'-U<?#WQ`+2&\U'Q5:S"&&TAM/G:22
M)BL9+0JR%F.?F7OM%`'@_P#P3E_X*\?M!?\`!1;_`(*\W&BP:+I_AGX(6'AJ
M34FTN2U9[A;)V8VEW(_F9%U*2N!PHCZID$U[U_P<F_')?A__`,$V]2\'P:II
MFG:E\6M;T[P=#/>R%8[:.>='EE)!X"*FYB<X5C7PS_P2(_9P\2?M1_%/XS7_
M`.RKX[UKX0?`>^N--\,ZQK]VCW7B77;JTMII7N;:5RK1-NN]WW@55XQU&*^^
M/CA_P0*\#?M+^&/ASH/Q$^(GQ,\=:'X)NKK4M3@UW6I[^?Q)>7%M%;^?+/*[
M/&46)=BKD*"0,4`4?^"U7Q8\/_LK_P#!&;6O"W@F^TZUL=>L]*^&WA]('\^,
M6]PT-M)"#N_Y\4F`8G@@&NW_`."N'B;_`(5E_P`$A/B5#X=T.W\<7FB^'8-)
MMK.,QSBW=O*MUN<=`8A()O7"'':N&^)G_!NQ\&?B+\"_`GPPAU?QKIO@'P;X
MBN/$=WI@U*69M:GE@$($DC-N39M4KCD?-C&37;^"O^"-7A?X1?L7>)O@_P"&
M_%WBAE\8ZO:ZUJFLZI<M?7$\EO-;.J8D8X5H[9(L`]&)ZT`>#?\`!(7_`()^
M_$#Q=^U/X9_:,^*'@_2OA:?!O@[_`(0_PCX5L$_TN:`J5>]U"0LQ>=_,E!QM
MR!&0``0?U4J.W"F)2`.G6I*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@#/A\+:?;ZO-?QV=M'>72A)IUB422J"2H9L9
M(!+$#.`6/J:N+;*,]]W6I**`(6LHR^['S#H?2A-/CC'`Y[G/6IJ*`(_LJYZ<
M=`/2D^QH$*C(4@C&:EHH`C-JI]>I/YT&V!/4^X]:DHH`A>Q5P!\V/3_/X_G3
M91]DB(C^\1GIGH,?X58K/\11S3:;,MNYCN!$QB;`.U\?*<'CK0!^=OAW]I;1
M_C5\6?VE/VFM=T=;SP3^S;9:KX7\'37*JQEGT^)YM3N8.2NZ2:-(T;))55(P
M6(KU3_@@_P#!_5_AU_P3=\%ZMXG:23Q5\2)KOQOJ\D@`9KC4IC<G\"K*1Z`X
MK\R_!WQ0L]5_X-A_`/PP\)6N_P`4?%3XCQ?#K4K4LRS)>SZT]PP`)RV8UMXC
MU&)#FOWI\">!=/\`AOX3TO0](MUM=*T6TBL;.`$L(88D"1H,^B@#\*`-,V2%
M-O/M[4&S4GJ=N,8[=O\`"IJ*`*]Q:K#$S*OS;<8S][C`_P`*^._^"CGPZA_;
M'^-_PM^`=]?_`&?P;>1WOCGQY9"<PMJ.D:?Y4,%H[#GRYKRZB9AD;DM7YX(/
MV1>?\>LGS%?E(R.HK\K_`/@H?K/Q>;_@I9JW@WP;X?N;BZ^.'PZM/!7AW7TB
M/V?PU:_;II=4NYWZ;HD?**<DM+%P5S0![%_P0,\$:>O[/WQ8\9Z386NE>&_B
M/\5]=UO1-/@C\M+.SA\C3HU';:?L)<$<%7%?=BV:(?ER!C`'I7%_LT?`_1_V
M:O@3X7\!>'UD31?"FG0Z=:!SN8I&@&2?4G+'W)KNJ`(S:J6SZT-;*W7IZ5)1
M0`*NT8'2BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"HYHO-(]*DHH`_+BX_P""&/B3
MP;_P5F\#_$?P[?Z?<?`^#Q;>_$?5=!N&56TG7I+9T0P)GYT,YCE!"C:R#K7Z
MCT44`%%%%`$=PGF1;<9Y'X<CG\*IG25,R2&&%I(]RQL0-R!L;L'T.!D>U:%%
M`$=LC1!E;H&^4Y^]P/ZYJ2BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HKYY^(_P`0?&7QD_:ZU;X4
M^$_%UW\/]/\`!_A>S\1:MJUCI]I>7UY->W%Q%;01BZBEB2)5LYFD/EEF+H%9
M,$GS_7OVB?C]\-?VI?"?P[_LWP?XZU2;P!J&M:E&M]_8VG3W,%_%%%<M,;>:
M:,O"V#$D;*'8_P`(#4XJ]KZ7N_E%2;?W1?X=-1RBTVNUO_)N6W_I2_X?0^QJ
M*^-?&_\`P5=OM&_9L\*_%#2?`NBR:)K7A`^+[ZWU?Q5]@NXT1"TMI9QQVTS7
M,R[6P7$,9^7+KGCI)_VYO'WQ+^(_C3P]\.?A[X;OK'PGH.G:TVLZYXJDT\2K
M?6C7"*D$=E<$NF!D,0I!^]GY2JB<%*_V;W\K7_R=NCL.,6[>?_`_^25^NI]3
M45\3_!C_`(*)>/\`3OV6/A!J'C;0_`-Q\1/BJ\T>EB3Q4^GZ5+#!`9I;FZN&
ML1]G(`V^7%#+DLF&Y.W7\#?\%._$'QL\8^#?#O@/X>Z#K&K^(+/6Y=4DO_%I
MM+'1[C2KU+2XB6:.TF:=69BR2*@R-I(4,2-)4VI.':_X*[^26[Z;/70SIRYX
M*:V>O]>;Z+KNM#[!HKY"^%'_``5>TWQ[XD\+W&I:/X:TWP?X[DU"+P_?6GBE
M+[5'-I'-+NNK+R$\A98H)'0K+(<`!@A.*K_#;]N+XD?%W]I#X"*WAO1_"WPW
M^+&EZUJ]KY6JC4+W4;:&TAFM#<(UM&;63#[]L4DJD-@MD8J>5O\`KUW[/1V6
M^A4M-'_7]=]C[%HKY0_X*1_M/?$#X6:WX7\*_"FZM8?%/V#4/&6LK+:)=%M&
MTY4,L(5@0K3RRQQ*PP1\Q!R*Z'6?VX]<\;^(/#^C_"?P9I7CK5-5\)0^,[G^
MT/$!TB""RF;9$D;K;S^9/(P<*K!$^0[G6ICJKKO;[KZ^GNR7K%^5R2L[/M^J
M5O7WH_\`@2/HZBOG7PE^V=XR^(WCK6E\/_#.UNO!WA'6(]"\1ZA<^(A!J5A<
M^5%+<&*U$#1316XE`=C<(Q*MM5L#/)VO_!3#6K'P=X5\::Q\.[*P^'_Q$DN;
M?PMJ,/B$SWUQ-':W-S`+NV-LJ6Z3I;/L:.:8@LH91FB6BN_+\=5]_P!GOTN.
M,7)V7]6W^ZVO;K8^MJ*^1OC+_P`%2I/A-\#_`(<^,D\"?VF_Q`\)ZCXG%B-9
M\HV9M+6*X%N',)#[_-V[R%QC.#G`X[]J?_@I%\5_AO\`!;XA1P^`/#OA#QA;
M?#:Z\>>&KIO$AU)(XH=JR+<I]C")/&9%944RQOT,B\XOV<N9PZJ_X7O_`.DO
M[A4VIM)=;?BTO_;E]Y]U45\D?'+_`(*!>//V:OA7I^M^)O`O@6:ZL_#C^(=9
M1/&TD8FCC!9HK!38>9<3>6-Q$D<$:E@OF=Z;XX_X*3>+(?$'Q'7PC\+=/U[0
M/AKH>G>(K[4]0\4?V<;NVNK7[48XHEM9F\]4Z*V$;O(IXI2C;F_N[^73]&%.
M\TI+JKK\/_DE]Y]<T5\+_!G_`(*-?%#4]._:`\8ZSX/T/7O!?@/4[0:#::=J
MTIU***XTVPN4BDC%D`8P+EI9)2[NAW(J.JAC]1?LQ?'*?]H'X>/KTL7A<1_:
M7AAF\/Z]_;-E.@`Y$IAA=7!)5HWC4JRGJ,$U*E*._9/TNDU?SU_RTU)4DU=;
M7:7G8]&HHHK,H****`"BBB@`HHHH`****`"BBB@`HJAXI\1VO@_PSJ&K7S^7
M9Z7;27<[?W412S'\@:\&^"_[1/Q8^)VE>$?&TG@SPY)\.O&06X2&TO'76-&L
MI(V>*[G\PB.52`FZ.,;QY@QNP10M?E;T5[V^^S^X'HK_`-:;_P!>G5GT117S
M/XH_X*4Z-9>&O%1M_"?B[1=:TWPKJ?BG0(_$5I%:V_B."R3,C1B.9YHP"8\K
M/'%)M?(4\X;XE_X*;^'_``)\-FUR\\(^,_$DF@^$K7Q;XK_X1NUM[B#PW;S6
MQN%\TSSQ,Y*JY"Q"1L+E@HYHZ<S_`*O?_P"1=^UM2_9RNDNK:7JN7_Y)6[WT
M/IJBO!]?_P""@WA7PSXJTFTO/#OC:#0M5O-.TW_A))+"&/2K6[OS&+6!RTPG
M8N\L2%XH9(U9P&<<XS?^'DWAJ;2?'&KV_@?XE77AKX=WMYI^M:W'IMJ+.*>U
M<)*L8:Y$L@`);<D94!6!(8;:KDE^?X6O?[U]Z[HRC).UNMK>=[VMWV?W/LSZ
M*HK@O"7[1WAOQU\9+KP3I+7=]J5CX?L_$L]S'&K6<=K=R2QVX+[L^8_DR,%V
MXVKG/2N>_:%^/NN^"_B/X1\!>#--TW4/&'C)+JYAFU-I%L--M;95,DTHC^=L
MLZ*JJ1DD\C%+E=TK:N_X7O\`=9_<5=?E^*37WW5O4]>HKP6Y_:P\6?"CPW';
M^//AKX@U'Q4]W<Q0V_A(075K?VL"*[7HDN)XD@CPV/+FD$A8$*KUC7/_``5#
M\$:AJ]EI_AGPQ\1/&U]?^%(_&<<6AZ1'(J:>\TL),DDTT<<<B/"X*.X+8PF\
MY`6F_P#6S?Y)W[6=]F-1;_KS2_-I>=U;<^DZ*^>?%O\`P4J\$^&?!ND^)K?0
M?&^M^%;_`$6V\0WFMV.GQ+8Z+93L522X:::,LPVL6C@661`,LH!!//\`[6G_
M``4QL_@;X4\5W'A+PCX@\97'A&[TVQU+4X88_P"QM.N+R:W58)I/-$V\0W"R
M9CB=%W+N9<U7*T^5K6]OG>WYZ>NA',K7\K_+?\M?34^IJ*\5N?VY_#FG?&O3
M?!M]X=\::=;ZSK+>'=/\0W5C%%I-[J2PO-]F0F7[0<K&X$A@$3,NT2$D`^U5
M/3FZ?U^C3]&GU*>CY7O_`,.OS37JFMTPHHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`/'_BU^S-K&N_&6/XB>`_%T'@KQ
M?-I"Z!J<EWHXU:QU2R25IH0\/FPL)8G>4I(L@`$SAE<8QF_#?]BH>`OC'H?C
M2Z\:>(/$FI:5X4O/#4\FJ_OYKYKF[2Z>X,A;Y`&7:L2J$52`,!0*]RHHB[*R
M\_\`R9-/[U)_??<<G=W?E^%K?=9?)6V/B[2/^"1MUX/^%P\)Z#\3/LMCJ'@0
M>`=7FOO#B7L\MJ%F7SK0F=1:R$3-N!$JM@<`C->T_`S]C>S^#'BGQ7J3:Y<:
MJ/%FB:5HLT1MA"(4L;3[-O!#')<'=C^'ID]:]HHIMWYK_:W\]6_SD_O&Y-RY
MGO\`_L__`",?N/E/P_\`\$W]8\,^`O!>FV_Q"T^XU7X6WEP_@V^N_"ZS165G
M/$T4MK>0_:0+O<K#YU:$@QH0,@Y[CX<?L8S>$?C!X5\;:QXNF\0:QX?T74])
MN5_LF"RAO3>W$4[.J186)(_*"*F'8KC<[-EC[I13YFW=^?XJS^]-W[O7?4F*
M25HZ?\/?_ANVVQ\X_!?]@:X^#OV+P]#XQM;KX:Z*MW%IN@+X=@BOEAG\P"">
M_+LTL42RLJ;(XGP%#.^#FC\&?^">^L?"WXH_"[5+SXCMK/AKX.Z?J&D^&M&&
M@I;RK:W,"0*MQ<^<QE>)(U4,J(&`Y7/S'Z<HI*37]>N_=ZNS>JNPEKO_`%_E
MZ'@/C#_@G+\._C'^T3XJ^(GQ(T/0?B)=ZUI]EI&DV6M:3%<0^'K.`2,\4.\M
MDS2RL[MA2<(.0H-<3\,O^"9&J?L_:5I\?PY^)TWAF]T_3;OPY%<7&@I?+#HT
MEY+=6MK&AF3;+:>:T<4Q+#:!NC;I7UI12CIHOZW7ZO[WW8V[ZOR_"UONLON7
M9'SQX8_8>USP!XOU+_A'_B9JFG^$?$NK0ZYXATV33(Y]0U6[6.*.;%X7`BBN
M!$IE00DDEMK)GC"T'_@FL1I7A7POK_CFXUSX<?#^:XN/#&A)I*VMS:22V]Q;
M1_:+L2M]H6&*YE$8$4>#M+%RHKZDHH>JL_ZMHONZ?R]+"C=:K^M[_??7OUN?
M%GB'_@DEK'COP?X7T'Q!\7;J^TGP3X>U+PSHUM;>&X;98K:[ACB$DI\UGDG1
M8U&X,J,/X%/->G_'/_@GOHOQ]U*Z;5]>OH;*^^'M]\/IX((%5C#<F,FY5R>'
M7RQA<$'/6OH2BJYI-WOKKZZIIZ]_>>N^OH*"4)<T=_\`)I_G%?=ZGR#XH_X)
MJ>-/&UGXD75/BYIMQ=>-/"G_``A^MW(\&KN^QB*2)&M`UVPMI"LAWD^8KGD*
MG&.XT3]@"ST?PY\3M/\`^$GN9/\`A9?ARP\/32?8E7["MK8_9!*HW_.6'S[3
MC!XR>M?0U%2]5)/[6C\U=O\`-O[QQ]UIKIM_Y+_\C'[CYM^$G["7B+X`:SXI
M;P7\2DTO3?%MO92W=O=>'([R5-0M;&"R%PDC3!?)>*VCW0E"<YVR+FN\_9K_
M`&8Q\!-?\;:Y=:K9ZIKGCW48M0U$Z?IO]F6$9B@6!!%;"23:Q507<N2[<\``
M#U:BM)5)2?-)ZVM\M-/P7R26Q*BDE%;+_AOZ^_<****S*"BBB@`HHHH`****
M`"BBB@`HHHH`R_&OA6W\=>#M6T2\W?9-8LY;*;'79(A1OT-?.WPN^!OQZ\!?
M"_PW\-[;7/`.@^&_"-F-/@\36=Q<7NK:K;1PO%!&UC);)#;,/W1:1;B8GRSA
M5W9'T[7F_P`1/VG]`^%WQQT'P/JT=U;S:[X>U7Q)_:!V_9+.VT][59O,.=VX
M_:D(PI&$;)'&3O'^;?\`[=3=_DN9_?>Y4>9VMT_6R_'3\+'R+;?\$S/BEX@:
MWFU:W^&>GZI9^!?$/A2ZU:#Q!J&HWOB&[U""-([VX:6RC,2[T):)6D"!CM9N
ME<7^UGX)U_\`9;^!?QN\.Z1KWPWUB_\`&7PNL]*UG2=1UJYLM3M+N#2Y+)'T
M^%;63[<)^%6,M"0P!)YQ7W1\2_VO?`WPV^&R^))-7AU&&]T"\\2:7;6IS-J]
MI:P>?*T.[`/R%3\Q'WA638_'[X1?$SPC=>--8D\-K)X+T>V\0:G+JEM&]UX;
MMY[8722.Q4E/W>3E"1\IYXJFFU*+VVEZ7E]VKEMHK6TL71FX2A.*NTVX^ON?
M/91\W?K=GS#XA_X)T?%KXA:?;V^H+\/]6C_X23PUXBL-<U;6[Y=2T6ST^XL9
MY=-BLEM'AC.+>4"59\L9,,HR6'T-\`?@1#^SC\(OB18?$+4_#:Z+XM\4ZOJ\
MDINBMLEG?2DI'*TJH%?:V"!D9/!->E_%?XTV/PK^&#^*?[-USQ!:LD;6]KH]
MDUU=76\93:@Q@'J2V`!UQ7FA_;$\%_%']CW0/B)J7A?4+_1_&DD-II_AR_M8
M)[N]NI9S#%;%&8Q;S(.I;:,9)&*TJ5)RC.%M&[-6ZRY5;U?(EW?75W>%-**A
MKM9I_P"%/7T]YOLNFBT\2_X)4_#GQKX"\%W'B"T6#Q%IOC;Q==62:O?@I+:^
M%]-B:TTSRP&!9I/++@\@^>6QS7T#^T5\#/%6O?%[P7\2/`;:!<^)_!L%Y8/I
M>MW<ME9:M:7(3>AN8H9WA=6C5@PAD!Y!7G(ZSX"_$J\\>Z'?6NH>!=<^']YH
M4ZVC:;J`MV388U=&ADMW>%X\''R-\I!!`(J_\9/BA<?"KPQ#>6/AO7/%FHWE
MTEG::;I:)YLTC9P6>1ECC0`$EW8*/6IJS?,GU5K/=[)?-M;]VV.,4[JVCOIT
MW;^273LDCYQ^*G[,GQV^*_C'0=>\17'PW\56$27T=SX,N=:O=/TC2S.(EAF2
MXCLY'OWA59!MGAB5O-R-F!5/]B__`()[>-/V==4$^MZAX3EC'PQ@\%A--GG9
M5NTO[ZY+@/"F(-ES&`?O95AMP`3WX_X**:*FC-:3>$O$T?C[_A(QX4B\'AK9
M[^?4#;FZV+*LIM]@MU>4R>9M55.3GBM_PA^VMI?B/P/XLOKKPMXML/$/@>^C
MTW6?#26JWFI6\\B(\040LR2*Z.K!U8K@GD8-1M3<>EOP::WZZ3WU>JUV*BW?
MS=OPDG\M8;:+1];GR9XI_P""5OQ@U/X`WG@.:;X9^*K>\\`6?A:PFU;7M0MX
M/"MY"DHFEM[9+*1+A9F=&\US%(FS`##BNV^,G_!/SXM:AX!^)O@KP?-\.[CP
M]\4M<TOQ'=:AK&KWEO>:5<6_V!;B&.&.SD69'6R!1S*A4M@H1R/;_#G[>V@^
M)OV+%^-4/A[Q##I<VY(M&F$,>HR3"[-HL/+^6&:4`#+X`/)%>C_!WX@>(OB#
MH]Q<>(O`NK>!9HG"Q6]_J%E>/<*1G<#:RR*`.F&(-:RJ3<I2??7SU4K?>D]-
M=KZ;Y*"4(VVV7R27Y::Z:Z'RC=?L`_%'7_CAX9UO6O\`A7^K1^&?B4OC+_A)
MKG6[V76+O3@+A4L$M#:>3;^4DRJ-D[*_E\A2<U]O445C'W8>S6U[_.T8_E%?
MGU-)>]/VCWM;Y7E+\Y/\MD@HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`*VLWDVG:3=7%O:R
M7L\,3/';HP5IV`R$!/`)Z9/%?)/C[X:>,_VN?C]/XI_X0O7O!&E^'/ASX@\+
M6RZ\8$FU._U-[0CRUADD`AC6TY=B"3(..#7U_14N-_N:_P#`HN+_``;-(5'!
MIQWNG]S3_-'YL>)O@?\`%KXJ_#KX=Z`GPJ\2Z/\`\(/\+O$?AB\N+ZYM%%QJ
M,VFQV\,<2I*Q:.1E.USCW`J]^U7^S;K]G??L_P#AJQACL;CXL:7I7@/QW8,P
M\R2QL5BO)6P,AMJ0SP,<XVW'6OT9KB=._9V\'Z;\8;KQ\NESS>*KJ,P_;+G4
M+FY2V4JJL((9)&B@W!%#&)$+8YS71&L_:*;[W?FTY.UNSYVGY6,7']VX+SMY
M745?U7(FO/R.JUNT:;P_>00I\S6[QH@XY*D`5\/W7[&WBS6O^"<_P=\-ZMX9
MU&\UCX?^);37M6\.P7P@N+^WBN9S)`KHX4L8Y=P4N`V,$C-?=E%9)M;=XOYQ
M=U^.XVDU9[6:^4E9_@?(O[,UEX@_9^\8>,M6TOX=^)O"_P`._%VJZ/IOAKP9
M*8Q-I=QMD2^OO+CDDCMK=@828U;!,+-@%SGUC]MKQ_\`$+P)\)+=?AMX<UC7
M-<U;48;&>XTR"WN+C1;5LF:[2&:2-)711A5+8W,I((!%>Q443?,K/R^Y6T_#
M\?)#C[KNOZ>NOY?-7=[L^)K#X%W7A>#X7>.O!7PX^($=W\-_%5[JGB#3_$;6
MQ\0>*!?:?/:SWJR"=DEG5Y(V`9T&U650H"BO7?V2_AYXBE^,/Q<^)6O:+?>&
M5^(EYIZ:=I%\8_MEO;6=H(0\PC9T61W9S@,<*%YKWRBG*7->_56]-MONT[7:
MVM:8QMK]_GJWK]^KZV7G?X^^$'[..L:#_P`$TM+\$^,OAS<>*KRUU.XN[_PU
M_:7V6:>+^U);A&22.0!F"E'"%P&^Z>XKKOV&_ACK7@KXE_$'4[/PGJWP[^&N
ML"R_L+PMJ+1+):72+(+J=(8I)(X$D)C^16P2I;`).?I.BB,N6_G_`,#_`"7]
M6M4M?Z\[_+Y=-.K"BBBI`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
;`****`"BBB@`HHHH`****`"BBB@`HHHH`__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
